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Hereditary spastic paraplegias (HSPs) are genetically inherited neurological diseases characterised by 
the distal axonal degeneration of corticospinal neurons. Of the 80 genes currently associated with 
HSP, mutations in SPAST, encoding the protein spastin, are by far the most common cause of 
pathology. Spastin functions as a microtubule remodelling enzyme by using energy derived from ATP 
hydrolysis by its ATPase domain. The location of this activity is governed by spastin’s localisation 
domains which mediate recruitment to membrane sites including endosomes and the ER. In this thesis 
I aimed to elucidate the function of spastin at these sites, as well as to analyse the resulting effects on 
the cell surface proteome. Through this work, I have shown that spastin functions to mediate the 
fission of endosomal recycling tubule and have confirmed spastin’s localisation to ER exit sites, but 
show using synchronised secretion assays that spastin is dispensable for generalised cargo secretion 
of at least 2 classes of secretory cargo. Finally, through quantitative cell surface proteomics, I show 
that mutation of spastin’s ATPase domain induces substantial remodelling of the cell surface 
proteome, and through this have generated a list of pathological candidates whose change in surface 
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Chapter 1 - Introduction 
 
1.1 – Overview 
In this thesis I examine the function of the hereditary spastic paraplegia (HSP) protein spastin in the 
processes of endosomal tubule fission and ER exit, and the consequences of the expression of an 
ATPase-defective spastin on the cell surface proteome. By way of an introduction to these topics, this 
introduction will describe the following: 
1. Hereditary spastic paraplegia – The history and clinical features of HSP (1.2.1), an overview of 
the functions of HSP-associated genes (1.2.2), and the relative prevalence of pathogenic 
mutations in each HSP gene relative to the total HSP cases reported (1.2.3). 
2. Spastin – The history and clinical features of spastin-associated HSP (1.3.1), the isoforms of 
spastin (1.3.2), spastin’s functional domains (1.3.3), the mutational distribution in the spastin-
encoding gene SPAST (1.3.4), and the cell biological functions of spastin (1.3.5). 
3. Endocytic sorting – The identity of the sorting endosome (1.4.1), sorting endosome input 
pathways (1.4.2), cargo sorting within the sorting endosome (1.4.3), the mechanisms of 
endosomal recycling tubule formation (1.4.4), and a brief introduction to endosomal tubule 
fission (1.4.5). 
4. Membrane scission – Passive membrane remodelling (1.5.1), and energy-dependent 
membrane remodelling including the function of cytoskeletal elements (1.5.2) and specific 
fission machineries (1.5.3). 
  




1.2 – Hereditary Spastic Paraplegia 
1.2.1 – History and clinical features of hereditary spastic paraplegias 
The first description of hereditary spastic paraplegia (HSP) was by German physician Ernst Adolf von 
Strümpell in 1880. Upon neurological examination of a patient, he observed degeneration of the 
lateral corticospinal tract, fasciculus gracilis, and spinocerebellar tract. These descriptions were 
further developed by Maurice Lorrain. However, the rarity of the disease and the heterogeneity of 
pathologies presented resulted in an almost 100 year wait for HSPs to be methodologically clinically 
classified. In 1983, Anita Harding of the University of London defined the term hereditary spastic 
paraplegia (HSP), differentiating the disease from the phenotypically similar hereditary ataxias 
(Harding 1983). Harding introduced the classification of HSPs as being either pure or complex, and 
provided a description of the genetic inheritance patterns of each described subtype of the disease. 
 The clinical classification of HSPs into pure and complex subtypes remains in use today. HSPs 
are described as being monogenic disorders characterised by a dysfunction of the longer motor tracts 
of the spinal cord, resulting in progressive weakness and spasticity of the lower limbs (Faber et al. 
2017; Klebe et al. 2015). Pure forms of HSP display only pyramidal dysfunction in association with 
sphincter disturbances and potentially some deep sensory loss (de Souza et al. 2017). However 
complex forms of HSP display these symptoms with additional neurological or non-neurological 
features. These may include cerebellar dysfunction, cognitive impairment, psychiatric disturbances, 
myopathy, epilepsy, hypomyelination, and non-neurological pathologies such as ophthalmological 
abnormalities, dysmorphia, skin changes, and orthopaedic abnormalities (de Souza et al. 2017). The 
age of onset of the disease can range from infancy to more than 70 years old depending on which 
gene is mutated to cause the HSP, and the nature of the specific mutation (de Souza et al. 2017). 
 
HSPs have been associated with all types of genetic inheritance. In total 80 genes have been associated 
with HSPs (Table 1; de Souza et al. 2017). In addition, there are 15 genomic regions that have been 
associated with HSP-causing mutations with the causative gene having not been identified (Klebe et 
al. 2015). In total, 51 genes show autosomal recessive inheritance, 18 genes autosomal dominant, 2 
genes autosomal but have no stated inheritance pattern, 3 show X-linked, and 4 are mitochondrially 
inherited. In addition, 2 genes can present both autosomal dominant and autosomal recessive 
inheritance (Klebe et al. 2015; de Souza et al. 2017). Autosomal recessive and X-linked HSPs typically 
present with complex HSP phenotypes, with only 2/51 autosomal recessive and no X-linked HSPs 
classified as pure HSPs. Conversely, autosomal dominant HSPs present as mainly pure HSPs (12/18). 




Mitochondrially inherited HSPs may present as either pure or complex depending on the severity of 
the phenotype dependent on heteroplasmy rate and the tissue affected (Klebe et al. 2015).  
 Despite HSPs being described in many different countries, it is difficult to accurately determine 
their global prevalence. One problem is that detailed analyses of HSP prevalence have been mainly 
performed in Europe, creating a substantial geographic bias (Ruano et al. 2014). Furthermore, these 
studies may not necessarily have had the same criteria for patient inclusion, may not have been 
performed in low prevalence regions, may be skewed by small geographic regions of isolated 
populations or consanguinity, and sufferers from poor or rural communities may not present for 
medical care (Klebe et al. 2015). Acknowledging these biases, from a global meta-analysis performed 
by Ruano et al. (2014), the mean global prevalence of both autosomal recessive and autosomal 
dominant HSP was 1.8/100,000. However, there was substantial variation depending on survey 
country. For autosomal recessive HSP, the highest reported prevalence was 5.3/100,000 in Tunisia 
(Boukhris et al. 2009), and the lowest was 0 from 115,270 in the Valle d’Aosta region in Italy (Leone et 
al. 2009). For autosomal dominant HSPs, the highest reported prevalence was 5.5/100,000 in Norway 
(Erichsen et al. 2007), and the lowest was 0.5/100,000 in Tunisia (Boukhris et al. 2009). 
 The overlap between HSP pathologies and other neurodegenerative diseases make HSP 
diagnosis challenging (Klebe et al. 2015). Examples of other diseases presenting similar pathologies 
include hereditary ataxias, amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS), and 
Charcot-Marie-Tooth disease (CMT). To appropriately diagnose HSP a range of tools are used by 
clinicians. Familial cases of HSP can by identified by family history. However, for sporadic HSPs 
techniques such as magnetic resonance imaging (MRI) of the head and spinal cord, a lumbar puncture, 
and electrophysiological examinations of the upper and lower limbs are typically performed to exclude 
alternative diagnoses (Klebe et al. 2015). Furthermore, the presence of urinary urgency or 
incontinence is often symptomatic of pure HSP phenotypes (Fourtassi et al. 2012). It is also important 
to rule out neurological metabolic disorders such as Krabbe disease and GM1/GM2 gangliosides. This 
can be performed by blood and serum metabolomics and analysis of specific enzyme abundance and 
activity (Wang et al. 2011). More recently, 1st line molecular genetic sequencing of HSP gene panels, 
whole exomes, or genomes, has been used to identify common mutations in known HSP genes 
(Hensiek et al. 2015). 
  




1.2.2 – Hereditary Spastic Paraplegia associated genes 
One of the most distinctive features of HSP is the heterogeneity of protein functions encoded by HSP 
genes. Despite the presentation of similar HSP disease phenotypes, these functions range from lipid 
metabolism, mitochondrial function, endocytic and autophagosomal pathways, secretion, regulation 
of endoplasmic reticulum (ER) morphology, microtubule-dependent trafficking, protein folding and 
modification, ion and solute transport, cell-cell contact formation, immunity, nucleotide processing, 
and regulation of axon myelination (Table 1). The function and a disease and functional reference for 
of each gene is presented in Table 1, and a brief introduction to each of these major functional themes 
is provided below.  






















































































































































Neural cell adhesion molecule
L1




Myelin proteolipid protein PLP1 SPG2 X P/C  Cell surface protein that functio ns in the myelin sheath to













Spastin SPAST SPG4 AD P     
ATPase mediating microtubule severing in abscission,
nuclear membrane reformation. Also functions in fission








CYP7B1 SPG5 AR P/C 





e et al. 2011
NIPA1 NIPA1 SPG6 AD P  Inhibitor of BMP signalling by promoting BMPRII





Paraplegin SPG7 SPG7 AR P/C 
Mitochondrial protein that functio ns as an AAA
metalloprotease and part of the mitochondrial






Strumpellin KIAA0196 SPG8 AD P  Part of the WASH complex that interacts with retromer to









ALDH18A1 SPG9 AD C  Mitochondrial enzyme that catalyses the reduction of





Kinesin heavy chain isoform 5A
(KIF5A)
KIF5A SPG10 AD P    
Neuron specific microtubule plus end directed motor with






























































































































































Spatacsin SPG11 SPG11 AR C 
Endosomal protein that functions with AP5 to mediate
















Spastizin ZFYVE26 SPG15 AR C 
Endosomal protein that functions with AP5 to mediate
endocytic traffic. Also functions in autophagosome-











Erlin 2 ERLIN2 SPG18 AR C    
ER protein part of Erlin1/Erlin2 complex that mediates ER-
associated degradation of inositol 1,4,5-trisphosph ate
receptors (IP3Rs). Functio ns in lipogenesis. Also functions







Spartin SPG20 SPG20 AR C   
Mediates lipid droplet biogenesis and endocytic
trafficking of epidermal growth factor (EGF). Functio ns as
an inhibi tor of bone morphogenic signalling. Also



















B4GALNT1 SPG26 AR C   Catalyses the transfer of N-acetylgalactosamine in



























































































































































Phospholipase DDHD1 DDHD1 SPG28 AR P/C  Functio ns in the synthesis of arachidonic acid-containing





Kinesin-like protein KIF1A KIF1A SPG30 AR P/C  
Microtubule plus end directed motor that functions in the






REEP1 REEP1 SPG31 AD P   
ER shaping protein shaping highly curved ER tubules. Also












Neuropathy target esterase PNPLA6 SPG39 AR C  
ER protein that functions as a phospholip ase that






Acetyl coenzyme A transporter
1
SLC33A1 SPG42 AD P  ER protein mediating the import of Acetyl-CoA into the





Protein C19orf12 C19ORF12 SPG43 AR C  ER and mitochondrial protein that potentially functions in





Connexin 47 GJC2 SPG44 AR C 
Cell membrane proteins that function in gap junction
formation allowing cytoplasmic exchange of ions and








GBA2 SPG46 AR C 
Cell surface enzyme functio ning in lipid metabolism in the
non-lysosomal conversion of glucosylceramide to free




















TECPR2 SPG49 AR C   ER localised protein that functions in the formation of













































































































































































Vacuolar protein sorting 37
homolog A
VPS37A SPG53 AR C 
Cytosolic protein that forms part of the ESCRT-I complex







Phospholipase DDHD2 DDHD2 SPG54 AR C  Functions as a neuron specific triglyceride lipase. Also






Probable peptide chain release
factor C12orf65, mitochondrial
C12ORF65 SPG55 AR C  
Mitochondrial protein that functions as a codon






Cytochrome P450 2U1 CYP2U1 SPG56 AR P/C  
Mitochondrial and ER protein that functio ns in the






TRK Fused Gene 1 TFG SPG57 AR C 
ER protein that functions at ERES to regulate ER-Golgi-






Kinesin-like protein KIF1C KIF1 C SPG58 AR P/C  
Microtubule plus end directed motor that localises at the








USP8 SPG59 AR C 
Cytosolic deubiquitin ates that interacts with ESCRT-III
proteins on endosomes to regulate the stability and








WDR48 SPG60 AR C
Recruits UPS12 deubiquitin ase to remove ubiquitin chains
from PHLPP1 that functions in the phosphatid ylinositol 3-







protein 6-interacting protein 1






Erlin 1 ERLIN1 SPG62 AR P  
ER protein part of Erlin1/Erlin2 complex that mediates ER-




























































































































































AMP deaminase 2 AMPD2 SPG63 AR C  Cell surface enzyme that functio ns in purine nucleotide







ENTPD1 SPG64 AR C  
Cell surface enzyme that catalyses the phosphohydrolysis








NT5C2 SPG65 AR P/C 
Cytosolic nucleotidase that functions in the homeostasis






Arylsulfatase I ARSI SPG66 AR C  Lysosomal enzymes that catalyses the hydrolysis of





GPI inositol-deacylase PGAP1 SPG67 AR C  
ER localises protein that catalyses the removal of an acyl








FLRT1 SPG68 AR C 
Cell surface protein that functions as a guidance factor for
vascular and neural development by promoting cell





Rab3 GTPase-activati ng protein
non-catalytic subunit
RAB3GAP2 SPG69 AR C  
Part of the RAB3GAP1/RAB3GAP2 complex that functions
as a Rab18 GEF and a Rab3 GAP. This regulates synaptic












Popow et al .
2012
Zinc finger RNA-binding protein ZFR SPG71 AR P  
Enzyme that functions to regulate alternative splicing of








REEP2 SPG72 AD/AR P  ER localises protein that facilitates the formation of high







CPT1C SPG73 AD P 
ER localised neuron specific enzyme that catalyses the




















































































































































































IFIH1 - AD C  Cytoplasmic protein that functions as a sensor of viral







ADAR - AD P  Nuclear enzyme that catalyses the hydrolytic deamination













Lysosomal-trafficking regulator LYST - AR C  
Cytoplasmic protein that regulates endolysosomal
responses to Toll Like Receptor (TLR) 3 and TLR4 induced





Myelin-associated glycoprotein MAG - AR C  
Cell surface glycoprotein that functions in the myelin






T-complex protein 1 subunit
epsilon
CCT5 - AR C  ER protein that functio ns ensuring the efficient folding of





Exosome component 3 EXOSC3 - AR C   Part of the multisubunit RNA exosome complex that







FARS2 - AR C   Mitochondrial enzyme that functions in ligating





Alsin ALS2 - AR C  
Protein that functions as a Rab5 GEF regulating Rab5-
bound endosome dynamics and localisation including
recruitment to damaged mitochondria. Also functio ns as







Kinesin light chain 2 KLC2 - AR C 
Microtubule plus end directed motor that functio ns in









GAD1 - AR C   Golgi localised enzyme that functio ns to synthesis the










Table 1 - The HSP genes and their functions. All the identified HSP genes are listed with their function. Column order is: (1) Protein name; (2) Gene name; (3) Inheritance 
pattern (AD = autosomal dominant; AR = autosomal recessive; A? = autosomal but unclear dominant or recessive; AD/AR = both autosomal dominant and recessive depending 
on the mutation; M = mitochondrially inherited; X = X-linked); (4) Pure or complex HSP pathology; (5-16) Groups of HSP functions; (17) Protein function; (18) Disease reference; 
(19) Protein function reference. Data from Lo Giudice et al. 2014; Klebe et al. 2015.  

















































































































































Kinesin light chain 4 KLC4 AR C 
Microtubule plus end directed motor that functions in






Reticulophagy regulator 1 RETREG1 - AR C 
ER localised protein that mediates ER turnover by acting






Protein bicaudal D homolog 2 BICD2 - AD/AR C   
Cytosolic adaptor protein that interacts with the dynein-
dynactin complex and Rab6 to facilitate Golgi to ER







GRID2 - A? C  Cell surface receptor for glutamate that promotes











Cytochrome c oxidase subunit
3, mitochondrial
MT-CO3 - M P/C 
Mitochondrial enzyme of the electron transport chain of
complex 4 that reduces oxygen and transports hydrogen











Complex V, ATP synthase,
subunit ATPase 6






MT-ND4 - M P/C 
Mitochondrial enzyme of the electron transport chain of










Endosomal or autophagosomal 
The endosomal pathway will be described in more detail in Introduction Section 1.4. Briefly however, 
cell surface cargos can be internalised by endocytosis into endosomes. Cargos are then either 
redistributed via endocytic recycling tubules or are degraded in the lysosome (Maxfield and McGraw 
2004)(McNally and Cullen 2018). In macroautophagy, autophagosomal membranes engulf proteins or 
organelles to be degraded before then fusing with the lysosome to mediate their degradation (Pavel 
and Rubinsztein 2017). HSP proteins associated with either endocytic and autophagosomal trafficking 
pathways constitute the largest group of HSP proteins, with 24/80 associated HSP proteins functioning 
in these pathways. Functions include mediating Golgi to endosome traffic (SPG47, SPG50, SPG51, 
SPG52), mediating endocytic recycling (SPG4, DNM2, SPG8, SPG11, SPG15, SPG48, SPG20), mediating 
endosomal sorting complex required for transport (ESCRT) activity (SPG53, SPG59), mediating 
endosome motility (SPG10), mediating autophagosome formation (SPG49), and in lysosome function 
(SPG4, SPG8, SPG31, SPG11, SPG15, SPG66). Of note is that several proteins such as spartin, spastin, 
NIPA1 function in mediating the recycling of bone morphogenic protein II (BMPRII). It should be noted 
that along with spastin, spartin, dynamin-2, and strumpellin, the ER shaping proteins are involved in 
the process of endocytic recycling by ER-endosome contacts facilitating endosomal tubule fission 
(Rowland et al. 2014). Membrane trafficking pathways are often interdependent, meaning that some 
proteins may have described functions in more than one of these membrane sites, with primary 
defects having knock-on effects on downstream pathways. 
 
Mitochondrial 
Mitochondrial function in cells includes ATP synthesis, metabolite and lipid synthesis, heat production, 
apoptosis, and lipid synthesis. The proteins which drive these functions are either encoded by the 
mitochondrial genome or encoded by the nuclear genome and imported as proteins into the 
mitochondria (Osellame et al. 2012). This category represents the second largest grouping of HSP 
proteins, with 18/80 HSP proteins associated with mitochondrial function. These include proteins that 
function within the mitochondria such as in the electron transport chain (MIT-CO3, MT-ATP6, MT-
ND4), in mitochondrial translation (SPG55, FARS2, MT-TI), and mitochondrial metabolite synthesis 
(SPG56, SPG9, SPG74). In addition, it also includes cytoplasmic mitochondrially related proteins such 
as those involved in mitochondrial fission (SPG31, DNM2), mitochondrial positioning (SPG10, SPG20), 
and mitochondrial turnover (ALS2). Of note also is paraplegin (SPG7), a protein that functions as part 
of the mitochondrial AAA metalloprotease, as it is the most commonly mutated mitochondrial protein 
to cause HSP. 





Lipids are essential components of all cells as they function in membrane formation, energy storage, 
and extracellular and intracellular signalling (Welte and Gould 2017). Lipid metabolism is the third 
largest grouping of HSP genes, with 17/80 HSP genes associated with the processing of lipids. Lipid-
related HSP proteins function in a diverse range of lipid metabolism activities, including cholesterol 
synthesis (SPG5), ganglioside and sphingolipid synthesis for myelination (SPG26, SPG35) and inositol 
processing (SPG18, SPG28, SPG67). Another theme that emerges is the involvement of several HSP 
proteins with lipid droplet biogenesis. This includes the proteins atlastin-1 (SPG3), spastin (SPG4), 
seipin (SPG17), spartin (SPG20), REEP1 (SPG31), and phospholipase DDHD2 (SPG54). Lipid droplets are 
crucial in every cell type to provide a storage of energy. These can be synthesised or hydrolysed during 
times of energy surplus or deficiency respectively. In addition, lipid droplets can also function as 
storage sites for signalling precursors and vitamins, to mitigate the effects of ER and oxidative stress, 
and in protein maturation, storage, and turnover (Welte and Gould 2017). 
 
Secretory pathway 
After being correctly folded in the ER, proteins destined for the Golgi apparatus, the cell surface, the 
endocytic pathway, or secretion enter the secretory pathway (Presley et al. 1997). This pathway 
describes export from the ER, transition to the Golgi, and transport away from the Golgi. Proteins 
involved in secretion form the fourth largest cluster of HSP proteins, with 14/80 HSP proteins 
associated with secretion. This includes proteins that function as motor proteins or motor adaptors in 
vesicle trafficking (SPG30, SPG10, SPG58, BICD2), cargo transport away from the Golgi apparatus 
(SPG47, SPG50, SPG51, SPG52, SPG69), and at ER exit sites (ERES; SPG4, SPG49, SPG57). Of note is that 
4 subunits of AP4 complex involved in Golgi to endosome traffic are HSP proteins. 
 
Nucleotide processing 
Nucleotides are essential molecules for life as they provide information and temporary energy and 
phosphate storage. Proteins involved in nucleotide processing form the fifth largest group of HSP 
associated proteins, with a total of 11/80 HSP associated proteins. This includes proteins that function 
in mitochondrial and cytoplasmic translation (FARS2, MI-TI, SPG55, SPG70), RNA degradation 
(EXOSC3, RNASEH2E), and purine metabolism (SPG63, SPG65, ADAR).  
  





Microtubules are cytoskeletal elements that function in long range vesicular transport, cell division, 
cilia and flagella formation, and cell motility. Vesicular transport is mediated by microtubule motor 
proteins dynein and kinesin that travels towards and away from the nucleated minus end of 
microtubule respectively (Janke and Chloë Bulinski 2011). In total 9/80 HSP proteins are microtubule 
associated. These include motor proteins (SPG10, SPG30, SPG58, KLC2, KLC4), and adaptor proteins 
linking vesicle transport to microtubules (BICD2, SPG18). Spastin (SPG4) is unique among these 
proteins in its ability to regulate microtubule architecture by regulating microtubule stability and 
severing (Vemu et al. 2018). 
 
ER shaping 
The ER is composed of a continuous network of hollow membranes that take the shape of distinct 
tubules, dense tubular matrices, or sheets (Nixon-Abell et al. 2016). The architecture of the ER is 
generated by ER shaping proteins that control the formation of ER junctions and tubule/sheet ratio. 
In total, 9/80 HSP proteins function in ER shaping. This includes the GTPase atlastin-1 (SPG3) that 
mediates ER junction formation. Many of these HSP proteins contain long hydrophobic domains that 
allow them to embed into the outer leaflet of the ER membrane, acting as a hydrophobic wedge to 
mediate its curvature. These include spastin (SPG4), REEP1 (SPG31), reticulon-2 (SPG12), protrudin 
(SPG33), ADP-ribosylation factor-like protein 6-interacting protein 1 (SPG61), and REEP2 (SPG72). 
Spastin, atlastin, reticulons and REEPs are thought to interact in the ER to form an ER morphogen 
complex (Blackstone et al. 2011). 
 
Immune related 
The immune system is responsible for protecting the body against infection. 4/80 HSP proteins are 
involved in immunity. All these proteins were only recently associated with HSP (Lo Giudice et al. 
2014). These include interferon-induced helicase C domain-containing protein 1 (IFIH1) and lysosomal-
trafficking regulator (LYST) that function as a sensor of viral nucleic acids and as receptors or Toll Like 
Receptor (TLR) 3 and 4 activation respectively (Pichlmair et al. 2009; Westphal et al. 2017). In addition, 
zinc finger RNA-binding protein (SPG71) functions in alternative mRNA splicing in interferon regulation 
(Haque et al. 2018), and ectonucleoside triphosphate diphosphohydrolase 1 (SPG64) functions at the 
cell surface to hydrolyse ATP and ADP during cell injury and inflammation (Takenaka et al. 2016). 
  





Cell-cell contacts are important in mediating the rapid exchange of solutes between cells, as well as in 
cell guidance and signalling. Four HSP proteins are associated with cell-cell contact formation. These 
include myelin-associated glycoprotein (MAG) that functions in glia-neuron interactions (Quarles 
2007), neural cell adhesion molecule L1 (SPG1) that functions in neuronal adhesion (Samatov et al. 
2016), connexin 47 (SPG44) that functions in gap junction formation (Goodenough and Paul 2009), 
and leucine-rich repeat transmembrane protein FLRT1 (SPG68) that functions in neuronal guidance 
(Jackson et al. 2016). 
 
Myelination 
The myelination of axons is essential to provide the fast transmission of action potentials in the axon. 
Rather than action potentials having to continuously move down the entire length of the axon 
membrane, they are able to jump between unmyelinated breaks in the axon by saltatory conduction, 
thereby dramatically increasing conduction speed (Schnaar 2010). Only 4 HSP proteins are directly 
associated with myelination. These include the lipid synthesis proteins fatty acid 2-hydoxylase (SPG35) 
and beta-1,4 N-acetylgalactosaminyltransferase 1 (SPG26), and myelin sheath associated proteins 
myelin proteolipid protein (SPG2), and myelin-associated glycoprotein (MAG). Of note is that myelin 
proteolipid protein (SPG2) is the major myelin protein in the central nervous system. 
 
Nascent protein processing 
In the secretory pathway proteins must be correctly folded and postranslationally modified before 
they are secreted. Any protein that fails this process is degraded in the ER-associated degradation 
(ERAD) pathway (Benham 2012). Four HSP proteins are associated with ER-based protein modification, 
folding, or degradation. These include Erlin 1 (SPG62) and Erlin 2 (SPG18) which function in ERAD of 
inositol 1,4,5-trisphosphate receptors (Pearce et al. 2009), T-complex protein 1 subunit epsilon (CCT5) 
that functions in protein folding (Pereira et al. 2017), and GPI inositol-deacetylase (SPG67) that 
functions in GPI anchor modification on nascent GPI anchored proteins (Liu et al. 2018). 
  





Non-cell permeable solutes and ions that move across membranes must do so through channels, or 
proteins that facilitate diffusion or active transport. This activity is essential for the homeostatic 
balance of all cellular compartments and in cell signalling. Only 3 HSP proteins have been associated 
with transport across membranes. These include monocarboxylate transporter 8 (SPG22) that 
functions in thyroid hormone transport (Heuer et al. 2005), acetyl coenzyme A transporter 1 (SPG42) 
that functions in the import of acetyl-CoA into the ER (Jonas et al. 2010), and plasma membrane 
calcium transporting ATPase 4 (PMCA4) that functions in ATP-dependent calcium export (Filoteo 
1995).  
 
A diverse set of proteins related to the same disease 
How can mutations in such a diverse set of proteins lead to a similar pathology? Two non-mutually 
exclusive possibilities have been proposed. One possibility is that there is a unifying molecular 
biological process involving all or many proteins. Previous suggestions have included dysfunctional 
BMP signalling (Blackstone et al. 2011) and lysosome dysfunction (Allison et al. 2017). Although it is 
currently unclear how these processes may apply to all HSP proteins, precedent has suggested that 
seemingly diverse HSP proteins can function in a common pathway. One example is the discovery that 
ER architecture is essential for the fission of endosomal recycling tubules, with mutations in either 
sets of proteins leading to lysosome dysfunction (Allison et al. 2017; Rowland et al. 2014). This 
therefore united the HSP proteins involved in endolysosomal pathways with those involved in ER 
shaping. Other hints that there may be only one or a few core mechanisms of HSP are provided by 
several HSP proteins appearing in multiple functional groups, such as the proteins involved in both 
membrane traffic and lipid biology. An intermediate model in which pathology results from a 
collection of distinct unifying pathways perhaps is the most likely. 
 The alternative possibility is that instead of a common molecular pathway, HSP proteins are 
components of multiple pathways that are united only by their requirement for axonal health and the 
disproportionate effect that their pathogenic mutations have upon corticospinal neurons. 
Corticospinal neurons are unique by their length, with axons able to grow to 1m in length (Blackstone 
et al. 2011). This allows the rapid transmission of action potentials, but also creates high demands on 
cellular processes such as axonal transport, homogenously distributed energy production, lipid 
synthesis, and myelination. This demand may render these neurons vulnerable to even small 
deviations in molecular efficiency. By contrast, the same loss of inefficacy may result in a negligible 
effect on cell types with less extreme morphology.  




1.2.3 – Relative contribution of each gene to overall HSPs 
The majority of familial and sporadic HSP are caused by mutations in only a few genes (Figure 1; Lo 
Giudice et al. 2014; Klebe et al. 2015). From data from Lo Giudice et al. (2014), these include the genes 
encoding spastin (SPG4), atlastin-1 (SPG3), kinesin heavy chain isoform 5A (SPG10), REEP1 (SPG31), 
25-hydroxycholesterol 7-alpha-hydroxylase (SPG5), paraplegin (SPG7), spatacsin (SPG11), spastizin 
(SPG15), and neural cell adhesion molecule L1 (SPG1).  ~20% of familial HSP and ~50% of sporadic HSP 
were caused by mutations in unmapped genetic loci in 2014. 
By far the most common cause of HSP is mutation in the SPAST gene (SPG4) encoding the 
protein spastin. Mutations in SPAST are the single largest cause of HSP in both familial and sporadic 
HSP, accounting for ~40% of all familial HSP cases, and ~20% of all sporadic HSPs. This accounts for 
more than double the contribution of any other HSP gene to the incidence of HSP in both familial and 
sporadic HSP. Research into understanding the function of spastin is therefore critical to 
understanding the pathology of HSP.  
 
 
Figure 1 - Prevalence of familial and sporadic pathogenic mutations in HSP genes by gene. Bar chart showing 
the relative contribution of pathogenic inherited or sporadic mutations in HSP-associated proteins against the 
total reported cases of HSP. Inherited mutations and sporadic mutations are displayed by blue and red bars 
respectively. Only the most common proteins mutated in HSP pathogenesis are displayed. The pie chart shows 
the proportion of pathogenic HSP mutations that are caused by genetically inherited or sporadic mutations. Data 





































































































1.3 – Spastin 
1.3.1 – Historical and clinical features of spastin-related HSP 
The SPAST gene encodes the protein spastin. SPAST was first discovered as an HSP gene in 1999 by a 
positional cloning approach on the SPG4 locus, the position on chromosome 2p21-22 known to be 
responsible for a considerable proportion of autosomal dominant HSP (Hazan et al. 1999; Raskind et 
al. 1997). Since this discovery, 467 papers have been published with keywords SPG4, SPAST, or spastin 
(Figure 2). These papers include clinical reports of novel and reoccurring SPAST mutations from every 
continent, as well as structural and functional studies. Of the major HSP genes contributing to familial 
or sporadic HSP (Figure 1), spastin is the second most researched protein behind L1CAM (Figure 2).  
 
 
Figure 2 - Publication history of most commonly mutated HSP genes. Cumulative line plot showing the 
cumulative total number of publications for the most commonly mutated HSP genes causing HSP from 1996 to 
2018. Publication counts were generated by searching the NCBI PubMed database for the protein (including 
synonyms), gene name, or HSP reference name (e.g. spastin/SPAST/SPG4). Data accurate to August 2018. 
 
SPAST-associated HSP is an autosomal dominant pure form of spastic paraplegia. The major disease 
phenotype is a progressive bilateral lower limb spasticity. This is often associated with brisk reflexes, 
ankle clonus, and involuntary movement of the toes upon stroking the underside of the foot (Babinski 



















































sign). More than 50% of patients have proximal weakness in the lower libs, and 33% have urinary 
urgency or incontinence (Reid 1999). Subtle cognitive impairment has been reported in some cases 
(Byrne et al. 1998; Reid et al. 1999; Tisher and Salardini 2016; Webb and Hutchinson 1998), and 
depression has been reported in 41% of cases (du Montcel et al. 2008). Onset occurs mostly in early 
adult life but can vary between infancy to old age (Fonknechten et al. 2000). Age of onset can be 
accelerated by epistatic mutations in the contiguous gene DPY30 (Newton et al. 2018). Life expectancy 
is not affected by the disease. Currently there are no etiological treatments. However symptomatic 
treatments include use of antispastic drugs for leg spasticity, anticholinergic antispasmodic drugs for 
urinary urgency, and physiotherapy for stretching spastic muscles (Dürr et al. 2003; Reid et al. 1999). 
In addition, botulinum toxin injections may be given to severe patients (Rousseaux et al. 2007). ~40% 
patients also use assisted walking, including wheelchair use (Reid et al. 1999). SPAST mutations 
causing HSP have been described globally. The prevalence of SPAST associated HSP varies by country 
but is estimated to be between 2/100,000 and 6/100,000 for most countries (Durr et al. 1993). 
 
  




1.3.2 – Spastin isoforms 
SPAST has homologs in all vertebrates including sea squirts (e.g. Ciona intestinalis), the arthropods 
(e.g. Drosophila melanogaster), nematodes (e.g. Caenorhabditis elegans), as well as in yeast (e.g. 
Saccharomyces cerevisiae; Ensembl, 2018). In humans it is located on chromosome 2 at band 2p22-
23. It is composed of 17 exons and is ~94kb in length (Ensembl). The gene contains two promoters: a 
TATA-less promoter 310bp upstream of the first ATG (Canbaz et al. 2011; Mancuso and Rugarli 2008), 
and a cryptic promoter that covers the 5’-untranslated region (UTR) and part of exon 1 (Mancuso and 
Rugarli 2008). The TATA-less promoter contains a CAAT box and a CpG island and appears able to bind 
transcription factor Elk1 (Canbaz et al. 2011). 
 The presence of these two promoters drives the production of two of four main spastin 
transcripts (Figure 3A). The long ‘M1 spastin’ transcript encodes a protein 616 amino acids in length 
and is driven by the TATA-less promoter upstream of the first ATG. The short ‘M87 spastin’ transcript, 
driven by the cryptic protomer, encodes a protein 530 amino acids in length. These two transcripts 
also have further variety by the alternative splicing of exons 4, 8, or 15, although of these, only exon 
4 spliced spastin is expressed at significant levels (Svenson et al. 2001). In addition to these 
transcriptional mechanisms for generation spastin isoforms, a poor Kozak sequence surrounding the 
first ATG codon leads to leaky scanning of the 40S ribosomal subunit through to the strong Kozak 
sequence at initiation codon M87, causing some M87 spastin to be translated from M1 spastin 
transcript (CLAUDIANI et al. 2005). These mechanisms result in M87 spastin being expressed at a 
higher level than M1 spastin (Solowska et al. 2008, 2010). Both M1 and M87 isoforms are expressed 
in all tissues but M1 spastin is specifically enriched in the brain and spinal cord (Charvin 2003; 
CLAUDIANI et al. 2005; Solowska et al. 2010). 
 
  




1.3.3 – Spastin functional domains 
The properties of a protein are conferred by its functional domains. Spastin contains five different 
domains: a hydrophobic hairpin-loop domain, nuclear localisation and export motifs, a microtubule 
interacting and trafficking (MIT) domain, a microtubule binding domain (MTBD), and an ATPases 
associated with diverse cellular activities (AAA+) domain (Figure 3). All domains except the 
hydrophobic hairpin-loop and the nuclear export motif are contained by both M1 and M87 isoforms 
of the protein. The hydrophobic hairpin-loop and the nuclear export motif are encoded in exon 1 so 
are excluded from the M87 isoform of spastin. 
 
 
Figure 3 - Aligned exon and domain structure of SPAST and M1 and M87 spastin isoforms. (A) Exon structure 
of spastin mature transcript, scaled to the number of amino acids in each exon, and in line with the below M1 
and M87 spastin domains. Exon 4 is highlighted as it may be alternatively spliced, and exon 1 as it contains a 
cryptic promoter. (B) Size-proportionate domain cartoon of M1 and M87 spastin. M1 spastin contains a weak 
Kozak sequence at its N-terminus (tgaATGa), causing leaky scanning of the 40S ribosomal subunit to a second 
start site encoding a stronger Kozak sequence (ctcATGg: M87). In order, M1 spastin contains: a nuclear 
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localisation sequence (4-10), a hydrophobic hairpin transmembrane domain (49-80), two nuclear export 
sequences (in total between 50-87), an microtubule interacting and trafficking (MIT) domain (116-194), a 
microtubule binding domain (MTBD) (270-328), a second nuclear localisation sequence (309-312), and a ATPase 
associated with diverse cellular activities (AAA+) domain (324-599). (C) M87 spastin also has a unique transcript 
due a cryptic promoter in exon 1. M87 spastin lacks all domains N-terminally of M87. (D) Size-proportionate 
motif cartoon of the AAA+ domain. In order, the AAA+ domain contains: Walker-A motif (382-390), Pore Loop 1 
(408-421), Walker-B motif (441-444), Pore Loop 2 (445-458), and a Second Region of Homology (SRH) domain 




The hydrophobic hairpin-loop, which is only present in the full 616 amino acid M1 isoform of spastin, 
is encoded by exon 1 and is located between amino acids 49-80. This motif allows the M1 spastin 
isoform to be localised to the ER by insertion into the outer leaflet of the ER membrane, making M1 
spastin an integral membrane protein (Chang et al. 2013; Connell et al. 2009; Park et al. 2010). Due to 
the hairpin nature of the hydrophobic motif, the N and C termini are cytoplasmic (Chang et al. 2013; 
Park et al. 2010). The precise mechanism of how M1 spastin is inserted into the ER membrane has not 
been investigated. However, by homology of hydrophobic hairpin-loop to that of Arl6IP1 and the 
reticulons, it is possible that the insertion of M1 spastin may be mediated by either the translocon or 
a PEX3-PEX19 posttranslational insertion pathway (Yamamoto and Sakisaka 2018). 
 The hydrophobic hairpin of M1 spastin is similar to that of other HSP proteins (Yamamoto et 
al. 2014). These include atlastin-1 (SPG3), protrudin (SPG33), reticulon-2 (SPG12), REEP1 (SPG31), 
REEP2 (SPG72), and ARL6IP1 (SPG61). Through this domain, spastin is able to interact with atlastin-1 
(Evans et al. 2006; Park et al. 2010; Sanderson et al. 2006), REEP1 (Park et al. 2010), protrudin (Chang 
et al. 2013), and reticulon-1 (Mannan et al. 2006; Montenegro et al. 2012). These proteins are thought 
to work together in an ‘ER-morphogen complex’ to regulate the morphology of the ER (Blackstone et 
al. 2011). This complex is able to generate curvature of ER membranes through hydrophobic wedging 
(Shibata et al. 2009; Voeltz et al. 2006), thereby allowing the formation of the tubular ER network. In 
addition, the M1 domain of spastin allows it to interact with the centrosomal protein NA14 (Errico 
2004). 
  




Nuclear localisation and export domains 
Spastin was hypothesised to be a nuclear protein upon its discovery (Hazan et al. 1999). This was based 
upon the presence of an RGKKK putative nuclear localisation signal in amino acids 7-11 of the M1 
isoform of spastin. However, this signal sequence was later disregarded as it did not cause exclusive 
import of spastin into the nucleus (Beetz et al. 2004). Instead, spastin was confirmed to have two 
functional nuclear localisation signals: PGGRGKK in exon 1 at amino acid positions 4-10, and RKKK in 
exon 6 at amino acid positions 309-312 (Beetz et al. 2004). In addition, spastin contains two 
overlapping nuclear export signals located between amino acids 50 to 87 in exon 1 (CLAUDIANI et al. 
2005).  
The combination of these motifs results in M1 spastin containing two nuclear localisation 
signals and two nuclear export signals, and M87 spastin containing one nuclear localisation signal but 
no nuclear export signal. As a result, M1 spastin is not localised in the nucleus (CLAUDIANI et al. 2005; 
Connell et al. 2009). Due to lack of an export signal, M87 spastin however is localised both 
cytoplasmically and in the nucleus (Beetz et al. 2004; CLAUDIANI et al. 2005; Connell et al. 2009). This 
difference in isoform localisation helps explain initially conflicting observations regarding the 
cytoplasmic or nuclear localisation of spastin (Charvin 2003; Errico 2002, 2004; McDermott et al. 2003; 
Reid et al. 2005; Wharton et al. 2003). Despite extensive research into the cytoplasmic function of 
spastin, there is currently only one publication suggesting an intranuclear function for spastin (Daftary 
et al. 2011). 
 
The microtubule interacting and trafficking (MIT) domain 
The microtubule interacting and trafficking (MIT) domain of spastin was first identified in 2003 
(Ciccarelli et al. 2003). This was discovered by comparisons between a non-redundant protein 
database and the N-terminal of spartin (SPG20). This analysis identified conserved domains in the 
proteins spartin, spastin, sorting nexin 15, RPK118, SKD1, VPS4, and calpain-7, of approximately 80 
amino acids overlapping with the previously termed ESP domain. This list of MIT domain containing 
proteins was later expanded to include the VPS4 cofactor LIP5 (Shim et al. 2008), deubiquitinating 
enzymes AMSH (Solomons et al. 2011; Tsang et al. 2006) and USP8 (Row et al. 2007), autophagy 
initiation protein ULK1 (Fujioka et al. 2014), and microtubule interacting and trafficking domain 
containing protein 1 (MITD1; Tsang et al. 2006). 
The MIT domain of spastin is located between amino acids 116 and 194 and is encoded by 
exons 1, 2, and 3. It is therefore present in both M1 and M87 spastin isoforms. The structure of MIT 
domains was identified by nuclear magnetic resonance (NMR) spectroscopy and x-ray crystallography 




of the VPS4 MIT domain. It was shown to consist of three α-helices arranged asymmetrically, with the 
α-helices 1 and 3 running parallel, and antiparallel to helix 2 (Obita et al. 2007; A. Scott et al. 2005; 
Takasu et al. 2005). Spastin’s MIT domain was shown to be structurally similar to that of VPS4 (Yang 
et al. 2008). 
 MIT domains specifically interact with MIT-interacting motifs (MIMs), primarily found in 
endosomal sorting complexes required for transport (ESCRT)-III proteins, typically located at the C-
terminus (Kieffer et al. 2008; Schöneberg et al. 2017; A. Scott et al. 2005). Proteins may either contain 
a single MIM (e.g. Charged multivesicular body protein (CHMP) 1, CHMP2, CHHMP5, CHMP7) or MIMs 
in tandem (e.g. CHMP4, Increased sodium tolerance 1 (IST1); Schöneberg et al. 2017). Currently there 
are five different described modes of MIT-MIM interaction (Table 2). Typically, MIMs interact in a 
groove created by the MIT α-helices, lying parallel to the orientation of the first MIT helix. These 
interaction modes are displayed in Figure 4 and described in Table 2. 
 
 
Figure 4 - MIT-MIM interaction modes and spastin MIT-CHMP1B MIM interaction. (Left) The different MIT-
MIM interaction modes. A detailed description of each mode is provided in proceeding table (Table 2). Protein 
structures from McCullough et al. (2018). (Right) Interaction structure of spastin’s MIT domain and the MIM of 
CHMP1B. The MIM of CHMP1B sits in a groove between α-helices 1 and 3 of spastin’s MIT domain. Key residues 
mediating the interaction are displayed, with blue and orange indicating residues from the MIT domain and MIM 

































Table 2 – Table showing the different MIT-MIM modes of interaction. 
 
 
The MIT domain of spastin allows it to specifically interact with the ESCRT-III proteins CHMP1B and 
IST1. These interactions were first identified by yeast two-hybrid experiments and were confirmed by 
coimmunoprecipitation, microscopy and structural studies (Allison et al. 2017; Reid et al. 2005; 
Renvoisé et al. 2010; Yang et al. 2008). 
The MIT-MIM interaction between spastin and CHMP1B has been mapped by x-ray 
crystallography at 2.5-Å resolution (Yang et al. 2008). This revealed that spastin interacts with CHMP1B 
through a unique mode of MIT-MIM interaction (mode 3), with CHMP1B’s MIM filling a 30-Å groove 
between spastin’s MIT α-helices 1 and 3 that runs the entire length of the MIT domain. This interaction 
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MIT-MIM Mode 1 VPS4-VP2 
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2011 
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Skalicky et al., 
2012 




MIT groove consisting of phenylalanine124, leucine127, and isoleucine131 of spastin’s MIT domain α-
helix 1, and methionine187 of spastin’s MIT domain α-helix 3 (Figure 4). In addition, the MIT-MIM 
interaction is also facilitated by salt-bridge formation and hydrogen bonding. Recently, it has been 
shown that spastin’s MIT domain interacts with the MIMs of IST1 using the same MIM3 mode of 
interaction (BioRxiv non-peer reviewed - Talledge et al. 2018). This binding is proposed to be in a near 
identical position as the spastin-CHMP1B MIT-MIM interaction, preventing the same spastin monomer 
from being able to bind both CHMP1B and IST1 simultaneously. 
 
IST1 and CHMP1B ESCRT-III proteins are similar in structure, with both proteins containing the six α-
helices typical of ESCRT-III proteins as well as an additional helix, αA. However, IST1 contains an 
additional short helix αB as well as two MIMs compared to CHMP1B’s single MIM. CHMP1B and IST1 
interact to form a double-stranded heteropolymeric helical tube in vitro (Figure 5; McCullough et al. 
2015; BioRxiv non-peer reviewed - Talledge et al. 2018). In this complex, IST1 is present in a closed 
folded conformation, mediated by a long N-terminal hairpin that packs against helices 3, 4, and 5 
(McCullough et al. 2015). CHMP1B however is present in a hyperextended open conformation, with 
both helices 1-3 and helices 4 and A forming extended structures (McCullough et al. 2015). The 
complex itself is formed by salt bridge interactions between CHMP1B’s extended helix 4 and IST1’s 
helix 1 (McCullough et al. 2015), as well as the MIM of CHMP1B binding to the IST1 helices 1 and 2 on 
the outside of the complex (Talledge et al. 2018). 
Despite IST1 and CHMP1B existing in closed and open confirmations respectively, both are 
able to form homomeric polymers: IST1 via its N-C terminal interactions of helix 2, and CHMP1B 
prolifically interacting with eight other CHMP1B subunits via multiple hydrophobic interaction sites 
(McCullough et al. 2015; Talledge et al. 2018). As a result, IST1 closed conformation polymers form 
the outer layer of the helical tube IST1-CHMP1B complex, and the CHMP1B extended conformation 
polymers form the inner layer. In this conformation, CHMP1B’s highly basic helix 1 lines the inside of 
the helix, allowing interaction with electronegative phospholipid heads of membranes. Furthermore, 
the MIMs of each of the CHMP1B subunits are able to protrude through the IST1 outer layer, making 
both CHMP1B and IST1 MIMs available for binding by spastin’s MIT domain (Talledge et al. 2018). The 
binding of spastin to CHMP1B and IST1 however is mutually exclusive in the same spastin molecule, 
as the CHMP1B and IST1 MIMs bind spastin’s MIT domain in the same location (Talledge et al. 2018). 
The binding of spastin to the CHMP1B MIM dissociates CHMP1B MIM-IST1 binding, destabilising the 
CHMP1B-IST1 polymer, priming it for remodelling or disassembly (Talledge et al. 2018). 




 The structure of the CHMP1B-IST1 copolymer means that it binds positively curved membrane 
within the lumen of the helix (McCullough et al. 2015). Due to the curvature required, this complex is 
likely to form on the outside of membranes, differing from canonical ESCRT-III formation on the inside 
of membrane necks (Schöneberg et al. 2017). As ESCRT-III complexes typically cause membrane 
constriction and fission, the structural model of the CHMP1B-IST1 complex therefore predicts it to 
function in the fission of membrane tubules. This data supports in vivo data that shows that a spastin-
IST1 interaction is required for the fission of endosomal recycling tubules, localising at endosomal 
tubule constrictions (Allison et al. 2013, 2017). In addition, this interaction is also required for 
localising spastin to the nuclear envelope during nuclear envelope reformation (Vietri et al. 2015), and 
to the zone of abscission (Connell et al. 2009; Yang et al. 2008).  
 
 
Figure 5 - IST1-CHMP1B co-polymer filament. (Left) End on view of a turn of the IST1-CHMP1B co-polymer 
assembled on a lipid bilayer. The N-terminal IST1 polymer is formed on the outside of the IST-CHMP1B complex, 
and the multicoloured CHMP1B polymer is formed on the inside to interact with the lipid bilayer. The MIM 
domain protrusions of CHMP1B through the IST1 structure are displayed. (Right) Side view of a section of the 
IST1-CHMP1B co-polymer viewed from the membrane. Seven interacting CHMP1B subunits are displayed 
(although CHMP1B has recently been shown to form 8 other CHMP1B interactions (Talledge et al., 2018)), and 
the CHMP1B MIM protruding through the IST1 monomer. Only a single IST1 is displayed for viewing clarity. 



















Microtubule binding domain 
The earliest studies of spastin showed that it is able to interact with microtubules (Errico 2002, 2004; 
McDermott et al. 2003; Sherwood et al. 2004; Trotta et al. 2004). This interaction was originally 
mapped to the N-terminal transmembrane domain of spastin (Errico 2002), but both the N-terminus 
and the MIT domain was later shown to be dispensable for spastin-microtubule interaction (Roll-
Mecak and Vale 2005). Spastin was revealed to have two distinct interaction domains with 
microtubules (White et al. 2007). One interaction is mediated at the microtubule binding domain 
(MTBD), and one is within the C-terminal ATPases associated with diverse cellular activities (AAA+) 
domain.  
 The MTBD spans between 270-328 amino acids and is encoded by exons 5 and 6. It is present 
in both the M1 and M87 isoforms of spastin. The domain itself has proved hard to crystallise (Taylor 
et al. 2012), meaning there is no confirmed structure. It has been proposed that the MTBD interacts 
with microtubules through an essential RKKK motif (Eckert, Le, et al. 2012). However, despite its 
discovery in 2007, the specific biology of the MTBD has not been extensively studied. Instead the 




Spastin was identified as a member of the AAA (ATPases associated with diverse cellular activities) 
protein family upon its discovery (Hazan et al. 1999). This family, now called the AAA+ proteins, is a 
subset of the p-loop nucleotide triphosphate (NTP)ase protein superfamily that use the hydrolysis of 
an NTP to generate mechanical work (Hanson and Whiteheart 2005). The AAA+ proteins specifically 
do this via the hydrolysis of adenosine triphosphate (ATP). The AAA+ protein family is large and 
diverse, functioning in processes such as protein folding and degeneration, DNA replication and 
recombination, peroxisome biogenesis, ESCRT complex disassembly, motor protein transport, and 
microtubule severing (Miller and Enemark 2016; Snider et al. 2008).  
 
Spastin’s AAA+ domain is encoded by exons 7 to 16 and is located between amino acids 342 to 599. It 
is therefore present in all spastin isoforms. The AAA+ domain allows spastin to bind ATP and 
hexamerise on microtubules to mediate microtubule severing and microtubule GTP-island formation 
(Eckert, Link, et al. 2012; Hinnerwisch et al. 2005; Roll-Mecak and Vale 2008; Taylor et al. 2012; Vemu 
et al. 2018; White et al. 2007). This complex process requires the coordination of microtubule binding, 




ATP binding and hydrolysis, and hexamer formation (Roll-Mecak and Vale 2008; Zehr et al. 2017). The 
spastin hexamer itself forms an asymmetrical ring with a central pore (Figure 6; Roll-Mecak and Vale 
2008; Zehr et al. 2017). 
Spastin is able to bind polymerised microtubules via its AAA+ domain in addition to via its 
MTBD (White et al. 2007). This occurs via an interaction with acidic C-terminal tubulin tails that 
emanate from each microtubule α/β-tubulin dimer (Roll-Mecak and Vale 2008; White et al. 2007). In 
each spastin hexamer, each spastin monomer projects two peptide loops into the centre of the 
hexamer pore that interacts with the C-terminal tubulin tails (White et al. 2007). One pore loop is 
encoded between amino acids 407-421 and contains the conserved YVG sequence. Mutation of the 
aromatic tyrosine residue blocks tubulin binding (White et al. 2007). The second pore loop is encoded 
between amino acids 445 and 459 and contains basic amino acids that enable binding to the acidic 
tubulin tails (White et al. 2007). 
Posttranslational modifications of these C-terminal tubulin tails can aid in spastin binding 
(Lacroix et al. 2010; Valenstein and Roll-Mecak 2016). In particular, polyglutamylation increases 
spastin-microtubule binding by increasing the acidity of the tails (Lacroix et al. 2010). Spastin’s 
microtubule severing activity shows a graded response to the amount of C-terminal tubulin 
glutamylation, although excess glutamylation inhibits severing (Valenstein and Roll-Mecak 2016). It is 
worth noting that in addition to this C-terminal interaction, spastin binds microtubules independently 
of C-terminal tails via its MTBD (Eckert, Link, et al. 2012). This interaction is thought to stabilise spastin-
microtubule interactions to facilitate spastin’s AAA+ domain to bind the tubulin tails (White et al. 
2007). 
 
The ATPase function of spastin has largely been extrapolated from other AAA+ domain containing 
proteins. Spastin binds and hydrolyses ATP via conserved AAA+ domain components. These include 
the N-linker, the Walker-A motif, the Walker-B motif, the Second Region of Homology (SRH) motif that 
contains Sensor 1 and the Arginine fingers, and Sensor 2 (Monroe and Hill 2016). ATP binding is 
mediated by four motifs: the N-terminal linker, the Walker-A motif, the SRH motif, and Sensor 2. The 
N-terminal linker forms part of adenosine binding pocket (Smith et al. 2004). The Walker-A motif binds 
the phosphate of ATP via a conserved lysine (Hanson and Whiteheart 2005). Similarly, the arginine 
fingers at the C-terminus of the SRH and the arginine of Sensor 2 use the same mode of interaction to 
bind the phosphate of the ATP (Müller and Schulz 1992; Wendler et al. 2012). However, the arginine 
fingers differ in that they contact ATP molecules that are located in the binding pocket of adjacent 
spastin subunits of the spastin hexamer (Wendler et al. 2012). 




ATP hydrolysis is mediated by the nucleophilic attack of the ATP phosphate by an activated 
water molecule. This is mediated by the Walker-B motif and Sensor 1 of the SRH motif. The Walker-B 
motif coordinates Mg2+ via its C-terminal aspartate residue, and this in addition to an adjacent 
glutamate residue facilitate water activation for nucleophilic attack (Story and Steitz 1992). Sensor 1 
of the SRH motif functions as part of hydrogen-bonding network that positions the water molecule in 
relation to the phosphate of ATP via its polar residues (Lenzen et al. 1998). 
 
The AAA+ domain facilitates spastin’s hexamerisation. This is a key characteristic of the meiotic clade 
of AAA+ proteins that along with spastin include the microtubule severing enzymes katanin, fidgetin, 
and the ESCRT-III remodelling and disassembly protein Vps4 (Monroe and Hill 2016). Hexamer 
formation generates the central pore through which substrates can be translocated to be 
disassembled and is essential for catalytic activity (White et al. 2007). Each subunit of the spastin 
hexamer contacts two other subunits of the spastin hexamer (Roll-Mecak and Vale 2008; Zehr et al. 
2017). This interaction is mediated by multiple locations of contact, including by the N-terminal linker 
(Roll-Mecak and Vale 2008; Wendler et al. 2012; Zehr et al. 2017). It is worth noting that as M1 and 
M87 spastin’s AAA+ domains are the same, hexamer formation also allows M1 spastin to localise M87 
spastin to biologically relevant locations for microtubule severing (Allison et al. 2017). 
By homology to katanin, a change in spastin’s hexamer conformation is proposed to drive 
microtubule severing (Zehr et al. 2017). The asymmetric spastin hexamer is proposed to cycle between 
two different conformations: an open spiral, and a closed ring. In its ATP bound form, the hexamer 
exists as a spiral and binds tubulin in the first spastin subunit. Upon the hydrolysis of ATP, the hexamer 
reforms into a ring, thereby translocating the tubulin from the first subunit to the pore loops of the 
second spastin subunit. Upon ATP binding, the structure then resets to its spiral conformation, 
allowing a previously unbound region of tubulin to be accessed by the first spastin subunit. This cycle 
of hexamer spiral-ring conformational change coupled to ATP hydrolysis and tubulin translocation is 
proposed to pull the tubulin dimer off the polymerised microtubule, mediating microtubule severing 
(Figure 6; Roll-Mecak and Vale 2008; White et al. 2007; Zehr et al. 2017). 
  





Figure 6 - Spastin hexamer structure and proposed conformational changes during microtubule severing. (A) 
The C-terminal tails (red) of tubulin (green) are fed through the spastin hexamer (cyan). This is mediated by the 
bound tubulin passing between the pore loops of each spastin subunit. The two pore loops in spastin are labelled 
by numbers. The grey bars emanating from the hexamer indicate the MTBD. (B) The density map of the open 
spiral conformation of katanin. The pore loops that bind tubulin are shown in yellow and purple (Pore loop 1 = 
yellow; Pore loop 2 = purple). This structure of katanin is likely to also resemble that of the spastin hexamer. (C) 
A cartoon of the conformational changes of spastin facilitating tubulin dimer removal. The spastin hexamer is 
assembled in its open spiral conformation in its ATP bound form. The c-terminal tail of β-tubulin of an α/β-
tubulin dimer binds the pore loops of a single spastin protein within the hexamer. (Right) ATP hydrolysis induces 
a conformation change in hexamer, leading to the formation of a closed ring structure. This translocates tubulin-
tail to the pore loops of the next spastin protein in hexamer. Repeated action generates tension on the tubulin 
dimer, removing it from the polymerised microtubule, inducing either GTP-tubulin repair, or microtubule 









1.3.4 – Spastin mutational distribution 
Pathogenic mutations in SPAST are both numerous and diverse (Ensembl 2018; Fonknechten et al. 
2000; Hazan et al. 1999; Shoukier et al. 2009; Solowska and Baas 2015). From the Ensembl database, 
460 SPAST transcript variants are recorded that contain pathogenic mutations affecting SPAST exons 
(Ensembl, August 2018). These variants encode 368 unique mutations in spastin. These include 
missense mutations, insertions and deletions, splice site mutations, and nonsense mutations. In 
addition, SPAST is susceptible to Alu-mediated genomic rearrangements due to its Alu-rich genomic 
architecture (Beetz et al. 2006; Boone et al. 2014; Depienne et al. 2007; Jahic et al. 2016). These results 
in large deletions which are generally predicted to cause degradation of transcripts via nonsense-
mediated decay (NMD; Jahic et al. 2016; Solowska and Baas 2015). 
 
Figure 7 - Distribution of reported mutations relative to spastin’s domain architecture. Published pathogenic 
exon mutations in SPAST were obtained from Ensembl, filtered to remove duplicate listed mutation, and 
categorised into 15 amino acid bins based on their position within spastin. Resulting histograms were aligned 
against the domain structure of spastin (including the AAA+ domain motifs), and plotted for all reported 
mutations (top), missense mutations (second row), splice region mutations (third row), indel frameshift causing 
mutations (fourth row), novel stop causing mutations (bottom row). Mutation data accurate to August 2018. 
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Unique protein mutations were identified in every functional domain of spastin (Figure 7). Out of 368 
unique mutations in the Ensembl database (August 2018), 81% mapped to a functional domain. 47% 
of all unique mutations localised to the AAA+ domain, 15% to the MTBD, and 11% to the MIT domain. 
These figures are similar to those reported from a study of 200 unique HSP mutations by Shoukier et 
al. (2009). 
 The largest group of unique mutations in SPAST are missense mutations; single amino acids 
changes in the spastin protein. Out of the 368 unique mutations, 53% were missense mutations. 
Remarkably, 56% of these localised to the AAA+ domain, whilst only 17% localised to the MTBD, and 
7% localised to the MIT domain. Of the 131 unique missense mutations in the AAA+ domain, 33% 
mapped to either the Walker A/B motifs, the SRH, or the pore loops. 
 The majority of mRNA transcripts that contain either frameshift-inducing insertions or 
deletions, or premature stop codons are degraded by NMD mRNA processing machinery (Gatfield 
2003). As a result, no protein is produced from these transcripts. Out of the 368 unique mutations, 
20% were frameshift-inducing insertions or deletions. These mutations showed a relatively even 
distribution across SPAST, but with an increased proportion in the N-terminal region. In addition, 27 
single nucleotide polymorphisms were identified that would give rise to a novel premature stop 
codon. It is likely that these would also result in NMD, although they could theoretically result in 
spastin truncation products (Solowska et al. 2014; Solowska and Baas 2015). Such truncated products 
however have never been identified in physiological samples. 
 Truncated spastin protein variants could also be formed through in-frame insertions or 
deletions, or splice-site mutations. This has in vivo relevance as truncated spastin mRNA was observed 
in a spastin mouse model with a splice site mutation resulting in the loss of exon 7, although this did 
not produce spastin protein (Kasher et al. 2009). No in-frame insertions or deletions were identified 
from the 368 unique spastin mutations recorded. However, 47 splice site mutations were identified. 
These localised almost predominantly to the AAA+ domain (70%) and the MTBD (11%). 
 
The inheritance pattern and mutational spectrum in SPAST suggests that disease is often caused by 
loss of function haplo-insufficiency (Denton et al. 2014; Fonknechten et al. 2000; Shoukier et al. 2009). 
In this model, a decreased concentration of spastin would result in inefficient cellular functions, such 
as microtubule severing. NMD is likely to result in a lack of spastin protein produced from SPAST that 
contained either frameshifting insertions or deletions, or premature stop codons (Riano et al. 2009). 
Furthermore, the mutational spectrum includes whole gene deletions and deletion of exon 1, 
preventing the production of any spastin protein. In addition, mutated spastin that is successfully 




translated may not interact with appropriate binding partners, or may have defective ATP binding, 
ATP hydrolysis, hexamer formation, all leading to inability of spastin to severe microtubules.  
 In addition to a direct correlation between expression of mutated spastin and loss of protein 
activity, it is possible that some missense mutations may also generate dominant negative loss of 
function effects. In the case of microtubule severing by the AAA+ domain, the C-terminal tail of tubulin 
is translocated through the spastin hexamer pore by being passed between spastin monomers (Zehr 
et al. 2017). If only one of these spastin monomers was dysfunctional, the entire complex may fail. 
This would therefore lead to only a small amount of mutated protein displaying a disproportionately 
large loss of function effect. However, such missense mutations have never been identified as causing 
a more severe phenotype than other mutational classes. 
 It has been proposed that some SPAST mutations lead to a toxic gain of function (Leo et al. 
2017; Solowska et al. 2014; Solowska and Baas 2015). For example, it was shown their either 
premature stop mutations or missense mutations in M1 spastin lead to a decrease in fast axonal 
transport in giant axoplasm. However, all experiments investigating a toxic gain of function for spastin 
have used over-expression of exogenous truncated proteins which have never been identified 
physiologically. 
  




1.3.5 – The cell biology of spastin 
The domain architecture of spastin facilitates its biological function. The AAA+ domain allows spastin 
to function as a microtubule remodelling enzyme. However, the subcellular location of this activity is 
mediated by spastin’s hydrophobic hairpin, nuclear localisation, MIT, and MTBD localisation domains. 
These allow monomeric spastin to concentrate in specific locations, thereby likely facilitating hexamer 
formation and localised microtubule severing. These localisation domains therefore directly regulate 
the biological function of spastin. Furthermore, as the ATPase activity of spastin is not dependent on 
any of these domains, they are free to recruit spastin to different subcellular locations working either 
in isolation or simultaneously without affecting ATPase activity. In addition, spastin may function 
independently of its AAA+ domain, mediating its effects by presence in a membrane or complex. 
 Spastin has been reported to function in at least 10 different biological processes (Figure 8). 
A detailed analysis of each of these functions is provided below.  
 
 
Figure 8 - Diversity of spastin functions. (Left). The published mitotic and nuclear functions of spastin include 
chromatid movement, abscission, and nuclear envelope reformation. (Middle). Published growth phase generic 
functions of spastin include regulation of microtubule stability and nucleation, lipid droplet formation, 
transcriptional repression, ER morphology regulation, in ER exit, and in endosomal tubule fission. (Right) 
Published neuron specific functions of spastin include regulation of axonal outgrowth and branching, and axonal-
synapse remodelling. Details of each function are provided in the text. 
  
























Microtubule stability and nucleation 
Microtubules are essential cytoskeletal components that facilitate the long-range transport of cargos 
via molecular motor proteins kinesins and dyneins. Microtubules may exist as either stable arrays or 
dynamic filaments. The architecture of microtubules is mediated by the action of enzymes that 
regulate microtubule-end polymerisation and depolymerisation, cross-linking, and microtubule 
severing by controlling the tubulin composition and post-translational modification of the microtubule 
polymer (Janke and Chloë Bulinski 2011). 
The individual tubulin dimer subunit (α/β-tubulin) can either exist in a GTP or GDP bound 
state. During microtubule polymerisation, the GTP-bound α-tubulin protomer of the assembled 
microtubule binds the β-tubulin of an GTP-bound α/β-tubulin dimer. This causes the GTP in the binding 
site between the two tubulin dimers to be hydrolysed to GDP (Mitchison and Kirschner 1984). If the 
GTP on the α-tubulin monomer at the tip of the polymerised microtubule hydrolyses to GDP, the 
microtubule is prone to spontaneously disassemble by shrinkage (a catastrophe) (Carlier and Pantaloni 
1981). This depolymerisation either continues in the minus-end direction until the microtubule 
completely disassembles or is halted by either the plus-end tip regaining a GTP cap (a rescue), or the 
depolymerising microtubule reaching a trapped pocket of unhydrolysed GTP (Aumeier et al. 2016; 
Dimitrov et al. 2008). As a result, the higher the proportion of GTP incorporated into a microtubule 
polymer, the higher its stability. Due to the slow acting nature of tubulin post-translational 
modification enzymes on polymerised microtubules, stable microtubules often accumulate post-
translational modifications on their C-terminal tails such as detyrosination followed by glutamylation 
or acetylation (Janke and Chloë Bulinski 2011). 
Microtubule length and site of nucleation is also relevant to its function. In neurons for 
example, tubulin nucleation from the microtubule organising centre (MTOC) in the soma would likely 
limit the neuron’s ability to rapidly remodel during injury or development (Roll-Mecak and Vale 2006). 
Instead, new microtubules could be nucleated from small microtubule oligomers or severed 
microtubules in the location where microtubule reorganisation was relevant (Kalil et al. 2000; Keating 
and Borisy 1999). Importantly, the microtubule severing enzyme katanin has this function in 
Arabidopsis (Lindeboom et al. 2013), where it was shown that microtubule severing by katanin led to 
an increase in microtubule mass by nucleating the growth of new microtubules from severed 
microtubule ends. This accounted for ~80% of all new longitudinal microtubule growth, showing 
microtubule severing to be a mechanism for rapidly increasing microtubule populations. 
 




Recently spastin has been shown to function in the nucleation of new microtubules by microtubule 
severing, and the increase in microtubule stability by mediating the formation of GTP-islands (Vemu 
et al. 2018). Previous studies had shown that spastin functions to increase microtubule mass. A loss 
of spastin in Drosophila neurons was shown to result in a sparse disorganised microtubule network in 
axons at NMJs (Sherwood et al. 2004; Trotta et al. 2004). The same effect was also observed in 
zebrafish axons (Wood 2006) and mammalian cells (Schiel et al. 2011). This phenotype was similar to 
that observed upon depletion of katanin (Burk 2002; Lindeboom et al. 2013; Srayko et al. 2006).  
 Vemu et al. (2018) have recently shown the mechanism by which spastin mediates 
microtubule nucleation and enhanced stability. Spastin (and katanin) causes nanoscale damage 
(‘bites’) along the length of microtubule polymers by removing tubulin dimers via ATP hydrolysis 
(Figure 9). The amount of nanoscale damage along the microtubule is dependent on the concentration 
of spastin. This damage can be repaired by the incorporation of new GTP-bound tubulin dimers, 
creating GTP-tubulin islands within the polymerised microtubule. This results in a ~5x increase in 
probability of a microtubule rescue and regrowth during catastrophe in vitro, thereby increasing 
microtubule stability. However, if the rate of tubulin extraction by spastin (or katanin) exceeds the 
rate of tubulin incorporation, a severing event occurs. The severed microtubule has GTP bound at 
either end, protecting it from depolymerisation. This allows it to polymerise, meaning that each 
microtubule severing event increases microtubule number and mass.  
  





Figure 9 - Spastin ‘biting’ or ‘severing’ microtubules. Spastin (and katanin) form hexamers and use their AAA+ 
domain to remove tubule dimers from polymerised microtubules. These removed dimers are repaired by GTP-
bound tubulin. If the rate of tubulin removal is lower than the rate of tubulin incorporation, the area is repaired 
(blue box). If the rate of tubulin removal is higher than the rate of tubulin incorporation, the microtubule severs 
(red boxes). The severed microtubule is capped by GTP-bound tubulin, allowing the regrowth of the microtubule 
by polymerisation. Adapted from Vemu et al. (2018). 
 
The regulation of microtubule stability or new microtubule growth through microtubule severing is 
likely to drive some of the spastin-dependent biological processes associated with microtubule 
dynamics. However most functional studies have not differentiated between whether the AAA+ 
function of spastin depends on increased stability (via ‘biting’) or new microtubule formation (via 
‘severing’). One recent study however has shown that increased microtubule stability is important for 
normal peroxisome trafficking in the axon-like processes of olfactory neurosphere-derived stem cells 
(Wali et al. 2016). Spastin mutant patient-derived cells showed a decreased number of fast-moving 
peroxisomes, leading to oxidative stress. By comparison with the effect of microtubule stabilising drug 
Epothilone D on peroxisome movement, it was argued that spastin mediates peroxisome movement 
by stabilising microtubules (Wali et al. 2016). However, it is also important to note that the physical 
act of breaking the microtubule is likely to be the crucial element in other processes. Biological 
processes requiring these functions of spastin are described below.  
  




Axon outgrowth and branching 
The unique highly elongated morphology of neurons facilities their function in the transmission of 
nervous impulses. Dendrites surrounding the neuron soma receive electrical impulses from synaptic 
connections with the axon terminals of other neurons. These impulses are then rapidly transmitted 
down the length of the neuron’s axon by saltatory conduction, before being converted into 
neurotransmitter signals at the axon terminal’s synaptic connections.  
Axonal and dendritic morphology is important in regulating the connectivity of the neural 
network. This morphology can be maintained upon neuronal damage, with neurons displaying abilities 
to regrow both axons and dendrites. This extensive cell remodelling requires dramatic reshaping of 
the underlying microtubule cytoskeleton. Examples of reshaping events include the replacement of 
long stable microtubules with short microtubules, with this facilitated by microtubule severing (Hu et 
al. 2008; Yu et al. 2008, 1994). 
 
Spastin has been shown to function in regulating the morphology of neurons, both during 
development and during neuronal regeneration (Butler et al. 2010; Jinushi-Nakao et al. 2007; Rao et 
al. 2016; Riano et al. 2009; Stone et al. 2012; Wood 2006; Yu et al. 2008; Zhang et al. 2012). Wood et 
al. (2006) reported that both branchiomotor neurons and spinal motor neurons in zebrafish had a 
significant reduction in axon outgrowth upon spastin depletion. This was shown to lead to a disruption 
of axonal networks and neuromuscular synapse formation. This effect on axon outgrowth was later 
confirmed in both cultured rat and mouse hippocampal neurons depleted of spastin by siRNA (Riano 
et al. 2009; Yu et al. 2008). Later research showed that a depletion of spastin led to a strong reduction 
in microtubule-associated end-binding (EB) comets that mark the growing plus ends of microtubules 
in axonal growth cones, suggesting the necessity of microtubule remodelling in axonal growth (Butler 
et al. 2010). This suggests that this function of spastin may involve microtubule severing rather than 
biting. Furthermore, spastin was shown to interact and facilitate the function of protrudin in mediating 
neurite extension in PC12 cells and motor neuron axon outgrowth in zebrafish embryos (Zhang et al. 
2012).  
 In addition, spastin siRNA depletion led to a reduction in axonal branch frequency by 45% in 
rat hippocampal neurons (Yu et al. 2008). Overexpression of spastin led to a 70% increase in the 
number of neuronal processes, including a dramatic increase in axonal branching (Yu et al. 2008). 
Spastin was shown to concentrate both at the axonal growth cone and axonal branch points in 10 day 
cultured hippocampal neurons (Yu et al. 2008), in agreement with previous localisation studies (Errico 
2004; Svenson et al. 2005). Of note also is that the level of spastin expression has been shown to have 




differing effects on axonal morphology (Jinushi-Nakao et al. 2007; Riano et al. 2009). Whilst spastin 
loss leads to reduced neurite outgrowth, strong spastin overexpression also recreates the same effect, 
and subtle increases in spastin expression can lead to enhanced axon elongation and branching 
(Jinushi-Nakao et al. 2007; Riano et al. 2009). In Drosophila neurons, spastin levels are regulated by 
the transcription factor Knot (Jinushi-Nakao et al. 2007). The regulation of spastin’s expression by Knot 
was shown to regulate spastin’s activity at neurite arbours by microtubule severing (Jinushi-Nakao et 
al. 2007). 
Spastin is also required for axon regeneration (Rao et al. 2016; Stone et al. 2012). RNAi 
depletion of spastin in Drosophila neurons led to a significant reduction in the regeneration of axons 
from dendrites and axon stumps after proximal axotomy (Rao et al. 2016; Stone et al. 2012). The loss 
of one spastin allele by using the Drosophila mutant spastin5.75 led to the complete abolition of both 
types of regeneration (Stone et al. 2012). This however has been debated as Rao et al. (2016) showed 
that this effect was dependent on the overexpression of EB proteins. The overexpression of spastin 
also led to inefficient axonal regeneration, overall indicating that regeneration is sensitive to spastin 
dosage. These effects were not related to the reversal of microtubule polarity typically associated with 
axonal regeneration (Stone et al. 2010, 2012), but are likely to be related to microtubule dynamics 
(Rao et al. 2016). The effect of spastin on neurite regeneration is specific to axons as spastin depletion 
had no effect on dendrite regeneration (Rao et al. 2016). 
 
Axonal-synapse remodelling 
During embryonic development multiple neuronal axons form synaptic contacts at neuromuscular 
junctions (NMJ; Meltzer and Schuldiner 2016). However, in the early postnatal period, axonal pruning 
occurs so that only a single axon remains connected to the NMJ. Pruning occurs as a result of 
competition between NMJ axons, with the losing axon branch being shed from its parent neuron 
(Bishop et al. 2004; Brill et al. 2016; Walsh and Lichtman 2003). In addition, neuronal rewiring away 
from the NMJ also requires synapse elimination as well as formation (Destexhe and Marder 2004). 
 Brill et al. (2016) show that spastin functions in pruning of motor neurons at NMJs. By 
fluorescence microscopy and CLEM, it was shown that there was a substantial loss of microtubules 
specifically in axonal branches retreating from NMJs. These axon branches specifically showed high 
levels of EB protein compared to the stem axon, suggesting a highly localised dynamic remodelling of 
the cytoskeleton caused by severing. Stabilisation of these microtubules by Epothilone prevented 
axonal pruning and was phenocopied in spastin knockout (KO) neurons, which showed a significant 
reduction in the rate of axonal retraction, and an inhibition of NMJ synapse elimination. These 




retreating axon microtubules showed an ~8x increase in polyglutamylation, suggesting a mechanism 
by which spastin could specifically be recruited to axonal branches to be pruned to mediate 
microtubule severing (Brill et al. 2016; Lacroix et al. 2010; Valenstein and Roll-Mecak 2016). 
 Spastin has also been shown to function in the synaptic remodelling of GABAergic dorsal D-
type neurons in C.elegans (Kurup et al. 2015). Although most of the research was focused upon the 
action of the Mitogen-activated protein kinase kinase kinase Dlk-1, it was shown that spastin (and also 
kinesin-13) depletion led to impaired remodelling of D-type neurons. It was proposed that Dlk-1 may 




During mitotic anaphase, chromosomes are separated into chromatids and are moved to opposite 
sides of the cell towards the centrioles. This movement is facilitated by microtubules that are bound 
to the centrioles at their minus-end and the kinetochore at the centromere of the chromatid at their 
plus-end. The chromatid moves towards the centriole via a two-part mechanism termed ‘Pacman-
Flux’ (Rogers et al. 2004; Zhang et al. 2007). For the Pacman mechanism, microtubules are actively 
depolymerised by the kinetochore at their plus end, allowing the chromatids to move towards the 
centrioles by ‘chewing up’ the microtubule (Gorbsky 1987; Mitchison et al. 1986). For the Flux 
mechanism, chromatids are pulled towards the poles by depolymerisation of the microtubule from 
their minus-end at the centriole (Mitchison 1989). 
 Spastin, along with katanin and fidgetin, has been shown to function in the Pacman-flux 
mechanism of chromatid movement (Zhang et al. 2007). This provided functional relevance to the 
early localisation studies that showed spastin localises to centrosomes and spindle poles in 
mammalian cells (Errico 2004; Svenson et al. 2005). Zhang et al. (2007) showed that Drosophila spastin 
also localised to centrosomes. Significantly, inhibition of spastin by RNAi led to a decrease in the rate 
of poleward chromatid flux in both metaphase and anaphase. Spastin likely mediates this by 
facilitating the turnover of tubulin at the centrosome via microtubule severing. This releases the 
microtubule minus end from the nucleating complex, allowing it to be depolymerised by kinesin-13. 
Despite this work however, no other studies have been performed to further elucidate the mechanism 
of spastin function in chromatid migration. 
  




Nuclear envelope reformation 
In mitotic prometaphase the nuclear envelope breaks down to allow the attachment of microtubule 
spindle fibres to the kinetochores of chromatids. After chromatid separation in anaphase, the nuclear 
envelope reforms in telophase, but requires the spindle fibres that connect the chromatids to the 
centrioles to be removed to allow the complete nuclear membrane sealing (Vietri et al. 2015). In 
addition, small gaps in the nuclear envelope are closed by ESCRT-III proteins, in particular CHMP7 
(Olmos et al. 2015). 
 Spastin functions to disrupt spindle microtubules at the nuclear envelope to allow nuclear 
envelope reformation (Vietri et al. 2015). Vietri et al. (2015) show by siRNA depletion and fluorescence 
microscopy that CHMP7 facilitates the recruitment of CHMP4B to the nuclear envelope during 
anaphase. By correlative light and electron microscopy (CLEM) and super resolution structural 
illumination microscopy (SIM), CHMP4B was shown to localise specifically to sites of unclosed nuclear 
envelope that also contained microtubules. Depletion of other ESCRT-III components CHMP2A and 
IST1 impaired the disassembly of these microtubules, suggesting their function at the site of 
microtubule-nuclear envelope interface. Either depletion of spastin or mutation of IST1’s MIMs led 
these microtubules to persist at these sites. Furthermore, by confocal imaging, live-cell imaging, and 
SIM, both M1 and M87 spastin was shown to localise directly to these sites. Together, this implies that 
spastin is recruited by ESCRT-III proteins to sever these nuclear-envelope protruding microtubules to 
allow nuclear envelope closure. Remarkably, the MTBD was not required for this process, further 
showing that not all of spastin’s localisation domains need to function simultaneously to localise 
spastin for its severing activity. 
 
Abscission 
During mitotic telophase, the two daughter nuclei are physically separated by cleaving the cytoplasmic 
join at the centre of the mother cell. This separation is termed cytokinesis and is a complex process 
requiring the coordinated spatio-temporal recruitment of abscission machinery. These function to 
contract the membrane surrounding the site of abscission (the midbody) until the two edges of the 
cell membrane touch and the two daughter cells separate. An important process during abscission is 
the removal of cytoskeletal elements (e.g. microtubules) from the midbody to allow complete 
cleavage (Steigemann and Gerlich 2009). 
 Spastin functions at cytokinetic midbodies to facilitate abscission (Connell et al. 2009; Goliand 
et al. 2018; Guizetti et al. 2011). Spastin shows a strong specific recruitment to the midbody in cells 
undergoing cytokinesis (Connell et al. 2009; Errico 2004; Yang et al. 2008), forming a double ring 




structure (Connell et al. 2009). By siRNA depletion experiments, the ESCRT-III protein CHMP1B was 
shown to be essential for spastin’s recruitment via interacting with spastin’s MIT domain (Yang et al. 
2008). The importance of spastin’s MIT domain in recruitment was also shown by the expression of a 
spastin mutant lacking the N-terminus and the MIT domain (Connell et al. 2009).  
 Depletion of spastin using siRNAs revealed that spastin was essential for efficient cytokinesis 
(Connell et al. 2009). This was also observed by RNAi experiments studying abscission in the 
trypanosome Trypanosoma brucei (Benz et al. 2012). Depletion of spastin in mammalian cells led to 
the formation of extended cytokinetic bridges containing tubulin that took an abnormally long time 
to break (Connell et al. 2009). This was also confirmed in spastin KO cells, and it was shown that when 
cytokinetic bridge is finally cleaved, it is cleaved adjacent to one of the cells rather than at the typical 
constriction zone (Goliand et al. 2018).  
 Spastin’s role in abscission is suggested to be via its microtubule severing activity. By the 
expression of a Walker-A AAA+ domain K338R spastin mutant, it was shown that extended cytokinetic 
bridges also formed upon impaired spastin ATPase activity (Connell et al., 2009). This was confirmed 
by Guizetti et al. (2011) who showed both that the timing of abscission correlates with microtubule 
disassembly, and that this microtubule disassembly is driven by spastin. It was further shown that 
there is strong high resolution colocalisation between spastin and the ESCRT-III machinery to facilitate 
membrane constriction, indicating both a spatial and temporal coordination between microtubule 
severing and membrane constriction (Guizetti et al. 2011). This however contradicts evidence by Schiel 
et al. (2011) who show that spastin depletion did not induce microtubule severing at the abscission 
site, but rather led to highly disordered microtubule arrays. Additionally, it was shown recently in 
spastin KO cells that spastin is required for helical ESCRT-III polymers to appropriately compress to 
constrict the cytokinetic bridge (Goliand et al. 2018). This is suggested to be due to a failure of the 
underlying microtubules being severed. 
 
  




Lipid droplet formation and metabolism 
Cells store neutral lipids such as cholesterols and triacylglycerols in the form of lipid droplets (Fujimoto 
and Parton 2011). These form from the ER membrane and are either found attached to the ER or 
unattached in the cytoplasm. They are able to vary in size dramatically based on whether depending 
on the cellular balance of lipid synthesis and hydrolysis, with proteins on the surface of the lipid 
droplet mediating lipid metabolism (Welte 2015). 
 Papadopoulos et al. (2015) show that both overexpressed and endogenous M1 spastin 
recruits to lipid droplets. This colocalisation increased after cells were treated with oleic acid to 
stimulate lipid droplet biosynthesis. Mutation experiments showed that the localisation of 
overexpressed M1 spastin on lipid droplets was mediated by the hydrophobic hairpin-loop domain 
and is dependent upon an arginine at amino acid 65. As a result, M87 spastin does not recruit to lipid 
droplets. High levels of spastin expression led to fewer but larger lipid droplets in both mammalian 
cells and Drosophila. Depletion of spastin in Drosophila and C.elegans, but not mammalian cell 
cultures, led to a reduction in lipid droplets. In addition, the MTBD of spastin was required to avoid 
the nuclear clustering of lipid droplets. 
 Despite this work, the precise mechanism of spastin’s function in lipid droplet biology remains 
to be elucidated. The decrease in lipid droplet formation observed upon the depletion of spastin in 
Drosophila and C.elegans implies it may function in lipid droplet formation. This would place spastin 
with other HSP proteins involved in lipid droplet metabolism such as seipin, spartin, REEP1, and 
DDHD2. 
 
ER morphology regulation 
The ER is a continuous membrane that links the nuclear envelope and peripheral ER by a series of 
tubules, tubular matrices, and sheets (Nixon-Abell et al. 2016; Schwarz and Blower 2016). ER 
morphology is essential for its function in forming ER-organelle contacts (Rowland et al. 2014; Wu et 
al. 2018). ER morphology is controlled by a large number of proteins, including the atlastins and 
lunapark which mediate ER-tubule junction formation and stabilisation, the REEPs, reticulons and 
protrudin which mediate ER-tubule curvature, Climp63 which mediates sheet formation, and ER-
microtubule interacting proteins such as STIM1 (Schwarz and Blower 2016). 
 M1 spastin has been shown to interact with the ER shaping proteins atlastin-1 and REEP1 (Park 
et al. 2010; Sanderson et al. 2006), protrudin (Chang et al. 2013; Mannan et al. 2006; Zhang et al. 
2012), and reticulon-1 and reticulon-2 (Mannan et al. 2006; Montenegro et al. 2012). These 




interactions require the N-terminal hydrophobic hairpin-loop (Chang et al. 2013; Park et al. 2010). 
These hydrophobic hairpins insert into the outer leaflet of the ER lipid bilayer and have been shown 
to be necessary to generate membrane bending required for ER tubule formation (Goyal and 
Blackstone 2013). 
 Despite the interaction with ER shaping proteins, it is unclear therefore whether M1 spastin 
regulates ER morphology physiologically. ER architecture is regulated by microtubule dynamics and 
motors (Goyal and Blackstone 2013), and overexpression of ATPase defective mutant spastin led to a 
dramatic redistribution of ER onto bundled microtubules (Connell et al. 2009), suggesting that 
microtubule severing by spastin was important in regulating ER architecture. In addition to working 
enzymatically, spastin may also provide a mechanism of facilitating ER-microtubule interaction by 
simultaneously binding the ER via its hydrophobic hairpin-loop domain, and microtubules via its 
MTBD. In addition, spastin was shown to function in the recruitment of ER to the tip of axons 
regenerating from axonal damage (Rao et al. 2016). 
 
EMX2 transcriptional corepression 
Early studies of spastin identified M87 spastin both in the cytoplasm and the nucleus (Beetz et al. 
2004; CLAUDIANI et al. 2005; Connell et al. 2009). This is mediated by the presence of a nuclear 
localisation signal but no export signal (as described in Section 1.3.3).  
To date, only one publication has shown a functional effect of spastin in the nucleus. Daftary 
et al. (2011) reported that endogenous spastin was co-immunoprecipitated with the nuclear 
transcription complex HOAX10 by mass spectrometry in uterine epithelial Ishikawa cells. This was also 
verified by co-immunoprecipitation and western blotting using a spastin antibody. By chromatin 
immunoprecipitation (ChIP), spastin was shown to specifically bind to the HOAX10-binding EMX2 
promoter element. Spastin likely functions as a corepressor of EMX2, as siRNA depletion of spastin led 
to a significantly increased expression of EMX2. This was also validated in a breast adenocarcinoma 
cell line BT-20. In addition, Daftary et al. (2011) showed by mutation experiments that the nuclear 
localisation signal of spastin was required for its function in EMX2 repression. 
Despite the relative lack of research of spastin’s function in the nucleus, this is an area worthy 
of revisiting. For example, despite Daftary et al. (2011) characterising spastin-HOAX10 function on 
EMX2 repression in uterine cells, EMX2 has been shown to play an important role in neuronal 
development and in the cerebral cortex (Desmaris et al. 2018; Falcone and Mallamaci 2015; Ji et al. 
2018; Zhang et al. 2018). Furthermore, spastin’s ESCRT-III interacting protein CHMP1B localises to the 




nucleus (Reid et al. 2005), and recently in a non-peer-reviewed paper, Talledge et al. (2018) show that 
the spastin-interacting CHMP1B-IST1 complex is able to bind nucleic acids. 
 
ER exit 
Proteins that are correctly folded in the ER are transported from the ER to the Golgi via COPII-coated 
vesicles that form at ER exit sites (ERES; Venditti, Wilson, and De Matteis 2014). M1 spastin localises 
to ERES, and overexpressed ATPase defective spastin, but not spastin depletion, was shown to impair 
cargo secretion (Connell et al. 2009). As a result, the function of spastin at ERES is currently unclear. 
This unknown function of spastin is the topic of investigation in Chapter 4. 
 
Endosomal tubule fission 
Cargos in the endocytic pathway may either be degraded in the lysosome or are retrieved from 
degradation and recycled back to the site of origin. This recycling occurs via the fission of endosomal 
tubules from the sorting endosome (Maxfield and McGraw 2004). Depletion of spastin, or mutations 
in spastin’s MIT or AAA+ domains, lead to the formation of abnormally long endosomal tubules, and 
cause the mistrafficking of typically recycled cargos such as transferrin receptor (TfnR; Allison et al. 
2013). It was predicted that elongated tubules resulted from a failure in endosomal tubule fission, but 
this was not tested experimentally. This unknown function of spastin in endosomal tubule fission is 
the topic of investigation in Chapter 3, and an introduction to the sorting endosome and membrane 
fission mechanisms are provided below. 
  




1.4 – Endocytic Recycling 
The first results chapter of this thesis investigates the function of spastin in the fission of endosomal 
recycling tubules from sorting endosomes (Chapter 3). The key features of sorting endosome biology 
and membrane fission are reviewed below. 
 
1.4.1 – Sorting endosome identity 
The sorting endosome is an intermediary endocytic structure that is at the centre of fate decisions in 
the endocytic pathway. The sorting endosome receives input from both the cell surface and the Golgi 
apparatus, and sorts cargo to be transported either back to the cell surface, to the Golgi apparatus, to 
specialised organelles such as melanosomes, or to the lysosome via multivesicular body (MVB) 
formation (McNally and Cullen 2018). 
The sorting endosome is in a constant state of flux, being continuously formed through the 
maturation and homotypic fusion of plasma membrane-derived vesicles and fusion with Golgi-derived 
vesicles, and dismantled by membrane export through recycling tubule fission and MVB formation 
(Figure 10). As a result, it is typically characterised by its acidity, its membrane composition, and the 
identity of associated proteins (Naslavsky and Caplan 2018).  
As endocytosed cargo moves from the plasma membrane to the lysosome, the lumenal 
environment of the endosome becomes increasingly acidified (Mellman et al. 1986). This is mediated 
by the action of vacuolar H+-ATPases (V-ATPase), and in early endosomes by the a2-isoform of the V-
ATPase (Hurtado-Lorenzo et al. 2006). This acidity increase facilitates the dissociation of cargo from 
their receptors, allowing cargo to be degraded in the lysosome, and their receptors to be recycled 
(Mellman 1992). The sorting endosome is typically at ~pH6.2, more basic than late endosomes (<pH 
5.5) and lysosomes (as low as pH 4.6) (Mellman 1992).  
The sorting endosome also has a distinct membrane lipid composition, typified by enriched 
presence of PI3P (Corvera et al. 1999), although other phosphoinositides such as PI4P and PI(4,5)P2 
have also been identified on endosome subdomains (Dong et al. 2016; Yoshida et al. 2017). This 
confers distinct membrane identity, differentiating the sorting endosome from the plasma membrane 
and late endosomes, typically characterised by the enriched presence of PI(4,5)P2 and PI(3,5)P2 
respectively (Balla 2013; Corvera et al. 1999; Shaw et al. 2003). The enrichment of PI3P on sorting 
endosomes is mediated by the activity of class III PI3 kinases on phosphatidylinositol (Murray et al. 
2002). The high composition of PI3P on endosomes is important as it facilitates the binding of effector 
proteins that contain FYVE and phox homology (PX) domains (Kanai et al. 2001; Xu et al. 2001). 




Examples of these proteins include early endosome antigen 1 (EEA1) and rabenosyn-5 which both bind 
Rab5 (Nielsen et al. 2000). 
The Rab-GTPases (Rabs) are crucial proteins in defining membrane identity (Wandinger-Ness 
and Zerial 2014). Rabs are numerous and diverse, with each functioning as an effector to mediate the 
activity of the bound organelle or vesicle. Rabs exist either in their cytosolic inactive GDP-bound state, 
or their membrane-bound active GTP-bound state (Progida and Bakke 2016). Transition between 
different Rabs on endocytic membranes is a key characteristic of endosome maturation. The early 
endocytic pathway is characterised by the presence of Rab5, Rab4, and Rab11 (Bucci et al. 1992; van 
der Sluijs et al. 1992; Ullrich et al. 1996), and is distinct from the late endosome/MVB which is 
characterised by Rab7 (Feng et al. 1995). In addition, Rab13, Rab22, Rab35, Rab15, and Rab17 are all 
associated with endocytic recycling from the sorting endosome (Wandinger-Ness and Zerial 2014). 
Rab proteins mediate their effects via effector proteins that can influence diverse processes such as 
phosphoinositide metabolism, microtubule motor protein activation, and complex recruitment such 
as retromer (Wandinger-Ness and Zerial 2014). Due to the central position between the early 
endocytic pathway, the late endocytic pathway, and the recycling pathways, the sorting endosome 
can have multiple Rab identities, although these divide into spatially-separate subdomains 
(Sönnichsen et al. 2000). 
 
1.4.2 – Sorting endosome input pathways 
Sorting endosomes predominantly receive their cargo and membrane input from the cell surface and 
from the Golgi apparatus (Figure 10). At the cell surface, endocytosis facilitates the internalisation of 
external cargo into the cell. There are different modes of endocytosis, including macropinocytosis, 
phagocytosis, and via caveolae, but the major route of the internalisation of many cargos is via 
clathrin-mediated endocytosis (CME) (Kaksonen and Roux 2018). CME facilitates the internalisation of 
transmembrane proteins typically bound to extracellular ligands. One example is endocytic 
internalisation of transferrin receptor upon its binding to an extracellular transferrin-iron complex. 
During endocytosis, the binding of cargo to its receptor leads to the clustering of coat proteins on the 
cytoplasmic side of the plasma membrane. This is mediated by adaptor proteins such as adaptor 
protein 2 (AP2) and clathrin assembly lymphoid myeloid leukaemia protein (CALM). This leads to 
membrane bending to form a cargo filled clathrin-coated pit which is then scissioned by 
Bin/Amphiphysin/Rvs (BAR) domain-containing proteins such as FCH domain only 1 (FCHO1) and 
endophilin, and the GTPase dynamin. The clathrin-coat of clathrin-coated vesicles (CCVs) rapidly 




disassembles, allowing the maturation of the vesicle to an early endosome/sorting endosome by Rab5 
recruitment (Kaksonen and Roux 2018). 
 The second input pathway for sorting endosomes is from the trans-Golgi network (TGN). This 
route is used by proteins such as the hydrolytic lysosomal cathepsin enzymes, and the lysosome-
associated membrane proteins (LAMPs), via their interaction with transmembrane sorting receptors 
such as mannose-6-phosphate receptor (M6PR) and sortilins (Progida and Bakke 2016). In the example 
of M6PR-dependent transport, newly synthesised soluble lysosomal enzymes are glycosylated with 
mannose-6-phosphate in the Golgi, allowing them to interact with M6PR. In a manner similar to CME, 
once these receptor-ligand interactions have formed, adaptor proteins such as ADP-ribosylation-
factor-binding proteins (GGAs) and adaptor protein 1 (AP1) lead clathrin coat requirement, and 
ultimately the formation of endosome-directed CCVs (Progida and Bakke 2016). This is facilitated by 
the PI4P composition of the TGN (J. Wang et al. 2007) and Rabs such as Rab31 and Rab9 (Rodriguez-
Gabin et al. 2009). It is worth noting that M6PRs exist as both cation-independent (CI-M6PR) and 
cation-dependent (CD-M6PR) forms. These have distinct but similar functions in Golgi to endosome 
trafficking, but CI-M6PR has additional functionality at the cell surface (Ghosh et al. 2003). In addition, 
there are M6PR-independent TGN to endosome transport pathways. LAMPs, for example, are 
trafficked independently of M6PR via adaptor protein 3 (AP3) (Pols et al. 2013). 
 Vesicles derived from the cell surface and the TGN converge via microtubule-based transport 
at sorting endosomes. A crucial process is the fusion of these vesicles to generate sorting endosomes 
with a similar membrane identity. Vesicle fusion is mediate by the formation of trans-soluble NSF 
attachment protein receptors (SNAREs) complexes. SNAREs involved in endocytic vesicle fusion 
include syntaxin 6 and syntaxin 13 (McBride et al. 1999; Simonsen et al. 1999) via EEA1-dependent 
recruitment (Gorvel et al. 1991). TGN-derived vesicles containing LAMPs contain hVPs41 and VAMP7 
SNARES to mediate their fusion with endosomes via endosomal syntaxin 7 and syntaxin 8 (Dingjan et 
al. 2018; Pols et al. 2013). In addition, TGN-derived vesicles use VAMP4 to associate with early 
endosomes (Steegmaier et al. 1999). 
  





Figure 10 - Cargo sorting in the endocytic pathway. Cargo predominantly arrives at the sorting endosome via 
two main pathways: from the plasma membrane via endocytosis (e.g. EGFR, CI-M6PR, TfnR), and from the TGN 
via M6PR-dependent or independent Golgi to endosome traffic (e.g. lysosomal hydrolases). Cargo that recycles 
back to the cell surface can do so via SNX4-dependent trafficking, either via a direct pathway, or via the endocytic 
recycling compartment. Cargo that recycles back to TGN is typically associated with SNX1-coated endosomal 
tubules. The fission of endosomal recycling tubules occurs at sites of ER-endosome contact, and the fissioned 
tubule is transported on microtubules via microtubule motors. Cargo that is not recycled is internalised into 
MVBs and is ultimately degraded in the endolysosome. Cartoon adapted from Allison et al. (2017). 
 
1.4.3 – Cargo sorting within the sorting endosome 
Once the receptor-ligand complex has dissociated, endosomal cargos must be separated between 
those destined for degradation or recycling. Further complexity is added as recycling pathways have 
multiple destinations such as the TGN or cell surface, and multiple recycling pathways exist for 
different cargos recycled to the same destination (Hsu et al. 2012). 
 An original mechanism proposed for the separation of recycled vs degraded cargo was 
‘geometric-based sorting’ (Maxfield and McGraw 2004). This model worked on the basis that: 1) 
receptor-ligand complexes disassemble as a result of increased acidity in the sorting endosome, 
leaving a to-be-recycled membrane fraction, and a to-be-degraded luminal fraction; 2) membranous 
tubules protrude from the body of the sorting endosome are required for recycling (Marsh et al. 1986); 




















scission of these tubules, recycled cargo could be separated from degraded cargo (Dunn 1989; 
Maxfield and McGraw 2004). 
 However, it is now clear that this model is inadequate in accommodating recycling pathway 
diversity. In addition, it fails to explain how integral membrane proteins are lysosomally degraded. 
Instead, it has now been shown that cargo sorting is facilitated by sequence-dependent cargo capture 
by multimeric protein complexes on sub-domains of the sorting endosome (Hsu et al. 2012; McNally 
and Cullen 2018). These complexes include retromer, retriever, the CCDC22, CCDC93, and COMMD 
(CCC) complex, and the Wiskott-Aldrich syndrome protein and SCAR homolog (WASH) complex (Figure 
11). These function to concentrate cargo to be recycled in a specific subdomain of the sorting 
endosome that ultimately becomes the endosomal recycling tubule. 
 
Lysosomal degradation 
Cargos destined for lysosomal degradation are internalised into intraluminal vesicles (ILVs) within the 
sorting endosome. This internalisation blocks the ability of transmembrane receptors such as EGFR 
from signalling to the cytosol (Raiborg and Stenmark 2009). The sorting endosome progressively 
matures into a multivesicular body (MVB) as recycled cargos are removed from the sorting endosome 
in endosomal tubules and cargos-to-be-degraded are internalised into ILVs. Cargo degradation occurs 
when the MVB fuses with a lysosome to form an endolysosome, with lysosomal lipases digesting the 
membrane of the ILVs to expose transmembrane proteins to lysosomal proteases (Raiborg and 
Stenmark 2009; Figure 10). 
 Cargo internalisation into ILVs is mediated by the action of ubiquitin ligases and the ESCRT-0, 
-I, -II, -III complexes. Cargos destined for degradation are tagged with polyubiquitin lysine-63 chains 
by E3 ubiquitin ligases during the cargo’s endocytosis and residency in the sorting endosome, with 
one example being the ubiquitination of EGFR by c-Cbl (Duan et al. 2003; Grøvdal et al. 2004; Ravid et 
al. 2004). This ubiquitination attracts the binding of ESCRT-0 proteins such as Hrs and STAM which 
contain ubiquitin-binding motifs in their VHS domains (Ren and Hurley 2010). In addition, the ESCRT-
0 proteins contain clathrin-binding domains, helping form clathrin-rich microdomains on the 
endosomal membrane to cluster ubiquitinated cargos (Raiborg 2001; Sachse et al. 2002). Importantly, 
the ESCRT-0 proteins facilitate the localisation of ESCRT-I proteins to the ubiquitinated cargo, with this 
allowing the subsequent recruitment of ESCRT-II proteins. Both ESCRT-I and ESCRT-II proteins are able 
to bind the endosome membrane, and the ESCRT-I complex has been suggested to begin the 
membrane deformation to generate invaginations in which cargos-to-be-degraded are concentrated 




(Kostelansky et al. 2007). ESCRT-II proteins facilitate the binding of ESCRT-III complexes such as CHMP2 
and CHMP3 proteins. These ESCRT-III proteins form extended polymers that contain large regions of 
basic amino acids allowing a strong interaction with the phospholipid-rich membrane (Williams and 
Urbé 2007). ILVs are then generated by the continued invagination of the membrane and their 
eventual closure mediated by the joint action of ESCRT-III proteins and the ATPase VPS4 (Raiborg and 
Stenmark 2009). The proposed mechanism of ESCRT-III mediated membrane deformation and scission 
is discussed in Introduction Section 1.5. 
 
Figure 11 - Cargo sorting machinery of the sorting endosome. (1) The WASH complex facilitates the 
polymerisation of branched actin on the endosome membrane via WASH1 and is recruited to the endosome by 
its FAM21 tail, either by direct binding to the membrane, or by interaction with endosomal proteins such as 
retromer. This FAM21 tail also facilitates its interaction with the CCC complex. (2) The heterotrimer retromer is 
recruited to the endosomal membrane by interaction with Rab7 and SNX3. SNX3 and SNX27 act as cargo 
adaptors allowing it to bind to additional cargo. Cargo with φxL/M (φ = aromatic amino acid; x = any amino acid) 
can bind directly to retromer. Retromer interacts with FAM21 of WASH via VPS35. (3) The CCC complex interacts 
with the FAM21 tail of WASH and retriever through an unknown mechanism. It may also bind cargo directly. (4) 
The heterotrimer retriever is recruited to membrane via interaction with WASH, mediated by the CCC complex, 
although its interaction site with the CCC complex is not known. It uses SNX17 as a cargo adaptor, allowing the 
sorting of cargo with NPxY or NPxF motifs. Cartoon adapted from McNally & Cullen, 2018. 
 
Cargo recycling 
The pentameric WASH complex is composed of WASH1, FAM21, CCDC53, strumpellin, and strumpellin 
and WASH interacting protein (SWIP; Derivery et al. 2009). The WASH complex is recruited to the 
endosome membrane through FAM21 which can both directly bind PI3P on the endosome membrane 
(Derivery et al. 2009), or bind endosomal proteins such as FK506-binding protein 15 (FKBP15) (Harbour 
et al. 2010), RME-8 (Freeman et al. 2014), and the VPS35 subunit of retromer (Harbour et al. 2012; 
McGough et al. 2014). The WASH complex is essential for the recycling of many cargos, including 




cation-independent M6PR (CI-M6PR) (Gomez and Billadeau 2009), transferrin receptor (TfnR) 
(Derivery et al. 2009), and β2-adrenergic receptor (Puthenveedu et al. 2010). 
 WASH has several functions in mediating cargo sorting. The first is in the polymerisation of 
branched actin on the endosome surface. This is mediated by WASH1 which functions as a nucleation 
promoting factor for the actin polymerising enzyme Arp2/3 (Puthenveedu et al. 2010). The branched 
actin has two purposes: to generate distinct retrieval subdomains on the endosome (Derivery et al. 
2012); and to help generate and stabilise endosomal recycling tubules (Puthenveedu et al. 2010). Actin 
polymerisation by WASH is initiated by PI4P and was recently shown to be regulated by ER-endosome 
contact formation, with these contacts allowing endosomal PI4P to be removed by ER-resident PI4P 
phosphatase Sac1 in conjunction with oxysterol-binding protein 1 (OSBP1) (Dong et al. 2016). The 
second function for WASH in mediating cargo sorting is by acting as a scaffold for the recruitment of 
multimeric retrieval complexes. For example, WASH facilitates the recruitment of the CCC complex 
and retriever onto endosomal membranes (McNally et al. 2017).  
 
Retromer is involved in the retrograde transport of cargo back to the TGN (Seaman et al. 1998) and 
recycling of cargo to the cell surface (Steinberg et al. 2013). In mammals, retromer is formed of a 
hetero-trimer of vacuolar protein sorting-associated 26 (VPS26), VPS35, and VPS29 (Seaman et al. 
1997). This can bind directly to cargo via motifs in cargo’s cytosolic tails, with examples including the 
φxL/M motif (φ=aromatic AA, x=any AA) of iron transporter diavalent metal transporter 1 (DMT1-II) 
(Tabuchi et al. 2010), and the FANSHY motif of sortilin-related receptor L (SORL1) (Fjorback et al. 
2012). In addition, retromer can bind cargo adaptors to increase the range of cargo it can interact with 
(Lucas et al. 2016). Examples include the binding of SNX3, allowing retromer interaction with DMT1-II 
(Lucas et al. 2016) and the recycling of Wnt sorting receptor Wntless (Harterink et al. 2011), and the 
binding of SNX27, allowing retromer interaction with PDZbm domain-containing proteins such as 
glucose transporter GLUT1 and B2-adrenoreceptor that interact with SNX27’s PDZ domain, and with 
NPxY-NxxY motif-containing proteins that bind SNX27’s FERM-like domain (Ghai et al. 2011; Lauffer et 
al. 2010; Steinberg et al. 2013). The binding of retromer to SNX3 and Rab7 facilitates its binding to the 
endosome membrane (Rojas et al. 2008; Seaman et al. 2009). 
In addition, retromer is able to interact with the SNX-BAR family of proteins (Hierro et al. 
2007). These proteins form hetero-dimers composed of either SNX1 or SNX2 and SNX5, SNX6, or 
SNX32 (Wassmer et al. 2006; van Weering et al. 2012). These proteins contain a BAR domain that are 
able to sense and induce membrane curvature, allowing the formation of endosomal recycling tubules 
(Carlton et al. 2004; Peter 2004). Their interaction with retromer couples both tubule formation and 




cargo selection, allowing recycled cargo to be packaged into recycling tubules. In addition, these SNX-
BAR proteins are also able to directly interact with cargos such as CI-M6PR and insulin-like growth 
factor 1 receptor (Kvainickas et al. 2017; Simonetti et al. 2017). 
 
The recently discovered retriever complex bears similarities to retromer (McNally et al. 2017). It is a 
hetero-trimer composed of the retromer component VPS29, the VPS26 paralog Downs syndrome 
critical region 3 (DSCR3), and C16orf62 (McNally et al. 2017). Like retromer, retriever interacts with 
WASH, and also interacts with SNX17 and the CCC complex. The binding of retriever to SNX17 
facilitates cargo recruitment via its FERM-like domain binding cargos such as α5β1 and T-cell receptor 
that contain NPxY or NPxF motifs (McNally et al. 2017; Osborne et al. 2015). SNX17 is able to bind 
membrane via its PX domain but also localises to endosomal membranes via the CCC complex which 
interacts with the WASH component FAM21 (McNally et al. 2017). 
 
The CCC complex is a three-protein complex composed of the heterodimer of coiled-coil domain-
containing protein 22 (CCDC22), and CCDC93, and a member of the copper metabolism MURR1 
domain-containing (COMMD) protein family (Phillips-Krawczak et al. 2015). It is able to interact with 
membrane by binding to FAM21 of the WASH complex, and retriever (McNally and Cullen 2018). In 
this way, it facilitates the action of retriever in cargo retrieval and recycling. Indeed, when depleted, 
integrin α5β1 trafficking is impaired (McNally et al. 2017). 
 In addition to its function in a complex with WASH and retriever, it is likely that the CCC is also 
able to independently bind cargo (Bartuzi et al. 2016; Li et al. 2015). A CCC complex containing 
COMMD9 was shown to function in the retrieval and recycling of developmental receptor Notch 2 (Li 
et al. 2015), and a complex containing COMMD1 was shown to function in the recycling of ATP7A and 
low-density lipoprotein receptor (LDLR) (Bartuzi et al. 2016; Phillips-Krawczak et al. 2015). 
 
1.4.4 – Endosomal recycling tubule formation 
Recycled cargos are physically partitioned into long sorting endosome membrane protrusions. These 
protrusions, ‘endosomal recycling tubules’, undergo fission away from the main body of the sorting 
endosome, allowing microtubule-based transport of recycled cargos to either the cell surface, the 
TGN, or other destinations. Due to the hydrophobic effect, the structure of the high surface area low 
volume endosomal tubule is energetically unfavourable compared to the spherical parent sorting 
endosome (Qualmann et al. 2011). As a result, energy is required to deform the sorting endosome 




membrane into tubules. This deformation is mediated by the sorting nexins (SNXs), and cytoskeletal 
elements actin, microtubules, and motor proteins. 
 An important subgroup of SNX proteins involved in endosomal tubule formation is the SNX-
BAR proteins. These, like all SNX proteins, contain a phosphoinositide-binding PX domain, but at their 
C-terminal contain a BAR domain (Carlton et al. 2004). SNX-BAR proteins dimerise to form a rigid 
curved structure. Rigidity is conferred by a tightly-packed 6 helix central bundle, and the curvature 
can range from 10o at the lowest (e.g. F-Bar proteins), to 30o (N-Bar proteins) (Qualmann et al. 2011). 
In addition, SNX-BAR proteins are able to self-associate to form large lattice structures, mediated by 
‘tip-to-tip’ contact between the BAR-domain tip loop of different SNX proteins (Dislich et al. 2011; van 
Weering et al. 2012). The banana-shaped BAR module displays positive charges on its membrane 
binding surface, facilitating interaction with the negatively charged phospholipids of the endosomal 
membrane (Peter 2004). In total, these properties allow SNX-BAR proteins to bind curved membrane, 
but due to the protein’s rigidity and self-associating lattice formation this also means that bound 
membrane is deformed to the shape of the protein (Qualmann et al. 2011). In addition, the presence 
of a N-terminal amphipathic helices in the N-BAR subset of proteins facilitates additional membrane 
bending by the partial embedding into the membrane bilayer, in a manner similar to that proposed in 
ER shaping (Gallop et al. 2006). 
 By in vitro experiments not all SNX-BAR proteins induce membrane curvature (van Weering et 
al. 2012). However, many SNX-BAR proteins that do not induce membrane curvature heterodimerise 
with proteins that are able to induce curvature. These include SNX1, SNX2, and SNX4 (van Weering et 
al. 2012). As a result of curvature-inducing SNX-BAR lattice formation, the relatively low-curvature of 
the sorting endosome membrane is modelled into the high curvature structure characteristic of an 
endosomal tubule (van Weering et al. 2012). In addition to being able to directly bind cargo (Kvainickas 
et al. 2017), these SNX-BAR proteins are recruited by retromer to the site of cargo capture. This allows 
the site of the tubule formation to be correlated with a high concentration of cargo to be recycled. It 
should be noted however that not all endosomal tubules contain the same SNX-BAR proteins. For 
example, SNX1-containing endosomal tubules recycle cargo to the TGN (Carlton et al. 2004), whereas 
SNX4-containing endosomal tubules recycle to the plasma membrane via a perinuclear endosomal 
compartment termed the recycling endosome (Traer et al. 2007).  
 
  




Actin polymerisation by WASH is also thought to stabilise the formation of endosomal tubules (Dong 
et al. 2016; Puthenveedu et al. 2010). Endosomal tubules can be observed to be decorated in a highly 
localised actin cytoskeleton, and inhibition of actin led to a 25% reduction in the number of endosomal 
tubules (Puthenveedu et al. 2010). WASH also binds to tubulin, potentially helping coordinate actin 
and microtubule recruitment onto endosomal tubules (Gomez and Billadeau 2009). 
 Microtubules have an important role in endosomal tubule formation (Hunt et al. 2013). In 
vitro studies show that kinesins are able to pull tubules from liposomes (Roux et al. 2002), and electron 
microscopy shows endosomal tubules in close proximity to microtubules (Friedman et al. 2013). The 
microtubule motor dynein is required for the formation of transferrin-positive endosomal tubules 
(Horgan and McCaffrey 2011; Palmer et al. 2009). Microtubule motors can couple to SNX proteins of 
endosomal tubules (Hunt and Stephens 2011; Wassmer et al. 2009; van Weering et al. 2010), with one 
example being the coupling of SNX5 to dynein via the dynactin complex (Hong et al. 2009). Hunt et al. 
(2013) define dynein-1 and kinesin-1 motors associating with SNX1 labelled membranes, and dynein-
1 and kinesin-2 motors for SNX4 labelled membranes. In addition, the microtubule motor kinesin 13A 
(KIF13A) localises to endosomal tubules, and its depletion leads to a reduction in the number of 
recycling tubules that emanate from the sorting endosome (Delevoye et al. 2014). Conversely, 
overexpression of KIF13A leads to a dramatic endosomal tubulation (Delevoye et al. 2014). 
 
1.4.5 – Endosomal tubule fission 
The first results chapter of my thesis provides a detailed discussion of endosomal tubule fission. In 
addition, a more general introduction to membrane scission mechanisms is provided in the following 
section (Introduction Section 1.5). 
  




1.5 – Membrane scission 
Membrane scission describes the process where two edges of a continuous lipid membrane come 
together resulting in the production of two distinct lipid membrane structures. This process is 
ubiquitous in eukaryotes, facilitating processes such as cellular abscission, MVB formation, 
endocytosis, viral exit, mitochondrial division, ER remodelling, and endosomal tubule fission (Shibata 
et al. 2009). This process may be driven by two types of process: 1) passive remodelling by processes 
such as amphipathic helix insertion; or 2) NTP-hydrolysing processes such as by scission machinery 
dynamin or ESCRT, or by cytoskeletal polymers actin or microtubules (Renard et al. 2018). Spastin has 
been associated with both types of membrane remodelling. 
 
 
Figure 12 - Modes of passive membrane scission. (Top) Amphipathic helix insertion into the outer leaflet of the 
lipid bilayer induces curvature due an increase in surface area of the outer leaflet compared to the inner leaflet. 
If insertion is at a high concentration, scission can occur. (Bottom) The insertion or binding of a high density of 
proteins to the outer leaflet of a lipid bilayer can induce membrane deformation and fission. This occurs by the 








1.5.1 – Passive membrane remodelling 
Passive membrane remodelling describes the spontaneous reorganisation of lipids that leads to 
constriction without a direct use of NTP hydrolysis (Renard et al. 2018). Proposed passive remodelling 
mechanisms include amphipathic helix insertion and protein crowding (Figure 12). It should be noted 
that these proposed mechanisms have been largely generated by in vitro and in silico experiments and 
remain to be tested in cells (Renard et al. 2018). 
 
Amphipathic helix insertion 
The shallow insertion of hydrophobic domains (e.g. amphipathic helices) into the outer leaflet of the 
lipid bilayer leads to membrane bending by ‘membrane wedging’ (Drin and Antonny 2010). This is 
caused by the increase of surface area of the outer membrane leaflet compared to the lipid bilayer 
midplane and inner leaflet. If the density of wedging is high enough, it leads to the formation of a 
membrane neck which can spontaneously resolve, causing membrane scission (Campelo et al. 2008). 
Boucrot et al. (2012) showed in vitro that the insertion of hydrophobic helices of epsin into liposomes 
can lead to vesiculation, and simultaneously showed that epsin and the amphipathic helix of BAR 
containing proteins function in CCV fission during endocytosis. Amphipathic helix insertion has also 
been proposed as the mechanism by which Sar1 drives the fission of COPII vesicles during ER exit (Lee 
et al. 2005). Sar1 was shown to induce membrane tubulation and vesiculation of liposomes, and 
mutations of hydrophobic residues prevented this effect. This however has not been shown in vivo. 
 
Protein crowding 
Membrane deformation by protein crowding bears some similarities to deformation by amphipathic 
helix insertion. The insertion or binding of a high density of proteins to the outer leaflet of a lipid 
bilayer can result in repulsion effects between the bound proteins. As these proteins are attached to 
the membrane, the repulsion leads to the underlying membrane bending. This however assumes that 
the inner leaflet has a lower number of similar opposing repulsion effects occurring (Snead et al. 2017; 
Stachowiak et al. 2010). It has been shown that as little as 20% coverage of membrane in proteins 
lacking intrinsic bending properties (e.g. green fluorescent protein (GFP)) can result in membrane 
bending (Stachowiak et al. 2012). Snead et al. (2017) showed that an increase in protein coverage of 
a membrane, or an increase in protein size can lead to the fission of tubules from liposomes. It is 
unclear however whether protein crowding to cause fission occurs in vivo. 
  




1.5.2 – Active membrane remodelling: cytoskeleton-induced scission 
Actin 
The cytoskeletal element actin is able to induce membrane bending effects by the formation of rigid 
polymerised actin arrays to constrict membrane, or the action of myosin motor proteins to push or 
pull membranes. High membrane tension during endocytosis caused by osmotic swelling can lead to 
a stalling of CCV formation (Boulant et al. 2011). In these circumstances, the polymerisation of actin 
can allow the continued invagination of the vesicle, although it is not clear if this occurs by neck 
constriction or by pushing the plasma membrane away from the vesicle (Boulant et al. 2011). In yeast, 
actin polymerisation is also required for endocytosis by working in concert with dynamin (Palmer et 
al. 2015). Actin polymerisation has also been shown necessary for endosomal tubule fission. A burst 
of actin polymerisation is observed at the fission location during tubule fission (Puthenveedu et al. 
2010), occurs at ER-endosome contacts which marks the endosomal fission location (Dong et al. 2016; 
Rowland et al. 2014), and depletion of WASH component strumpellin leads to aberrantly long 
endosomal tubules implying a defect in fission (Harbour et al. 2010). In addition, polymerisation of 
actin at the TGN has also been implicated in the formation of post-Golgi vesicles (Salvarezza et al. 
2009). 
 Actin-based myosin motors are also important in membrane scission. For example, myosin II 
was implicated in the fission of Rab6 positive post-Golgi vesicles from the TGN (Miserey-Lenkei et al. 
2010). In addition, myosin plays an important role during mitochondrial fission. Actin 
depolymerisation inhibits dynamin recruitment to the mitochondria resulting in defective 
mitochondrial fission (De Vos et al. 2005). Furthermore, depletion of myosin regulatory light chain or 
myosin heavy chain II, or myosin drug-inhibition results in aberrant mitochondrial elongation, 
suggesting a fission defect (DuBoff et al. 2012; Korobova et al. 2014). 
 
Microtubules 
Microtubule motor proteins are able to generate pulling forces on membranes to induce scission (Day 
et al. 2015). An important requirement for this process is that the neck of the tubule or invagination 
is stabilised to prevent increased lipid diffusion into the tensioned area (Renard et al. 2015), and in 
the case of endosomal tubule fission, that the whole body of the endosome is prevented from moving. 
Stabilisation of the membrane body can be done by opposing cytoskeletal elements such as actin 
filaments at the cell surface (Flanagan and Koch 1978), or microtubules on sorting endosomes 
(Friedman et al. 2013). BAR containing proteins (e.g. SNX-BAR proteins) are able to prevent lipid 




diffusion by forming scaffolds around membrane necks (Simunovic et al. 2016, 2017). This process is 
sometimes termed friction-driven scission (Renard et al. 2018). 
 Microtubule-induced scission is proposed to occur in clathrin-independent endocytosis and 
endosomal tubule fission. During clathrin-independent endocytosis, dynein-mediated pulling leads to 
membrane fission upon membrane necks being scaffolded by BAR protein endophilin-A2 (Renard et 
al. 2015). In endosomal tubule fission, the endosomal tubule is also scaffolded by BAR containing 
proteins, suggesting a pulling force could also generated scission (van Weering et al. 2012). Spastin’s 
microtubule severing activity may induce motor protein loading at the endosomal tubule to generate 
pulling forces (Allison et al. 2013), and various kinesin and dynein motor proteins have been shown to 
be required for endosomal tubule formation (see Introduction Section 1.4.4). 
 
  




1.5.3 – Active membrane remodelling: scission enzymes 
 
 
Figure 13 - Modes of active membrane scission. (Top) The polymerisation of actin can induce membrane 
constriction and fission by the formation of filamentous actin scaffolds or via myosin motor proteins generating 
a pushing or pulling force. (Second row) Microtubule motors can exert a pulling force on membranes to induce 
membrane constrictions. This depends on scaffolding beyond the neck of the constriction to stop lipid diffusion, 
and attachment of the body of the membrane to stop transport of the entire lipid structure. (Third row) The 
GTPase dynamin forms helical polymers which are able to contract in a ratchet mechanism upon GTP hydrolysis. 
This leads to membranes constricting to form a state of hemi-fission, where the membrane can spontaneously 
undergo fission. (Bottom) Inside-out example of ESCRT-III polymer formation leading to membrane constriction. 
No consensus view exists of the mechanism by which ESCRT-III polymers drive membrane fission. Supported 
models for scission include the formation of increasingly tight helical spirals, and spontaneous buckling to 
alleviate energetic unfavorability in the assembled ESCRT-III polymer. In all figures the membrane tubulates into 
the cytosol with the exception of the ESCRT figure where the membrane tubulates into the lumen or extracellular 













The GTPase dynamin is expressed as three isoforms: dynamin 1 and 3 are neuron specific, while 
dynamin 2 is ubiquitously expressed (Antonny et al. 2016). It is composed of a GTPase domain, a 
central four helix bundle stalk, a flexible linker domain (the bundle signalling element), and a PI(4,5)P2 
binding pleckstrin homology (PH) domain. GDP bound dynamin is able to oligomerise into a 50nm 
cylindrical helix on membranes (Hinshaw and Schmid 1995), with PH domains and GTPase domains on 
the inside and outside of the helix respectively (Zhang and Hinshaw 2001). Oligomerisation is driven 
by protein-protein interactions in the helical stalk (Faelber et al. 2011). 
 The function of dynamin is to fission membrane tubules from the outside (Antonny et al. 
2016). Depletion of dynamin leads to defective fission of clathrin-coated pits (Raimondi et al. 2011), 
and expression of GTPase defective dynamin blocks transferrin internalisation and increases clathrin 
residence on the plasma membrane (Marks et al. 2001; Taylor et al. 2011). GTP hydrolysis causes a 
constriction of the dynamin helical oligomer. Expression of a GTPase mutant dynamin leads to 
extended membrane necks during endocytosis (Takei et al. 1995) and endosomal recycling tubule 
formation (Chi et al. 2014; Derivery et al. 2009), and during GTP hydrolysis membrane necks are more 
constricted (Sweitzer and Hinshaw 1998). Constriction occurs via the twisting of the helical collar of 
dynamin (Morlot et al. 2012), powered by GTP hydrolysis causing adjacent turns of the dynamin helix 
to slide over one another (Chappie et al. 2011). This leads to the formation of a hemi-fission state, 
where the tubule is constricted to a radius of 1.9nm and composed of a single lipid layer (Sundborger 
et al. 2014). This hemi-fission state then undergoes spontaneous and stochastic complete fission 
(Mattila et al. 2015), which can be accelerated by membrane tension (Cocucci et al. 2014; Roux et al. 
2006). 
 Dynamin has been shown to be required for CME, mitochondrial fission, and endocytic 
recycling (Antonny et al. 2016). In all of these processes, dynamin is thought to work in concert with 
other constriction proteins help constrict the membrane neck of the tubule to a diameter than can be 
bound by dynamin (Roux et al. 2010). For example, in mitochondrial fission, dynamin requires the 
action of actin and Drp1 to constrict mitochondria division points before it can bind (Ji et al. 2015; 
Korobova et al. 2013). In endocytosis, dynamin requires the action of BAR containing proteins such as 









The ESCRT machinery comprises a large set of cytosolic proteins that are coordinated to mediate 
membrane scission (Christ et al. 2017). This is typically mediated on the inside of membrane necks to 
‘pull shut’ membrane, with examples including during MVB formation, cytokinesis, and viral budding. 
It can also form on the outside of membranes to constrict membranes during endosomal tubule fission 
(McCullough et al. 2018). The core ESCRT machinery consists of ESCRT-I, ESCRT-II, and ESCRT-III 
complexes, Alix protein, and VPS4-LIP5 (Schöneberg et al. 2017). Proteins of these groups interact to 
form large hetero-polymer complexes that mediate membrane fission. Fission itself is carried out by 
the ESCRT-III proteins in association with the ATPase VPS4 (Adell et al. 2017; Mierzwa et al. 2017). The 
function of the other ESCRT machinery components are to recruit ESCRT-III to an appropriate site of 
action and initiate membrane bending (McCullough et al. 2018). 
 ESCRT-III can be recruited to membranes by two different modes. The ‘canonical recruitment’ 
pathway’ is mediated by heterotetrametric ESCRT-I and ESCRT-II complexes that interact with a 1:1 
stoichiometry (Schöneberg et al. 2017). This is observed in processes such as MVB formation (Babst 
2011) and cytokinesis (Goliand et al. 2014). The alternative pathway is via the Alix protein, which 
allows direct binding to ESCRT-III protein CHMP4 (McCullough et al. 2008), and typically observed 
during viral budding (Strack et al. 2003). There is however redundancy in these pathways (Tang et al. 
2016). During MVB formation, ESCRT-I is recruited to ubiquitinated proteins by the ESCRT-0 protein 
Hrs, which also binds the PI3P rich membrane of the endosome (Christ et al. 2017). 
 
ESCRT-III complexes drive membrane remodelling via polymerising into helical spirals or conical 
configurations (Hanson et al. 2008; Lata et al. 2008). ESCRT-III polymerisation is mediated by ESCRT-II 
proteins by removing ESCRT-III autoinhibition (Bajorek et al. 2009). This allows the ESCRT-III protein 
to convert from a closed monomeric soluble state into a membrane bound configuration that is 
capable of polymerisation. These polymer configurations have inherently curved structures, with the 
membrane interacting region decorated in basic amino acids. For most ESCRT-III proteins this is on the 
convex surface of the complex (Im et al., 2009), but for the proposed constriction fission ESCRT 
complex of IST1-CHMP1B, these are on the concave face (see Introduction Section 1.3.3; McCullough 
et al. 2015). ESCRT-III proteins typically containing MIMs, facilitating their interaction with MIT-
domain-containing proteins such as VPS4 and spastin (see Introduction Section 1.3.3). 
 Despite their evident importance in membrane scission, a consensus model of how ESCRT-III 
proteins induce scission has not been established (Schöneberg et al. 2017). One set of models, 
proposes that ESCRT-III polymers may form on membranes with an energetically unfavourable 




underbent conformation (Fabrikant et al. 2009). The ESCRT-III polymer resolves this energetic 
unfavorability by forming restricting spirals, driving membrane constriction and fission by tight 
association between ESCRT-III and the membrane. Extensions of this model include the ESCRT-III 
subunits being replaced with those of tighter curvature as the membrane constrictions (Fabrikant et 
al. 2009), potentially by the action of VPS4 (Adell et al. 2017; Mierzwa et al. 2017).  
The alternative most supported model is the buckling/spiral spring model (Chiaruttini et al. 
2015; Lenz et al. 2009; Schöneberg et al. 2017; Shen et al. 2014). This model is able to explain both 
inside-out and outside-in membrane fission (Schöneberg et al. 2017). In this model, ESCRT-III polymers 
form either at the neck of membranes or on flat membrane surfaces and grow with increasingly wide 
ESCRT-III subunits. This results in high energetic unfavorability, with some regions of the polymer 
being underbent and some overbent. Continued polymerisation drives this unfavorability to a critical 
point whereby the ESCRT-III filament buckles, releasing energy to deform the membrane (McCullough 
et al. 2018; Schöneberg et al. 2017). 
  




1.6 – Thesis Aims 
This thesis investigates the function of spastin in endosomal tubule fission and cargo export from the 
ER. As highlighted above (Section 1.3), spastin has been associated with these processes but a direct 
functional relationship has not been shown (Allison et al. 2013; Connell et al. 2009). In addition, I 
quantify the effect of a spastin ATPase mutation on the cell surface proteome, with an idea to 
identifying candidate proteins whose altered endomembrane transport could lead to the axonopathy 
observed in HSP. Each of these aims is discussed in more detail below. 
 
The function of spastin in endosomal tubule fission (Chapter 3) 
Allison et al. (2013) reported that a depletion of spastin or IST1, or mutation in spastin’s MIT or AAA+ 
domains, led to the formation of abnormally elongated endosomal SNX1 and SNX4 recycling tubules. 
This suggested that spastin functions in mediating the fission of endosomal recycling tubules from the 
sorting endosome via an ESCRT-III interaction and microtubule remodelling. However, several 
unanswered questions remain: 1) whether the aberrantly long endosomal tubules formed are in fact 
due to defective tubule fission; 2) whether spastin and IST1 localise to endosomal tubules or enact 
their endocytic function from alternative locations; and 3) how spastin’s microtubule remodelling 
activity relates to endosomal tubule dynamics. These topics are investigated in my first results chapter. 
 
The function of spastin in the early secretory pathway (Chapter 4) 
Connell et al. (2009) showed that M1 spastin recruited to ERES, and overexpression of an ATPase 
defective spastin, but not spastin depletion, led to impaired export of cargo from the ER. This therefore 
left the function of spastin at ERES ambiguous. My second results chapter investigates the localisation 
of spastin to ERES and investigates the function of spastin in cargo secretion.  
 
The impact of ATPase defective spastin on the cell surface proteome (Chapter 5) 
Due to the central role of spastin in microtubule remodelling (Vemu et al. 2018), endocytic cargo 
recycling (Allison et al. 2013, 2017), and lysosome function (Allison et al. 2017), it can be predicted 
that a loss of functional spastin may have dramatic downstream consequences. One predicted 
outcome is a change in the trafficking of proteins to and from the cell surface. This would likely lead 
to a remodelling of the cell surface proteome, as shown by investigations that have blocked endocytic 
cargo retrieval during endocytic recycling (McNally et al. 2017; Steinberg et al. 2013). Such changes 




may impact the interaction of a cell and its environment, potentially leading to pathology such as the 
axonopathy observed in HSP. In my third results chapter, I use quantitative cell surface proteomics to 
explore the effect of spastin loss of function in mouse embryonic fibroblasts (MEFs) and primary 
cortical neurons. This was performed with the dual of aim of firstly exploring whether spastin loss of 
function remodels the cell surface proteome, and secondly aiming to identify pathological candidates 
in spastin-HSP.  




Chapter 2 - Materials and Methods 
 
2.1 – Cell Culture Techniques 
2.1.1 – List of cells used 




Advantages Stable Cell 
Line Variants 






Diploid, large with easy-to-
image ER and microtubules, 



























Stably express RUSH reporter 
and hook; previously verified 






















Easy to culture and 
transfect/transduce, direct 



















Easy to culture and 
transfect/transduce, direct 





























Easy to culture and 
transfect/transduce, direct 













Diploid, very large and very 
flat with ideal ER for imaging, 


















Large production of retrovirus 
with the stable expression of 













Direct association with spastin 
mutation-induced pathology; 














Direct association with Spastin 
mutation-induced pathology; 














Direct association with Spastin 
mutation-induced pathology; 
the tissue affected by HSP 
None 
Table 1  - Table of cell lines 
  




2.1.2 – Cell maintenance 
Cell line maintenance 
Cell lines were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM (Sigma-Aldrich – D6546)) or 
DMEM without Phenol Red (Sigma-Aldrich – D5921) supplemented with 10% Foetal Bovine Serum 
(FBS (Sigma-Aldrich – F7524)), 2mM L-Glutamine (Sigma-Aldrich – G7513), and 100µg/mL Penicillin-
Streptomycin (Sigma-Aldrich – P0781). DMEM lacking Phenol Red was used for cells cultured for live 
cell imaging to avoid autofluorescence. For the selection of stable cell lines, media was supplemented 
with 200µg/mL Gentamicin (Sigma-Aldrich – G1397), or 190µg/mL Hygromycin-B (ThermoFisher – 
10687010) depending on the selection cassette expressed. All cells were grown at 37oC and 5% CO2. 
To remove adherent cells from the growth surface, cells were washed once with phosphate 
buffered saline (PBS) lacking MgCl2 and CaCl2 (Sigma-Aldrich – D8637)) and incubated with 0.05% 
Trypsin-EDTA (Sigma-Aldrich - T3924) for ~5mins with gentle tapping to help loosen adhered cells. 
Before being replated, trypsinised cells were resuspended in growth media to neutralise the trypsin, 
and then centrifuged and the pellet suspended in fresh media. Cell counting was performed using a 
haemocytometer (Hausser Scientific – 3720). 
 
Maintenance of E16 mouse neurons 
Primary neurons extracted from E16 mice cortices were cultured in 10cm2 dishes coated with 
0.05mg/mL Poly-D-Lysine (Sigma-Aldrich – 6407) allowing for full extension of neurites. Neurons were 
cultured in neuronal culture media consisting of Neurobasal Media minus Phenol Red (ThermoFisher 
– 12348017) supplemented with GIBCO 50x, serum free B-27 (ThermoFisher - A3582801), 0.5mM 
GlutaMAX (ThermoFisher – 35050061), 1mM sodium pyruvate (ThermoFisher – 11360070), and 
100µg/mL Penicillin-Streptomycin (Sigma-Aldrich – G1397). Neurons were maintained in culture for 
14 days, with half the culture media replaced every three days with fresh media.  
 
Freezing and thawing cell lines 
To freeze cell lines, a cell pellet was resuspended in a freeze medium consisting of 50% FBS, 40% 
growth media, and 10% dimethyl sulfoxide (DMSO (Sigma-Aldrich – D8418)). The resuspended cells 
were then aliquoted into 1.8mL Cryotubes (ThermoFisher – 377267) and placed onto dry ice before 
being stored at -80oC. After several days, the Cryotubes were transferred to liquid nitrogen-cooled cell 
banks for long-term storage. To defrost cells, the Cryotube was opened and a small volume of pre-
warmed growth media was pipetted into the vial, defrosting a small volume of the frozen cell pellet. 




This defrosted volume was extracted and pipetted into a T25 flask pre-filled with growth media. This 
process was repeated until the entire frozen cell suspension was defrosted and transferred to the T25 
flask. The following day, the media was replaced with fresh growth media. 
 
2.1.3 – Primary cortical neuron extraction 
Poly-D-lysine coating 
Poly-D-Lysine (PDL) was used to coat cell culture plastic and coverslip glass to allow neurites to form. 
The day before neural dissection, Poly-D-Lysine Hydrobromide (Sigma-Aldrich - 6407) was 
resuspended in 50mL sterile H2O (100µg/mL) and added to a 15cm2 dish for 2hrs before being 
recollected back into a 50mL Falcon tube, thus removing any undissolved toxic PDL from the solution. 
The solution was then diluted to its working concentration of 50µg/mL with sterile H2O. This solution 
was then added to 10cm2 dishes and glass coverslips placed within the wells of a 6-well plate (with 
enough to cover the surface of the dish/wells) and the dishes/plates incubated in an incubator 
overnight at 37oC. The following morning, the PDL was removed, and plates were washed 3xs with 
sterile H2O, with the final wash kept on the plate for 1hr before being removed. After the final H2O 
wash had been removed, 10mL of neuronal growth media was added to each dish and 2mL of neuronal 
growth media was added to each well of the 6-well plate, and both were warmed in a cell incubator 
at 37oC. 
 
Dissection of cortices 
All elements of the dissection protocol were performed as quickly as possible to ensure maximum 
neuron viability post-dissection. Apart from where stated, all tissue was kept in ice-cold phenol-red-
free Hanks Balanced Salt Solution (HBSS (ThermoFisher - H6648)) before and duration dissection.  
 The pre-dissected uterus was placed in a 15cm2 dish, and each individual embryo was 
obtained. Using scissors, each embryo was decapitated, with the heads collected in a 15mL Falcon 
tube. Each head was placed in a 10cm2 dish so that the top of the head was facing upwards. With 
forceps inserted through the nose, the skin was pealed back from the top of the skull using scissors to 
create an incision along the length of the top of the head, and forceps to peel back the skin. This 
method was then used to cut through the soft skull of the embryo for the same effect to reveal the 
brain. The flat of the forceps was then used to gently push the brain towards the back of the neck, 
thereby dislodging the brain from the head. The entire brain was then transferred to a new 10cm2 dish 




to ensure the brain could be kept ice-cold. A small section of skin was kept and transferred to an 
Eppendorf tube for use in DNA extraction and genotyping. 
 Once the brain had been extracted, the cerebellum, medulla oblongata, and olfactory lobes 
were removed by using scissors, leaving just the cerebral hemispheres. The two hemispheres were 
separated by cutting between them. For each hemisphere in turn, forceps were used to carefully peel 
back the meninge coating so that it was removed completely as one membrane. Using forceps, the 
hippocampus was then removed, leaving just the cortices of each hemisphere. The two dissected 
cortices were then placed back on ice in a 15mL Falcon tube. 
 
Dissociation of neurons 
Once all embryos had been dissected, the HBSS was removed and replaced with 1mL 0.25% Trypsin-
EDTA (ThermoFisher – 25200056) with 0.1% DNase (ThermoFisher – EN0521), and the tube placed in 
a 37oC waterbath for 15mins with the tube inverted every 3mins. During this period, 3 Pasteur glass 
pipettes per embryo were occluded so each had progressively smaller diameter holes. After 15mins, 
the trypsin mixture was removed without disturbing the cortices and replaced with 1mL pre-warmed 
HBSS supplemented with 10% FBS (Sigma-Aldrich – F7524). After 2mins, this solution was removed 
and replaced with fresh pre-warmed HBSS to wash the cortices. This liquid was then removed and 
replaced with 1mL neuronal culture media. Using the pre-occluded Pasteur pipettes, the cortex was 
then homogenised by sucking the cortex into the pipette and expelling it 10 times using each pipette 
starting from the pipette with the widest diameter, careful to avoid bubble formation. The 
homogenised cortices were then pipetted through a 70µm cell strainer and the resulting solution 
added to the pre-warmed media of the PDL-coated 10cm2 dishes, with a small amount also added to 
similarly prepared glass coverslips placed within a 6-well plate. After ~4hrs, all the media was removed 
and replaced with pre-heated fresh neuronal growth media. 
  




2.1.4 – Transfection and transduction 
Transfection 
Cells were transfected with either Lipofectamine 2000 (ThermoFisher - 11668019) or Lipofectamine 
3000 (ThermoFisher - L3000008) transfection reagents using the manufacturer’s protocol. For both 
methods for one well of a 6-well plate, 250µL Opti-MEM (ThermoFisher – 31985062) was mixed with 
5µL Lipofectamine reagent, and in a separate tube 250µL Opti-MEM was mixed with 1000ng DNA (for 
Lipofectamine 3000 reactions, also 5µL of P3000 reagent), and incubated separately for 5mins. After 
the elapsed time, both tubes were mixed and incubated for 10mins. In this time, cells were washed 
twice with PBS (Sigma-Aldrich – D8637) and 2mL of fresh growth media was added to the well. After 
the elapsed 10mins, 500µL transfection mixture was added dropwise to the well. After transfection, 
cells were typically used within 24hrs to prevent cell mortality from severe overexpression of the 
protein of interest. No washing steps were performed for the transfection of cells previously 
transfected using siRNA oligonucleotides. 
 
Transduction 
All transductions were performed using either pLXIN or pBMN retroviral vectors transfected into the 
Phoenix retrovirus producer HEK 293T cell lines using the methods detailed by the Nolan lab (Stanford 
University). Firstly, Phoenix cells were plated at 1x106 in 10cm2 dishes. The following day, the cells 
were transfected with the retroviral vector containing the desired gene for stable expression. This 
media was replaced the next morning with fresh growth media and the cells transferred to a viral 
incubator at 32oC to allow virus production to occur. On the next day, the cells to be transduced were 
trypsinised and 2x106 cells were pelleted, the media removed, and the pellet resuspended in the 
remaining media droplet followed by the addition of Polybrene (Sigma-Aldrich - H9268) to a working 
concentration of 4µg/mL. The viral media from the Phoenix cells was then collected and filtered 
through a 0.45µm filter into the 15mL Falcon tube containing the cells to be transduced. The viral 
media and cells were then mixed, before the cells were transferred to a T75 growth flask and grown 
at 37oC overnight. The next day, the viral media was removed from the cells and the transduced cells 
were grown in selection-free media. When the cells had grown to confluency, they were split into 4 
10cm2 dishes and grown in media supplemented with selective agents.  
  





siRNA knockdowns were performed using Oligofectamine reagent (ThermoFisher – 12252011) 
following the manufacturer’s protocol with siRNAs typically used at a final concentration of either 
10nM or 20nM (Dharmacon). For one well of a 6-well plate, cells were plated at 4x104 cells (for 
microscopy) or 1x105 (for lysis and western blotting). The following day, two solutions for both mock 
and knockdown treatments were made: 1) 5µL H2O or 5µL siRNA (at 4µM resuspended in H2O) with 
165µL Opti-MEM (ThermoFisher – 31985062); 2) 5µL Oligofectamine reagent with 25µL Opti-MEM. 
These were mixed gently and incubated at room temperature for 5mins. After the elapsed time, 30µL 
of each Oligofectamine solution was mixed with the appropriate mock (H2O) and knockdown (siRNA) 
solutions and incubated at room temperature for 20mins. After the incubation, the 200µL volume for 
each solution was transferred into a different tube and 800µL Opti-MEM was added to each and mixed 
by inversion. Cells were then washed twice in PBS (Sigma-Aldrich – D8637) and the 1mL mixture was 
added dropwise to the cells. This 1mL volume was then supplemented with 1mL 20% FBS growth 
media (the standard growth media with double the concentration of FBS) and incubated for 72hrs 
before being used in experimentation. The efficacy of knockdown was verified by cell lysis and western 
blotting. 
 
Target Gene Oligonucleotide Name Oligonucleotide Sequence Manufacturer 
SPAST Spastin siRNA '1' GAACUUCAACCUUCUAUAA Dharmacon 
SPAST Spastin siRNA '3' UAUAAGUGCUGCAAGUUUA Dharmacon 
IST1 IST1 siRNA '1' CCAAGUAUAGCAAGGAAUA Dharmacon 
Table 2 - Table of siRNAs 
 
  




2.1.5 – Cell sorting 
All cell sorting was performed by the CIMR Flow Cytometry team using a Becton Dickinson Influx cell 
sorter and was used to isolate either single cells or populations of cells from cell lines stably expressing 
fluorescent proteins. To prepare cells for sorting, cells were trypsined, pelleted, and the trypsin 
neutralised as previously described, before an appropriate number of cells were pelleted again and 
resuspended in 2.5mL of growth media in 5mL Polystyrene Round-Bottom Falcon tubes. A non-
fluorescent cell sample was then loaded onto the cell sorter and the laser voltage was adjusted to set 
any signal from these cells to almost zero. The fluorescent cells to be sorted were then loaded and the 
same laser voltages applied. After gating for singlets, the fluorescent population (or a subset) was 
gated and sorted into polystyrene tubes prefilled with growth media or 96-well plates (for clonal 
expansion). Cells sorted into tubes were pelleted and resuspended in fresh media before being 
replated to minimise potential contamination. 
  




2.2 – Molecular Biology 
2.2.1 – Cloning Methods 
Polymerase chain reaction (PCR) 
All PCR reactions were performed using the Phusion polymerase (New England Biolabs - M0530) in 
50µL volumes using the PCR mixture described in Table 3. For negative controls, H2O was added 
instead of DNA to check against DNA contamination. A range of DMSO concentrations were often used 
for primers with strong secondary structure. PCR thermocycling was performed as stated in Table 4. 
Primer annealing temperatures were calculated using the online Tm Calculator tool, or for Gibson 
Assembly PCR from the online tool NEBuilder® Assembly Tool (detailed below). 
 
Name Volume (for a single 50µL 
mixture) 
GC-Rich Phusion Buffer 10µL 
10mM dNTPs 1µL 
10µM Forward Primer 2.5µL 
10µM Reverse Primer 2.5µL 
DMSO 1.5µL 
H2O 27µL 
Phusion Polymerase 0.5µL 
DNA @ 50ng/µL 5µL 
Table 3 - Table of the Phusion PCR mixture. All components purchased from New England Biolabs (E0553). 
 
Stage Duration Temperature 
1. Initial Denaturation 30secs 98oC 
2a. Denaturation 8secs 98oC 
2b. Annealing 20secs Variable 
2c. Elongation 22secs per kb 72oC 
 35 cycles  
3. Final elongation 8mins 72oC 
Table 4 - Table of PCR thermocycling conditions when using Phusion polymerase. 
  




Restriction enzyme digest 
For the digestion of plasmids, 5µg of plasmid DNA was incubated with 2µL of each restriction enzyme 
and 5µL of the appropriate NEB Buffer, with the final volume made to 50µL with H2O. For the 
restriction digest of PCR products, the protocol was the same but 30µL of the PCR product DNA was 
used instead. Digestions were performed at 37oC for 3hrs. 
 
DNA dephosphorylation and phosphorylation 
DNA dephosphorylation was performed when a single restriction site was used during cloning to 
prevent undesired plasmid reannealing during ligation. In a reaction volume of 30µL, 3µL of Alkaline 
Phosphatase Buffer (New England Biolabs - M0290) was mixed with 1µL Alkaline Phosphatase (New 
England Biolabs - M0290) and 26µL of DNA. For insertion of PCR fragments into dephosphorylated 
DNA the PCR product must be phosphorylated. For a reaction volume of 30µL, 3µL of T4 DNA Ligase 
Buffer (New England Biolabs - B0202) was mixed with 1µL T4 DNA Kinase (New England Biolabs - 
M0201) and 26µL DNA. To proceed, both reactions were then heated at 37oC for 1hr before being 
heated at 65oC for 10mins to denature the enzymes. 
 
DNA ligation 
The DNA ligation protocol was performed for all cloning where Gibson Assembly was not used and 
performed between plasmids and DNA fragments digested using the same restriction enzymes. For a 
20µL ligation, 2µL of a 1:20 and a 1:50 dilution of the digested vector DNA was incubated with 10µL 
of digested DNA fragment to be inserted, 2µL of NEB T4 Ligase Buffer (New England Biolabs - B0202), 
and 1µL of T4 DNA Ligase (New England Biolabs – M0202), with the total volume made to 20µL with 
H2O. Two comparable control reactions were set up with 10µL H2O in place of the DNA insert. For the 








Bacterial transformations and clone amplification 
For bacterial transformations, competent XL-10 Gold bacteria stored at -80oC were defrosted on ice 
for 20mins. Once defrosted, 50µL of bacteria were mixed with 2µL plasmid DNA and incubated on ice 
for 25mins with occasional gentle shaking. The bacterial solutions were then heat-shocked at 42oC for 
1min before being placed back onto ice. After several minutes, the bacteria were then plated and 
spread on Lysogeny broth (LB) plates with the appropriate selection antibiotic, and the plates were 
incubated at 37oC overnight. For bacterial clone amplification, either a single bacterial colony or a 
sweep of identical bacterial clones were collected using a pipette tip and placed in either a 15mL 
Falcon tube containing 5mL of LB (for single colonies) or a 250mL conical flask containing 100mL LB 
(large amplification of multiple clones). Inoculated LB was then heated overnight at 37oC in a shaking 
incubator. All LB plates and media were prepared by the CIMR core team. The LB formulation used 
was 0.5% NaCl, 1% Bacto Peptone, 1% yeast extract (and 1.5% Bacto Agar for LB plates). Either 
100mg/ml ampicillin or 30mg/ml kanamycin antibiotics were added for selection. 
 
DNA agarose purification 
DNA agarose gel purification was used to extract DNA fragments separated by agarose gel 
electrophoresis. DNA purification from agarose was performed by using a QIAquick DNA Gel Extraction 
Kit (Qiagen – 28704) following the manufacturer’s protocol. To dissolve isolated agarose, the agarose 
containing the DNA of interest was weighed and incubated with 3x the weight in volume of QG Buffer 
and heated at 50oC for 10mins. After the agarose had dissolved, an equivalent volume of isopropanol 
(Sigma-Aldrich – 190764) to the mass of the original agarose was added, and the mixed solution 
poured into a QIAquick spin column and centrifuged at 17900RCF for 1min. The column membrane 
was then washed with 750µL PE buffer and centrifuged again. The column was then dried by further 
centrifugation, before 30µL H2O was added to the membrane and the tube centrifuged as before to 
elute the DNA. 
 
DNA concentration measurement 
DNA concentrations were measured using the ratio of optical absorbance at 260nm and 280nm 
wavelengths using a Nanodrop 200C spectrophotometer (ThermoFisher - ND-2000). 
 
  





For all Gibson Assembly reactions, the destination vector backbone was linearised using restriction 
enzymes, and all DNA inserts were generated using PCR using Phusion polymerase (New England 
Biolabs - M0530), with initial primer design performed using the online NEBuilder® Assembly tool. The 
section of primers that annealed to the desired PCR insert were checked through the online tool 
Primer3Plus to verify the quality of the suggested primer. If Primer3Plus highlighted potential 
problems with the primers (e.g. primer self-complementarity), the length of the annealing section was 
adjusted. Digested vector and PCR products were then run through an agarose gel, and size-
appropriate DNA bands were then cut from the agarose. After purification, DNA concentration was 
measured, and vector backbone and PCR inserts were mixed with Gibson Assembly Master Mix (New 
England Biolabs - E2611) made to 20µL with H2O. DNA concentration in pmols was calculated using 
the below equation (1) and mixed in the below ratio (2). 
 
1. pmols = ((weight in ng) *1000)/ (base pairs x 650) 
2. (Backbone Vector) 100ng vector: (PCR Insert) 3*pmols of 100ng vector  
 
The reaction mixture was then heated to 50oC for 1hr allowing the Gibson Assembly reactions to occur. 
After 1hr, 2µL Gibson mixture was transformed into bacteria by 42oC heat shock, and bacteria were 
then plated on LB plates with the appropriate bacterial selection matching the resistance conveyed by 
the plasmid. 
 
Small-scale preparation of DNA 
The small-scale preparation of plasmid DNA was performed from overnight 5mL bacterial cultures 
using the QIAGEN Spin Miniprep Kit (Qiagen – 27104). The bacterial culture was centrifuged at 
2350RCF for 15mins, and the pellet was resuspended in 250µL P1 buffer which had been premixed 
with LyseBlue reagent and RNase A solution. This suspension was transferred to 1.5mL Eppendorf 
tubes and 250µL P2 lysis buffer was added and the solution was mixed. After 5mins, 350µL N3 buffer 
was added and the solution mixed until it became homogenously white. The solution was then 
centrifuged at 17900RCF for 10mins, and the supernatant applied to a QIAGEN spin column by 
decanting. The column was then spun for 1min at 17900RCF and washed with 750µL PE buffer. The 
column was then spun twice more, and the plasmid was eluted by the addition 50µL H2O followed by 
centrifugation at 17900RCF. 




Large-scale preparation of DNA 
The large-scale preparation of plasmid DNA was performed from overnight 100mL bacterial cultures 
using the QIAfilter Plasmid Midi Kit (Qiagen – 12243). The bacteria were pelleted by centrifugation at 
2350RCF for 30mins. The pellet was resuspended in 4mL P1 buffer which had been premixed with 
LyseBlue and RNase A buffer. 4mL of P2 buffer was added and the tube mixed until it became 
homogenously blue and left to stand for 5mins. During this time, a QIAGEN tip column was 
equilibrated using 4mL QBT buffer. After 5mins, 4mL of ice-cold P3 buffer was added to the lysed 
bacteria and mixed until the solution turned white. This was then applied to a capped QIAfilter 
cartridge and left to stand for 5mins. The cap was then removed, and the solution pushed through the 
cartridge resin by a plunger, with the solution entering the equilibrated QIAGEN tip column. After this 
solution had passed through the QIAGEN tip column, the tip was washed twice with 10mL QC buffer 
and the DNA was eluted by the addition of 5mL QF buffer. The eluted DNA was precipitated by the 
addition of 3.5mL isopropanol (Sigma-Aldrich – 190764) and centrifuged at 4oC for 1hr at 2350RCF. 
The solution was then decanted to leave the DNA pellet which was washed with 2mL 70% ethanol 
(Sigma-Aldrich – 51976). The resuspended DNA was then centrifuged at 15000RCF for 10mins before 
the supernatant was removed and the pellet allowed to airdry. The dried pellet was then resuspended 
in 200µL H2O. 
 
Tissue DNA extraction and spastin mouse genotyping 
DNA extraction using the Dneasy Blood and Tissue Kit (Qiagen – 69504) was used to obtain DNA from 
tissue or cells for genotyping. Ear punches or skin (e.g. from neural dissections) were incubated in 
180µL ATL buffer and 20µL Proteinase K at 56oC until the tissue was completely lysed. The lysate was 
then vortexed and 200µL AL buffer and 200µL 100% ethanol (Sigma-Aldrich – 51976) were added. This 
mixture was then vortexed and pipetted into a DNeasy Mini Spin Column and centrifuged at 6000RCF 
for 1min. The column was then washed with 500µL AW1 buffer and centrifuged as before. 500µL AW2 
buffer was then added and the column dried by centrifugation at 20000RCF for 3mins. DNA was eluted 
by the addition of 100µL AE buffer and centrifugation at 6000RCF. For DNA extraction from cells, a 
maximum of 5x106 cells were pelleted and resuspended in 200µL AL buffer, 20uL Proteinase K and 
200µL PBS (Sigma-Aldrich – D8637) and heated at 56oC for 10mins. 200µL 100% ethanol (Sigma-Aldrich 
– 51976) was then added, and the protocol continued as above. 
For genotyping, ‘Spastin Forward/Reverse Genotyping’ primers were used to amplify around 
intron 4 of spastin using PCR. This allowed the identification of the presence/absence of an inserted 




loxP site in the spastin-mutated alleles. PCR products were run on a 1% gel, with the WT bands at 
707bp and mutated spastin bands at 899bp. 
 
Name Sequence 
Spastin Forward Genotyping TTGAACCGCCCTACTTGCCT 
Spastin Reverse Genotyping TAAGGGGTCTTTCCTCTTCGG 
Table 5 - Table of spastin genotyping primers 
 












Ampicillin CMV Used as a mammalian expression 
vector with the additional optional 
function of adding a selection element 
downstream of an Internal Ribosomal 
Entry Site (IRES). 
pBMN-I-Hygro pBMN-GFP-
Spastin M87A 
mt 1,3-I-Hygro;  
Ampicillin Viral 5' 
LTR 
Used to generate retrovirus that 
incorporates a gene of interest 
followed by an IRES element and a 
Hygromycin B resistance gene into 
transduced cells. Typically used with 
Phoenix retroviral packaging cell lines 







Ampicillin Viral 5' 
LTR 
Used to generate retrovirus that 
incorporates a gene of interest 
followed by an IRES element and a 
Neomycin (G418) resistance gene into 
transduced cells. Typically used with 
Phoenix retroviral packaging cell lines 







Kanamycin CMV Used as a mammalian expression 
vector to express a protein of interest 
fused to mCherry fluorescent protein. 
pmFusionRed pmFusionRed-
SIT 
Kanamycin CMV Used as a mammalian expression 
vector to express a protein of interest 
fused to mFusionRed fluorescent 
protein. 
pmRFP pmRFP-KDEL Kanamycin CMV Used as a mammalian expression 
vector to express a protein of 
interested fused to mRFP fluorescent 
protein. 











pEF321-T  pEF321-T  Ampicillin EF-1α Used to immortalise primary 
fibroblasts. 
Table 6 - Table of vector backbones and plasmids 
 
Plasmid Name Donor Reference 
pIRESneo2-myc-spastin M87A mt 1,3 R. Allison Allison et al. 2013 
pIRES GFP-SNX1 M. Seaman Harbour, Breusegem, and 
Seaman 2012 
pmCherry-Sec23 J. Lippincott-Schwartz NA 
pmFusionRed-SIT J. Lippincott-Schwartz NA 
pmRFP-KDEL J. Lippincott-Schwartz Altan-Bonnet 2005 
EB3-mCherry J. Lippincott-Schwartz NA 
pEF321-T expressing SV40 large T 
antigen 
S. Sugano Kim et al. 1990 
Table 7 - Table of plasmids obtained from donors 
 
2.2.3 – Plasmid construction 
pLXIN-GFP-SNX1-I-NeoR 
GFP-SNX1 was PCRed from pIRES GFP-SNX1 (Harbour et al. 2012) using ‘Sal1 GFP Forward’ and ‘Not1 
SNX1 Reverse’ oligonucleotide primers. These primers introduced a Sal1 restriction site at the 5’ end 
and a Not1 restriction site at the 3’ end of the GFP-SNX1 PCR product. The GFP-SNX1 PCR product and 
a pLXIN-I-NeoR plasmid were digested using Sal1 (New England Biolabs - R3138) and Not1 (New 
England Biolabs - R3189) restriction enzymes, and GFP-SNX1 was then ligated into the digested pLXIN-
I-NeoR plasmid. The ligated plasmid was amplified in bacteria selected with ampicillin, and bacterial 
clones were selected by DNA extraction and diagnostic digest using BglII (New England Biolabs - 
R0144). In clones positive for pLXIN-GFP-SNX1-I-NeoR, the GFP-SNX1 insert was checked for mutations 
by Sanger sequencing using the oligonucleotide primers listed in Table 8. 
 
  





SNX1 was PCRed from pIRES GFP-SNX1 using ‘BglII SNX1 Forward’ and ‘Sal1 SNX1 Reverse’ 
oligonucleotide primers. These primers introduced a BglII restriction site at the 5’ end and a Sal1 
restriction site at the 3’ end of the SNX1 PCR product. The SNX1 PCR product and a pmCherry plasmid 
were digested using BglII (New England Biolabs - R0144) and Sal1 (New England Biolabs - R3138) 
restriction enzymes, and SNX1 was then ligated into the digested pmCherry plasmid. The ligated 
plasmid was amplified in bacteria selected with kanamycin, and bacterial clones were selected by DNA 
extraction and diagnostic digest using Bts1 (New England Biolabs – R0614) restriction enzyme. In 
clones positive for pmCherry-SNX1, the SNX1 insert was checked for mutations by Sanger sequencing 
using the oligonucleotide primers listed in Table 8. 
 
pLXIN-mCherry-SNX1-I-NeoR 
pLXIN-mCherry-SNX1-I-NeoR was generated by Gibson Assembly. mCherry-SNX1 was PCRed from 
pmCherry-SNX1 using ‘Gibson mCherry-SNX1 Forward’ and ‘Gibson mcherry-SNX1 Reverse’ 
oligonucleotide primers, and pLXIN-I-NeoR was digested using Sal1 (New England Biolabs - R3138) and 
Not1 (New England Biolabs - R3189) restriction enzymes. PCRed mcherry-SNX1 and digested pLXIN-I-
NeoR were then mixed with Gibson Assembly master mix leading to the formation of pLXIN-mCherry-
SNX1-I-NeoR. The ligated plasmid was amplified in bacteria selected with ampicillin, and bacterial 
clones were selected by DNA extraction and diagnostic digest using BsrGI (New England Biolabs – 
R3575) restriction enzyme. In positive clones for pLXIN-mCherry-SNX1-I-NeoR, the SNX1 insert was 
checked for mutations by Sanger sequencing using the oligonucleotide primers listed in Table 8. 
 
pIRESneo2-myc-GFP-Spastin M87A mt1,3 (M1 expression only, siRNA resistant) 
GFP without its stop codon was PCRed from GFP-SNX1 using ‘Nhe1 GFP Forward’ and ‘Nhe1 GFP 
Reverse’ oligonucleotide primers. These primers introduced a Nhe1 restriction site at the 5’ and 3’ 
ends of the GFP PCR product. The GFP PCR product and a pIRESneo2-myc-spastin M87A mt1,3 plasmid 
obtained from Rachel Allison (Allison et al. 2013) were digested using the Nhe1 (New England Biolabs 
- R3131) restriction enzyme, opening the pIRESneo2-Myc-Spastin M87A mt 1,3 plasmid between myc 
and spastin. The digested plasmid was then dephosphorylated and the GFP PCR product was 
phosphorylated. The GFP PCR product was then ligated into the digested pIRESneo2-Myc-Spastin 
M87A mt 1,3 plasmid. The ligated plasmid was amplified in bacteria selected with ampicillin, and 
bacterial clones were selected by DNA extraction and diagnostic digest using BsrGI (New England 
Biolabs – R3575) restriction enzyme. In positive clones for pIRESneo2-myc-GFP-Spastin M87A mt1,3, 




the GFP insert was checked for mutations by Sanger sequencing using the oligonucleotide primers 
listed in Table 8. 
 
pBMN-GFP-Spastin M87A mt1,3-I-Hygro 
GFP-spastin M87A mt1,3 was PCRed from pIRESneo2-myc-GFP-Spastin M87A mt1,3 using ‘BamH1 
GFP-M1 Spastin Forward’ and ‘GFP-M1 Spastin Reverse’ oligonucleotide primers. These primers 
introduced a BamH1 restriction site at the 5’ and retained a BamH1 restriction site at the 3’ end of the 
GFP-spastin M87A mt1,3 sequence. The GFP-spastin M87A mt1,3 PCR product and a pBMN-I-Hygro 
plasmid were digested using BamH1 (New England Biolabs - R3136) restriction enzyme, the digested 
PCR product was phosphorylated and the pBMN-I-Hygro plasmid was dephosphorylated, and GFP-
spastin M87A mt1,3 was ligated into the digested pBMN-I-Hygro plasmid. The ligated plasmid was 
amplified in bacteria selected with ampicillin, and bacterial clones were selected by DNA extraction 
and diagnostic digest using Xho1 (New England Biolabs –R0146) restriction enzyme. In clones positive 
for pBMN-GFP-Spastin M87A mt1,3-I-Hygro, the GFP-spastin M87A mt1,3 insert was checked for 

















PCR Primer TCCCTAGCGGCCGCAGGGCTAAGTCCAGCCAAGG 
 





































PCR Primer TAGGGAAGATCTATGGATCCGGAGTCGGAAGG 





























































































PCR Primer ATCCCTGCTAGCCTTGTACAGCTCGTCCATGCC 
 




GFP Reverse Sequencing 
Primer 
GTTCAGGGGGAGGTGTG 









PCR Primer TAGGGAGGATCCGCTAGCATGGTGAGCAAGGG 














PCR Primer GGAGTACTCACCCCAACAGC 
 































Table 8 - Oligonucleotide table of PCR and sequencing primers. Underlined sequences indicate a restriction site, 
and italic sequences in Gibson Assembly primers indicate the region of the primer that is complementary to the 
destination of the PCR product. 
 
 
2.2.4 – In silico DNA analysis 
 Gibson Assembly Design: All Gibson Assembly design was performed using NEBuilder® 
Assembly Tool (http://nebuilder.neb.com/). Preferences were left as default, with Phusion 
and GC Buffer selected as the PCR product group. Where necessary, bases were added to the 
forward or reverse primers generated to ensure that all inserts were in the appropriate codon 
frame in the vector backbone. All suggested annealing sequences were analysed using the 
‘Check Primers’ task on Primer3Plus (http://www.primer3plus.com/cgi-
bin/dev/primer3plus.cgi). If the annealing region of the suggested primers were poor, the 
length of the annealing region was varied, with each length of primer checked through 
Primer3Plus. Of the variants, the nucleotide length that gave the lowest Penalty score was 
used as the annealing nucleotides of the Gibson PCR primer.  
 Primer Selection: The online web application Primer3Plus (http://www.primer3plus.com/cgi-
bin/dev/primer3plus.cgi) was used to generate optimal primers from a DNA region, or to 
check pre-selected primers against characteristics which would be detrimental to any PCR 
reactions to be performed. Example primer features that Primer3Plus evaluates are dimer 
formation, primer hairpin formation, primer 3’ stability, and template mispriming.  




 DNA Sequencing: Source BioScience Sanger Sequencing was used for the sequencing of all 
plasmids. Plasmid DNA was provided at 100ng/µl, with at least 5µL provided per reaction. 
Primers were supplied at 3.2pmol/µL with at least 5µL provided per reaction.  
 DNA Sequencing Chromatogram Analysis: The free software Finch TV (Geospiza, Inc) was 
used to analyse the chromatogram generated by DNA Sanger Sequencing. In particular, 
chromatograms were checked for mixed traces indicating DNA contamination, and used to 
give an estimate of the confidence of a generated DNA sequence. 
 DNA Sequencing Viewing: The free software Serial Cloner 2.6 was used to view, annotate, 
and store all DNA sequences. This tool also allowed identification of restriction sites for 
cloning and diagnostic digest. It was also used to align DNA sequences (e.g. for comparison 
between a sequenced plasmid and a predicted plasmid sequence) using the ‘Align two 
sequences’ function to identify any replication errors generated during PCR during plasmid 
generation.  
 DNA Sequence Lookup: To search for DNA sequences, the online databases Ensembl 
(http://www.ensembl.org/index.html) or NCBI (https://www.ncbi.nlm.nih.gov/) were used. 
 Nucleotide Queries: To match DNA sequences against annotated genomes, the online tool 
BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi) was used. 
  




2.3 – Protein Techniques 
2.3.1 – Antibody-based protein detection 
Cell lysis 
For each well of a 6-well dish, cells were washed twice with ice-cold PBS (Sigma-Aldrich – D8537), with 
the PBS completely aspirated before continuing. After aspiration, chilled 50µL NP-40 lysis buffer (Table 
9) supplemented with Protease Inhibitors (Sigma-Aldrich – COEDTAF-RO Roche) was added to each 
well, cells scraped using a cell scraper, and the lysates pipetted into chilled Eppendorf tubes. The tubes 
were kept on ice for 15mins with frequent vortexing to allow complete cell lysis. The lysates were then 
centrifuged at 10000RCF for 10mins at 4oC to pellet the nuclear fraction. The supernatant was kept 
and frozen at 20oC for short-term storage. 
 
Name Concentration Manufacturer 
TRIS pH7.5 10nM CIMR Core Stock 
NaCl 150mM CIMR Core Stock 
EDTA 0.5mM CIMR Core Stock 
IGEPAL CA-630 0.5% Sigma-Aldrich - I8896 
Table 9 - NP-40 lysis buffer formulation 
 
Bicinchoninic acid (BCA) assay and protein normalisation 
The BCA assay was used to normalise protein concentrations and performed using Pierce BCA reagents 
(ThermoFisher – 23225). Dilutions of Bovine Serum Albumin (BSA (ThermoFisher – BP1605-100)) at 0, 
0.1, 0.2, 0.5, 1, 1.5, 2, 2.5 mg/mL were prepared, and 10µL was pipetted in triplicate into a 96-well 
plate. The sample was diluted ten-fold and 10µL was pipetted in triplicate into the 96-well plate. With 
the plate on ice, 200µL of BCA solution was added to each well, with the plate then incubated for 
30mins at 37oC. The optical absorbance of each well at 562nm was determined, and the protein 
concentrations of each sample determined by comparing to a standard curve generated from the BSA 
standards. 
 Normalised protein concentrations were typically made up in a volume of 75µL, with 25µL of 
this volume consisting of 3x DTT SDS-Sample Buffer (Table 10). The remaining 50µL was composed of 
a combination of protein lysate and PBS in a proportion that allowed each sample to have an 
equivalent maximum concentration of protein. The volume of lysate in each sample was made in 
relation to the concentration of protein in the least concentrated sample if 50µL lysate volume was 
used. This was determined using the following equation: 





C = (Lv*Lcmin)/Dv 
where lysate volume (Lv) = 50µL; desired volume (Dv) = 75µL; C = final concentration; Lc = lysate 
protein concentration; Lcmin = lowest lysate protein concentration 
 
Name Concentration Manufacturer 
Glycerol 20% ThermoFisher – G/P460/53 
Tris pH6.8 100mM CIMR Core Team 
Sodium dodecyl sulphate (SDS) 140mM ThermoFisher – S/P530/53 
Dithiothreitol (DTT) 200mM ThermoFisher – R0861 
Bromophenol Blue 0.04% VWR – 97061-690 
Table 10 - 3x DTT SDS-Sample Buffer formulation 
 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE using the BioRad Mini-PROTEAN system was used to separate denatured proteins on a 
polyacrylamide gel based on their molecular weight. 10% polyacrylamide gels were cast for separation 
of proteins between 30-100kDa. For a 1mm-thick 10% polyacrylamide gel, a resolving buffer-
acrylamide solution (Table 11) was poured between 1mm spacer BioRad glass plates placed in a 
casting frame to leave a ~2cm gap at the top of the plates, with a layer of isopropanol (Sigma-Aldrich 
– 190764) added to prevent the top of the gel from drying. After the gel had set, the isopropanol was 
discarded, and the top of the gel was washed several times with H2O. A stacking buffer-acrylamide 
solution (Table 12) was then poured onto the set resolving gel to fill the glass plates, and a 10-well 
comb was placed in the stacking gel to create the lanes for protein loading. After the gel was set, the 
plate was placed within the BioRad Electrode Assembly unit, and the Mini Tank filled to the 
appropriate height with SDS-Electrophoresis Buffer (Table 13). The well comb was then removed to 
form the protein loading lanes. 20µL See Blue Plus 2 Prestained protein ladder (ThermoFisher – 
LC5925) was added into the first lane, and 30µL of DTT SDS-Sample Buffer lysates that been boiled at 
98oC for 10mins were loaded, with blank lanes filled with 30µL 1x DTT SDS-Sample Buffer. The gel was 









Name Concentration Manufacturer 
Acrylamide Bis-Acrylamide 
Solution (Ratio 37.5:1) 
34% Severn Biotech – 20-2100-10 
Resolving gel buffer 25% See below 
Ammonium persulfate 1.75mM Sigma-Aldrich – A3678 
Tetramethylethylenediamine 
(TEMED) 
0.15% Sigma-Aldrich –T9281 
Resolving gel buffer (pH8.8) - - 
Tris 1.5M Sigma-Aldrich – T1503 
Sodium dodecyl sulphate (SDS) 0.4% ThermoFisher – S/P530/53 
Table 11 - 10% polyacrylamide resolving gel formulation 
 
Name Concentration Manufacturer 
Acrylamide Bis-Acrylamide 
Solution (Ratio 37.5:1) 
13% Severn Biotech – 20-2100-10 
Resolving gel buffer 25% See below 
Ammonium persulfate 1.75mM Sigma-Aldrich – A3678 
Tetramethylethylenediamine 
(TEMED) 
0.15% Sigma-Aldrich –T9281 
Stacking gel buffer (pH6.8) - - 
Tris 0.5M Sigma-Aldrich – T1503 
Sodium dodecyl sulphate (SDS) 0.4% ThermoFisher – S/P530/53 
Table 12 - Polyacrylamide stacking gel formulation 
 
Name Concentration Manufacturer 
Tris 2.5mM Sigma-Aldrich – T1503 
Glycine 1.92mM ThermoFisher – G/0800/60 
Sodium dodecyl sulphate (SDS) 0.01% ThermoFisher – S/P530/53 
Table 13 - 1x SDS-electrophoresis buffer 
 
Western blotting and antibody labelling 
After proteins were separated using SDS-PAGE, proteins were transferred onto polyvinylidene fluoride 
(PVDF) membranes. To do this, a transfer sandwich was constructed in a BioRad Mini Gel Holder 
Cassette consisting of: a foam pad, two pieces of 10cm x 8cm chromatography filter paper (Whatman 
– 3030-917), the polyacrylamide gel, a 9cm x 7cm PVDF membrane (Millipore – IPVH00010) pre-
activated by incubation with methanol (ThermoFisher – M/4056/17), two pieces of 10cm x 8cm 
chromatography filter paper (Whatman – 3030-917), and a foam pad. The closed cassette was placed 
within the Mini Trans-Blot Central Core which was placed within the Mini Tank. The tank was filled 
using SDS Transfer Buffer (Table 14) and the system run at 100V for 75mins. The membrane was then 
blocked using 5% skimmed milk (Marvel) in TBS-Tween (Table 15) for 1hr at room temperature before 
being incubated in primary antibody (Table 16) diluted in 5% skimmed milk overnight at 4oC. The 




following day, the membrane was washed three times for 5mins in TBS-Tween (Table 15) before the 
addition of secondary antibody (Table 16) diluted in 5% skimmed milk for 1hr at room temperature. 
After this time, the membrane was washed 3 times for 5mins in TBS-Tween and placed onto 2mL 
aliquots of pre-mixed SuperSignal West Pico Chemiluminescent Substrate (ThermoFisher – 34578) on 
clingfilm for 5mins. The membrane was then gently blotted to remove excess liquid, wrapped in 
clingfilm, and placed in a Hypercasette (ThermoFisher – RPN11649) where it used expose Fuji Super 
RX X-Ray film (FUJIFILM – 4741019289) which was then developed.  
 
Name Concentration Manufacturer 
Tris 48mM Sigma-Aldrich – T1503 
Glycine 39mM ThermoFisher – G/0800/60 
Sodium dodecyl sulphate (SDS) 0.0375% ThermoFisher – S/P530/53 
Methanol 20% ThermoFisher – M/4056/17 
Table 14 - 1x SDS-transfer buffer 
 
Name Concentration Manufacturer 
10x Tris-buffer saline (TBS) 10% See below 
Polyoxyethylene-20 (Tween-
20) 
0.0001% NBS Biologicals – TB0560 
10x Tris-buffer saline (pH7.4) - - 
NaCl 0.9% Sigma-Aldrich –71387 
Tris 10mM Sigma-Aldrich – T1503 
Table 15 - TBS-Tween formulation 
  














1:5000 Cell Signalling - 
2118 
Spastin Amino acids 





1:500 Allison et al. 2013 


















Rabbit IgG Donkey - 1:150000 Sigma-Aldrich – 
SAB3700934 
Table 16 - Primary and secondary western blotting antibodies 
 
2.3.2 – Plasma membrane profiling 
Cell surface biotinylation 
The procedure of cell surface biotinylation is detailed by Zeng et al. 2009. This uses sodium periodate 
to oxidise glycosylated (sialylated) proteins to produce aldehyde groups and, in the presence of the 
catalyst Aniline, the compound aminooxy-biotin then forms stable oxime linkage hence biotinylating 
cell surface proteins. At 4oC, the sodium periodate and/or aminooxy-biotin are cell impermeable, 
hence allowing the procedure to specifically biotinylate cell surface proteins. 
 Firstly, the pre-made biotinylation mixture (Table 17) was activated by the addition of 4.2mL 
10x Sodium Periodate (Table 17), with this active mixture kept at 4oC under foil and used within 
10mins. Cells were washed twice with ice-cold PBS (Sigma-Aldrich – D8662), with this wash solution 
completely aspirated from the dish before continuing. The washed cells were then biotinylated by the 
addition of 6mL activated biotinylation mix to each dish which was placed on a rocker for 30mins at 
4oC in the dark. During this incubation time, the lysis buffer with iodoacetamide was prepared (Table 
18). After the biotinylation incubation, the reaction was quenched by the addition of 1.5mL 5mM 
glycerol (ThermoFisher – G/P460/53) dissolved in PBS (Sigma-Aldrich – D8662). The cells were then 
washed twice with ice-cold PBS (Sigma-Aldrich – D8662), with this removed completely after the 
second wash. 1mL of the lysis buffer was added to each dish, the cells scraped, and lysates were 
transferred to chilled Eppendorf tubes and kept on ice for 30mins. The lysates were then centrifuged 




at 13000RCF at 4oC for 5mins with the supernatant kept. This process was repeated 3x and the final 
supernatant snap frozen in liquid nitrogen and stored at -80oC. 
 
Name Concentration Manufacturer 
Aminooxy-biotin 97µM Biotium – 90113 
Aniline (dissolved in PBS pH6.7) 0.095% Acros Organics – 423425000 
10x Sodium periodate (added 
last) 
10% See below 
10x Sodium periodate dissolved 
in PBS (Sigma-Aldrich - D8662) 
pH6.7 
10mM ThermoFisher – 20504 
Table 17 - Biotinylation mixture formulation. The mixture is made using PBS (Sigma-Aldrich – D8662), with the 
10X sodium periodate added immediately before starting the biotinylation reaction. 
 
Name Concentration Manufacturer 
Tris 10mM Sigma-Aldrich – T1503 
Triton X-100 1.6% ThermoFisher – 28314 
NaCl 150mM Sigma-Aldrich – 71387 
Roche Protease Inhibitor 
Cocktail Tablet 
1 per 10mL Sigma-Aldrich - COEDTAF-RO 
Roche 
Iodoacetamide 5µM Sigma-Aldrich – I1149 
Table 18 - Biotinylation reaction lysis buffer formulation. 
 
Biotinylated protein pulldown and digestion (Performed by Weekes Lab) 
Streptavidin beads (ThermoFisher – 65601) were prepared by removing 500µL beads and pipetting 
into a 10mL Polyprep column (BioRad – 731-1550) placed on a vacuum manifold and washing 4 times 
with 800µL ice-cold 1% lysis buffer (as Table 18, but with 1% Triton-X100). Once washed, 600µL 1% 
lysis buffer was added to the beads. Previously biotinylated lysates were thawed on ice and protein 
pulldown was performed by mixing 95µL of resuspended streptavidin bead solution to each lysate and 
rotating the solution at 4oC for 75mins. After the elapsed time, the beads were washed. To do this, 
the entire contents of the bead-incubated lysates were transferred to new Polyprep vacuum columns 
(with 500µL 1% lysis buffer used to wash the bead incubation tube and added to the column to ensure 
complete transfer) and washed using 9 sequential wash/incubation steps (Table 19). 
 Tryptic digest was then performed. The washed beads were resuspended in 600µL HPLC-grade 
H2O (WVR – 23595.328) and transferred to a spin column in a microcentrifuge tube, ensuring that all 
resuspended beads were transferred to the column. Samples were then centrifuged at 2000RCF for 
1min, the spin column transferred to a new microcentrifuge tube and the bottom of spin column 
screwed on and digested by the addition of 35µL Trypsin-HEPES solution (0.8% Trypsin (ThermoFisher 




– 90305)) in 200mM HEPES (Sigma-Aldrich – H0887) dissolved in PBS (Sigma-Aldrich – D8537)) and 
shook at 37oC for 3hrs. The caps were then removed, and the columns centrifuged at 2000RCF for 
1min to obtain the digested samples. 
 
Wash Step Solution 
Component 
Concentration Manufacturer Incubation 
Time (if 
applicable) 
1. 4 washes in 1% 
lysate buffer 
1% lysate buffer See Table 18 See Table 18 NA 
2. 4 washes in 
1mL PBS-SDS-
DTT solution 
Solution made up 
in PBS (Sigma-
Aldrich - D8537) 
   
 Dithiothreitol 100mM  NA 





3. Incubation with 
500µL PBS-SDS-
DTT solution 
   20mins RT 
4. 8 washes with 
1.5mL urea 
solution 
Solution made up 
in HPLC-grade H2O 
(WVR – 23595.328) 
   
 Urea 6M CalBiochem – 
9530 
NA 
 Tris 0.1M Sigma-Aldrich 
– T1503 
NA 
5. 1 wash with 
10mL urea 
solution 
    











20mins RT in 
dark 
7. 2 washes with 
1.5mL urea 
solution 
    





    





    
Table 19 - Washing protocol of the streptavidin beads with bound biotinylated proteins. 9 sequential steps are 
required for the washing of the streptavidin-biotinylated protein bead conjugates. Where solution formulations 
are required, they are noted underneath each washing step. 




TMT labelling and SepPak peptide purification (Performed by Weekes Lab) 
After the elution of the digested peptides, 10µL of 100% acetonitrile (AcN; Acros Organics – 
364311000) was added to each sample, followed by incubation for 1hr at room temperature with 6µL 
of TMT reagent (ThermoFisher – 90111 and A34807) resuspended in 100% AcN, with different TMT 
labels added to each sample. After the TMT labels had bound the peptides, a ‘Single Shot’ sample was 
extracted by removing a 5µL aliquot from each sample. The Single Shot extraction allowed a quick 
determination of whether the TMT labelling had been successful and the relative abundances of the 
samples. The extracted samples were then mixed separately with 0.55µL 5% hydroxylamine (Sigma-
Aldrich – 467804) made in 200mM HEPES (Sigma-Aldrich – H0887) pH8.5 to quench the TMT reaction, 
before being combined into a single tube. 1.9mL of 1% formic acid (ThermoFisher – 85178) was then 
added to acidify the combined samples and bring the AcN concentration below 3%. Excess salt was 
then removed using SepPak C18 columns (Waters – WAT05960), with columns equilibrated by 
washing 2 times with 1mL 70% AcN (Acros Organics – 364311000), followed by 3 washes with 1mL 1% 
formic acid (ThermoFisher – 85178). The peptide mixture was then added to the column to bind the 
peptides to the C18 resin. The column was then washed 3 times with 1% formic acid (ThermoFisher – 
85178) to remove any salt residues, before being eluted in 700µL of buffer composed of 70% AcN 
(Acros Organics – 364311000) and 1% Formic acid (ThermoFisher – 85178). This eluate was then dried 
completely using a centrifugal evaporator, with the dried sample then resuspended in 10µL of a buffer 
composed of 4% AcN (Acros Organics – 364311000) and 5% formic acid (ThermoFisher – 85178) for 
mass spectrometry. 
 After the Single Shot data had been acquired, the remaining eluate from the individually 
labelled TMT samples were quenched by the addition of 3.3µL 5% hydroxylamine (Sigma-Aldrich – 
467804), and the samples were combined, ensuring that the combined volume contained a roughly 
equal proportion of peptide from each sample. This combined sample was then dried, acidified, 
removed of salt contaminants using the SepPak C18 column as previously described, and dried 
completely before being fractionated. 
 
Strong-cation-exchange (SCX) peptide fractionation (Performed by Weekes Lab) 
SCX fractionation was used to separate the TMT-labelled peptides into subsets based on peptide 
hydrophobicity. To begin, the SCX resin filter was constructed by removing the filter from a P10 pipette 
tip and inserting it into a P200 tip and adding 150µL of Polysulfoethyl A resin (The Nest Group – 
BMSE2003). The tip was then washed and equilibrated by using 800µL SCX Buffer A, 400µL SCX Buffer 
B, and finally 1.6mL SCX Buffer A again, with the key difference in the buffers being their concentration 




of KCl (Table 20). The dried peptide sample was then resuspended in 400µL SCX Buffer A and added 
to the SCX filter tip, with run through collected in a microcentrifuge tube labelled 0, with all peptides 
binding to the SCX resin. The tip was then washed with 150µL ‘0’ buffer into the same tube (Table 21). 
The tip was then moved to another microcentrifuge tube, the ‘10’ wash buffer applied to elute the 
first fraction, and eluate collected, with this process repeated using the different wash buffers until all 
fractions had been collected, with the ‘150’ buffer eluting all remaining peptides. When all fractions 
had been collected, the peptides were dried completely using a centrifugal evaporator. To remove 
high salt concentrations, dried fractionated peptides had to be washed before being loaded into the 
mass spectrometer. This was done using an identical method to the SepPak method described above. 
 
Name Concentration Manufacturer 
SCX Buffer A (pH2.8)   
Acetonitrile (AcN) 30% Acros Organics – 364311000 
Potassium phosphate 7mM Sigma-Aldrich – P0662 
   
SCX Buffer B (pH2.8)   
Acetonitrile (AcN) 30% Acros Organics – 364311000 
Potassium phosphate 7mM Sigma-Aldrich – P0662 
Potassium chloride 350mM Sigma-Aldrich – P9541 
Table 20 - SCX buffer formulations. All buffers were made in HPLC-grade H2O (WVR – 23595.328) 
 
Wash Buffer Name Proportion of SCX Buffer B Proportion of SCX Buffer A 
Wash Buffer ‘0’ 0% 100% 
Wash Buffer ‘10’ 2.9% 97.1% 
Wash Buffer ‘25’ 7.1% 92.9% 
Wash Buffer ‘40’ 11.4% 88.6% 
Wash Buffer ‘60’ 17.1% 82.9% 
Wash Buffer ‘90’ 25.7% 74.3% 
Wash Buffer ‘150’ 42.9% 57.1% 
Table 21 - SCX wash buffer formulations. 
 
Mass spectrometry (Performed by CIMR Proteomics Core) 
Resuspended peptides were analysed by Liquid Chromatography Tandem Mass Spectrometry (LC-
MS/MS) using a Thermo Orbitrap Fusion Lumos (ThermoFisher) coupled to an RSLC3000 nanoUPLC 
(ThermoFisher). Peptides were fractionated using a 75cm Acclaim PepMap column (ThermoFisher) 
with solvent A (0.1% formic acid) and B (80% MeCN, 0.1% formic acid) at a flow rate of 250nl/min. 
Single shot analyses used a gradient rising from 3-37% B by 180mins, and SCX fractions used 3-37% B 
by 120mins with MS spectra acquired using an MS3-TMT strategy. MS2 spectra were obtained by CID 




fragmentation (normalized collision energy (NCE) 35) with ion trap scanning in turbo mode. MS3 
acquisition used Synchronous Precursor Selection of the top six MS2 ions for HCD fragmentation (NCE 
65). Fragments were scanned in the Orbitrap at 60,000 resolution and were not accumulated for all 
parallelisable time. The entire MS/MS/MS cycle had a target time of 3s with dynamic exclusion for 
70s. The six SCX fractions and the Single Shot data were processed together in the final data set using 
a Sequest-based-in-house software pipeline, using the mouse Uniprot database (January 2017). 
  




2.4 – Microscopy 
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Table 22 - List of microscopes used. 




2.4.2 – General microscopy techniques 
Cell plating 
For fixed cell microscopy, cells were plated on 10mm coverslips within a 6-well plate. For super 
resolution microscopy, cells were grown on high precision MatTek glass bottom dishes (MatTek – 
P35G-0.170-14-C). For live cell microscopy, cells were plated on MatTek glass bottom dishes (MatTek 
– Part # P35G-1.5-20-C). Typically dishes and coverslips were left uncoated, however for imaging the 
ER, coverglasses were coated with 500µg/mL Matrigel (Corning – 354277). All cells were seeded to 
achieve a ~60% confluency at the time of imaging.  
 
Fixation and permeabilisation 
Cells were washed once with PBS (Sigma-Aldrich – D8537) before the addition of 3.6% 
paraformaldehyde (PFA; VWR – 20909.290) made in PBS (Sigma-Aldrich – D8537) per well for 20mins 
at room temperature. After 20mins, the PFA was aspirated and the cells were washed with PBS three 
times. For the fixed ER imaging, the 3.6% PFA was supplemented with 0.1% glutaraldehyde (Sigma-
Aldrich – G5882), with the fixation and PBS washes performed with simultaneous aspiration and 
solution addition to ensure cells were kept moist. After fixation, cells to-be-permeabilised were 
treated with 0.1% Triton-X100 (ThermoFisher – 28314) for 4mins at room temperature, and the cells 
washed three times with PBS (Sigma-Aldrich – D8537). 
 
Immunostaining 
For cells grown on coverslips, after permeabilisation coverslips were blocked by the transferring the 
coverslip cell-side-down onto Parafilm (Sigma-Aldrich – P7793) dotted with 100µL FBS blocking 
solution (10% FBS (Sigma-Aldrich – F7524)) in PBS (Sigma-Aldrich – D8537) for 1hr at room 
temperature. Coverslips were then transferred to a new 100µL dot of primary antibody diluted in FBS 
blocking buffer (Table 23) and incubated for 1hr at room temperature. The coverslips were then 
washed by immersing the coverslip twice in FBS blocking solution, twice in PBS (Sigma-Aldrich – 
D8537) and twice in H2O, with the process repeated 6 times. The coverslips were then placed cell-side-
down onto a 100µL dot of secondary antibody (Table 23) diluted in FBS blocking buffer for 1hr at room 
temperature. The coverslips were then washed as before, and mounted cell-side-down onto 
microscope slides dotted with ProLong Gold Antifade mountant (ThermoFisher – P36930/P36936). 
For cells grown in MatTek dishes, cells were blocked, treated with primary antibody, washed and 




treated with secondary antibody as above, but with a sufficient volume added to the dish to cover the 
embedded glass slide during each stage. Cells were then imaged in PBS (Sigma-Aldrich – D8537). 
 
Name Antigen Host IgG Type Dilution Source/Reference 




























Mouse IgG Donkey NA 1:300 ThermoFisher – A-
31571 
Table 23 - List of primary and secondary antibodies used for immunofluorescence 
 
 
2.4.3 – Live cell imaging methods 
Retention using selective hooks (RUSH) assay 
Two HeLa stable cell lines expressing the RUSH system were obtained from the Perez Lab (Curie 
Institute, Paris): TNFα-SBP-GFP KDEL-Streptavidin and GPI-SBP-GFP KDEL-Streptavidin. Upon receipt, 
cells were sorted by flow cytometry to enrich GFP-high populations to aid signal detection during live 
cell imaging. 
 For siRNA depletion experiments, cells were plated on MatTek dishes and in a 6-well plate for 
knockdown validation by lysis and western blotting. The following day, cells were transfected with 
siRNA. This protocol was similar to the one described above, but the transfection mixture was made 
using FBS-free growth media rather than Opti-MEM as Opti-MEM contains biotin that leads to the 
aberrant release of the reporter, and FBS blocks oligonucleotide-lipid complex formation. Once the 
oligonucleotide-lipid complex had formed, the mixture was combined with regular growth media for 
addition to the cells as in the standard protocol. The following day, cells were transfected with SiT-
FusRed to highlight the Golgi, with the transfection method similar that previously described, but using 
FBS-free growth media rather than Opti-MEM. This mixture was then added directly onto the siRNA-




mixture already on the cells without washing the cells. 6hrs post transfection, the media on the cells 
was completely changed and replaced with 2mL normal growth media.  
 RUSH imaging was performed the following morning using a LSM780 confocal with an 63x 
objective, autofocus, heated stage, and CO2 incubation (Table 22). A dish was loaded onto microscope 
and 10 healthy cells with bright reticular GFP signal and low background Golgi signal were selected 
and stored as positions. The imaging was set to move between the 10 positions and image in both 
channels before returning to the first position and repeating the process with no delay. ~200 cycles 
were imaged with ~40secs between each cycle. After several repeated cells to image the cell without 
biotin addition, the CO2 incubator lid was removed and 2mL of 2x preheated 80µM biotin (Sigma-
Aldrich – B4639) in growth media was added dropwise whilst the imaging was occurring, with the cycle 
and position number recorded of when the biotin was added. The CO2 lid was then replaced, and the 
imaging allowed to continue. After the imaging was complete, a new dish was imaged using the same 
process. Per experimental repeat, 3 dishes of each treatment were imaged, with 10 cells imaged per 
dish. After imaging, both the imaged cells and the cells plated in the 6-well dish were lysed for 
knockdown validation. A handwritten ImageJ and Visual Basic for Applications Excel code was used to 
measure the secretion dynamics of the RUSH cargos.  
 
RUSH assay positive control 
During the RUSH assay, secretory transport was artificially disrupted by using H-89 dihydrochloride 
hydrate (Lee & Linstedt, 2000). Cells were plated at 350,000, 400,000 and 450,000 cells per dish with 
two sets of dishes per condition. The following day, media was replaced with 1mL fresh media. For 
cells with the H89 treatment, 1mL of 200μM (2x) H89 (Sigma-Aldrich – B1427) dissolved in fresh media 
was then added 30mins before imaging, with untreated cells having 1mL growth media added. After 
30mins, the RUSH assay was performed as described above. 
  
Live cell imaging of endosomal tubules 
Cells expressing GFP-SNX1 were plated in triplicate on 25mm coverslips in a 6-well plate at 30,000 cells 
per well per experimental condition, with 1250,000 cells also plated in a separate 6-well plate for lysis 
to validate the efficacy of knockdown. The following day, cells were transfected with siRNAs as 
previously described. After 72hrs, cells were washed in PBS before being imaged using an 
AxioObserverZ1 inverted microscope fitted with a spinning disk scanhead (Table 22) for 3mins at 
400ms per frame. Images were processed in ImageJ using a Single Pixel Filter and a mild Gaussian Blur 




to help remove hot pixels. Concurrently with imaging, cells plated for knockdown verification were 
lysed and processed. The quantification of GFP-SNX1 endosomal tubule dynamics was done manually, 
with filenames coded using a random number generator to avoid measurement biases. Tubules were 
defined as stated in Figure 3 of Chapter 3. Tubules were only counted if they were not present at the 
start or end of the acquired movie.  
 
Live cell imaging of ER-endosome contacts 
ER-endosome contacts were imaged in cells stably expressing GFP-SNX1 and transiently expressing 
RFP-KDEL. Cells for imaging were grown on MatTek dishes, with cells also plated in 6-well dishes for 
lysis and knockdown verification. The following day, cells were transfected as previously described, 
and after 48hrs, cells were transfected with RFP-KDEL as previously described. Cells were imaged in 
growth media 72hrs post-siRNA transfection. Imaging was performed using a Nikon Eclipse Ti 
microscope fitted with a spinning disk, a beamsplitter, and two cameras (Table 22). Imaging was 
performed at 400ms per frame simultaneously in both colours. The quantification of ER-endosome 
contacts was done manually, with filenames coded using a random number generator. 15 GFP-SNX1 
tubules were identified in regions of the cell with resolvable ER tubules per cell, and five cells were 
measured per condition per experimental repeat. To avoid bias, the endosomal tubules were 
identified first without the ER channel visible, with this only displayed after the 15 endosomal tubules 
had been selected. ER-endosome contacts were defined as when the two organelles overlapped. 
 
Live cell imaging of EB comets 
Cells for imaging were plated in MatTek dishes and cells for knockdown verification were plated in 6-
well plates as previously described. The following day, cells were treated with siRNAs as appropriate 
(e.g. not during the imaging of MEFs). 72hrs after plating, cells were transfected with EB3-mCherry as 
previous described. 6hrs after transfection, the media was completely removed from the cells, the 
cells washed twice with PBS (Sigma-Aldrich – D8537), and 2mL growth media was added to the cells. 
The cells were imaged 18hrs after their transfection, with the concurrent lysis of the cells designated 
for knockdown verification. Imaging was performed using an AxioObserverZ1 widefield microscope 
(Table 22), at 500ms per frame continuously for 90secs. A minimum of 15 cells were recorded for each 
experimental repeat per condition. 
 For image analysis, images were pre-processed with ImageJ before being analysed by particle 
tracking using Imaris 9.1.0 software (Bitplane, Inc.). In ImageJ, a region of interest was generated and 




saved that only contained one successfully transfected cell. These processed images were then 
analysed using the ‘Spots’ tool of the Imaris software, with the parameters used described in Table 
24. In Imaris, the region of interest selected was a rectangle within the ImageJ processed image. Spot 
filtering was typically performed using the automatic ‘quality’ metric, but this was adjusted if obvious 
errors occurred, and additional filters were applied to repress noise where necessary. Statistics were 
exported from Imaris, and track filtering and summary statistics generation was performed using a 
custom-made MATLAB script, with tracks filtered using the parameters listed in Table 25.  
 
Imaris Spot Wizard Parameters Value (if applicable) 
Segment only a Region of Interest TRUE 
Track Spots (over Time) TRUE 
Estimated XY Diameter 0.65µm 
Spot Filtering Quality (automatic) 
Tracking Method Autoregressive 
Motion 
                 Maximum Distance 0.75µm 
                 Maximum Gap Size 3 frames 
Table 24 - Imaris spot detection parameters. 
 
MATLAB Filter Parameter Value 
Track Straightness 0.4 < X < 1 
Track Duration 3.75secs < X < 45secs 
Track Length X > 2.5µm 
Track Speed 0.05µm/s < X < 0.35µm/s 
Track Speed Variation 0.1 < X < 0.85 
Table 25 - MATLAB track filtering parameters. 
 
  




2.5 – Data Processing 
2.5.1 – Image processing 
ImageJ software 
Image processing was performed primarily using the Fiji distribution of image processing freeware 
ImageJ2 (Rueden et al. 2017; Schindelin et al. 2012). Raw microscopy formats (e.g. Zeiss’s .czi or 
Nikon’s .nd2 format) were batch pre-converted into 16-bit TIFF file format using a custom macro 
making use of the OME Bio-Format plugin for ImageJ. Images were then manipulated as appropriate, 
with common manipulations including: adjusting brightness/contrast, adding or removing channels, 
bleach correction (histogram matching), thresholding, adjusting look-up-tables, resizing, cropping, 
image transformations, pixel value subtraction/addition/multiplication/division, and application of 
gaussian blur and/or single pixel filters to supress high noise. Images were then either analysed for 
quantification or finalised into exported images or movies. For image quantification, the ‘Measure’ 
tool on regions of interest, and the ‘Analyse Particles’ tool for thresholded images was used 
extensively, with several custom-made macros designed to efficiently make use of these features. All 
2D movies were created in ImageJ, making use of the Stack Tools such as ‘Combine’ to place different 
images in panels, ‘Concatenate’ to merge multiple image stacks, ‘Insert’ to add an image stack overlay 
into an existing image stack, ‘Z-project’ to merge multiple Z-positions into a single Z plane, and ‘Time 
Stamper’ and ‘Text’ and ‘Draw’ to overlay a time stamp and labels on the movie. To finalise and export 
movies or images, images were converted to RGB format and saved as either TIFF or AVI formats as 
appropriate. 
 
Imaris 9.1.0 software 
Imaris 9.1.0 (Bitplane, Inc.) software was used for particle tracking and for the visualisation and movie 
creation of 3D data sets. Images imported into Imaris were either raw microscopy format images, or 
pre-processed TIFF files. The ‘Spots’ tool was used extensively for measuring the dynamics of EB 
comets by particle tracking, the ‘Surface’ tool was used for 3D structure segmentation, and the 
‘Animation’ tool was used for the generation of 3D movies. 
 
  




Huygens Professional software 
Huygens Professional (Scientific Volume Imaging) software was used for high-quality microscopy 
deconvolution, bleach correction, background elimination, Z-drift correction, and for judging Nyquist 
sampling rate for images taken with either widefield, spinning disk, or confocal microscopes. For each 
image to be deconvolved, the theoretical point-spread-function based on the microscope and 
fluorophore parameters was used, with the deconvolution parameters adjusted to produce a sharp 
but low artefact image.  
 
2.5.2 – Data processing 
Microsoft Excel 2016 software 
Most of medium and small data handling and processing tasks was performed in Microsoft Excel 2016. 
This included the manual input of quantification data, the concatenation of multiple data sets, and the 
production of summary data using the Analysis ToolPak Excel add-in (e.g. averages, standard errors, 
and statistical tests). For more time-consuming repetitive tasks, several custom-built Visual Basic for 




MATLAB software (MathWorks) was used for data handling and processing tasks involving large 
numerical datasets. This included the simultaneous extraction of data from multiple Microsoft 
worksheets, concatenation into single matrices, data filtering and manipulation, summary statistic 
generation, and data export. Custom-built MATLAB scripts were used for these tasks. MATLAB was 
used extensively in the analysis and filtering of cell surface proteomics data and EB comet data. 
MATLAB was also used for hierarchical clustering using a Euclidean pairwise distance method using 
the ‘clustergram’ function. All scripts were written using Notepad++ software. 
 
DAVID analysis 
Gene ontology enrichment analysis was performed using DAVID 6.8 (Huang et al. 2009b, 2009a). The 
input was set as a filtered gene list (e.g. by relative fold change), the background set to the entire list 
of proteins identified by the proteomics, and searches performed against a mouse background.  
  





Statistical tests such a paired and unpaired one and two tail t-tests were typically performed either in 
Microsoft Excel 2016 manually, using the Analysis ToolPak add-in, PRISM 7 software, or JMP 10 (SAS) 
statistical software. All critical alpha values were set at 0.05, with the Bonferroni correction or 
Benjamini-Hochberg correction used to adjust the alpha value when performing multiple t-tests.  
 
2.5.3 – Data presentation 
MATLAB R2018a 
All graphs were produced using MATLAB R2018a software. This including the plotting of grouped and 
individual bar charts with standard errors, boxplots, XY scatter plots, line plots, cumulative line plots, 
histograms, pie charts, and heatmaps. XY scatter plots with ellipses were generated using the 
‘ellipsate’ MATLAB plugin with standard deviation set to 1. 
 
Adobe Illustrator and Photoshop CS6 
Multipart figures were constructed using Adobe Illustrator CS6 (Adobe). This included the organisation 
of images and graphs into a complete figure, the addition of labels, inserts, and text onto images, the 
export of the complete figure into a graphics file that could be inserted into presentation or text 
document and imported PDF editing. Adobe Photoshop CS6 (Adobe) was used for the 
brightness/contrast editing of some images, as well as the generation of high-quality image crops to 
be used as zoom inserts. 
 
Microsoft Word 2016 
Thesis writing was prepared using Microsoft Word 2016.




Chapter 3 – The function of spastin in 
endosomal tubule fission 
 
3.1 – Introduction 
3.1.1 – The function of spastin in endocytic recycling 
Endocytic recycling 
As reviewed in the Introduction (Section 1.4 and Section 1.5), endocytic sorting is a fundamental 
cellular process that facilitates the separation of lysosomally degraded cargos from those that are 
recycled. Cargo that is destined for recycling is retrieved from degradation in the sorting endosome 
by the action of multimeric cargo sorting machineries such as retromer, retriever, the CCC complex, 
the WASH complex, and their associated accessory proteins (McNally and Cullen 2018). These retained 
cargos are sorted into tubules that undergo WASH and dynamin-dependent fission from the sorting 
endosome body. Fissioned endosomal tubules then traffic along microtubules to their target 
destinations which include the cell surface (e.g. the route of TfnR), or the TGN (e.g. the route of M6PR; 
Maxfield and McGraw 2004). 
 
Spastin functions in endocytic recycling 
Several HSP proteins have been associated with endosomal sorting and recycling, including the WASH 
component strumpellin and the membrane scission enzyme dynamin-2 (reviewed in Introduction 
Section 1.2.2). The first evidence for a potential endosomal function for spastin came through the 
observed colocalisation between endogenous spastin and GFP-tagged mutant VSP4-E235Q (Connell 
et al. 2009). This ATP hydrolysis-defective VPS4 functions as a dominant negative and prevents the 
disassembly of ESCRT complexes on endosomal membranes (Bishop and Woodman 2000; Stuchell-
Brereton et al. 2007). The localisation between spastin and VPS4 therefore revealed that spastin could 
be dynamically recruited to endosomes, and that spastin was likely to have a relationship with ESCRT 
proteins. 
 Spastin was later shown to have an endocytic function. Allison et al. (2013) showed that 
depletion of spastin or spastin’s ESCRT-III interaction partner IST1 in HeLa cells led to the aberrant 




elongation of SNX1 and SNX4-positive endosomal tubules and the mistrafficking of TfnR to the 
lysosome. This endosomal elongation phenotype was also observed in spastin depleted zebrafish 
neurons and could not be rescued by the reintroduction of siRNA-resistant spastin mutants that were 
ATPase defective (K388R) or unable to bind to ESCRT-III binding partners via a mutation in spastin’s 
MIT domain (F124D). Collectively, this suggested that spastin depletion or loss of function inhibited 
endosomal recycling by causing defective endosomal tubule fission that is typically driven by spastin’s 
ESCRT-III interaction and microtubule remodelling activity. This proposed role for the spastin-IST1 
interaction is consistent with the model of the ESCRT-III IST1-CHMP1B copolymer assembling on 
tubular membranes to mediate fission (reviewed in Introduction Section 1.3.3 and 1.5.3). However, 
the function of spastin or IST1 in endosomal tubule fission was not formally proven, nor was the nature 
of spastin’s microtubule remodelling activity during endosomal tubule fission. 
 Endosomal tubule fission events have been shown to occur at sites of ER-endosome contact 
(Rowland et al. 2014). This provided a potential explanation of the somewhat puzzling observation 
that ER-localised M1 spastin was able to rescue the endosomal tubule elongation phenotype (Allison 
et al. 2013). Specifically, the necessity for ER-endosome contacts raised the hypothesis that M1 spastin 
may be located at these sites of ER-endosome contact to function in endosomal tubule fission. This 
however has not been tested. 
 
3.1.2 – Experimental approach 
Two outstanding questions surround the function of spastin in endocytic recycling: 1) do spastin and 
IST1 mediate endosomal tubule fission; and 2) what are the mechanisms by which spastin mediates 
its endosomal tubule function? In relation to this second question, areas of enquiry included 
investigating whether spastin or IST1 need to localise to endosomal tubules to mediate their fission, 
whether spastin participates in ER-mediated endosomal tubule fission, and whether tubule fission is 
driven by spastin’s ATPase domain and its microtubule remodelling function. 
 In this results chapter, I investigate these questions using high spatial and temporal resolution 
fixed and live cell microscopy. This was performed to generate a large dataset of endosomal tubule 
fission dynamics in cells with and without spastin or IST1. In addition, microscopy was used to 
investigate whether spastin or IST1 localised to endosomal tubules, whether this localisation was 
associated with tubule constriction, and whether spastin’s recruitment to endosomal tubules 
temporally and spatially correlated with endosomal tubule fission. Finally, two-colour live cell imaging 
was used to test whether spastin promotes ER-mediated endosomal tubule fission, and whether 
microtubule severing drives the fission of endosomal tubules. As each of these methods depend on 




the extensive use of microscopy techniques, a brief introduction to the microscopy methods used is 
provided below. 
 
3.1.3 – Microscopy approaches 
The experimental aims generated two main microscopy problems. In the study of endosomal tubule 
dynamics, a challenge was that tubules form and undergo fission in timescale of seconds and are thin 
(<1µm). This therefore required that high spatial and temporal resolution microscopy was used to 
adequately sample endosomal tubule dynamics. In particular, the imaging rate must be high enough 
to differentiate between endosomal tubules with normal or abnormal fission dynamics. This was 
achieved using spinning disk microscopy (described below). 
 Secondly, in studies of the localisation of spastin on endosomal tubules in living cells, it was 
necessary to express a fluorescently tagged spastin construct. Due to the cytosolic localisation of M87 
spastin and the punctate localisation of M1 spastin on the ER (Connell et al. 2009), M1 spastin was 
chosen for fluorescent tagging. However, overexpression of spastin can result in substantially altered 
microtubule dynamics due to the increased severing of microtubules (Roll-Mecak and Vale 2005). It 
was therefore required to express GFP-M1 spastin at a low level to avoid overexpression artefacts, 
but this led to dim spastin signal. This required microscopy with increased signal to noise capabilities 
to accurately observe M1 spastin’s live cell dynamics, with this achieved by using Airyscan microscopy 
(detailed below). 
 
Spinning disk microscopy 
In spinning disk microscopy, two rapidly rotating discs are placed between the light source and the 
sample. The second of these discs contains thousands of 50µm confocal pinholes which allow multiple 
parallel light beams to illuminate the image plane near-simultaneously. This light is then passed back 
through the objective and the confocal pinholes of the disk and is detected using high sensitivity 
cameras. Once through the disk, the light can be split using dichroic mirrors and sent to different 
cameras, meaning that multiple excited fluorophores with different spectral properties can be 
acquired simultaneously (Figure 1A). 
 The key advantage of this method is that it allows confocal sampling of the entire field of view 
near-simultaneously. This differs from the raster scanning method employed in conventional confocal 
microscopy. As the imaging plane is illuminated in millisecond timescales, this imaging modality can 
achieve speeds of up to 1000 frames per second whilst simultaneously blocking out-of-focus light from 




other axial planes. This makes this methodology a suitable tool for imaging the growth and fission of 
endosomal tubules on the second timescale range. 
 
Airyscan microscopy 
Despite the benefits of confocal microscopy in achieving axial image resolution, the presence of a 
pinhole also limits the amount of light that reaches the detector, ultimately resulting in dim signal 
even for bright fluorophores. The pinhole can be opened to increase the proportion of light received 
by the detector, but only at the expense of axial image resolution. Airyscan microscopy circumvents 
this problem by removing the physical pinhole, allowing a much higher proportion of light emitted 
from each fluorophore to be captured (Korobchevskaya et al. 2017). The light is collected by a radial 
array of detectors, and computationally integrating and reassigning the signal from each detector to 
the central detector results in a well resolved bright image (Figure 1B). 
 The major benefit of this method over conventional confocal microscopy is that by removing 
the physical pinhole, a far greater proportion of the emitted light is collected. This allows even dim 
samples to be represented with a high signal to noise ratio. In addition, as the light collected contains 
more high spatial frequency information (represented in the angle of light emitted from a 
fluorophore), the image itself is of higher resolution compared to conventional confocal microscopy. 
This therefore makes it well suited to study the dim expression of GFP-tagged M1 with high resolution 
in both fixed and live cells. 
 
 
Figure 1 - Spinning disk and Airyscan microscopy. (A) The light pathway of the spinning disk microscopy used. 
Light from the laser source passes through a rotating disk that contains a radial array of microlenses. These 
separate the light into light beams which are then passed through a dichroic mirror and into a second disk which 
contains a radial array of pinholes which spins relative to the first disk. This light then passes through the 
objective and illuminates the sample causing fluorophores to emit light. This light then passes back through the 
objective onto the spinning disk. Out-of-focus light is blocked by the confocal pinholes, leaving only in-focus light 



















Stokes Shift) to be reflected towards the camera. A dichroic beam-splitter splits the light depending on its 
wavelength, allowing light emitted from different fluorophores with different emission wavelengths to be 
detected by each camera. The information from both cameras then represents two channels in the final image 
and can be aligned spatially. (B) The light path of the Airyscan microscope. The light from laser passes onto the 
sample via the objective and is deflected via a dichroic mirror towards the detectors. The top path represents 
the light path in confocal microscopy, with out-of-focus light being filtered by a confocal pinhole before being 
detected using a single photomultiplier detector. The bottom light path represents the Airyscan detection mode. 
The light is spread using mirrors of a variable distance and projected on a radial array of photomultiplier 
detectors. The strongest signal is detected in the centre of the array, but the light that would have been blocked 
by the confocal pinhole is also collected. The red line is a representation of the brightness of signal at relative 
positions of the detector. Whilst being the dimmest, the edges of the array receive information with the highest 
spatial information. As this area of light is detected rather than excluded by a pinhole, it means that once the 
signal information is reassigned, the image is both brighter and of a higher spatial resolution. 
Image (A) adapted from http://zeiss-campus.magnet.fsu.edu/tutorials/spinningdisk/yokogawa/indexflash.html; 
Image (B) adapted from Korobchevskaya et al. (2017). 
  




3.2 – Results 
3.2.1 – Spastin is necessary for efficient fission of SNX1 tubules in MRC5 cells 
Generation of GFP-SNX1 expressing cell lines 
To determine whether spastin promotes endosomal tubule fission it was necessary to visualise SNX1 
dynamics. Therefore, cell lines were retrovirally transduced to stably express N-terminally tagged GFP-
SNX1 at low levels (see Materials and Methods – Section 2.2.3 for cloning methods). Human lung 
fibroblast MRC5 cells and money kidney fibroblast COS7 cells were chosen as an appropriate cell 
model. This was because are both relatively flat when adhered to glass, meaning that a large volume 
of the cell could be resolved in a thin axial plane making them suitable for imaging the ER. MRC5 cells 
are also known to have a relatively sparse microtubule network, making them suitable for imaging 
microtubule dynamics. Also transduced were immortalised embryonic fibroblasts derived from either 
wildtype or spastinN384K mice that were heterozygous or homozygous for a mutation in spastin’s 
ATPase domain that made the protein ATPase defective (Connell et al. 2016). These mouse embryonic 
fibroblasts (MEFs) are referred to as WT (spastinWT/WT), HET (spastinWT/N384K, and HOM 
(spastinN384K/N384K). 
 In the mixed clonality populations used for experimentation, the abundance of GFP-SNX1 was 
below endogenous SNX1 abundance in all three MEF cell genotypes, equal to endogenous SNX1 
abundance in COS7 cells, and somewhat increased above the abundance of endogenous SNX1 in the 
MRC5 cell line (Figure 2).  
 
Figure 2 - GFP-SNX1 expression levels in MEF, COS7 and MRC5 cells. WT, HET, HOM MEFs, and COS7 and MRC5 
cell lines were retrovirally transduced to express N-terminally tagged GFP-SNX1. Lysates from the clonal 
populations were collected and the relative abundance of GFP-SNX1 to endogenous SNX1 was determined by 





































Imaging and quantification of GFP-SNX1 dynamics in mock and spastin depleted MRC5 cells 
Spinning disk live cell imaging of GFP-SNX1 dynamics was performed in mock treated MRC5 cells and 
MRC5 cells depleted of spastin using a pool of two different spastin siRNAs. This revealed a dramatic 
difference in the dynamics of GFP-SNX1 endosomal tubules in mock versus spastin siRNA depleted 
cells (Movie 1 and Figure 3A). Tubules in spastin depleted cells appeared to grow for a longer period 
of time before fission, with more tubules fissioning along the length of the tubule or collapsing back 
into the parent endosome without fission. Growth rates however appeared unchanged (Movie 1). 
 To quantify these differences, the maximum length, total duration, and fate of each 
endosomal tubule was manually measured and recorded. An endosomal tubule was defined as a 
SNX1-positive tubular protrusion of >1µm emerging from a roughly spherical SNX1 labelled punctum. 
The definitions of maximum length, total duration and tubule fate are defined in the Figure 3B legend. 
 
There was a statistically significant increase in the length of endosomal tubules between mock and 
spastin depleted cells (Figure 3Bi), confirming the effect observed in HeLa cells by Allison et al. (2013). 
Importantly, there was also a significant increase in the duration of endosomal tubules between mock 
and spastin depleted cells (Figure 3Bii), highly suggestive of defective fission in spastin depleted cells. 
 It was also possible to compare the tubule fates between mock and spastin depleted cells. For 
the efficient recycling of sorted endosomal cargo, it would be expected for tubules to fission at the 
endosome body to allow the largest possible amount of cargo to be recycled. However, spastin 
depleted cells showed a significant reduction in the percentage of tubules that underwent fission at 
the endosome body (Figure 3Biii). Instead there was a significantly increased proportion of tubules 
that underwent fission along the tubule or which collapsed back into the parent endosome, suggesting 
that inefficient or failed fission was more common in spastin depleted cells. 
By plotting all duration against length data for mock and spastin siRNA treated cells and 
plotting the 1 standard deviation ellipse lines that contained 68% of all data points (Figure 3C), it can 
be observed that there was a correlation between tubule duration and length, and that the shape of 
both data sets was similar in their directionality. Ellipse directionality can be used to get an impression 
of tubule growth rates, but it should be noted that correlation coefficients were not calculated as 
tubule growth rates cannot be calculated directly from this data as maximum tubule length and tubule 
duration was recorded and plotted. This data therefore does not consider whether the tubule growth 
was continuous or intermittent, or even whether the tubule had other behaviours such as semi-
collapsing before continued growth and fission. Overall the data showed that spastin depleted cells 




were on average longer with a longer duration and suggested that mock treated and spastin depleted 
cells had similar rates of growth. This overall pattern also held approximately true when subdividing 
data by their fission fates, with all fates showing longer length tubules that persisted for longer in 
spastin depleted cells compared to mock cells (Figure 3D). This showed that all GFP-SNX1 tubules were 
affected by depletion of spastin irrespective of fission fate. For all experiments, the siRNA treatment 
was shown to strongly reduce the cellular abundance of spastin (Figure 3E). 
  














































































































































































































Figure 3 - Live cell microscopy of GFP-SNX1 shows spastin to be required for efficient endosomal tubule fission 
in MRC5 cells. 
A) Whole cell and zoom images of GFP-SNX1 tubule dynamics in mock and spastin siRNA depleted MRC5 
cells – MRC5 cells stably expressing GFP-SNX1 were treated with either mock or spastin siRNA and 
imaged using live-cell spinning disk microscopy to visualise endosomal tubule fission dynamics. Imaging 
was performed at 400ms per frame for 3 minutes. The main panels show an overview of the mock and 
spastin depleted cells, with the small panels showing a tubule fission sequence at the location 
highlighted by the box in the main panels. Time 0 corresponds to the frame in which the highlighted 
tubule first emerges. Yellow arrows show the tip of the growing or fissioned tubule. Of note is the 
difference in time between initial tubule growth and fission between the mock and spastin depleted 
cells. Scale bar in the overview and zoom images represents 10µm and 2µm respectively. This image 
accompanies Movie 1. 
 
B) Bar charts showing the quantification of GFP-SNX1 tubule dynamics in mock and spastin siRNA 
depleted MRC5 cells – GFP-SNX1 tubule dynamics were manually quantified from the live-cell imaging 
of mock and spastin siRNA depleted stably expressing GFP-SNX1 MRC5 cells. Tubule length (i) was 
defined as the maximum distance between the tubule forming edge of the endosome body and the tip 
of the tubule before fission or collapse. Tubule duration (ii) was defined as the time between the first 
emergence of the tubule from the endosome body until the frame of fission or complete collapse back 
into the endosome body. Fission at the endosome (iii) was defined as a tubule fissioning from the 
endosome body less than 1.5µm from the near edge of the endosome body, fission along the tubule 
(iii) was any fission event that occurred more than 1.5µm from the near edge of the endosome body, 
and collapse (iii) was defined as a tubule that did not undergo fission but instead retracted back into 
the endosome body. 15 tubules were quantified per cell, with 5 cells per condition, and 6 experimental 
repeats performed (5 for the fission fate data). P values were generated by paired two-tail t-tests, with 
error bars indicating standard error of the mean. 
 
C) Scatter plot showing all length and duration data for GFP-SNX1 tubules quantified in mock and 
spastin siRNA depleted GFP-SNX1 stably expressing MRC5 cells – The length (Y-axis) and duration (X-
axis) data was plotted for each endosomal tubule quantified in all cells from all six experimental repeats 
in mock and spastin siRNA depleted cells. Blue and red dots show mock and spastin siRNA depleted 
data respectively. Ellipses contain 68% of each respective population (1 standard deviation). Mock N = 
401, spastin KD N = 437. 
 
D) Scatter plots showing length and duration data for GFP-SNX1 tubules quantified in mock and spastin 
siRNA depleted GFP-SNX1 stably expressing MRC5 cells separated by tubule fate – The length (Y-axis) 
and duration (X-axis) data was plotted for tubules that underwent fission at the endosome (top), along 
the tubule (middle), or collapsed (bottom) from all five experimental repeats in mock and spastin siRNA 
depleted cells. Blue and red dots show mock and spastin siRNA depleted data respectively. Ellipses 
contain 68% of each respective population (1 standard deviation). Fission at endosome mock N = 257, 
spastin KD N = 171, fission along tubule mock N = 10, spastin KD N = 50, collapse mock N = 101, spastin 
KD N = 154. 
 
E) Western blot showing spastin protein abundance in mock and spastin siRNA depleted MRC5 cells – 
MRC5 cells treated with mock or spastin siRNA were lysed and proteins separated by SDS-PAGE, with 
proteins transferred onto PVDF membrane by western blotting. The abundance of spastin was detected 
by the use of a spastin antibody. Equal loading between lanes was verified by also blotting for the 
housekeeping protein GAPDH.  
  




3.2.2 – Spastin is necessary for efficient fission of endosomal SNX1 tubules in COS7 cells 
To verify that a depletion of spastin leads to inefficient SNX1 tubule fission in another cell type, the 
analogous experimental procedures were repeated using COS7 cells. As with MRC5 cells, spastin 
depleted COS7 cells showed a marked difference in GFP-SNX1 endosomal tubule dynamics compared 
to mock treated cells (Movie 2 and Figure 4A). Spastin depleted cells subjectively appeared to have 
longer tubules that had a longer duration, with no clear difference in growth rate, and also appeared 
to have fewer tubule fission events occurring at the endosome body (Movie 2 and Figure 4A). 
 The mean tubule length of spastin depleted cells was significantly increased (Figure 4Bi), 
although more subtly than in MRC5 cells, with spastin depleted COS7 tubules being on average 1µm 
shorter than their MRC5 equivalents. Similarly, GFP-SNX1 tubule duration was significantly increased 
in spastin depleted cells, but once again showed a subtler increase compared to the MRC5 cells, with 
tubule duration lasting on average 10s less than the MRC5 cells with the same treatment (Figure 4Bii). 
Furthermore, there were no statistically significant changes in the proportion of tubules that 
underwent each fission fate (Figure 4Biii), although there were clear trends of a reduced fission at the 
endosome body, increased fission along the tubule, and increased collapse events in spastin depleted 
cells. 
 The plot of duration by length data for all endosomal tubules illustrated the subtle but 
significant inefficient fission of endosomal tubules in spastin depleted COS7 cells (Figure 4C). The 
distribution of the data, marked by the ellipses, was similar to the MRC5 data in that it showed an 
equal increase in both tubule length and tubule duration in spastin depleted cells compared to mock 
cells, with the directionality of the ellipses suggesting similar rates of growth (Figure 4C and Figure 
4D). However, a marked difference between the MRC5 and COS7 data is that in the COS7 spastin 
depleted data there were far fewer extreme values, with few tubules growing beyond 25s or more 
than 3µm. Despite the smaller effect, the COS7 data showed that spastin was required for efficient 
endosomal tubule fission, verifying the MRC5 data. For all experiments, the siRNA treatment was 
shown to strongly reduce the cellular abundance of spastin (Figure 4E). 
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Figure 4 - Live cell microscopy of GFP-SNX1 shows spastin to be required for efficient endosomal tubule fission 
in COS7 cells. 
A) Whole cell and zoom images of GFP-SNX1 tubule dynamics in mock and spastin siRNA depleted COS7 
cells – COS7 cells stably expressing GFP-SNX1 were treated with either mock or spastin siRNA and 
imaged using live-cell spinning disk microscopy to visualise endosomal tubule fission dynamics. Imaging 
was performed at 400ms per frame for 3 minutes. The main panels show an overview of the mock and 
spastin depleted cells, with the small panels showing a tubule fission sequence in the mock cell and a 
tubule collapse sequence in the spastin depleted cell, both at the location highlighted by the box in the 
main panels. Time 0 corresponds to the frame in which the highlighted tubule first emerges. Yellow 
arrows show the tip of the growing, collapsing, or fissioned tubule. Of note is the difference in time 
between initial tubule growth and fission and tubule grown and collapse between the mock and spastin 
depleted cells. Scale bar in the overview and zoom images represents 10µm and 2µm respectively. This 
image accompanies Movie 2. 
 
B) Bar charts showing the quantification of GFP-SNX1 tubule dynamics in mock and spastin siRNA 
depleted COS7 cells – GFP-SNX1 tubule dynamics were manually quantified from the live-cell imaging 
of mock and spastin siRNA depleted stably expressing GFP-SNX1 COS7 cells. Definitions of 
quantifications of tubule length (i), duration (ii), and fates (iii) were as previously described in Figure 
3B. 15 tubules were quantified per cell, with 5 cells per condition, and 3 experimental repeats 
performed. P values were generated by paired two-tail t-tests, with error bars indicating standard error 
of the mean. 
 
C) Scatter plot showing all length and duration data for GFP-SNX1 tubules quantified in mock and 
spastin siRNA depleted GFP-SNX1 stably expressing COS7 cells – The length (Y-axis) and duration (X-
axis) data was plotted for each endosomal tubule quantified in all cells from all three experimental 
repeats in mock and spastin siRNA depleted cells. Blue and red dots show mock and spastin siRNA 
depleted data respectively. Ellipses contain 68% of each respective population (1 standard deviation). 
Mock N = 210, spastin KD N = 225. 
 
D) Scatter plots showing length and duration data for GFP-SNX1 tubules quantified in mock and spastin 
siRNA depleted GFP-SNX1 stably expressing COS7 cells separated by tubule fate – The length (Y-axis) 
and duration (X-axis) data was plotted for tubules that underwent fission at the endosome (top), along 
the tubule (middle), or collapsed (bottom) from all three experimental repeats in mock and spastin 
siRNA depleted cells. Blue and red dots show mock and spastin siRNA depleted data respectively. 
Ellipses contain 68% of each respective population (1 standard deviation). No ellipse was drawn for 
fission along tubule data due to low number of data points. Fission at endosome mock N = 148, spastin 
KD N = 128, fission along tubule mock N = 1, spastin KD N = 5, collapse mock N = 61, spastin KD N = 92. 
 
E) Western blot showing spastin protein abundance in mock and spastin siRNA depleted COS7 cells – 
COS7 cells treated with mock or spastin siRNA were lysed and proteins separated by SDS-PAGE, with 
proteins transferred onto PVDF membrane by western blotting. The abundance of spastin was detected 
by the use of a spastin antibody. Equal loading between lanes was verified by also blotting for the 
housekeeping protein GAPDH.  
  




3.2.3 – Spastin’s ESCRT-III binding partner IST1 is necessary for efficient fission of endosomal SNX1 
tubules in MRC5 cells 
Allison et al. (2013) showed that depletion of IST1 causes increased endosomal tubulation, and that 
rescue of this phenotype required IST1’s ability to bind to spastin. It was therefore investigated 
whether IST1 was also required for endosomal tubule fission. 
 When GFP-SNX1 MRC5 cells were depleted of IST1 using siRNA, IST1 depleted cells develop 
abnormally elongated endosomal tubules that had increased durations between formation and 
resolution, and often collapsed or underwent fission along the tubule length (Movie 3 and Figure 5A). 
Quantifying this as previously described, tubule length and duration was significantly increased in the 
IST1 depleted cells (Figure 5Bi and Figure 5Bii). These effects however were not as large as those 
observed with spastin depletion in MRC5 cells. Interestingly, there were some further differences 
compared to the spastin data. As for spastin, there was a significant decrease in the proportion of 
endosomal tubules that underwent fission at the base of endosomal tubules and this was 
accompanied by a significant increase in the proportion of fission along the tubule events, however, 
unlike spastin, there was no increase in collapse events (Figure 5Biii). 
 The plots of duration against length data for mock and IST1 depletion GFP-SNX1 tubules 
showed no discernible differences in the rate of tubule growth as determined by the relative 
directionality of the 1 S.D. ellipses (Figure 5C). This was also seen when subdividing this data by fate 
(Figure 5D), with this data also showing that tubules that underwent fission at the endosome and 
fission along the tubule had longer length and durations in the IST1 depleted cells. This was also seen 
for tubules that collapsed, with the position of the ellipse showing that these tubules were relatively 
longer with a longer duration on average compared to their mock counterparts, despite there being 
no increase in the proportion of collapsed tubules between the two treatments overall. Altogether, 
these data appear similar to the spastin depletion data in MRC5 and COS7 cells, and therefore indicate 
that IST1 also functions in endosomal tubule fission. For all experiments, the siRNA treatment was 
shown to strongly reduce the cellular abundance of IST1 (Figure 5E). 
  




































































































































































































Figure 5 - Live cell microscopy of GFP-SNX1 shows the spastin interaction partner IST1 to be required for efficient 
endosomal tubule fission in MRC5 cells. 
A) Whole cell and zoom images of GFP-SNX1 tubule dynamics in mock and IST1 siRNA depleted MRC5 
cells – MRC5 cells stably expressing GFP-SNX1 were treated with either mock or IST1 siRNA and imaged 
using live-cell spinning disk microscopy to visualise endosomal tubule fission dynamics. Imaging was 
performed at 400ms per frame for 3 minutes. The main panels show an overview of the mock and IST1 
depleted cells, with the small panels showing a tubule fission sequence at the location highlighted by 
the box in the main panels. Time 0 corresponds to the frame in which the highlighted tubule first 
emerges. Yellow arrows show the tip of the growing or fissioned tubule. Of note is the difference in 
time between initial tubule growth and fission between the mock and IST1 depleted cells. Scale bar in 
the overview and zoom images represents 10µm and 2µm respectively. This image accompanies Movie 
3. 
 
B) Bar charts showing the quantification of GFP-SNX1 tubule dynamics in mock and IST1 siRNA depleted 
MRC5 cells – GFP-SNX1 tubule dynamics were manually quantified from the live-cell imaging of mock 
and IST1 siRNA depleted stably expressing GFP-SNX1 MRC5 cells. Tubule length (i), duration (ii), and 
fates (iii) were measured as previously described. 15 tubules were quantified per cell, with 5 cells per 
condition, and 5 experimental repeats performed. P values were generated by paired two-tail t-tests, 
with error bars indicating standard error of the mean. 
 
C) Scatter plot showing all length and duration data for GFP-SNX1 tubules quantified in mock and IST1 
siRNA depleted GFP-SNX1 stably expressing MRC5 cells – The length (Y-axis) and duration (X-axis) data 
was plotted for each endosomal tubule quantified in all cells from all five experimental repeats in mock 
and IST1 siRNA depleted cells. Blue and red dots show mock and IST1 siRNA depleted data respectively. 
Ellipses contain 68% of each respective population (1 standard deviation). Mock N = 448, IST1 KD N = 
450. 
 
D) Scatter plots showing length and duration data for GFP-SNX1 tubules quantified in mock and IST1 
siRNA depleted GFP-SNX1 stably expressing MRC5 cells separated by tubule fate – The length (Y-axis) 
and duration (X-axis) data was plotted for tubules that underwent fission at the endosome (top), along 
the tubule (middle), or collapsed (bottom) from all five experimental repeats in mock and IST1 siRNA 
depleted cells. Blue and red dots show mock and IST1 siRNA depleted data respectively. Ellipses contain 
68% of each respective population (1 standard deviation). Fission at endosome mock N = 283, IST1 KD 
N = 247, fission along tubule mock N = 17, IST1 KD N = 59, collapse mock N = 148, IST1 KD N = 144. 
 
E) Western blot showing IST1 protein abundance in mock and IST1 siRNA depleted MRC5 cells – MRC5 
cells treated with mock or IST1 siRNA were lysed and proteins separated by SDS-PAGE, with proteins 
transferred onto PVDF membrane by western blotting. The abundance of IST1 was detected by the use 
of an IST1 antibody. Equal loading between lanes was verified by also blotting for the housekeeping 
protein GAPDH.  
  




3.2.4 – Efficient SNX1 endosomal tubule fission requires spastin’s ATPase activity 
Spastin functions as an enzyme, with its C-terminal ATPase domain converting the release of energy 
from ATPase hydrolysis into a mechanical force that severs microtubules (Roll-Mecak and Vale 2008). 
It is possible that this function of microtubule severing may be relevant to the tubule fission 
mechanism, as endosomal tubules have an inherent relationship with the microtubule network 
(Granger et al. 2014). Furthermore, Allison et al. (2013) showed that ATPase defective spastin was 
unable to rescue the abnormal SNX1 endosomal tubule phenotype observed upon spastin depletion 
in HeLa cells. Thus, it was tested whether the ATPase domain of spastin was important for its function 
in endosomal tubule fission. 
 This was tested using WT, HET and HOM MEFs stably expressing GFP-SNX1 (detailed in Section 
3.2.2). The HET and HOM MEF are heterozygous and homozygous respectively for a spastinN384K 
mutation that renders the ATPase domain of spastin catalytically null (Connell et al. 2016). Live cell 
imaging revealed both HET and HOM spastin mutants to display GFP-SNX1 endosomal tubules that 
were longer and persisted for a longer duration than WT MEFs, with apparently more collapse and 
fission along the tubule events (Movie 4 and Figure 6A). Quantification confirmed these observations. 
There was a significant increase in GFP-SNX1 tubule length in the HOM compared to the WT MEFs, 
with a similar although non-significant trend seen between the HET and WT MEFs (Figure 6Bi). 
Similarly, there was a significant increase in the total duration of tubules between the HOM and WT 
MEFs, with a similar non-significant trend seen when comparing the HET and WT MEFs (Figure 6Bii). 
For tubule fission fates, both HET and HOM MEFs had small but significant reductions in the proportion 
of GFP-SNX1 tubules that underwent fission at the endosome body (Figure 6Biii). This was 
accompanied by non-statistically significant increases in the proportion of fission events along the 
tubule and collapse events. 
 Duration against length plots showed a strong pattern of similarity between the HET and HOM 
MEFs, with a near identical overlap between the 1 S.D. ellipse plots, with both elongated compared 
to WT data (Figure 6C). The directionality of the ellipses suggested that the rate of tubule growth was 
similar between the three conditions, with a minor deviation towards slower growth in the spastin 
mutant MEFs. When segregating the data by fate, this pattern was mirrored closely when looking at 
tubules that underwent fission at the endosome body or collapse. However, there did appear to be 
some differences in ellipse directionality for tubules that underwent fission along the tubule, with 
tubules from wildtype animals appearing to have a much slower rate of growth than heterozygous or 
homozygous mutant MEFs (Figure 6D). It is worth noting however that out of the three fission fates, 
fission along the tubule had the fewest collective data points, potentially limiting the 
representativeness of this data.  




In summary, MEFs expressing ATPase-defective spastin had impaired endosomal tubule 
fission, with the effects of the mutation roughly mirroring the effects of spastin depletion in MRC5 
and COS7 cells, and IST1 depletion in MRC5 cells. Thus, spastin requires a functional ATPase domain 
to mediate endosomal tubule fission.  
  










































































































































































































Figure 6 - Live cell microscopy of GFP-SNX1 shows that spastin requires a functional ATPase domain for its role 
in efficient endosomal tubule fission in immortalised mouse embryonic fibroblasts (MEFs). 
A) Whole cell and zoom images of GFP-SNX1 tubule dynamics in spastinWT/WT (WT), spastinWT/N384K (HET), 
and spastinN384K/N384K (HOM) immortalised MEFs – SV-40 immortalised MEFs stably expressing GFP-
SNX1 were imaged using live-cell spinning disk microscopy to visualise endosomal tubule fission 
dynamics. Imaging was performed at 400ms per frame for 3 minutes. Each of the large images shows 
an overview of the spastinWT/WT, spastinWT/N384K, and spastinN384K/N384K cells, with the small panels 
showing a tubule fission event in the case of wildtype and homozygous mutant cells, and a tubule 
collapse event in the case of heterozygous mutant cells, at the location highlighted by the white box in 
the overview images. Time 0 corresponds to the frame in which the highlighted tubule first emerges. 
Yellow arrows show the tip of the growing, collapsing, or fissioned tubule. Of note is the difference in 
time between the tubule growth and fission or collapse between the wildtype and spastin mutants. 
Scale bars in the overview and zoom images represent 10µm and 2µm respectively. This image 
accompanies Movie 4. 
 
B) Bar charts showing the quantification of GFP-SNX1 tubule dynamics in spastinWT/WT (WT), 
spastinWT/N384K (HET), and spastinN384K/N384K (HOM) immortalised MEFs – GFP-SNX1 tubule dynamics 
were manually quantified from the live-cell imaging of spastin wildtype (WT), heterozygous mutant 
(HET), and homozygous mutant (HOM) MEFS stably expressing GFP-SNX1. Tubule length (i), duration 
(ii), and fates (iii) were measured as previously described. 15 tubules were quantified per cell, with 5 
cells per condition, and 4 experimental repeats performed per spastin mutant type. P values were 
generated by paired two-tail t-tests with Tukey-Kramer correction applied to correct for multiple testing 
with error bars indicating standard error of the mean. 
 
C) Scatter plot showing all length and duration data for GFP-SNX1 tubules quantified in spastinWT/WT 
(WT), spastinWT/N384K (HET), and spastinN384K/N384K (HOM) immortalised MEFs – The length (Y-axis) and 
duration (X-axis) data was plotted for each endosomal tubule quantified in all cells from all four 
experimental repeats in wildtype, heterozygous, and homozygous spastin mutant GFP-SNX1 stably 
expressing immortalised MEFs. Blue, green, and red dots show wildtype, heterozygous, and 
homozygous spastin mutant data respectively. Ellipses contain 68% of each respective population (1 
standard deviation). WT N = 300, HET N = 300, HOM N = 300. 
 
D) Scatter plot showing all length and duration data for GFP-SNX1 tubules quantified in spastinWT/WT 
(WT), spastinWT/N384K (HET), and spastinN384K/N384K (HOM) immortalised MEFs by tubule fate – The 
length (Y-axis) and duration (X-axis) data was plotted for tubules that underwent fission at the 
endosome (top), along the tubule (middle), or collapsed (bottom) from all four experimental repeats in 
wildtype, heterozygous, and homozygous spastin mutant GFP-SNX1 stately expressing MEF cells. Blue, 
green, and red dots show wildtype, heterozygous, and homozygous spastin mutant data respectively. 
Ellipses contain 68% of each respective population (1 standard deviation). Fission at endosome WT = 
244, HET = 213, HOM = 219, fission along tubule WT = 3, HET = 9, HOM = 12, collapse WT = 53, HET = 
78, HOM = 69. 
  




3.2.5 – Spastin and IST1 localise to SNX1 tubules at tubule constrictions, and spastin spatio-
temporally localises to sites of endosomal tubule fission 
Having established spastin and IST1 to be required for endosomal SNX1 tubule fission, it was 
investigated whether spastin and IST1 are located at sites of tubule fission. This was done by using 
both fixed and live cell imaging, with fixed cell imaging used to investigate the spatial localisation of 
spastin and its binding partner IST1 in relation to SNX1 tubules, and live cell imaging used to visualise 
whether spastin was spatio-temporally present at the location of endosomal tubule fission. 
 To achieve this, a new set of MRC5 cell lines were generated via retroviral transduction that 
stably expressed N-terminally tagged GFP-M1 spastin (the isoform of spastin that localises to the ER 
at steady state). A clonal GFP-M1 cell line was selected which expressed GFP-M1 spastin at very low 
levels to avoid artefacts of spastin overexpression (Figure 7A). From these clonal cells, retroviral 
transduction was used to produce a double stable cell line that expressed both GFP-M1 spastin and a 
mixed population of mCherry-SNX1. Imaging was performed on these cells using Airyscan microscopy, 
necessary given the low expression of the GFP-M1 spastin (reviewed in Section 3.1.3). 
 
Fixed cell localisation of GFP-M1 spastin and IST1 on mCherry-SNX1 tubules 
Four-colour fixed cell Airyscan microscopy showed a clear association between GFP-M1 spastin and 
endogenous IST1 on mCherry-SNX1 tubules that grew along α-tubulin labelled microtubules (Movie 5 
and Figure 7B). From the high spatial resolution imaging, GFP-M1 spastin was seen as constrictions 
along mCherry-SNX1 tubules (Figure 7B), with it clear in the 3D reconstruction that spastin was 
wrapping around the tubule at a constriction near the tubule base (Movie 5). At this point and also at 
other constrictions, IST1 was shown to be in close proximity to spastin, with the whole structure placed 
along a microtubule that was aligned in the direction of the endosomal tubule (Figure 7B). Thus, 
spastin and IST1 colocalise at likely sites of endosomal tubule fission. 
 
Live cell visualisation of GFP-M1 spastin’s localisation on mCherry-SNX1 tubules during tubule fission 
To test whether spastin localises to pre-formed SNX1 constrictions or drives constriction formation, 
live cell microscopy was performed imaging GFP-M1 spastin and mCherry-SNX1 to visualise 
endosomal tubule fission events. Imaging was performed using Airyscan imaging at 2.88 second per 
frame in both colours simultaneously at a higher resolution than standard confocal microscopy. 
 The imaging showed that spastin was present at the spatial and temporal location of 
endosomal tubule fission (Movie 6 and Figure 7C), with the highlighted tubule showing GFP-M1 




spastin puncta localising to the tubule when and where it underwent fission. From the selected 
endosomal tubule, spastin did not appear to recruit to preformed constrictions, with spastin present 
near the endosome body during growth of the tubule. By looking at a change in the RGB intensity plots 
through the growth and fission path of the tubule, there appeared to be a direct correlation between 
an increase in GFP-M1 spastin and a decrease in mCherry-SNX1 signal, suggesting that an increase in 
spastin concentration along the tubule led to a tubule constriction. Interestingly however, the increase 
in spastin concentration and the constriction event did not lead to an immediate fission of the 
endosomal tubule, with spastin intensity not increasing, nor mCherry-SNX1 signal decreasing, for 5.5s 
after the formation of the constriction. This relationship between GFP-M1 spastin recruitment and 
mCherry-SNX1 tubule constriction and subsequent fission is representative of the appearance seen in 
multiple endosomal tubule fission events. This however was not quantified. Overall this suggests that 
spastin induces constriction formation and fission at constriction sites, but the recruitment of spastin 
does not perfectly temporally correlate to fission. 
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Figure 7 - Fixed and live cell Airyscan imaging shows spastin to spatio-temporally localise to the location of 
endosomal tubule fission. 
A) Western blot showing GFP-M1 spastin protein abundance in stably expressing GFP-M1 spastin MRC5 
cells – Mock and GFP-M1 spastin stably expressing MRC5 cells were lysed, proteins separated by SDS-
PAGE, and proteins transferred onto PVDF membrane by western blotting. The 6C6 spastin antibody 
was used to show the relative abundance of GFP-M1 spastin and endogenous isoforms of spastin, with 
the GFP-M1 spastin band inferred by the known sizes of GFP and M1 spastin. The red dashed box 
indicates the GFP-M1 spastin clone that was used for imaging. The left and right blots show a 2 minute 
and 40 minute exposure respectively.  
 
B) Fixed 4 colour Airyscan imaging of GFP-M1 spastin, mCherry-SNX1, IST1, and α-tubulin in MRC5 cells 
– MRC5 cells stably expressing GFP-M1 spastin and mCherry-SNX1 were fixed and stained using IST1 
and α-tubulin antibodies, before being imaged using Airyscan microscopy. The large overview panel 
shows mCherry-SNX1, GFP-M1 spastin, and IST1 channels, with α-tubulin not displayed. Smaller panels 
show a zoom of an mCherry-SNX1 endosomal tubule with a variety of colour channel combinations 
displayed. Scale bars on the overview and large zoom image represent 10µm and 1µm respectively.  
White arrows on the zoom images show locations of constrictions on the mCherry-SNX1 endosomal 
tubule. The white box on the overview image indicates the zoom region. This image accompanies Movie 
5.  
 
C) Live cell 2 colour Airyscan imaging of GFP-M1 spastin and mCherry-SNX1 in MRC5 cells – MRC5 cells 
stably expressing GFP-M1 spastin and mCherry-SNX1 were imaged using live cell Airyscan microscopy. 
Imaging was performed at 2.88 seconds per frame for 2 minutes in both channels simultaneously. The 
two large images on the left show an overview of the highlighted cell, with the top panel displaying only 
mCherry-SNX1 and the bottom panel displaying GFP-M1 spastin and mCherry-SNX1. The smaller central 
images show a time-lapse of an endosomal tubule fission event (by row), with the first column panels 
showing mCherry-SNX1 alone, the second column panels showing both GFP-M1 spastin and mCherry-
SNX1, and the third column panels showing the RGB plot line used to measure the RGB intensity profile 
through the endosomal tubule during the tubule fission event. The final column shows RGB intensity 
(Y-axis) plots along the length of the RGB plot line (X-axis) through the tubule, with the red and green 
plot lines indicating the intensity of the mCherry-SNX1 and GFP-M1 spastin signal along the length of 
the line respectively. Black arrows on the RGB plots indicate the location of the endosome body and 
the tubule fission point along the RGB line. White arrows on the zoom panels show the tip of the 
endosomal tubule. White boxes on the overview panels show the location of the zoom panels. Scale 
bars of the overview and zoom panels represent 5µm and 1µm respectively. This image accompanies 
Movie 6.  
  




3.2.6 – The function of spastin in SNX1 tubule fission is not related to the formation of ER-endosome 
contacts 
ER-endosome contacts are important for endosomal tubule fission (Rowland et al. 2014). Spastin is 
able to associate with both ER and endosome membranes, with the hydrophobic domain of M1 spastin 
being required to localise it to the ER (Connell et al. 2009), while the MIT domain allows it to localise 
to endosomal membranes via an interaction with IST1 (Allison et al. 2013). It is therefore possible that 
spastin may function in the formation of these contacts, with a potential reason for impaired 
endosomal tubule fission upon spastin depletion being the inefficient formation of endosome-ER 
contacts. 
 
ER-endosomal tubule contacts form in fixed cells despite spastin depletion 
Fixed and live cell imaging was used to investigate the function of endosomal SNX1 tubules in relation 
to ER dynamics. Imaging was performed in MRC5 and COS7 cells stably expressing GFP-SNX1 and 
transiently expressing RFP-KDEL to visualise the endoplasmic reticulum. The close spatial association 
between endosomal tubules and the endoplasmic reticulum was initially verified by use of fixed cell 
super resolution structural illumination microscopy that allowed a spatial resolution of 100nm 
laterally, and 280nm axially. In spastin depleted MRC5 cells, endosomal tubules had many points of 
contact between the endosomal tubule and the endoplasmic reticulum (Figure 8A). 
 
ER-endosomal tubule contacts form in live cells despite spastin depletion 
Live cell imaging was then performed to visualise endosomal tubule fission in relation to the ER 
network. Imaging of the GFP-SNX1 and RFP-KDEL expressing mock transfected and spastin siRNA 
depleted MRC5 and COS7 cells was performed using spinning disk microscopy. This revealed that in 
both mock transfected and spastin depleted cells there was still a strong overlap between endosomal 
SNX1 tubules and the ER, with the formation of potential endosomal tubule-ER contacts subjectively 
appearing unaffected by spastin depletion, but with GFP-SNX1 tubules taking longer to undergo fission 
or collapse after initial contact in spastin depleted cells (Movie 7 and Figure 8B). 
This observation was quantified manually by measuring the proportion of SNX1 tubules that 
underwent fission at the point of contact with an ER tubule, as well as measuring the total duration 
from the formation of an endosomal tubule-ER contact to either endosomal tubule fission or collapse. 
Potential endosomal tubule-ER contacts were defined as when the two organelles had clear 
colocalisation. In both MRC5 and COS7 cells, this analysis showed no significant difference between 




mock or spastin depleted cells in the proportion of GFP-SNX1 tubules that underwent fission on an ER 
tubule (Figure 8C). Reassuringly, the percentage of tubules breaking at the ER for mock and spastin 
depleted cells was ~80%, similar to figures published by Rowland et al. (2014). 
 
Spastin depletion causes a delay in the fission of endosomal tubules upon ER-endosome contact 
formation 
Interestingly, spastin-depleted MRC5 cells had a longer duration between organelle contact formation 
and endosomal tubule fission or collapse (Figure 8D). A similar non-significant trend was also observed 
in COS7 cells. Overall, this implies that impairment of endosomal tubule fission upon spastin depletion 
is not caused by a failure of ER-endosome tubule contact formation. 
  

























































































































Figure 8 - Spastin depletion does not impair the formation of ER-endosome contacts but delays endosomal 
tubule fission once contacts are formed. 
A) Maximum intensity Z-projection of fixed super-resolution 3D-Structural Illumination Microscopy of 
GFP-SNX1 and RFP-KDEL in MRC5 cells – Spastin siRNA treated GFP-SNX1 stably expressing MRC5 cells 
were transfected with RFP-KDEL and fixed before being imaged using 3D-Structural Illumination 
Microscopy to visualise endosome-endoplasmic reticulum (ER) colocalisation. The images displayed 
shows a maximum intensity Z-projection of a Z stack taken ranging from the top to bottom of the cell. 
The left large image shows an overview of the highlighted cell, and the right image shows a zoom of the 
endosomal tubule highlighted by the white box in the overview image. Cyan and yellow colour schemes 
were chosen to allow best visualisation of the complex ER ultrastructure, with the cyan colour scheme 
ranging from blue to white depending on signal intensity. White arrows on the zoom image show points 
of potential contact between the SNX1 endosomal tubule and the ER. The scale of the overview and 
zoom images were 10µm and 2µm respectively.  
 
B) Live cell imaging of GFP-SNX1 and RFP-KDEL in mock and spastin siRNA depleted MRC5 cells – MRC5 
cells stably expressing GFP-SNX1 were treated with either mock or spastin siRNA and transfected with 
RFP-KDEL before being imaged by spinning disk live cell microscopy. Imaging was performed at 400ms 
per frame simultaneously for both colour for three minutes. The top half of the figure shows an 
overview and a zoom from a mock treated cell, and the bottom half the same for a spastin siRNA treated 
cell. The left large images show images of the mock and spastin depleted cell, with the right smaller 
panels showing a time-lapse (by column) of an endosomal tubule fission event in relation to an ER 
tubule. The location for these events was marked by the white boxes on the overview images. Both top 
and bottom halves of the zoom panels display GFP-SNX1 alone in the top half of each panel and both 
GFP-SNX1 and RFP-KDEL in the second half. The white arrows in the zoom boxes indicate the point of 
endosomal tubule fission. Scale bars in the overview and zoom images represent 10µm and 2µm 
respectively. Of note is the difference in duration between tubule formation and fission in the mock 
and spastin depleted cell. This image corresponds to Movie 7.  
 
C) Bar charts showing the quantification of percentage of GFP-SNX1 tubules that undergo fission on an 
ER tubule in MRC5 and COS7 cells – Endosomal tubule-ER interactions were manually quantified from 
the live cell imaging of GFP-SNX1 and RFP-KDEL in mock and spastin siRNA depleted GFP-SNX1 stably 
expressing MRC5 and COS7 cells. The left bar charts show the proportion of GFP-SNX1 endosomal 
tubule fission that occurred on an ER tubule in MRC5 cells, with the right bar charts showing the 
equivalent in COS7 cells. Approximately 15 endosomal tubules in areas of resolvable ER tubules were 
counted per cell, with 5 cells counted per experimental repeat, and 3 experimental repeats performed 
for mock and spastin depleted conditions for both cell types. Statistical testing was performed using 
paired two-tailed t-tests, with error bars showing standard error of the mean. 
 
D) Bar charts showing the quantification of duration of ER-endosome contacts before tubule fission or 
collapse in MRC5 and COS7 cells – Endosomal tubule-ER interactions were manually quantified from 
the live cell imaging of GFP-SNX1 and RFP-KDEL in mock and spastin siRNA depleted GFP-SNX1 stably 
expressing MRC5 and COS7 cells. The left bar charts show the duration of endosome-ER contact before 
either tubule fission or collapse in mock and spastin depleted MRC5 cells, and the right bar charts show 
the equivalent in COS7 cells. The number of events quantified, and the details of statistical testing are 








3.2.7 – Investigating the role of microtubule severing in endosomal tubule fission 
The spastin ATPase domain is required for microtubule remodelling where it can introduce GTP-
tubulin islands to increase microtubule stability or sever microtubules to facilitate the nucleation of 
new microtubules (reviewed in Introduction – Section 1.3.5.; Vemu et al. 2018). As spastin’s ATPase 
domain was required for efficient endosomal tubule fission, this raised the possibility that spastin’s 
role in endosomal tubule fission was via microtubule severing. To test this, I investigated whether 
microtubule severing could be visualised in relation to endosomal tubule fission. Live cell imaging was 
therefore performed attempting to visualise the relationship between endosomal tubule fission and 
microtubule dynamics. 
 
SiR-tubulin dose optimisation 
Microtubules were imaged in GFP-SNX1 stably expressing MRC5 cells using the dye SiR-tubulin. This 
provided a bright photostable far-red probe for investing the microtubule cytoskeleton that had good 
spectral separation from the GFP fluorophore of GFP-SNX1. This docetaxel-based dye is reported to 
have little effect on cytoskeletal dynamics in HeLa cells (Lukinavičius et al. 2014), but it was important 
to verify this in MRC5 cells. 
 A dosage experiment was used to determine a concentration of SiR-tubulin that would allow 
the imaging of the dynamics of the microtubule network with a high signal to noise ratio. This was 
performed using spinning disc microscopy and revealed very similar results for the 100nM to 25nM 
dilutions, with the microtubule network being continuous, very brightly labelled, and with almost no 
background fluorescence (Movie 8 and Figure 9A). Whilst the 5nM and 1nM dilutions also had a good 
signal to noise ratios, the microtubule labelling appeared punctate rather than the continuous 
microtubule network seen with higher concentrations. The 10nM dilution was similar to the 25nM 
dilution, although slightly dimmer. For this reason, a 25nM dilution of SiR-tubulin was used in all future 
experiments. This was 4-fold lower than the manufacturer’s recommended dilution, giving further 
confidence that this concentration would have a limited impact on microtubule dynamics.  
 
  




SIR-tubulin does not block microtubule severing 
Having chosen an appropriate working concentration, it was important to verify that spastin was still 
able to sever 25nM SiR-tubulin labelled microtubules. Therefore, MRC5 cells were labelled with 25nM 
SiR-tubulin dye and transiently transfected with mEmerald-M87 spastin, allowing the effect of 
increasing expression of spastin on the SiR-tubulin labelled microtubule network to be revealed by live 
cell imaging. Movie 9 and Figure 9B show that SiR-tubulin labelled microtubules are still able to 
undergo microtubule severing by spastin, as there was a progressive loss of microtubule label in the 
cells that had increasing spastin concentrations. This validated the use of SIR-tubulin to investigate 
the relationship between endosomal tubule fission and microtubule severing.  
 
GFP-SNX1 endosomal tubules can grow, fission, and be transported on SiR-tubulin labelled 
microtubules 
To verify that GFP-SNX1 tubules have typical dynamics on SIR-tubulin labelled microtubules, GFP-SNX1 
and 25nM SiR-tubulin labelled microtubules were imaged using spinning disk microscopy. Endosomal 
tubules were able to undergo fission in GFP-SNX1 SiR-tubulin treated MRC5 cells, with tubules 
observed to grow along a microtubule, fissioning along a microtubule, and travelling along a 
microtubule after fission as expected (Movie 10 and Figure 9C). Quantifying this, ~80% of GFP-SNX1 
tubules formed and fissioned on SIR-tubulin labelled microtubules (Figure 9Di and Figure 9Dii), and 
90% of tubules travelled along microtubules after fission (Figure 9Diii). These proportions match 
previous descriptions of the intimate association between endosomal growth and transport dynamics 
and the microtubule network (Granger et al. 2014). 
 
GFP-SNX1 endosomal tubule fission does not correlate with visible microtubule severing 
Spinning disk imaging of stably expressing GFP-SNX1 cells treated with 25nM SiR-tubulin was used to 
determine whether there was a correlation between endosomal tubule fission and microtubule 
severing. Microtubule severing events were defined as occurring when a continuous section of 
microtubule was broken into two. 
 Quantification of the imaging revealed that almost no GFP-SNX1 tubule fission events 
correlated with microtubule severing events (Movie 10 and Figure 9E). In fact, it was had to visualise 
any microtubule severing events at all in MRC5 cells and they were much less frequent that endosomal 
tubule fission events. This difference between the rate of endosomal tubule fission events and 
microtubule severing events was also indicative of the lack of correlation between the two processes. 




This therefore implied that microtubule severing is not required for the fission of endosomal tubules. 
However, the possibility that microtubule severing is coupled to tubule fission in a manner not 
observable from this form of imaging could not be excluded. 
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Figure 9 - Live cell microscopy of GFP-SNX1 and microtubule dye SiR-tubulin shows endosomal tubule fission to 
have no correlation with observable microtubule severing in MRC5 cells. 
A) Whole cell images of a dilution series of SiR-tubulin to identify the appropriate concentration of SiR-
tubulin used to label microtubules for live-cell imaging in MRC5 cells – MRC5 cells were treated with 
100nM, 50nM, 25nM, 10nM, 5nM, 1nM SiR-tubulin for 8hrs before being imaged using live-cell spinning 
disk microscopy at 450ms per frame. Each image represents a still image from the imaging series. 25nM, 
identified by the yellow box, was chosen as the concentration of SiR-tubulin to give good microtubule 
labelling at the lowest concentration. Scale bars for images represent 20µM. This image accompanies 
Movie 8.  
 
B) Live-cell imaging of the effect of increasing M87 spastin concentration on SiR-tubulin labelled 
microtubules to verify labelled microtubules can still be severed – MRC5 cells were transfected with 
mEmerald-M87 spastin and after 2 hrs were treated with 25nM SiR-Tubulin for 8hrs.  10 hrs after 
transfection, Emerald-M87 spastin and SiR-tubulin was imaged, with imaging performed 
simultaneously in both channels at 2 minutes per frame for 24 hours. Panels show a time-series (by 
column) of the increasing expression of Emerald-M87 spastin and the effect on the SiR-tubulin 
microtubules. Top panels show Emerald-M87 spastin alone, middle panels show SiR-tubulin alone, and 
bottom panels show both channels combined. Time 0 represents 10hrs after transfection. Scale bars 
represent 20µM. This image accompanies Movie 9. 
 
C) Live-cell imaging of the GFP-SNX1 and SiR-tubulin labelled microtubules in MRC5 cells to verify 
endosomal tubule fission still occurs on labelled microtubules – MRC5 cells stably expressing GFP-
SNX1 were treated with 25nM SiR-tubulin microtubule dye for 8 hours. Cells were then imaged using 
spinning disk live cell microscopy, with imaging performed at 200ms per frame for 3 minutes. Images 
show a time-lapse of a GFP-SNX1 endosomal tubule growth and fission event in relation to a SiR-tubulin 
labelled microtubule. Image sequence by column. Top panels show GFP-SNX1 alone, bottom panels 
show both GFP-SNX1 and SiR-tubulin. Scale bar represents 2µM. This image accompanies Movie 10. 
 
D) Box plots of GFP-SNX1 endosomal tubule dynamics in relation to SiR-tubulin labelled microtubules in 
MRC5 cells – Endosomal tubule dynamics in relation to SiR-tubulin labelled microtubules were manually 
quantified from the live cell imaging of GFP-SNX1 stably expressing MRC5 cells treated with 25nM SiR-
tubulin dye. Plots show the percentage of GFP-SNX1 tubules that grow on SiR-tubulin labelled 
microtubules (i), fission on SiR-tubulin labelled microtubules (ii) and travel on SiR-tubulin labelled 
microtubules (iii). Black dots indicate the averaged endosomal tubule data from each cell, the red line 
on the box plot denotes the median, the blue edges of the box indicate the 25th and 75th percentiles, 
and the whiskers represent the most extreme data points not considered outliers. Approximately 15 
endosomal tubules were counted in regions of resolvable microtubules in 20 cells.  
 
E) Box plot of GFP-SNX1 endosomal tubule fission dynamics in relation to SiR-tubulin labelled 
microtubule fission dynamics in MRC5 cells – The spatio-temporal correlation between GFP-SNX1 
endosomal tubule fission and SiR-tubulin labelled microtubule severing from the live-cell imaging of 
GFP-SNX1 stately expressing MRC5 cells treated with 25nM SiR-tubulin was counted manually. Fission 
with a microtubule severing event was defined as there being a low/no SiR-tubulin signal in the frame 
after endosomal tubule fission at the point of endosomal tubule fission. Graph plotting details as 
previously described in Figure 9D. Approximately 15 endosomal tubules were counted in regions of 
resolvable microtubules for 20 cells. 
  




3.2.8 – Fission of SNX1 tubules is unrelated in space and time to the formation of a new microtubule 
plus-end 
A resolution problem in live cell microtubule imaging 
An inherent problem with the imaging of microtubules using non-super resolution methods is the 
difference between the resolution required to appropriately visualise microtubule filaments and the 
maximum resolution provided by diffraction limited microscopy. Microtubule filaments have a width 
of 24nm, whilst the lateral resolution limit for a far-red fluorophore using confocal microscopy is 
231nm. This large discrepancy means that it is not possible to know whether SiR-tubulin labelled 
microtubules imaged exist as individual filaments, or rather bundles of multiple parallel microtubules. 
If microtubule severing only occurred on a single filament along a bundle, it would not be possible to 
identify a severing event, but this could still result in functional consequences that drive endosomal 
tubule fission. 
 
The use of plus-end binding proteins (EB proteins) as a surrogate of microtubule severing 
A surrogate marker that would identify a breakage event involving a subset of microtubules in a bundle 
was required to address this potential problem. Previous unpublished work in the Reid lab had shown 
that depletion of spastin in HeLa cells led to a reduction in the rate of microtubule plus end formation 
suggesting that microtubule severing by spastin lead to the formation of new microtubule plus ends. 
Furthermore, spastin regulates the number of microtubule plus-ends in neurite extensions and axons 
(Fassier et al. 2013; Riano et al. 2009). These plus ends can be visualised by fluorescently tagged end 
binding (EB) proteins, and thus, the recruitment of these EB proteins at the site of endosomal tubule 
fission would provide evidence of microtubule severing driving tubule fission. 
 
Spastin depletion decreases the rate of microtubule plus-end formation 
First, experiments were performed to verify the Reid lab’s unpublished data that depletion of spastin 
reduces the number of cellular plus-ends. This was done by the live cell imaging of EB3-mCherry 
dynamics in mock and spastin siRNA transfected MRC5 and HeLa cells, and in spastin ATPase mutant 
MEFs. After imaging, plus-end dynamics were analysed by automated particle tracking before being 
represented as the number of formed comets per µm2 per minute, with normalisation for area. 
 In MRC5 cells, depletion of spastin led to a ~30% reduction in the rate of comet formation 
(Movie 11 and Figure 10A). Similar findings were also obtained in HeLa cells (Movie 12 and Figure 
10B). However, this pattern was not observed in ATPase spastinN384K mutant MEFs, where there was 
no significant difference in the rate of comet formation between WT, HET or HOM MEFs (Movie 13 




and Figure 10C). Of note was that the rate of comet formation in all MEF genotypes was substantially 
lower than that observed in the MRC5 or COS7 cells. Given the ATPase domain’s function in 
microtubule severing, this result is somewhat surprising and might perhaps be explained by 
compensation in this cell line (e.g. by an upregulation in other microtubule severing enzymes). 
However, given both the substantial effects of comet formation rate from siRNA-induced reduction of 
spastin in MRC5 and HeLa cells, it was concluded that spastin’s microtubule severing function likely 
did induce microtubule plus-end formation in vivo. 
 
EB3-mCherry does not localise to the spatial and temporal site of GFP-SNX1 tubule fission 
Next, live cell spinning disk imaging was performed to investigate whether there was a correlation 
between GFP-SNX1 endosomal tubule fission and the formation of EB3-mCherry labelled microtubule 
plus-ends. Initial subjective observations suggested little correlation between the spatio-temporal 
location of GFP-SNX1 tubule fission and EB3-mCherry plus-end formation (Movie 14 and Figure 10D). 
Upon quantification, the data showed decisively that bright EB3-mCherry puncta did not form at the 
location of endosomal tubule fission (Figure 10F). Thus, combined with the results on SiR-tubulin-
labelled microtubules, these experiments provided no evidence that endosomal tubule fission is 
spatially or temporally related to microtubule severing.  
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Figure 10 - Live cell imaging of GFP-SNX1 and EB3-mCherry shows that microtubule plus end formation does not 
spatio-temporally correlate with endosomal tubule fission, but spastin depletion impairs microtubule plus end 
formation in MRC5 cells. 
A) Whole cell still image of live-cell imaging and quantification of EB3-mCherry dynamics in MRC5 cells 
treated with mock or spastin siRNA – MRC5 cells were treated with mock or spastin siRNA and 
transfected with EB3-mCherry and imaged using live-cell widefield microscopy. Imaging was performed 
at 0.5 seconds per frame for three minutes. Scale bars represent 20µm in both images. EB comet 
particle tracking was performed using Imaris 9.1.0 and cell area measured using ImageJ, allowing the 
plot (right) of the number of comets formed per µm2 per minute in mock and spastin siRNA treated 
cells. The comets were analysed from approximately 15 cells per mock and spastin siRNA depletion 
experiment, with four experimental repeats. The bar graph shows the mean of the four experiments 
for mock and spastin siRNA treated cells, with error bars showing standard error of the mean. P values 
were generated by paired one-tail t-tests. This image accompanies Movie 11. 
 
B) Whole cell still image of live-cell imaging and quantification of EB3-mCherry dynamics in HeLa cells 
treated with mock or spastin siRNA – HeLa cells were treated with mock or spastin siRNA and 
transfected with EB3-mCherry and imaged using live-cell widefield microscopy. Imaging was performed 
at 0.5 seconds per frame for three minutes. Scale bars represent 20µm in both images. EB comet 
tracking, bar chart plots, and number of cells analysed were as described in Figure 10A. This image 
accompanies Movie 12.  
 
C) Whole cell image of live-cell imaging and quantification of EB3-mCherry dynamics in spastinWT/WT 
(WT), spastinWT/N384K (HET), and spastinN384K/N384K (HOM) immortalised MEFs – Wildtype, heterozygous, 
and homozygous spastin mutant MEFs were transfected with EB3-mCherry and imaged using live-cell 
spinning disk microscopy. Imaging was performed at 0.46 frames per second for three minutes. Scale 
bars represent 20µm in all images. EB comet tracking and bar chart plots were as described as in Figure 
10A. The comets were analysed from 5 cells per spastin mutant cell type, with six experimental repeats. 
This image accompanies Movie 13.  
 
D) Live cell imaging of GFP-SNX1 endosomal tubules and EB3-mCherry microtubule plus ends in MRC5 
cells to visualise the spatio-temporal correlation between endosomal tubule fission and EB comet 
formation – MRC5 cells stably expressing GFP-SNX1 were transfected with EB3-mCherry and imaged 
using live cell spinning disk microscopy. The large image (left) shows an overview of a cell with both 
GFP-SNX1 and EB3-mCherry displayed. The zoom images show a time-series of an GFP-SNX1 endosomal 
tubule fission event in relation to EB3 microtubule plus ends (by column). The top row shows only GFP-
SNX1, the middle row shows only EB3-mCheerry, and the bottom row shows both GFP-SNX1 and EB3-
mCherry channels. White arrows show the location of fission of the GFP-SNX1 endosomal tubule. The 
white box on the large image shows the zoom image location. The scale bars of the overview and zoom 
images represent 10µm and 1µm respectively. This image accompanies Movie 14. 
 
E) Box plot showing the quantification of the proportion of GFP-SNX1 endosomal tubules that had an 
EB-mCherry microtubule plus end form at the point of fission – The number of GFP-SNX1 endosomal 
tubules that had an EB3-mCherry comet form at the same time and space as endosomal tubule fission 
was manually scored from live cell movies of GFP-SNX1 stably expressing MRC5 cells transiently 
expressing EB3-mCherry. 15 endosomal tubules were scored per cell, with 20 cells analysed in total. 
Box plot details as described in Figure 9D. 
  




3.3 – Discussion 
3.3.1 – Summary of results 
High spatial and temporal resolution microscopy was used to investigate the role of spastin in 
endosomal tubule dynamics. These experiments showed spastin and its ESCRT-III interaction partner 
IST1 to be required for the efficient fission of SNX1 endosomal tubules. These proteins colocalised 
together at sites of tubule constrictions and marked the location of fission. Spastin did not function in 
the formation of ER-endosome contacts. However, the ATPase domain of spastin was required for 
tubule fission, suggesting a necessity for microtubule remodelling. There was no direct evidence of a 
correlation between microtubule severing and SNX1 tubule severing. Furthermore, despite 
microtubule severing leading to the formation of new microtubule plus-ends, no correlation was 
observed between SNX1 tubule fission and plus end formation, making it unlikely that the fission of 
endosomal tubules requires microtubule severing. Altogether, these results provide new insights into 
the mechanisms of endocytic recycling and endosomal tubule fission, as well as providing new insight 
into the mechanisms of HSP. 
 
3.3.2 – Spastin and IST1 function in endosomal tubule fission after ER-endosome contact formation 
A spastin-IST1 interaction mediates endosomal tubule fission 
Depletion of spastin and IST1 in HeLa cells leads to the formation of abnormally long endocytic 
recycling tubules (Allison et al. 2013). These tubules were hypothesised to result from the failure of 
endosomal tubule fission. The visualisation of IST1 assembling on positive curvature membranes (such 
as those found on endosomal tubules) in vitro strengthened this hypothesis, with IST1 being likely to 
form part of a machinery that promotes endosomal tubule constrictions (McCullough et al. 2015). 
The research performed supports these hypotheses. Spastin depletion in MRC5 and COS7 cells 
led to endosomal tubule elongation caused by a delay in tubule fission. The effects of this delay on 
endocytic trafficking were compounded by the resulting decrease in proportion of successful fission 
events. Upon spastin depletion, there was an increase in the proportion of tubules that either 
underwent fission along the length of the endosomal tubule, causing cargo packaged between the 
fission site and the body of the endosome to not be recycled. Furthermore, tubule collapse events 
were more common. These represent a major failure of endocytic recycling, with packaged cargo 
reabsorbed into the endosome body rather than being transported away from lysosomal degradation. 
Significantly, IST1 depletion led to a near identical phenotype, confirming that both spastin and IST1 
function in endosomal tubule fission. Considered with experiments showing that a spastin-IST1 




interaction was required to prevent abnormal tubule elongation (Allison et al. 2013), this suggests that 
tubule fission requires and is driven by a spastin-IST1 interaction. 
 Further evidence supporting a role of spastin and IST1 in tubule fission came through the use 
of high sensitivity high spatial resolution Airyscan imaging. In line with predictions from McCullough 
et al. (2015), spastin and IST1 were shown to localise to sites of tubule constrictions. By live cell 
imaging, M1 spastin was shown to localise to sites of tubule constriction formation, with these 
constrictions marking the location of subsequent tubule fission. 
 
A model for spastin-IST1 mediated endosomal tubule fission in the context of known endosomal tubule 
fission machinery 
The mechanism by which spastin and IST1 drive endosomal tubule fission, and how spastin-induced 
fission fits with other mechanisms known to function on the endosomal tubule is unclear. One 
established requirement for tubule fission is the formation of contact sites between the tubule and 
the ER (Rowland et al. 2014). Given that M1 spastin can both bind the ER through its hydrophobic 
hairpin (Connell et al. 2009), and interact with endosomes through its IST1 and CHMP1B binding MIT 
domain (Allison et al. 2013; Connell et al. 2009), it was hypothesised that spastin may facilitate contact 
formation. 
 However, live cell microscopy shows that spastin does not mediate the formation of ER-
endosome contacts. In spastin depleted MRC5 and COS7 cells, the same proportion of endosomal 
tubule fission events occurred at sites of overlap with the ER as in mock cells. Although the axial 
resolution of live cell microscopy cannot rule out that these two membranes are close or just overlap 
without contact formation, electron microscopy in spastin depleted cells showing an increase in 
membrane contact formation makes this unlikely (Allison et al. 2017). Significantly, depletion of 
spastin in both MRC5 and COS7 cells led to an extended duration of contact between the endosome 
and the ER before either a fission or collapse event. This data suggests a model where spastin acts 
after ER-endosome contact formation in mediating endosomal tubule fission. 
 
How then may spastin-mediated fission at ER-endosome contact sites function in relation to other 
known fission components? An essential component in endosomal tubule fission is the WASH complex 
(Derivery et al. 2009; Dong et al. 2016; Gautreau et al. 2014; Puthenveedu et al. 2010). As introduced 
in Introduction Section 1.4.3, WASH functions to facilitate the nucleation of actin on the sorting 
endosome and endosomal tubules and supports cargo sorting by mediating the endosomal 




recruitment of components of the cargo sorting machinery. Depletion of WASH components impairs 
endocytic recycling, as shown by the formation of abnormally elongated endosomal tubules and CI-
M6PR mistrafficking (Harbour et al. 2010). In addition, an intense burst of actin is observed at the 
spatial and temporal location of endosomal tubule fission, with this likely mediated by WASH 
(Puthenveedu et al. 2010). 
 WASH has also been connected with other proposed components of the endosomal tubule 
fission machinery. Firstly, it was shown that ER-endosome contacts involving VAP-A and SNX2 lead to 
the inhibition of WASH-dependent actin polymerisation on endosomal tubules (Dong et al. 2016). 
Secondly, WASH directly interacts with other proposed endosomal tubule membrane scission 
enzymes such as dynamin (Derivery et al. 2009), and the dynamin activating protein ATPase Eps15 
homology domain (EHD1; Gokool, Tattersall, and Seaman 2007; Jakobsson et al. 2011). Like WASH and 
spastin, dynamin has been shown to localise to tubulo-vesicular structures in HeLa cells. In addition, 
expression of a dominant dynamin leads CI-M6PR to mislocalise to lysosomes (Nicoziani et al. 2000), 
and inhibits the endosome to Golgi transport of endocytosed ricin (Llorente et al. 1998). Furthermore, 
endosomal recycling tubules elongate upon dynamin inhibition by Dynasore (Derivery et al. 2009), and 
in yeast, absence of the dynamin ortholog vps1 leads SNX1-coated endosomal tubules to have an 
extended duration between growth and fission, as well as frequently collapsing back into the mother 
endosome (Chi et al. 2014). Likewise, depletion of EHD1 led to impaired endosome to plasma 
membrane recycling of TfnR (Rapaport et al. 2006), and impaired endosome to Golgi traffic of Shiga 
toxin (McKenzie et al. 2012). 
 
How may spastin and IST1 function in tubule fission in relation to WASH and dynamin activity? One 
possibility is that spastin-IST1 mediated tubule fission may occur separately to dynamin-mediated 
tubule fission, potentially separated by cell type, or by acting on different subsets of endosomal 
tubules. This however seems unlikely, as WASH and dynamin depletion, as well as disruption of ER-
endosome contacts, led to the same phenotypes of endocytic mistrafficking as observed with spastin 
depletion in similar cell types (Dong et al. 2016; Nicoziani et al. 2000; Puthenveedu et al. 2010). 
Moreover, mutations in spastin, the WASH component strumpellin, or dynamin all result in HSP (Hazan 
et al. 1999; Sambuughin et al. 2015; Valdmanis et al. 2007). Given that HSP specifically affects cortical 
neurons, this makes it unlikely that two systems are separated by cell type. 
A model is therefore required of how spastin and IST1 may work cooperatively in endosomal 
tubule fission with WASH and dynamin. A suggestion of how this may occur comes by analogy to 
mitochondrial fission. Like endosomal tubules, mitochondria also require the formation of ER-




endosome contacts to mediate membrane fission, with fission occurring at the location of contact 
(Friedman et al. 2011). Intriguingly, like on endosomal tubules, the formation of this organelle-
organelle contact leads to a localised burst of actin polymerisation, with this causing the formation of 
an initial small constriction on the mitochondrion, marking the location of fission (Korobova et al. 
2013). This facilitates the recruitment of mitochondrial division dynamin Drp1 to the constriction sites 
which greatly tightens the constriction (Ji et al. 2015), allowing the recruitment of dynamin-2 which 
causes membrane cleavage by GTP hydrolysis (J. E. Lee et al. 2016).  
Interestingly, whilst dynamin-2 facilitates the final cleavage of the mitochondrion, due to its 
molecular structure, dynamin-2 is unable to polymerise on membranes that have not already been 
substantially constricted to a minimum of 30nm (Roux et al. 2010). Thus, dynamin-2 is dependent on 
an earlier constriction process. The endosomal equivalents of the initial and final stage of 
mitochondrial fission have been discovered: ER-endosome contacts facilitate an initial burst of actin 
polymerisation by WASH activation; and dynamin-2 is required for endocytic recycling. Crucially, the 
endosomal equivalent of Drp1 has not been identified. A spastin-IST1 interaction could do this; 
through the spastin-mediated action of the IST1-CHMP1B copolymer, endosomal tubules could 
constrict to a radius that allows dynamin-2 to facilitate the final stages of scission (Figure 11 (located 
after Section 3.3.3)). The precise role for spastin in mediating the action of ESCRT-III in endosomal 
tubule fission however remains to be elucidated (discussed below). A recent significant finding that 
provides a potential molecular link between these processes is the discovery that WASH recruitment 
to the endosome is facilitated by the ESCRT-0 protein hepatocyte growth factor-regulated tyrosine 
kinase substrate (HRS; MacDonald et al. 2018). This therefore suggests a mechanism whereby ESCRT-
III/spastin and WASH fission mechanisms can be coordinated.  
  




3.3.3 – Spastin requires its ATPase for fission, but fission is not driven by microtubule severing 
Spastin’s ATPase domain is required for endosomal tubule fission 
A crucial component of the above model is that spastin functions at ER-endosome contacts to 
generate constrictions on the endosomal tubule. Through its AAA+ domain, spastin is able to convert 
the hydrolysis of ATP into mechanical force, providing a mechanism by which energy could be 
conferred to deforming the tubule membrane. An important test of this model would therefore be 
whether spastin required the function of its ATPase domain to facilitate endosomal tubule fission. 
Experiments from cells derived from the spastinN384K ATPase-defective mutant mouse showed that this 
was the case. 
 
Spastin-induced microtubule severing does not drive endosomal tubule fission 
One microtubule remodelling function of spastin is the severing of microtubules. Microtubule severing 
could be envisaged to lead to tubule constriction formation by several mechanisms. Firstly, 
microtubule severing could lead to the rapid shortening of microtubules at either site of the severing 
location. If these microtubules were attached to different areas of the endosomal tubule membrane, 
it could generate tension on the tubule, leading to constriction formation.  
An alternative hypothesis is that microtubule severing could lead to an increase of 
microtubule motor protein loading at the GTP-tubulin rich microtubule severed ends. For example, 
the microtubule dynein motor has been shown to localise to GTP-tubulin rich microtubule plus ends 
(Lenz et al. 2006; Vaughan et al. 1999; Wassmer et al. 2009), either via the EB-dependent recruitment 
of dynactin (Moughamian et al. 2013; Watson 2006), or by kinesin-dependent trafficking moving 
dynein to plus-ends against its canonical direction of travel (Bieling et al. 2007; Roberts et al. 2014). 
This increased microtubule loading could lead to an increase in membrane tension via a pulling force, 
hence generating tubule constrictions. Of relevance is that depletion of p150glued component of the 
dynein-linker complex dynactin leads to aberrant endosomal tubulation (Wassmer et al. 2009). 
Against this background, it was tested whether microtubule severing was visible during 
endosomal tubule fission. Remarkably, using either microtubule labelling or EB3 as a marker of new 
microtubule plus-end formation, no microtubule severing events were shown to occur at the position 
of endosomal tubule fission. 
 
What then is spastin’s role in tubule fission if it does not involved microtubule severing at the fission 
point? A possible explanation is that spastin’s AAA+ domain is facilitating the formation of small 




microtubule ‘bites’ along the microtubule that leads to increased GTP-tubulin incorporation into the 
microtubule without severing (reviewed in Introduction 1.3.5; Vemu et al, 2018). Although these GTP-
tubulin islands recruit EB proteins (Vemu et al. 2018), it is probable that these could not be visualised 
by the microscopy performed as the few EB proteins recruited to each ‘bite’ would likely give a 
subthreshold signal. Importantly these bites could still be active in recruiting microtubule motors, with 
the EB-dependent recruitment of dynein still possible, and with kinesin-1 motors (e.g. KIF5A) having 
been shown to preferentially recruit to GTP-tubulin bound microtubules (Nakata et al. 2011). Thus, 
spastin’s microtubule ‘biting’ function could potentially induce motor protein loading to generate 
tubule constrictions via membrane tension (Figure 11). As stated, the temporal sequence of this event 
in relation to ESCRT-III mediated activity is not known, but it may be that this function of spastin occurs 
after ESCRT-III mediated constriction formation to further reduce the diameter of the endosomal 
tubule to facilitate dynein loading, and to ensure that the fissioned endosomal tubule can be rapidly 
transported away from the location of fission. 
 A more extreme model of spastin’s role is that it acts as an alternative VPS4. Spastin and VPS4 
have homology, with both proteins having an MIT domain for ESCRT-III binding and an ATPase AAA+ 
domain (Anna Scott et al. 2005). During membrane constriction, the MIT domain of VPS4 interacts 
with MIMs of ESCRT-III proteins that generate curvature by forming polymerised filaments (reviewed 
in Introduction 1.3.3 and 1.5.3). Despite previous dogma that VPS4 recruits to ESCRT-III to facilitate its 
disassembly (Lata et al. 2008), it has been shown recently that VPS4 and ESCRT-III spatially and 
temporally localise to generate membrane constrictions, with VPS4 working to facilitate the continued 
polymerisation of the ESCRT-III constriction polymer (Mierzwa et al. 2017). By analogy, spastin could 
conceivably function as an alternative VPS4 in endosomal tubule fission, thereby facilitating 
endosomal tubule constriction by facilitating the non-stalling polymerisation of the IST-CHMP1B 
copolymer. 
  





Figure 11 - Model for spastin-mediated endosomal tubule fission. (1) Cargo to-be-recycled is retrieved from 
degradation at the sorting endosome (blue) by cargo sorting machinery such as retriever, retromer, the CCC 
complex and WASH (orange). These cargos are sorted into tubular projections that grow along microtubules 
(grey) and by chance may happen to grow across ER tubules (red). This growth is stimulated by fast-polymerising 
actin comets (purple comets). (2) Increased cargo sorting is coupled to the growth of the endosomal tubule, with 
SNX-BAR proteins facilitating the high curvature formation of the tubule. (3) An unknown protein mediates the 
contact of an ER tubule and the endosomal tubule allowing an interaction between ER-localised VAP-A and 
endosome-localised SNX2 (not shown) allowing OSBP and Sac1 on the ER membrane to remove PI4P from the 
endosome membrane. (4) PI4P removal inhibits WASH-induced actin comet formation, allowing the formation 
of stable actin arrays (purple lines) which generate the first sign of tubule constriction. (5) Spastin (stars) and the 
IST1-CHMP1B (brown) copolymer assembles on the endosomal tubule membrane in an unknown sequence. The 
IST1-CHMP1B copolymer drive endosomal tubule constriction. (6) Microtubule remodelling by spastin at the site 
of ER-endosome contacts induces GDP-tubulin to be replaced by GTP-tubulin leading to increased EB 
recruitment (white). (7) Microtubule remodelling induces microtubule motor protein (orange) loading onto the 
microtubule beneath the endosomal tubule. This generates tension on the microtubule, causing further 
constriction to a critical diameter of 30nm. (8). Dynamin-2 polymers (green) are able to assemble on the 30nm 
endosomal tubule, and through a ratchet mechanism lead to the formation of a hemi-fission state. (9) This single 
lipid layer hemi-fission state spontaneously resolves, causing endosomal tubule fission. The fissioned endosomal 












































3.3.4 – The implications for the disease mechanism of HSP 
Simultaneously with this research, members of the Reid lab were investigating the effect of impaired 
endosomal tubule fission on the endocytic pathway (Allison et al. 2017). It was shown that inefficient 
endosomal tubule fission upon spastin or IST1 depletion led to a mistrafficking of CI-M6PR, with a 
decreased localisation of the receptor at the Golgi apparatus and an increased lysosomal localisation. 
This was shown to be dependent on spastin’s ATPase capability and an ability of spastin and IST1 to 
interact, mirroring the requirements for endosomal tubule fission. As a result of mistrafficked M6PR, 
M6P-tagged cargos that typically traffic from the Golgi to endosome (such as lysosomal hydrolase 
cathepsin D) was aberrantly secreted from the cell. As a likely result of this mistrafficking, lysosomes 
showed gross changes in their morphology and biology. Lysosomes in spastin depleted cells and cells 
from patients with spastin-mutation-induced spastic paraplegia had dramatically enlarged lysosomes 
many of which contained storage membrane. These were also shown to be abnormally acidic. Despite 
active research, it is not currently understood how lysosomal dysfunction could result in 
neurodegeneration observed in hereditary spastic paraplegia. Potential mechanisms could include 
failure in autophagy, failure in autophagic lysosomal reformation, or failure in the breakdown and 
consequent recycling of lipids and proteins (reviewed in Final Discussion – Section 6.2). 
 
3.3.5 – Future experimental plans 
The temporal relationship between spastin, IST1, and other endosomal tubule fission proteins 
The temporal relationship between the endosomal tubule fission components is currently unclear. 
This includes whether spastin recruits to the endosomal tubule before or after IST1, and whether the 
spastin-IST1 endosomal tubule interaction occurs before or after actin polymerisation by WASH or the 
endosomal tubule recruitment of dynamin. These experiments could be performed using live cell 
microscopy, for example by looking at the relationship between the recruitment of pairs of proteins 
to the endosomal tubule in relation to the fission event. In addition, bespoke microscopy designs could 
be used that allow 5 or 6-colour live cell imaging (Cohen et al. 2018; Valm et al. 2017). More simply, 
this could also be performed using a series of siRNA depletion experiments in combination with the 
live cell imaging of the protein of interest’s recruitment to the endosomal tubule. For example, the 
temporal recruitment of dynamin-2 in relation to spastin or IST1 could be investigated by depleting 
cells of spastin or IST1 and observing whether dynamin-2 could still recruit to endosomal tubules. This 
logic can be applied to any pair of endosomal tubule fission machinery components.  
  




The recruitment of microtubule motors to the endosomal tubule fission sites 
One hypothesis for how spastin mediates endosomal tubule fission is by recruiting microtubule 
motors to newly incorporated GTP-tubulin at repaired microtubule bites. This could be very difficult 
to prove, but approaches could include: 1) the use of fixed cell microscopy to visualise EB patches at 
the base of endosomal tubules, with the signal amplification provided by antibody labelling providing 
more sensitivity than live cell; 2) microtubule bites along the endosomal tubule could be visualised in 
vivo using serial-section scanning transmission electron microscopy (STEM), or focussed ion beam 
scanning electron microscopy (FIB-SEM). The location of these bites could also then be correlated with 
endosomal tubule constrictions by correlative light electron microscopy (CLEM) approaches. In 
addition, it might be possible to observe the recruitment of fluorescently labelled motor proteins (e.g. 
GFP-dynein) at the site of endosomal tubule fission. 
 
Validation in neuronal cells 
Given that HSP is caused by the axonal degeneration of cortical neurons, it is important to verify 
whether the role of spastin and IST1 in endosomal tubule fission also applies in neurons. A major 
technical difficulty in achieving this is the visualisation of endosomal tubule fission events in the axon 
which is both thin and may have a high density of cargos. Two potential live cell microscopy 
approaches could be used: 1) the use of live cell Airyscan may provide the spatial resolution increase 
required to visualise distinct fission events in the axon; 2) more demandingly, live cell super resolution 
techniques such as live-cell SIM could be used resolve axonal tubule fission events. These approaches 
could also be used in combination with a bright endosomal tubule marker expressed at extremely low 
levels to only label a small subset of endosomal tubule fission events. 




Chapter 4 – The function of spastin in the 
early secretory pathway 
 
4.1 - Introduction 
4.1.1 – Overview of the secretory pathway and COPII-coated vesicles 
The early secretory pathway 
Newly synthesised proteins that are destined for secretion, the cell surface, the endocytic pathway, 
or other membrane-bound organelles, are translated into the endoplasmic reticulum (ER) where they 
are folded and glycosylated (Palade 1975). These proteins are then exported from the ER at specialised 
export locations called ER exit sites (ERES). Proteins leaving these sites travel short distances to fuse 
with vesicular and tubular membrane clusters (VTCs) that surround each exit site (Bannykh 1996; 
Hobman et al. 1998). From here, these proteins are transported via microtubule motors in either 
vesicular or tubular membranes to the microtubule organising centre (MTOC)-localised Golgi 
apparatus (Presley et al. 1997; Watson et al. 2005). In the Golgi, these proteins may be processed 
further (e.g. O-linked glycosylation) before being sorted into vesicles that transport cargo to the 
endocytic pathway (e.g. lysosomal hydrolases), back to the ER, to the cell surface, or to other locations. 
Collectively these trafficking pathways are defined as the secretory pathway (Figure 1). 
  





Figure 1 - Schematic to show cargo trafficking in the early secretory pathway. Cargo is folded in the ER before 
being exported in COPII-coated vesicles (blue) to the ER-Golgi intermediate compartment (ERGIC), comprised of 
VTCs. Here cargo may either be retrieved back to the ER in COPI vesicles (red), with the remaining cargo entering 
the cis-Golgi complex. This cargo is modified in the Golgi (e.g. glycosylation) before being exported in the TGN. 
Export routes include transport directly to the cell surface, transport to immature secretory vesicles, or transport 
to the endocytic pathway. Cargo sorting in the endocytic pathway is also shown. Orange highlights indicate the 
location of clathrin. Cartoon adapted from Bonifacino and Glick 2004. 
 
COPII-coated vesicle formation and budding 
The majority of cargo that leaves the ER is transported in COPII-coated vesicles (Hanna et al. 2016). 
The formation of a COPII vesicle at an ERES is promoted by the integral ER membrane glycoprotein 
guanine nucleotide exchange factor (GEF) Sec12 which catalyses the exchange of GDP for GTP on the 
cytosolic GTPase Sar1 (d’Enfert 1991). This induces the release of an N-terminal amphipathic helix 
from Sar1 that allows it to integrate into the outer leaflet of the ER membrane (Bielli et al. 2005). The 
localisation of Sar1 onto the ER induces binding of the Sec23-Sec24 dimer (Barlowe 1994) that serves 
as a key location of cargo interaction via Sec24 (Miller et al. 2002). Most transmembrane proteins are 
able to interact directly with Sec24 through amino acid motifs (e.g. DxE) or folded epitopes (Miller et 
al. 2003), whilst soluble proteins and GPI-anchored proteins rely on membrane adaptor proteins such 
as ERGIC-53 (Nyfeler et al. 2008) and p24 (Takida et al. 2008) to allow their interaction with Sec24. 
Together Sec23-Sec24 with bound cargo makes up the inner layer of the coat. Sec23-Sec24 then 
recruit Sec13-Sec31 to form the outer layer of the COPII coat (Fath et al. 2007). A cartoon of COPII-
coated vesicle formation is shown in Figure 2. 
  





Figure 2 - A schematic of COPII vesicle formation. The GTPase Sar1 is recruited to the ER membrane by Sec12. 
This induces the recruitment of Sec23/Sec24 inner coat proteins which facilitate cargo recruitment, and in turn 
allow the recruitment of the Sec13/Sec31 outer coat. Sar1 then initiates vesicle neck constriction and cargo 
budding. Schematic obtained from Venditti, Wilson, and De Matteis 2014. 
 
Although these components form the basic machinery of COPII mediated ER exit, additional ERES 
proteins aid in the formation of the COPII bud. One example is Sec16, which functions in scaffolding 
the COPII coat during its assembly, as well as regulating the GTPase-activating protein (GAP) activity 
of Sec31 to facilitate the formation of vesicles of different sizes (Kung et al. 2012). For example, 
proteins exiting the ER can have a range of different sizes, with proteins such as procollagen being far 
larger than the typical 60-90nm size of COPII vesicles. COPII is able to accommodate this large cargo 
by the action of ERES associated proteins Tango1 and cTage5 (Saito et al. 2011; Wilson et al. 2011). 
cTage5 binds Tango1 and localises Sec12 to the nascent COPII bud, stimulating the increased 
recruitment of Sec23-Sec24 by Sar1-GTP, allowing the bud to increase beyond normal size (Saito et al. 
2014). 
Fission of the nascent COPII bud requires the neck of the COPII vesicle to be constricted. The 
action of the outer coat proteins Sec13-Sec31 is thought to bend the ER membrane to constrict the 
neck of the COPII vesicle by the interaction of basic amino acids with the acidic phospholipids of the 
ER membrane (Bi et al. 2002). The deformation of the ER membrane is also driven by Sar1 as its N-
terminal amphipathic helix is able to asymmetrically distort the two layers of the ER lipid bilayer so 
causing membrane bending (Bielli et al. 2005; Lee et al. 2005). As Sec12 remains localised at the ERES, 
Sar1-GTP is continually recruited to the COPII bud (Lindroth et al. 2004), despite the GAP activities of 
Sec23 and Sec31. This is thought to gradually increase the bending of the neck of the COPII vesicle. In 
addition, it has recently been suggested that Sar1 is able to bind more avidly to bent membrane, 
ultimately driving an accelerating cycle of Sar1-induced membrane bending and Sar1 recruitment 


















functions as the ER exit equivalent of dynamin in clathrin mediated endocytosis (Long et al. 2010). It 
is worth noting however that whilst Sar1 has been shown to induce membrane constrictions, the 
function of Sar1 in directly causing membrane fission has never been shown in vivo.  
 
4.1.2 – The potential role for spastin in ER exit 
Whilst ER exit does not appear to require any additional machinery to drive COPII vesicle fission, it is 
intriguing that the endosomal tubule fission protein spastin (Allison et al. 2017) has been associated 
with ER exit (Connell et al. 2009). This has been shown by making use of a GFP-tagged temperature 
sensitive vesicular stomatitis viral glycoprotein (VSVG). The temperature sensitive mutation in VSVG 
means that it misfolds at 39.5oC, blocking its exit from the ER (Lafay 1974). However, if cells expressing 
VSVG are cooled to 32oC, VSVG folds correctly and can be exported. This allows the cargo export of 
VSVG to be synchronised, with the visualisation of the trafficking of VSVG providing an insight into the 
dynamics of secretion (Presley et al. 1997). Connell et al. (2009) showed that a null mutation in the 
ATPase domain of spastin led to the impaired trafficking of GFP-tagged temperature-sensitive VSVG 
from the ER to the Golgi. Furthermore, it was shown that the ER-resident M1 isoform of spastin 
colocalised with temperature sensitive VSVG at early timepoints of its release from the ER, suggesting 
spastin to localise to components of the early secretory pathway. 
 There is additional circumstantial supporting evidence for the involvement of spastin in ER 
exit. Mass spectrometry of proteins bound to endogenously immunoprecipitated spastin identified 
the protein TRK-fused gene 1 (TFG; unpublished, Reid lab), with this also confirmed by yeast two-
hybrid interaction studies (unpublished, Sanderson lab). TFG functions at ERES to organise the 
apposition between ERES and the VTCs that form the ER-Golgi intermediate compartment (ERGIC) and 
is important for efficient procollagen secretion (McCaughey et al. 2016). Spastin’s ESCRT-III interacting 
protein IST1 was also suggested to interact with TFG with high confidence in a large scale human 
interactome study (Hein et al. 2015). Furthermore, mutations in TFG have recently been shown to 
result in autosomal recessive complex hereditary spastic paraplegia (Elsayed et al. 2017; Tariq and Naz 
2017). Given this data and the similarities in membrane topology between endosomal tubules and 
COPII buds, as well as the requirement of microtubules for ER to Golgi transport (Gurel et al. 2014), it 
is tempting to speculate that spastin could also function as a fission enzyme in ER exit. 
  




4.1.3 – Experimental approach 
Despite the work of Connell et al. (2009), no experiments have been performed directly looking at the 
localisation of spastin or IST1 onto ER exit machinery, nor at the effect of spastin or IST1 depletion in 
the secretion of cargo. Here, I directly test whether spastin and IST1 localise to ERES through the use 
of high spatial resolution fixed cell Airyscan microscopy and live cell spinning disk microscopy. 
Furthermore, the role of spastin and IST1 in the efficient trafficking of cargo in the early secretory 
pathway is tested by imaging the live cell secretion dynamics of TNFα-GFP and GFP fused to a GPI 
anchor (GFP-GPI). This was performed using the retention using selective hooks (RUSH) assay, allowing 
cargo release to be synchronised from the ER without the need for unphysiological temperature shifts 
(discussed below). 
 
4.1.4 – Assays of ER exit and secretion 
Traditional experimental methods 
Temperature-sensitive VSVG was one of the first tools to study the dynamics of secretion (Lafay 1974; 
Presley et al. 1997). As described previously, this assay makes use of the temperature-sensitive folding 
properties of a VSVG mutant to synchronise the export of VSVG from the ER. The synchronised release 
of VSVG can thereby be visualised, providing a kinetic insight into flux through the secretory pathway. 
Alternatively, secretory transport can be blocked by cooling cells to 15oC, with export resumed as cells 
are warmed to 37oC (Matlin and Simons 1983). 
 Alternative methods include expressing horseradish peroxidase (HRP) or luciferase fused to a 
signal peptide under a metallothionein promotor. When copper sulphate is added to the cell, it causes 
transcription and secretion of the HRP/luciferase, and the media of the cell can be regularly sampled 
and assayed for luminescence activity as a readout of the relative dynamics of the secretory pathway 
(Bard et al. 2006; Wendler et al. 2010).  
In addition, protein export from the ER can synchronised through the use of reversible 
aggregation (Gordon et al. 2010; Rivera 2000). This method makes use of mutant FK506 binding 
proteins (FKBP) fused to a cargo of interest. Under steady state conditions, these fusion proteins form 
ligand-reversible dimers which cannot be secreted. However, upon the addition of FKBP ligand 
AP21998, the aggregates are solubilised and the cargo-FKBP fusion protein is exported in a 
synchronised pulse from the ER. 
 
  




The Retention Using Selective Hooks (RUSH) assay 
The RUSH assay is a novel method to synchronise cargo export (Boncompain et al. 2012). This 
technique relies on the use of two proteins: a hook protein that is resident in the ER (or another 
organelle if desired), and a reporter protein that is a fluorescently tagged secreted protein of interest. 
The hook protein is fused to streptavidin and the reporter is fused to streptavidin binding protein, 
with the interaction between these two proteins sufficient to keep the reporter in the ER under 
steady-state conditions. However, upon the addition of biotin, the biotin outcompetes the 
streptavidin binding protein for streptavidin, dissociating the reporter from the hook, allowing it to 
exit the ER and traffic through the secretory pathway in a synchronised pulse. 
  
Benefits of the RUSH assay 
The RUSH assay has benefits over its predecessor techniques (Boncompain et al. 2012). These are: 1) 
no reliance on unphysiological temperature shifts to induce cargo synchronisation (not possible with 
the VSVG assay and cooling assay); 2) No delay between stimulus and cargo secretion (not possible 
with the VSVG, cooling, and HRP/luciferase assays); 3) Fluorescent-tagging of the reporter allowing 
live cell imaging of the reporters trafficking dynamics (not possible with the HRP/luciferase assays); 4) 
No upregulation of the unfolded protein response as is possible with the aggregation assay 
(Boncompain et al. 2012; Perez lab, personal communication). In addition, the reporter can be varied 
to study the trafficking dynamics of different proteins of interest. In the context of investigating the 
function of spastin in the secretory pathway, this was crucial as it allowed the effects of spastin on 
multiple trafficking pathways to be investigated. 
 
4.1.5 – Summary of aims 
The experiments in this chapter aimed to address the following questions: 
1. Does spastin and IST1 localise to ER exit machinery? 








4.2 – Results 
4.2.1 – Summary of methods 
The function of spastin in the early secretory pathway was investigated by using fixed and live cell 
imaging. Airyscan microscopy were used to investigate the localisation of spastin and IST1 at ERES with 
high spatial resolution, with the dynamics of spastin localisation at ERES investigated using live cell 
microscopy. The function of spastin and IST1 in ER exit was investigated by using the RUSH assay to 
monitor the secretory dynamics of TNFα-GFP and GFP-GPI RUSH cargo reporters. 
 
4.2.2 – Spastin and IST1 localise on ER exit sites in MRC5 cells 
Previous investigations of the ER localised M1 isoform of spastin had shown it to colocalise with 
temperature sensitive viral glycoprotein (VSVGtsO45) in HeLa cells very shortly after its release from 
the ER (Connell et al. 2009). This suggested that spastin may localise to ER exit sites and so may 
function in cargo exit from the ER. However, localisation experiments of spastin or its ESCRT-III binding 
partner IST1 onto ERES machinery were not performed. 
 To investigate the localisation of spastin and IST1 on ERES machinery, high spatial resolution 
fixed cell Airyscan imaging was performed in MRC5 cells stably expressing GFP-M1 spastin, transiently 
expressing mCherry-Sec23, and antibody labelled for endogenous IST1. The GFP-M1 spastin cell lines 
used were the same as used for experiments of GFP-M1 spastin and IST1 localisation on endosomal 
tubules detailed in Chapter 3. The imaging showed clear 3-way colocalisation between GFP-M1 
spastin, mCherry-Sec23, and IST1 (Figure 3A). This colocalisation was observed predominately in the 
perinuclear and central areas of the cell, with fewer examples of all three proteins colocalising in the 
cell periphery. Whilst there were many examples of all three proteins localising together, there were 
instances where GFP-M1 spastin and mCherry-Sec23 were colocalised without IST1, and instances 
were IST1 and mCherry-Sec23 were colocalised without GFP-M1 spastin. There were also many 
mCherry-Sec23 puncta that were not colocalised with either protein. Overall however, the high-
resolution imaging showed clear examples of spastin, IST1, and Sec23 colocalisation, providing new 
insight into ESCRT-III biology and confirming previous suggestions about M1 spastin localisation. 
 The fixed cell imaging could not reveal whether spastin and Sec23 had transient or stable 
colocalisation. To address this, high temporal resolution live cell spinning disk microscopy of MRC5 
cells stably expressing GFP-M1 spastin and transiently expressing mCherry-Sec23 was performed. 
Confirming the fixed cell imaging, there was a large amount of colocalisation observed between GFP-
M1 spastin and mCherry-Sec23 in the central regions of the cell, with less colocalisation observed at 




the cell periphery (Movie 1, Figure 3B). Significantly, the colocalisation of GFP-M1 spastin and 
mCherry-Sec23 appeared highly stable. For example, in Movie 1, all mCherry-Sec23 puncta that were 
colocalised with a GFP-M1 spastin puncta maintained that colocalisation for the full 30 second 
duration of the movie. Furthermore, although most GFP-M1 spastin and mCherry-Sec23 puncta were 
static (even when colocalised), some puncta were highly dynamic in the cell with the colocalisation of 
GFP-M1 spastin and mCherry-Sec23 maintained despite these rapid movements (white arrows in 


























































Figure 3 - Spastin and IST1 localise on Sec23-labelled ER exit sites. 
A) Fixed cell Airyscan microscopy of GFP-M1 spastin, mCherry-Sec23, and IST1 in MRC5 cells – MRC5 
cells stably expressing GFP-M1 spastin were transfected with mCherry-Sec23, fixed, and stained with 
fluorescent antibodies against IST1. Cells were then imaged using high resolution Airyscan microscopy. 
The left panel shows an overview of a cell, with the white dotted line indicating the outline of the cell. 
The smaller panels show a zoom of the region highlighted by the white square in the overview image, 
with the top left showing mCherry-Sec23 alone, top right showing GFP-M1 spastin and mCherry-Sec23, 
bottom left showing mCherry-Sec23 and IST1, and bottom right showing a merge of all three channels. 
White arrows indicate Sec23 puncta with both GFP-M1 spastin and IST1 colocalisation, grey arrows 
indicate Sec23 puncta that exclusively colocalise with GFP-M1 spastin, and orange arrows indicate 
Sec23 puncta that exclusively colocalise with IST1. Scales for the overview and zoom images represent 
10µm and 2µm respectively. See Chapter 3 for GFP-M1 spastin expression blots to show the level of 
GFP-M1 spastin expressed in this cell line. 
 
B) Live cell imaging of GFP-M1 spastin and mCherry-Sec23 in MRC5 cells – MRC5 cells stably expressing 
GFP-M1 spastin were transfected with mCherry-Sec23 and imaged using spinning disk microscopy. 
Imaging was performed at 420ms per frame for three minutes simultaneously in both channels. The 
large left panel shows an overview of two cells. The right smaller panels show a zoom of the region 
marked by the white square in the overview image. The top panels show GFP-M1 spastin alone, the 
middle panels show mCherry-Sec23 alone, and the bottom panels show both channels merged. The 
white arrow tracks a colocalised GFP-M1 spastin and mCherry-Sec23 puncta that moves dramatically in 
the cell. Scales of the overview and the zoom images represent 10µm and 2µm respectively. This figure 
corresponds to Movie 1. 
  




4.2.3 – Spastin and IST1 depletion have no effect on the synchronised export of RUSH reporter TNFα-
GFP from the ER to the Golgi 
Previous investigations of spastin had shown transient over-expression of ATPase defective spastin to 
impair the release and trafficking of VSVG-GFP from ERES to the Golgi apparatus (Connell et al. 2009). 
However, spastin depletion did not affect VSVG traffic (Connell et al. 2009). Both of these assays relied 
on using unphysiological temperature shifts to control the synchronised release of VSVG from the ER, 
and only looked at the trafficking of one cargo. To mitigate these problems, the RUSH assay was used 
to investigate the effect of spastin and IST1 function in the trafficking of multiple cargos in the early 
secretory pathway without the need for temperature shifts. 
 
The effect of spastin and IST1 depletion on the ER to Golgi export dynamics of the type-II 
transmembrane protein TNFα were studied in HeLa cells coexpressing TNFα-SBP-GFP reporter and 
KDEL-Streptavidin hook.  Cells were depleted of either spastin or IST1 using siRNAs, transfected with 
sialyltransferase fluorescently tagged with FusRed (SiT-FusRed) to label the Golgi apparatus, treated 
with biotin to induce reporter release, and imaged using live cell confocal microscopy. In addition, a 
set of TNFα RUSH cells were treated with Sar1-GTPase inhibitor H89 to provide a positive control of 
impaired ER exit. This imaging appeared to reveal little effect of spastin or IST1 depletion on TNFα 
trafficking between the ER, Golgi, and the plasma membrane (Movie 2 and Figure 4A). In mock, spastin 
depleted, and IST1 depleted cells, TNFα-GFP appeared to be localised in small punctate structures at 
5 minutes (likely to be ERES), have high colocalisation with SiT-FusRed at 15 minutes (Golgi), and have 
a diffuse localisation at 60 minutes (likely to be the cell surface). However, a substantial delay in TNFα-
GFP trafficking was observed in cells treated with the Sar1-GTPase inhibitor H89. By 15 minutes, there 
was some colocalisation of TNFα-GFP with SiT-FusRed labelled Golgi, but also much of the GFP signal 
was still in the form of small puncta, suggesting a block in ER exit. At 60 minutes, most of the TNFα-
GFP signal remained colocalised with SiT-FusRed, also suggesting a delay in export from the Golgi. 
TNFα-GFP dynamics in mock, spastin depleted, IST1 depleted, and H89 treated RUSH cells 
were quantified to provide a detailed description of TNFα-GFP trafficking in the early secretory 
pathway. To quantify TNFα-GFP dynamics, the Golgi apparatus was automatically segmented using 
the SiT-FusRed signal, and the amount of TNFα-GFP signal in this defined region was measured in each 
frame of each cell. This was normalised by the total segmented area of the Golgi to control for Golgi 
size variations. For each cell, the value of signal in the Golgi was expressed as a percentage of the 
maximum Golgi signal recorded. This allowed a detailed plot of the increase and decrease of TNFα-




GFP localisation in the Golgi region as the cargo exits the ER, enters the Golgi apparatus, and leaves 
the Golgi apparatus for the cell surface with 1 minute temporal resolution. 
 
The effect of spastin depletion on TNFα-GFP secretory dynamics 
There were no observable differences in the TNFα-GFP trafficking dynamics into and out of the Golgi 
in mock and spastin depleted cells over three experimental repeats (Figure 4B). No statistically 
significant differences in the TNFα-GFP signal in the Golgi region were observed for any time points 
for the 90 minute duration plotted between the two treatments. Moreover, the time for the maximum 
TNFα-GFP signal to appear in the Golgi was similar in mock and spastin depleted cells (Figure 4C), 
despite a strong reduction in spastin protein abundance in spastin siRNA treated cells (Figure 4D). 
Both mock and spastin depleted cell TNFα-GFP dynamics closely mirrored those observed by 
Boncompain et al. (2012) for wildtype cells. This therefore clearly strongly suggested that spastin is 
not required for the normal trafficking of TNFα-GFP RUSH cargo in the early secretory system. 
 
The effect of IST1 depletion on TNFα-GFP secretory dynamics 
The same analysis and quantification were also applied to TNFα-GFP RUSH cells treated with either 
mock or IST1 siRNAs. From one experimental repeat there was no observable difference in TNFα-GFP 
trafficking into and out of the Golgi between the two treatments, mirroring the effect seen with 
spastin depletion (Figure 4E). This was reflected in the near identical time for the maximum TNFα-GFP 
signal to appear in the Golgi region between the mock and IST1 depleted cells (Figure 4F), despite IST1 
siRNA treated cells having a reduction in IST1 abundance (Figure 4G). This showed that, like spastin, 
IST1 depletion had no effect on the trafficking of TNFα-GFP RUSH cargo in the early secretory pathway. 
 
The effect of H89 treatment on TNFα-GFP secretory dynamics 
TNFα-GFP RUSH cells were also treated with H89 as a positive control to show that a perturbation of 
ER export machinery would lead to changes in the trafficking of TNFα-GFP into and out of the Golgi 
apparatus (Figure 4H). In H89 treated cells there was a substantial delay in the time for maximum 
TNFα-GFP signal to appear in the Golgi region, with maximum signal in the Golgi approximately 10 
minutes later than in mock cells (Figure 4H, Figure 4I). Furthermore, the rate of TNFα-GFP signal 
increase into the Golgi and decrease out of the Golgi was substantially lower than in mock cells (Figure 
4H), confirming initial observations (Movie 2, Figure 4A). This therefore showed than Sar1-GTPase 
inhibition led to an impairment of TNFα-GFP trafficking in the early secretory pathway. This confirmed 




that manipulations in ER exit machinery could cause an observable change in trafficking of this RUSH 
assay cargo. 
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Figure 4 - Spastin and IST1 depletion does not impair TNFα-GFP RUSH cargo trafficking from the ER to the Golgi 
apparatus. 
A) Live cell imaging of TNFα-GFP cargo release and trafficking through the secretory pathway upon 
spastin and IST1 depletion and H89 treatment in TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells – 
HeLa cells stably coexpressing TNFα-SBP-GFP RUSH reporter and KDEL-Streptavidin RUSH hook were 
transfected using spastin siRNAs, IST1 siRNAs, or treated with 100µM H89, and transfected with SiT-
FusRed to label the Golgi apparatus. Cells were then imaged using live cell confocal microscopy at ~40 
seconds per frame for 90 minutes. The release of TNFα-SBP-GFP from KDEL-Streptavidin was stimulated 
using 40µM biotin solution, with time 0 corresponding to the time of biotin addition. The different sets 
of panels show mock treated cells (top main row), spastin depleted cells (2nd main row), IST1 depleted 
cells (3rd main row), and H89 treated positive control cells (bottom main row). In each main panel, the 
image on the left shows both TNFα-GFP and SiT-FusRed channels for the frame of biotin addition (t=0). 
The smaller right panels show 5, 15, 30, and 60 minutes after biotin addition, with the top and bottom 
panels showing TNFα-GFP alone, and both channels merged respectively. Scale bars for all images 
represent 20µm. This figure corresponds to Movie 2. 
 
B) Graph of TNFα-GFP signal in the SiT-FusRed labelled Golgi after reporter release in mock and spastin 
depleted TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells – HeLa cells stably coexpressing TNFα-SBP-
GFP RUSH reporter and KDEL-Streptavidin RUSH hook were treated with either mock or spastin siRNAs 
and transfected with SiT-FusRed to highlight the Golgi apparatus. Cells were treated with 40µM biotin 
to induce reporter release and imaged using live cell confocal microscopy at ~40s per frame for 90 
minutes. After imaging, images were processed automatically to threshold the SiT-FusRed labelled 
Golgi apparatus and determine the total TNFα-GFP signal in the defined area. This data was then 
processed automatically to calculate the signal per Golgi area for each frame of each image, and then 
calculate the signal in the Golgi for each frame normalised to the frame with the maximum signal for 
each cell. ~30 cells were imaged per treatment per experimental repeat, with three experimental 
repeats performed in total. The graph shows the mean normalised TNFα-GFP signal in the Golgi region 
during the biotin-induced release of the TNFα-GFP reporter over the three experimental repeats for 
each treatment. Time 0 corresponds to the addition of the biotin. Error bars at each minute represent 
standard error of the mean. Blue and red lines/bars show mock and spastin siRNA treated cells 
respectively.  
 
C) Bar chart showing the time for maximum localisation of TNFα-GFP signal in the SiT-FusRed defined 
Golgi region in mock and spastin depleted TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells – Live 
cell imaging and image analysis was performed on TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells 
treated with either mock or spastin siRNAs and transfected with SiT-FusRed as described in Figure 4A 
and Figure 4B. The time after biotin addition for the maximum localisation of TNFα-GFP signal in the 
SiT-FusRed defined Golgi region was recorded for each mock and spastin depleted cell. This data was 
averaged between the three experimental repeats for each treatment. Error bars indicate standard 
error of the mean. P values were generated by using paired two-tailed t-tests. 
 
D) Western blot showing spastin protein abundance in mock and spastin siRNA deleted TNFα-SBP-GFP 
KDEL-Streptavidin RUSH HeLa cells - TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells treated with 
mock or spastin siRNA were lysed and proteins separated by SDS-PAGE, with proteins transferred onto 
PVDF membrane by western blotting. The abundance of spastin was detected by using a spastin 
antibody. Equal loading between lanes was verified by also blotting for the housekeeping protein 
GAPDH. 
 
E) Graph of TNFα-GFP signal in the SiT-FusRed labelled Golgi after reporter release in mock and spastin 
depleted TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells – HeLa cells stably expressing TNFα-SBP-
GFP RUSH reporter and KDEL-Streptavidin RUSH hook were treated with either mock or IST1 siRNA and 
transfected with SiT-FusRed to highlight the Golgi apparatus. Cells were then treated with biotin, 




imaged, and analysed as described in Figure 4B. ~30 cells were imaged per treatment, with one 
experimental repeat performed. The graph shows the mean normalised TNFα-GFP signal in the Golgi 
region during the biotin-induced release of the TNFα-GFP reporter for each treatment. Time 0 
corresponds to the addition of the biotin. Blue and red lines show mock and IST1 siRNA treated cells 
respectively.  
 
F) Box plots showing the time for maximum localisation of TNFα-GFP signal in the SiT-FusRed defined 
Golgi region in mock and IST1 depleted TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells – Live cell 
imaging and image analysis was performed on TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells 
treated with either mock or IST1 siRNAs and transfected with SiT-FusRed as described in Figure 4A and 
Figure 4B. The time after biotin addition for the maximum localisation of TNFα-GFP signal in the SiT-
FusRed defined Golgi region was recorded for each mock and IST1 depleted cell and are depicted by 
black dots. The box plot red bar shows the median, the edges of the blue box show the 25th and 75th 
percentiles, and the whiskers extend the most extreme points not considered outliers (2.7 standard 
deviations). 
 
G) Western blot showing spastin protein abundance in mock and IST1 siRNA deleted TNFα-SBP-GFP 
KDEL-Streptavidin RUSH HeLa cells - TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells treated with 
mock or IST1 siRNA were lysed and proteins separated by SDS-PAGE, with proteins transferred onto 
PVDF membrane by western blotting. The abundance of IST1 was detected by using an IST1 antibody. 
Equal loading between lanes was verified by also blotting for the housekeeping protein GAPDH. 
 
H) Graph of TNFα-GFP signal in the SiT-FusRed labelled Golgi after reporter release in mock and H89 
treated TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells – HeLa cells stably expressing TNFα-SBP-
GFP RUSH reporter and KDEL-Streptavidin RUSH hook were treated with either mock or 100µM H89 
and transfected with SiT-FusRed to highlight the Golgi apparatus. Cells were then treated with biotin, 
imaged, and analysed as described in Figure 4B. ~30 cells were imaged per treatment, with one 
experimental repeat performed. The graph shows the mean normalised TNFα-GFP signal in the Golgi 
region during the biotin-induced release of the TNFα-GFP reporter for each treatment. Time 0 
corresponds to the addition of the biotin. Blue and red lines show mock and H89 treated cells 
respectively.  
 
I) Box plots showing the time for maximum localisation of TNFα-GFP signal in the SiT-FusRed defined 
Golgi region in mock and H89 depleted TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells – Live cell 
imaging and image analysis was performed on TNFα-SBP-GFP KDEL-Streptavidin RUSH HeLa cells 
treated with either mock or 100µM H89 and transfected with SiT-FusRed as described in Figure 4A and 
Figure 4B. The time after biotin addition for the maximum localisation of TNFα-GFP signal in the SiT-
FusRed defined Golgi region was recorded for each mock and H89 treated cell and are depicted by black 
dots. Box plot description as in Figure 4F.  
  




4.2.4 - Spastin depletion has no effect on the synchronised export of RUSH reporter GFP-GPI from 
the ER to the Golgi 
To investigate whether spastin depletion affected the trafficking of a different secretory cargo, the 
same assays were performed on HeLa cells expressing the GPI-anchored protein SBP-GFP-GPI reporter 
and KDEL-Streptavidin hook. This allowed the synchronised trafficking of GFP-GPI in the early 
secretory pathway to be imaged and quantified in mock and spastin siRNA depleted cells. 
 
Once again, initial visual observations suggested little difference in the early secretory pathway 
trafficking of GFP-GPI in mock and spastin depleted cells, although trafficking appeared impaired in 
H89 treated cells (Movie 3 and Figure 5A). In mock and spastin depleted cells, strong colocalisation 
between the GFP-GPI reporter and SiT-FusRed was observed between 15 and 30 minutes, with the 
colocalisation decreasing and the GFP-GPI signal becoming more diffuse after 60 minutes. This 
contrasted to H89 treated cells where there was only limited colocalisation between GFP-GPI and SiT-
FusRed after 30 minutes, and little diffuse localisation of the GFP-GPI signal after 60 minutes, with the 
majority of the signal remaining in the Golgi. Interestingly, the dynamics of GFP-GPI signal at the Golgi 
in mock, spastin depleted, and H89 treated cells appeared generally delayed compared to cells 
expressing TNFα-GFP reporter (Movie 3 and Figure 4A). This provided good evidence of the difference 
in trafficking dynamics between different secretory cargo and supported using GFP-GPI in addition to 
TNFα-GFP to study the effect of spastin depletion on potentially different modes of export in the early 
secretory pathway. 
 
The effect of spastin depletion on GFP-GPI secretory dynamics 
The movement of GFP-GPI into and out of the Golgi in mock, spastin depleted, and H89 treated GFP-
GPI RUSH cells was quantified to provide a detailed kinetic description of GFP-GPI trafficking in the 
early secretory pathway. This was performed as detailed before, using transiently transfected SiT-
FusRed to allow segmentation of the Golgi region and imaging using live cell confocal microscopy at 1 
minute temporal resolution.  
From 3 experimental repeats, little difference in the early secretory dynamics of GFP-GPI 
between mock and spastin depleted cells was observed (Figure 5B). Both treatments showed a near 
identical rate of increase of GFP-GPI signal in the Golgi region. Spastin depleted cells showed a slight 
trend toward a decrease in the amount of time for the maximum GFP-GPI signal to occur in the Golgi, 
but this difference was not statistically significant (Figure 5C). In addition, spastin depleted cells 
showed a trend towards an increased rate of export from the Golgi compared to mock cells, but at no 




time point was there a statistically significant difference in the signal in the Golgi between the two 
treatments (Figure 5B). These similarities were observed despite a substantial reduction in spastin 
abundance in spastin siRNA treated cells (Figure 5D). Overall therefore, the data showed that spastin 
depletion had no effect on the trafficking of synchronously released GFP-GPI RUSH cargo in the early 
secretory pathway. 
 
The effect of H89 treatment on GFP-GPI secretory dynamics 
As in the TNFα-GFP assays, GFP-GPI RUSH cells were also treated with H89 as a positive control to 
confirm that a perturbation of ER export machinery would lead to changes in the trafficking of GFP-
GPI into and out of the Golgi apparatus. As seen when TNFα-GFP RUSH cells were treated with H89, 
the reporter signal accumulated in the Golgi region at a substantially decreased rate compared to 
mock cells and had substantial impairment in its export from the Golgi (Figure 5E). The time for the 
maximum GFP-GPI signal to occur in the Golgi region was approximately 10 minutes later than in mock 
treated cells (Figure 5F). This together showed that Sar1-GTPase inhibition led to impairment GFP-GPI 
trafficking in the early secretory pathway, further validating that manipulations in the ER exit 
machinery could cause observable changes in the trafficking of RUSH assay cargo. 
  
































































Figure 5 - Spastin depletion does not impair GFP-GPI RUSH cargo trafficking from the ER to the Golgi apparatus. 
A) Live cell imaging of GFP-GPI cargo release and trafficking through the secretory pathway upon spastin 
depletion and H89 treatment in SBP-GFP-GPI KDEL-Streptavidin RUSH HeLa cells – HeLa cells stably 
coexpressing SBP-GFP-GPI RUSH reporter and KDEL-Streptavidin RUSH hook were transfected using 
spastin siRNAs or treated with 100µM H89 and transfected with SiT-FusRed to label the Golgi apparatus. 
Cells were then imaged using live cell confocal microscopy at ~40 seconds per frame for 90 minutes. 
The release SBP-GFP-GPI from KDEL-Streptavidin was stimulated using 40uM biotin solution, with time 
0 corresponding to the time of biotin addition. The different sets of panels show mock treated cells (top 
main row), spastin depleted cells (2nd main row), and H89 treated positive control cells (bottom main 
row). In each main panel, the image on the left shows both GFP-GPI and SiT-FusRed channels for the 
frame of biotin addition (t=0). The smaller right panels show 5, 15, 30, and 60 minutes after biotin 
addition, with the top and bottom panels showing GFP-GPI alone, and both channels merged 
respectively. Scale bars for all images represent 20µm. This figure corresponds to Movie 3. 
 
B) Graph of GFP-GPI signal in the SiT-FusRed labelled Golgi after reporter release in mock and spastin 
depleted SBP-GFP-GPI KDEL-Streptavidin RUSH HeLa cells – HeLa cells stably expressing SBP-GFP-GPI 
RUSH reporter and KDEL-Streptavidin RUSH hook were treated with either mock or spastin siRNA and 
transfected with SiT-FusRed to highlight the Golgi apparatus. Cells were then treated with biotin, 
imaged, and analysed as described in Figure 4B. ~30 cells were imaged per treatment per experimental 
repeat, with three experimental repeats performed in total. The graph shows the mean normalised 
GFP-GPI signal in the Golgi region during the biotin-induced release of the GFP-GPI reporter over the 
three experimental repeats for each treatment. Time 0 corresponds to the addition of the biotin. Error 
bars at each minute represent standard error of the mean. Blue and red lines/bars show mock and 
spastin siRNA treated cells respectively.  
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C) Bar chart showing the time for maximum localisation of GFP-GPI signal in the SiT-FusRed defined 
Golgi region in mock and spastin depleted SBP-GFP-GPI KDEL-Streptavidin RUSH HeLa cells – Live cell 
imaging and image analysis was performed on SBP-GFP-GPI KDEL-Streptavidin RUSH HeLa cells treated 
with either mock or spastin siRNAs and transfected with SiT-FusRed as described in Figure 5A and Figure 
5B. The time after biotin addition for the maximum localisation of GFP-GPI signal in the SiT-FusRed 
defined Golgi region was recorded for each mock and spastin depleted cell. This data was averaged 
between the three experimental repeats for each treatment. Error bars indicate standard error of the 
mean. P values were generated by using paired two-tailed t-tests. 
 
D) Western blot showing spastin protein abundance in mock and spastin siRNA deleted SBP-GFP-GPI 
KDEL-Streptavidin RUSH HeLa cells - SBP-GFP-GPI KDEL-Streptavidin RUSH HeLa cells treated with mock 
or spastin siRNA were lysed and proteins separated by SDS-PAGE, with proteins transferred onto PVDF 
membrane by western blotting. The abundance of spastin was detected by using a spastin antibody. 
Equal loading between lanes was verified by also blotting for the housekeeping protein GAPDH. 
 
E) Graph of GFP-GPI signal in the SiT-FusRed labelled Golgi after reporter release in mock and H89 
treated SBP-GFP-GPI KDEL-Streptavidin RUSH HeLa cells – HeLa cells stably expressing SBP-GFP-GPI 
RUSH reporter and KDEL-Streptavidin RUSH hook were treated with either mock or 100µM H89 and 
transfected with SiT-FusRed to highlight the Golgi apparatus. Cells were then treated with biotin, 
imaged, and analysed as described in Figure 5B. ~30 cells were imaged per treatment, with one 
experimental repeat performed. The graph shows the mean normalised GFP-GPI signal in the Golgi 
region during the biotin-induced release of the GFP-GPI reporter for each treatment. Time 0 
corresponds to the addition of the biotin. Blue and red lines show mock and H89 treated cells 
respectively.  
 
F) Box plots showing the time for maximum localisation of GFP-GPI signal in the SiT-FusRed defined 
Golgi region in mock and H89 depleted SBP-GFP-GPI KDEL-Streptavidin RUSH HeLa cells – Live cell 
imaging and image analysis was performed on SBP-GFP-GPI KDEL-Streptavidin RUSH HeLa cells treated 
with either mock or 100µM H89 and transfected with SiT-FusRed as described in Figure 5A and Figure 
5B. The time after biotin addition for the maximum localisation of GFP-GPI signal in the SiT-FusRed 
defined Golgi region was recorded for each mock and H89 treated cell and are depicted by black dots. 
Box plot description as in Figure 5F. 
  




4.3 – Discussion 
4.3.1 – Spastin and IST1 localise to ERES but are not required for the efficient secretion of TNFα-GFP 
or GFP-GPI RUSH cargo 
The background to this investigation was two observations from a publication by Connell et al. (2009). 
These were: 1) that the ER-localised M1 isoform of spastin colocalises with temperature sensitive 
VSVG at early timepoints during VSVG secretion; and 2) that overexpression of AAA+ domain mutant 
spastin blocks VSVG secretion from the ER. This suggested that M1 spastin may localise to components 
of the ER exit machinery (or ERGIC) and regulate secretion. Interaction studies of spastin and IST1 have 
strengthened this hypothesis, as both proteins have been suggested to interact with the accessory 
protein TFG (unpublished, Reid lab; Hein et al. 2015), which itself interacts and localises with the COPII 
coat proteins at ERES (Hanna et al. 2017; Johnson et al. 2015; McCaughey et al. 2016). 
Fixed cell imaging supported a role for spastin at ERES. Using high spatial resolution Airyscan 
microscopy, M1 spastin was shown to colocalise with Sec23 in the perinuclear and central regions of 
the cell, but not at the cell periphery. By spinning disk microscopy this interaction was seen to be 
stable, with M1 spastin remaining colocalised to both static Sec23-labelled ERES, and highly dynamic 
Sec23 puncta. Spastin’s ESCRT-III interacting protein IST1 was also shown to localise to Sec23-labelled 
ERES. Significantly, this is the first time that IST1 has been shown to localise to ER exit machinery. 
However, neither spastin nor IST1 depletion was shown to have any effect on ER to Golgi trafficking 
of TNFα-GFP or GFP-GPI RUSH cargos. 
 
The model for spastin and IST1’s function in cargo secretion 
It was hypothesised that spastin and IST1 may function in regulating secretion.  One dominant theme 
of spastin and IST1 colocalisation is that the two proteins interact to drive membrane remodelling. 
Examples of this include the cofunction of IST1 and spastin in abscission (Guizetti et al. 2011), during 
nuclear pore formation (Vietri et al. 2015), and in endosomal tubule fission (Chapter 3; Allison et al. 
2017). 
 In the context of ERES, one such membrane remodelling event is the fission of cargo-
containing ER membranes. One of the major membrane fission events that occurs at ERES is the fission 
of COPII vesicles to transport cargo to the ERGIC and ultimately to the Golgi on microtubules. There 
are parallels between this process and endosomal tubule fission. For example, topologically the 
processes are the same, with both cargo carriers being membranous cargo-filled protrusions 
emanating into the cytosol. Additionally, COPII vesicles can adopt tubular conformations. For example, 




tubular COPII vesicles are commonly observed during the secretion of collagen (Raote et al. 2017; 
Venditti et al. 2012) and tubular carriers are observed during the transport of other cargos such as 
VSVG (Presley et al. 1997), E-cadherin and TNFα (Boncompain et al. 2012). In addition, in vitro COPII 
coat reconstitution experiments have showed the ability of COPII to generate tubules (Zanetti et al. 
2013).  
The integral function of microtubules in both endosomal tubule fission and secretion provides 
further support to a putative role for spastin and IST1 in the fission of COPII vesicles. For example, the 
protein p150Glued of the dynein-dynactin complex is important in both pathways to maintain efficient 
membrane trafficking (Wassmer et al. 2009; Watson et al. 2005). In secretion, p150Glued was shown to 
interact with Sec23 of the COPII coat and upon its depletion impair the ER to Golgi trafficking of 
temperature sensitive VSVG (Watson et al. 2005). Similar to fissioned SNX1 tubule trafficking from 
endosomes to the Golgi (Jin and Snider 1993), cargo exiting the ER for the Golgi apparatus travels on 
microtubules and can be blocked by microtubule depolymerisation using nocodazole (Presley et al. 
1997). Furthermore, ERES and VTCs localise to microtubules (Mizuno and Singer 1994; Ralston et al. 
2001; Saraste and Svensson 1991; Watson et al. 2005), similar to the intimate localisation of 
endosomes and microtubules (Friedman et al. 2013; Nielsen et al. 1999). Therefore, it is plausible that 
a spastin-IST1 interaction may facilitate COPII vesicle fission, potentially working in combination with 
the established COPII neck constriction GTPase Sar1 (Bielli et al. 2005; Hanna et al. 2016; Lee et al. 
2005; Long et al. 2010). 
 
The evidence against spastin and IST1’s function in cargo secretion 
If spastin or IST1 was essential in COPII vesicle fission, it would be expected that cargo flux from the 
ER to Golgi would be delayed in cells depleted of spastin or IST1. However, this was categorically not 
the case in live cell RUSH assays measuring the synchronised ER export of TNFα-GFP and GFP-GPI. The 
kinetics of TNFα-GFP ER to Golgi transport was almost identical in spastin depleted, IST1 depleted and 
mock cells. Furthermore, this was also true for GFP-GPI transport in mock and spastin depleted cells. 
Significantly, GPI cargos have a different mode of transport from type II transmembrane proteins such 
as TNFα, requiring adaptor proteins such as p24 for their internalisation into COPII vesicles 
(Schimmöller et al. 1995; Takida et al. 2008) and exiting the ER in a distinct subset of exit sites (Bonnon 
et al. 2010). Spastin therefore appears to have no role in at least two different ER exit processes. 
These results are arguably not discordant with those from Connell et al. (2009). Although an 
effect on VSVG traffic was observed with an ATPase mutant form of M1 spastin, no effect on VSVG 
traffic was observed when spastin was depleted using siRNAs. Furthermore, the interpretation of 




spastin’s involvement in ER exit based on the use of the ATPase null isoform of spastin can be 
questioned. Substantial non-physiological microtubule bundling was observed upon the 
overexpression of ATPase mutant spastin, causing a dramatic loss of reticular ER architecture (Connell 
et al. 2009). Both microtubule and ER architecture are essential for secretory cargo transport 
(Okamoto et al. 2012; Presley et al. 1997; Watson et al. 2005), with high curvature ER tubules 
important for ERES organisation (Okamoto et al. 2012). Therefore, from these experiments it is hard 
to deconvolve spastin’s potential involvement in cargo secretion from the inhibitory effects of 
microtubule and ER architecture disruption generated through the overexpression of the spastin 
ATPase mutant. Overall, considering this with my experiments, it seems very unlikely that spastin 
functions in either TNFα, GPI anchored protein, or VSVG cargo transport between the ER and the Golgi. 
 
4.3.2 – Potential functions of spastin and IST1 at ERES 
In light of these results, what might be spastin’s function at ERES? Three models are discussed below: 
1) spastin functions in the secretion of selected cargos such as procollagens; 2) spastin functions in 
generalised cargo secretion, but these effects were not revealed by the RUSH assay; and 3) spastin 
has a function independent of conventional secretion at ERES. 
 
Procollagen secretion 
A clue to the function of spastin and IST1 at ERES may come from better understanding the functional 
interaction between spastin, IST1 and ERES accessory protein TFG. Like spastin and IST1, TFG was 
shown to localise to ERES but upon depletion had no effect on the trafficking of RUSH cargos such as 
mannosidase II, VSVG, E-cadherin, and galactose-1-phosphate uridylyl transferase (GalT; McCaughey 
et al. 2016). Although debated (Hanna et al. 2017), TFG was suggested to function specifically in the 
secretion of procollagen (McCaughey et al. 2016).  
The function of IST1 or spastin depletion on procollagen secretion has not yet been 
investigated, and lack of spastin function in VSVG, TNFα, and GPI-anchored protein traffic should not 
be assumed to apply to procollagen secretion. Procollagens are unique from other COPII cargo by their 
size, with procollagens able to form up to 400nm (Malhotra and Erlmann 2015). This is substantially 
larger than the typical 60-90nm diameter of COPII vesicles. As a result, specific machinery is required 
to distend the COPII vesicle to allow procollagen secretion (Bard et al. 2006; Raote et al. 2017; Saito 
et al. 2009, 2011). Furthermore, COPII vesicles containing procollagen form tubular structures (Raote 
et al. 2017, 2018; Venditti et al. 2012) reminiscent of endosomal tubules that form during endocytic 




recycling. Given spastin and IST1’s potential interaction with TFG and the unique nature of COPII 
vesicles in procollagen secretion, it would be worth testing whether spastin functions in procollagen 
secretion. 
 TFG is able to mediate procollagen secretion by regulation of ERES morphology (McCaughey 
et al. 2016). Upon TFG depletion, ERES become fragmented into smaller structures resolvable by super 
resolution light microscopy. This fragmentation is thought to have no effect on smaller cargos, but 
potentially provide inefficient platforms for procollagen secretion. Given the putative interaction 
between spastin, IST1, and TFG, and given the function of spastin and IST1 in membrane remodelling, 
it is possible that spastin may function to remodel the structure of ERES themselves rather than 
directly mediating the scission of COPII vesicles. This however remains to be tested. 
 
The effect of spastin or IST1 depletion on cargo secretion may be hidden by the RUSH assay 
Before discounting any role for spastin or IST1 in generalised cargo export from the ER however, it is 
worth examining the caveats of the RUSH assay. One of the problems of trying to observe cargo flux 
through a dynamic system is the difficulty in distinguishing the rate of transport of individual proteins. 
To address this, a pulse of label can be applied to the system at a defined time, allowing the flux of 
labelled proteins to be differentiated and measured against the background of unlabelled protein. In 
the case of the RUSH assay (and temperature sensitive VSVG release assay), this pulse comes by 
synchronising the release of a fluorescently labelled reporter cargo from the ER. However, a 
fundamental assumption of these assays is that the pulse (e.g. the synchronisation step in the RUSH 
assay) does not impact the normal physiology of the system being measured. 
 In the case of the RUSH assay, the synchronous release of cargo from the ER represents a non-
physiological situation. By the synchronous dissociation of RUSH reporter from the ER-resident hook, 
a high concentration of protein must flux through the early secretory pathway in a short amount of 
time. The cell has adaptions to respond to high cargo load, with one example being an increase in the 
number of ERES (Forster et al. 2006; Guo and Linstedt 2006; Stephens 2003). However, given the 
almost instantaneous action of biotin in the dissociation of the RUSH reporter from the hook 
(Boncompain et al. 2012), there is a likely temporal mismatch between the time between biotin 
addition and cargo export and cellular acclimation to high cargo load. 
 How may ER export accommodate such a high demand on ER exit machinery? One possibility 
is that a backlog of cargo accumulates in the ER, waiting to be exported. Live cell imaging of TNFα-GFP 
and GFP-GPI does not rule out this hypothesis as there is a clear temporal delay between the first and 




last reporter proteins arriving at the Golgi apparatus. However, an alternative possibility is that 
pressure on the secretory system is relieved through non-canonical ER export (Benham 2012). 
Significantly, the function of COPII is not essential for the secretion of all cargo (Mironov 2014). For 
example, siRNA depletion of all Sar1 and Sec23 isoforms leads to a delay but not a complete block in 
secretion of all cargos excluding procollagen (Cutrona et al. 2013; Townley et al. 2008). This can also 
be seen in trafficking of TNFα-GFP and GFP-GPI here when Sar1 was inhibited by H89, and in the 
trafficking of voltage-sensitive potassium channel 4 (Kv4) upon expression of a dominant negative Sar1 
(Hasdemir et al. 2005). This suggests that most cargo (excluding procollagen) is able to export from 
the ER using an inefficient alternative to COPII-mediated export. 
Although much of the machinery of COPII-independent export is unknown (Barlowe and 
Helenius 2016; Grieve and Rabouille 2011; Nickel and Rabouille 2009), the existence of multiple exit 
pathways at the ER is significant in the interpretation of data from RUSH or VSVG assays. An untested 
possibility is that the effect of spastin or IST1 depletion could be masked by the high export load 
created by the synchronous release of RUSH cargo. If as a result of this atypical load a significant 
proportion of RUSH cargo was exiting the ER through spastin-IST1 independent pathways, depletion 
of spastin or IST1 might only have a minimal effect on ER-Golgi traffic. In effect, the alternative export 
pathways of the ER would compensate for the pressure generated by inadequate COPII-mediated 
export. 
Although never tested directly, there is circumstantial evidence supporting these arguments. 
Firstly, no studies have ever shown cargo export in the RUSH assay to be fully blocked by disruption 
of COPII machinery. As described above, the addition of Sar1 inhibitor H89 merely caused a delay in 
cargo export from the ER to the Golgi. In addition, similar experiments performed with and without 
the RUSH assay have yielded significantly different results. One example is in the functional analysis 
of TFG. Whilst McCaughey et al. (2016) observed TFG depletion to have no effect on the secretion of 
all tested RUSH cargo, Hanna et al. (2017) showed that TFG depletion did have an effect on the 
secretion of both large cargos such as E-cadherin and small cargos such as the transmembrane domain 
of mannosidase II. Significantly, Hanna et al. (2017) did not use synchronisation-based methods. 
Although no literature has cited problems using RUSH previously, given the atypical load of cargo 
exiting the ER and the availability of other modes of ER exit, it would be useful to analyse the effects 
of spastin and IST1 depletion on secretion using synchronisation-independent methods.  
  




Functions for spastin and IST1 at ERES independent of conventional secretion 
Finally, it is worth speculating briefly that spastin and IST1 may function at ERES in processes unrelated 
to generalised cargo export. For example, ERES have also been suggested to function as the platform 
for the formation of autophagosome precursor membranes (Carlos Martín Zoppino et al. 2010; Ge et 
al. 2013; Ishihara et al. 2001; Reggiori et al. 2004; Sanchez-Wandelmer et al. 2015). Despite recent 
work identifying the proteins Serca and Vmp1 as important in ER-derived autophagosome biogenesis 
(Zhao et al. 2017, 2018), the fission mechanism central to autophagosome release from the ER has 
not yet been identified. Potentially significant is that both autophagosome proteins and ESCRT 
proteins were recently shown to be required for the secretion of cystic fibrosis transmembrane 
conductance regulator (CTFR) protein (Noh et al. 2018). Due to the topology of ER-derived 
autophagosome membranes, any ESCRT-III proteins recruited from the cytosol would have to form on 
the outside neck of the membrane bud. Of the ESCRT-III proteins, currently only IST1 and CHMP1B 
have been identified as being able to adopt these conformations (McCullough et al. 2015) and 
significantly, both of these proteins are interactors of spastin (Reid et al. 2005; Renvoisé et al. 2010; 
Yang et al. 2008). Despite the circumstantial nature of this evidence, it would therefore be interesting 
to investigate whether a spastin-IST1 interaction was required for ER-derived autophagosome 
biogenesis. 
 
4.3.3 – Future experimental plans 
Verifying the localisation of endogenous spastin on ERES 
The localisation of M1 spastin on ERES was shown through stably expressed N-terminally GFP-tagged 
M1 spastin. However, experiments localising endogenous spastin on ERES were not performed, 
although previous members of the Reid lab have observed antibody-labelled endogenous spastin to 
colocalise with the COPII-coat component Sec31 by confocal microscopy (unpublished data, Reid lab). 
These experiments require validation, and high resolution (Airyscan or SIM) microscopy could be used 
to more accurately define the position of spastin on ERES. 
 
  




Verifying the lack of effect of spastin and IST1 on ER exit 
One important future set of experiments is to validate the negative data from the RUSH assay using 
methods that do not generate a high load on the secretory pathway. Despite the criticisms presented 
above, this could be done using the RUSH assay. For example, a non-saturating concentration of biotin 
could be used to only release a small proportion of reporter from the ER. Similarly, a light-dependent 
caged biotin molecule could be used whose gradual release could be controlled by modulating laser 
intensity (Terai et al. 2011). Alternatively, rather than modulating the simultaneously release of 
reporter cargo, the volume of cargo could be reduced by endogenous expression of the RUSH 
constructs under low expression promoters or by endogenous tagging. A combination of these 
methods would act to overall reduce the simultaneously load on the secretory pathway. 
 New developments in protein tagging biology make the synchronous release of reporter 
unnecessary for the tracking of secreted cargo. Instead, light activation can be used to tag proteins in 
ER undergoing secretion. This would enable flux through the secretory pathway to be measured in 
near-endogenous environments. One method is to use photoswitchable proteins. These are proteins 
which are able to change their fluorescence emission upon irradiation by UV light (Shcherbakova et 
al. 2014). One example of such a protein is moxDendra2, unique among green to red photoswitchable 
proteins in its ability to function in the oxidising environment of the secretory pathway (Kaberniuk et 
al. 2017). By the coexpression of moxDendra2 fused to a secretory protein (e.g. TNFα) and a 
fluorescent marker of the ER or ERES, a pulse of UV light could be specifically applied to the tagged 
secretory protein in the ER. This would cause moxDendra2 to switch fluorescence from green to red, 
allowing the flux of the photoswitched protein to be measured against the background of unconverted 
proteins. 
 The use of fluorescence uncaging would also achieve a similar outcome. Like photoswitchable 
proteins, caged fluorophores rely on the impulse of UV light to cause a change in their fluorescent 
properties (Politz 1999). However, typically this would be a transition from a dark state to a light state, 
generated by the UV-induced cleavage of the cage component. Importantly, these caged fluorophores 
can be directed to a protein of interest by use of protein-specific attachment sites (Hauke et al. 2017). 
By fusing the protein of interest to such a tag (e.g. HaloTag) and adding the caged fluorophore 
covalently bound to the tag ligand (e.g. Halo-ligand) to the cell, the protein of interest would be 
labelled by the non-fluorescing caged fluorophore. Upon an organelle-directed pulse of UV light, it 
would allow the tagged secretory proteins in the ER to fluorescence. This would allow their flux 
through the secretory pathway to be imaged. In both this method and the photoswitching method, 
the tagged secretory proteins could be expressed endogenously, further ensuring negligible impact 
on the secretory pathway. 




Testing functions of spastin at ERES that are independent of generalised cargo secretion 
The function of spastin at ERES outside general protein secretion also needs to be tested. An important 
experiment is to validate the interaction between spastin and TFG. This could be performed using 
coimmunoprecipitation and colocalisation experiments. If an interaction between spastin and TFG was 
observed, based on the observations of McCaughey et al. (2016), the role of spastin in procollagen 
secretion or ERES reorganisation could be investigated. The rate of procollagen secretion can be 
determined by ascorbic acid addition (Graham et al. 1995). Ascorbic acid greatly increases the 
production of procollagen, allowing the rate of procollagen increase on the cell to be used as a 
surrogate of the rate of procollagen secretion. The cell surface abundance increase of collagen could 
then be compared by antibody detection and fluorescence microscopy between mock and spastin 
depleted cells. Light microscopy could also be used to measure the number of ERES in mock and 
spastin depleted cells, providing information as to spastin’s role in ERES remodelling. 
 Finally, the putative role of spastin and IST1 in ER-derived autophagosome biogenesis could 
be tested. This again could be examined using light microscopy, with experiments aiming to visualise 
whether ERES localised spastin and IST1 also colocalised with early markers of ER-derived 
autophagosome biogenesis such as Dfcp1 (Hayashi-Nishino et al. 2009). 




Chapter 5 – The impact of ATPase-defective 
spastin on the cell surface proteome 
 
5.1 - Introduction 
5.1.1 – The cell surface proteome as a clue to mechanisms of HSP 
The importance of cell surface proteins 
Cell surface proteins facilitate the interaction between a cell and its environment. This includes the 
bidirectional transport of ions and nutrients by ion channels, solute transporters, secretion machinery, 
and endocytic machinery; signal transduction in development or immunity by receptor proteins; and 
migration and adhesion by proteins that bind the extracellular matrix. Maintaining a homeostatic 
balance of this protein landscape is therefore essential to maintaining cellular function (Apaja and 
Lukacs 2014). 
 An aberrant change in the cell surface proteome can lead to disease. In antigen presenting 
immune cells, a loss of major histocompatibility complex (MHC) class II at the cell surface leads to a 
loss of antigen presentation, resulting in diseases such as bare lymphocyte syndrome (Reith and Mach 
2001). In cancer development, changes in the abundance of cell adhesion proteins facilitate cancer 
metastasis (Okegawa et al. 2004), and changes in receptor abundance facilitates uncontrolled growth 
(Witsch et al. 2011). In neurons, a loss of myelination proteins at the cell surface results in neurological 
diseases, including Charcot-Marie-Tooth disease (Berger et al. 2002) and Devic’s disease (Wingerchuk 
et al. 2006). In addition, remodelling of the neurotransmitter landscape is common during drug 
addiction (Volkow et al. 2016), and toxins such as clostridial cytotoxins can specifically act to prevent 
neuroreceptor localisation on the cell surface (Popoff and Poulain 2010).  
  




Cell surface protein homeostasis 
The cell surface proteome is maintained in a dynamic equilibrium, with proteins being continuously 
added or removed at the plasma membrane by the fusion or fission of protein-containing vesicles. 
Proteins added to the cell surface may either be newly synthesised proteins, or proteins that have 
already been internalised and have been recycled. Proteins are typically removed from the cell surface 
through endocytic pathways, including clathrin-mediated endocytosis, macropinocytosis and via 
caveolae (reviewed in Introduction Section 1.4.2). 
Newly synthesised proteins are typically derived from the secretory pathway as a result of 
vesicle trafficking from the TGN to the cell surface. However, newly synthesised proteins that are 
trafficked from the TGN to the lysosome via sorting endosomes can also reach the cell surface. This 
occurs via these ‘secretory lysosomes’ fusing with the plasma membrane, typically during times of 
stimulation such as during infection (Stinchcombe 2004). In addition, cell surface proteins that have 
been endocytically internalised can be trafficked back to the cell surface. These proteins are retrieved 
away from degradation at the sorting endosome and are packaged into endosomal recycling tubules. 
These tubules then bud away from the endosome body and are transported by microtubule motors 
to the plasma membrane (reviewed in Introduction Section 4). 
Disruption of these transport processes can lead to large changes in the protein landscape at 
the cell surface. For example, depletion of the secretory protein TFG leads to a loss of extracellular 
collagen (McCaughey et al. 2016). In endocytosis, the expression of a scission-defective dynamin leads 
to increased residence of TfnR on the cell surface (Marks et al. 2001). In secretory lysosome fusion, 
overexpression of synaptotagmin II results in inhibition of Ca2+ triggered exocytosis of lysosomes 
(Baram et al. 2001). In endocytic recycling, inhibition of the SNX-retromer complex by depletion of 
SNX27 or VPS35 leads to a substantial change in the cell surface proteome, with a particular effect on 
glucose and metal ion transporters (Steinberg et al. 2013). In addition, it was recently shown that 
inhibition of the retriever-interacting SNX protein, SNX17, also led to large changes in the surface 
proteome, with a particular effect on integrin abundance (McNally et al. 2017). 
 
  




A potential role of spastin in cell surface protein homeostasis 
Spastin is an important protein in the endocytic pathway (Allison et al. 2017). Depletion of spastin 
leads to the formation of long endosomal tubules as a result of impaired endosomal tubule fission 
(Chapter 3; Allison et al. 2017). This results in inefficient cargo recycling, both from the endosome to 
the cell surface (Allison et al. 2013), and from the endosome back to the TGN (Allison et al. 2017). As 
a result, typically recycled receptors such as TfnR and M6PR have decreased abundance at the cell 
surface and TGN respectively, and have an increased lysosomal localisation (Allison et al. 2013, 2017). 
In addition, spastin depleted cells and cells expressing ATPase-defective spastin, or MIT domain-
mutated spastin, display lysosomal abnormalities (Allison et al. 2017). These cells contain abnormally 
acidic lysosomes that are swollen in size and contain undigested membranes (Allison et al. 2017). IPSC-
derived neurons from patients with spastin-induced HSP also display the same phenotype (Allison et 
al. 2017). This suggests that spastin mutation or depletion not only disrupts the endocytic pathway by 
blocking recycling, but also by causing lysosomal dysfunction. 
 It can therefore be predicted that a loss of functional spastin would result in dramatic changes 
in the cell surface proteome. These changes could occur through a direct failure of endosome to 
plasma membrane recycling, but also as a result of wider-ranging consequences of lysosomal 
dysfunction. Although this has never been systematically studied, supporting evidence is that 
depletion of spastin leads to a reduction of TfnR at the cell surface (Allison et al. 2013). Moreover, if 
spastin was important in the homeostatic maintenance of the cell surface protein landscape, plasma 
membrane proteome changes upon spastin loss-of-function could drive disease pathology. Pathology 
could be caused either by the specific effect on one or a small group of proteins having an altered cell 
surface abundance, or by the combined effect of multiple proteins. 
 
  




5.1.2 – Experimental approach 
I aimed to test whether a loss of functional spastin led to changes in the cell surface proteome. This 
was done with the added aim of potentially identifying proteins with large changes in abundance that 
may help explain the mechanisms of spastin-HSP pathology. This was performed using quantitative 
mass spectrometry of cell surface isolated proteins, with peptide labelling performed using Tandem-
Mass-Tag labelling (detailed below and see Materials and Methods). 
 The cells used were obtained from a spastin mouse model that contained a N384K mutation 
in the phosphate binding site of the Walker-A motif of spastin’s AAA+ domain (Connell et al. 2016). 
The use of cells from this mouse conferred physiological relevance to any findings, as the human 
mutational equivalent (N386K) missense mutation was shown to cause HSP (Fonknechten et al. 2000), 
and the mouse model develops a gait phenotype typical of HSP (Connell et al. 2016). Mouse embryonic 
fibroblasts (MEFs) and embryonic primary cortical neurons were used for cell surface proteome 
analysis. MEFs were used initially as proof of concept and allowed comparisons between data 
previously collected using the spastin N384K MEF cells (e.g. Chapter 3; Allison et al. 2017). Primary 
cortical neurons were used to increase physiological relevance of any findings to the disease, as HSP 
is a specific axonopathy of corticospinal neurons. These experiments represent the first time that cell 
surface proteomics has been performed on neurons, and the first example of systematically analysing 
the cell surface proteome for clues into the mechanisms of a neurological disease. 
 
5.1.3 – Benefits of TMT labelling 
Introduction to quantitative proteomic labelling 
A labelling strategy is typically required to compare between different quantitative proteomic 
samples. This label is specific to the peptides of each sample, allowing all the peptides of multiple 
samples to be combined and run in a single mass spectrometry experiment. The abundances of each 
identified protein can then be assigned to the appropriate sample. Two basic labelling strategies exist: 
SILAC (isotopic) and TMT (isobaric). 
 In SILAC labelling, cells are cultured in the presence or absence of amino acids that have 
substituted isotopic nuclei, such as 13C or 15N. During repeated rounds of growth and cell division, 
these heavy amino acid isotopes are imported into the cell and incorporated into proteins. After an 
extended period of time, all proteins will contain a heavy amino acid label. Cells with and without the 
label (e.g. a control and a treatment) can then be lysed, combined, and processed for mass 
spectrometry. The relative abundance of each peptide can be assigned to the appropriate sample by 
small shifts in the mass/charge ratios obtained in the presence of the SILAC label. 




 In TMT labelling, cells are cultured in normal growth media until the time of lysis. Cells are 
then lysed, and the proteins of each sample kept separate during peptide digestion. These peptides 
are then labelled using isobaric chemical tags which bind to the N-terminus or a lysine residue in the 
digested peptide. These tags have different combinations of 13C and 15N substitutions in their ‘mass 
region’, allowing the peptides of each sample to have a unique identity. Labelled peptides are then 
mixed and processed together in a single mass spectrometry run. 
 
Benefits of TMT labelling 
The use of TMT labelling was advantageous in my work. SILAC has benefits in that it has a simple 
workflow, with the samples grown in the different SILAC media combined upon lysis. This potentially 
reduces experimental variability due to operational mistakes (e.g. pipetting errors, etc.). However, an 
important limitation is that SILAC labelling requires cells to undergo cell division for incorporation of 
the amino acid isotopes. Neurons do not undergo cell division, and hence could not be labelled by 
traditional SILAC labelling. TMT labelling however does not have this problem, as proteins are labelled 
post-peptide digestion.  
In addition, due to the variety of TMT labels available, up to 11 samples can be compared 
simultaneously in a single mass spectrometry run. For SILAC, the maximum comparison is three 
(unlabelled, 13C, 15N). Thus, with the TMT approach, more samples or multiple experimental repeats 
can be processed in the same mass spectrometry run, reducing experimental variability due to 
potential mass spectrometry run differences. 
 
5.1.4 – Summary of aims 
1. What is the impact of ATPase defective spastin on the cell surface proteome of MEFs and 
primary cortical neurons? 
2. How do these changes compare with other unbiased studies that have investigated the effects 
of defective endosomal recycling on the cell surface proteome? 
3. Can the changes observed elucidate mechanisms of axonopathy observed in HSP? 
  




5.2 – Results 
5.2.1 – Summary of methods 
The effect of the spastinN384K ATPase mutation on the mouse cell surface proteome was investigated 
by cell surface proteomics. This was performed using selective labelling and isolation of cell surface 
proteins, TMT peptide labelling, and high sensitivity quantitative mass spectrometry. Two different 
cell types were used: SV-40 immortalised MEFs, and embryonic primary cortical neurons. These were 
processed in two separate experiments. Each mass spectrometry run quantified peptides from 
samples extracted from wildtype (spastinwt/wt; ‘WT’), spastin heterozygous mutant (spastinwt/N384K; 
‘HET’), and spastin homozygous mutant (spastinN384K/N384K; ‘HOM’), allowing a direct comparison 
between different spastinN384K genotypes. 
 
5.2.2 – MEF plasma membrane proteomics selectively quantified cell surface proteins and showed 
the spastinN384K mutation drives intergenotypic differences 
An outline of the experimental protocol is shown in Figure 1A, as described in Materials and Methods 
(Section 2.3.2). In brief, three samples of WT, HET, and HOM MEFs were grown to confluency in 10cm 
dishes, and their cell surface biotinylated. Following cell lysis, biotinylated proteins were isolated by 
streptavidin pull-down, washed, digested to produce peptide fragments that were then labelled with 
TMT reagents. A unique TMT label was used for each sample. Labelled peptides were then combined 
and analysed by liquid chromatography tandem mass spectrometry using a rising acetonitrile (AcN) 
gradient. 
 
Out of the 837 proteins identified, 594 (71%) were annotated with plasma membrane terms based on 
the Swiss-Prot protein annotated database (Figure 1B). Five different plasma membrane terms were 
used to avoid incorrectly ignoring poorly annotated proteins. Proteins with multiple plasma 
membrane terms were only allocated to one category (see Figure 1B legend for details). Of the 
remaining proteins, 33 (4%) solely nuclear proteins were identified, and 209 (25%) proteins were 
identified that were identified as neither plasma membrane or nuclear. These enrichment proportions 
were similar to other published TMT cell surface proteomics experiments using unfractionated 
samples (Weekes et al. 2014). Collectively this shows the technique to have yielded a strong 
enrichment of plasma membrane proteins. 
 




Hierarchical clustering of the 9 samples was performed (Figure 1C). This generated a dissimilarity score 
based on the relative abundance of each protein between each sample which was used to link samples 
of similar scores (see Figure 1C legend for clustering details). This was performed to assess the validity 
of investigating intergenotypic differences between the WT and spastinN38K mutant samples. 
Encouragingly, there was strong intragenotypic clustering, with the samples of each genotype 
preferentially clustering with each other and separate from samples of the other two genotypes. 
Looking intergenotypically, HET samples preferentially clustered with WT samples rather than HOM 
samples (see Figure 1C dendrogram). This suggested differences in the cell surface proteome changes 
driven by the heterozygous and homozygous spastinN384K mutation in MEFs. 
  




























































Figure 1 - Overview of cell surface proteomics on WT (spastinwt/wt), HET (spastinwt/N384K), HOM (spastinN384K/N384K) 
Mouse Embryonic Fibroblasts (MEFs).  
A) Schematic of cell surface proteomic protocol – Triplicates of WT, HET, and HOM MEFs were grown to 
confluency and surface proteins biotinylated. Cell lysates were generated, and biotinylated proteins 
extracted using streptavidin pull down. Isolated proteins were washed extensively before being 
tryptically digested, with digested proteins from each sample then labelled with a unique Tandem Mass 
Tag (TMT) label. Labelled peptides were then combined and analysed by Liquid Chromatography 
Tandem Mass Spectrometry with a rising gradient of MeCN for 180 minutes in a Thermo Orbitrap Fusion 
Lumos mass spectrometer. 
 
B) Cell compartment analysis of identified proteins – All proteins identified from mass spectrometry 
analysis were annotated with their subcellular location by comparison against the mouse Uniprot 
(Swiss-Prot) subcellular location database. Plasma membrane terms were defined as annotations of 
‘plasma membrane’, ‘cell surface’, ‘cell membrane part’, ‘cell projection membrane’, and ‘extracellular’, 
with ‘nuclear’ annotations also recorded. If multiple annotations existed for any protein, they were 
given only one label of the first occurring term in the above list.  
 
C) Clustergram analysis to show intragenotypic and intergenotypic clustering – Peptide counts for each 
sample for each identified protein were normalised by the ratio of peptide counts for each sample 
summated over all proteins. These peptide counts were then normalised to the maximum peptide 
count for each protein, with the maximum value for each identified protein set to 1. A clustergram 
representing the hierarchical clustering of the protein set based on a Euclidean pairwise distance metric 
and an unweighted average distance linkage method was generated with the heatmap showing 
samples by row, and individual proteins by column. The heatmap scalebar ranges from bright red (1) 
for the maximum quantified value to black (0), with dark regions showing fewer detected peptides. The 
clustergram analysis shows strong intragenotypic clustering, indicating consistent trends of 
intergenotypic difference. 
  




5.2.3 – Heterozygous and homozygous spastinN384K mutation drive significant changes in the MEF 
cell surface proteome 
For each spastin mutant genotype, the mutant vs wildtype fold change for each protein was plotted 
against its Benjamini-Hochberg adjusted p-value (Figure 2). This provided a representation of the 
magnitude and variability of the plasma membrane protein landscape changes driven by the 
spastinN384K mutation. Heterozygous and homozygous spastinN384K mutant MEF data were plotted 
separately, with separate plots also produced for all proteins and those only annotated to be on the 
cell surface. 
 
Many proteins had significantly increased or decreased cell surface abundance in the HET MEFs 
compared to WT MEFs (Figure 2A). Using a threshold cut-off of a 2-fold increase or a 2-fold decrease 
(0.5-fold change) and an adjusted p-value of less than 0.01, 36 proteins (6%) had increased abundance 
at the cell surface compared to 22 proteins with decreased abundance (4%). Highlighting the six 
proteins within this grouping with the most statistically significant change in cell surface abundance, 
all 6 proteins with increased cell surface abundance were enriched at least 5-fold, and 6 proteins with 
decreased abundance were depleted at least 3-fold (Figure 2B). 
 Similarly, the WT vs HOM comparison showed many proteins with an increased or decreased 
surface abundance (Figure 2C). Using the same thresholds as before, 44 proteins (7%) had increased 
surface abundance and 54 proteins (9%) had decreased surface abundance in the HOM MEFs 
compared to the WT MEFs. The most statistically robust proteins with increased cell surface 
abundance all showed at least a 4-fold enrichment in their typical abundance, and those with a 
decreased abundance showed at least a 5-fold depletion from the cell surface (Figure 2D). 
 
These figures were also reproduced ignoring the subcellular location annotation filter (Figure 2E and 
Figure 2F). This was provided as a reference as poor or incorrect protein annotations could lead to 
plasma membrane proteins being falsely ignored. It is worth noting that the shape of both data sets 
was similar to the respective plasma membrane plots, and reassuringly, the proteins with the largest 
fold changes were proteins with plasma membrane annotations. 
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Figure 2 - Volcano plots reveal that both heterozygous and homozygous spastinN384K mutations drive significant 
changes in protein cell surface abundance in MEFs. 
A) Volcano plot showing changes in the cell surface abundance of plasma membrane annotated proteins 
driven by the heterozygous spastinN384K mutation – The mean HET vs mean WT peptide abundance for 
each plasma membrane annotated protein was plotted against its Benjamini-Hochberg adjusted p-
value (generated from unpaired two-tail t-tests between HET vs WT samples). Fold change (x) was 
plotted on a log2 scale, and adjusted p-value (y) plotted on a -log10 scale. Horizontal lines indicate p-
values of 0.05 and 0.01 respectively, and vertical lines indicate fold changes of 0.5, 0.67, 1.5, 2 
respectively. Proteins with a p-value of lower than 0.01 and less/more 0.5/2-fold change are named, 
with bold italic names given to proteins with plotted bar charts. 
 
B) Bar charts of proteins with the largest cell surface increase/decrease driven by the heterozygous 
spastinN384K mutation – 6 plasma membrane proteins with the largest HET-WT fold increase/decrease 
with the lowest HET-WT Benjamini-Hochberg adjusted p-values were selected, and the fold change 
relative to the mean WT peptide abundance for each sample was plotted for each protein. Chart axes 
show linear fold change, with axes maxima set to a 6-fold increase for increased abundance samples, 
and 1.2-fold for decreased abundance samples. Samples exceeding these values were denoted by 
having open bars. 
 
C) Volcano plot showing changes in the cell surface abundance of plasma membrane annotated proteins 
driven by homozygous spastinN384K mutations – The mean HOM vs mean WT peptide abundance for 
each plasma membrane annotated protein was plotted against its Benjamini-Hochberg adjusted p-
value (generated from unpaired two-tail t-tests between HOM vs WT samples). Chart details as in Figure 
2A.  
 
D) Bar charts of proteins with the largest cell surface increase/decrease driven by the homozygous 
spastinN384K mutation – 6 plasma membrane annotated proteins with the largest HOM-WT fold 
increase/decrease with the lowest HOM-WT Benjamini-Hochberg adjusted p-values were selected, and 
the fold change relative to the mean WT peptide abundance for each sample was plotted for each 
protein. Chart details as in Figure 2B.  
 
E) Volcano plot showing changes in the cell surface abundance of all detected proteins driven by the 
heterozygous spastinN384K mutation – As in Figure 2A ignoring subcellular location annotations. Grey 
text indicates non-plasma membrane annotated proteins.  
 
F) Volcano plot showing changes in the cell surface abundance of all detected proteins driven by 
homozygous spastinN384K mutations – As in Figure 2C, ignoring subcellular location annotations. Grey 
text indicates non-plasma membrane annotated proteins. 
  




5.2.4 – Comparisons between heterozygous and homozygous spastinN384K mutant MEFs reveals 
proteins with common cell surface abundance changes 
Having analysed abundance changes between HET vs WT and HOM vs WT, proteins that showed 
similar fold changes in both HET and HOM samples were identified. This was performed to identify a 
set of proteins in which there was a high confidence that their plasma membrane abundance was 
altered by the spastin mutation. This was performed for proteins with a plasma membrane annotation 
(Figure 3A) and all proteins (Figure 3B). 
 
For plasma membrane annotated proteins, there was a weak positive correlation between the fold 
change of the heterozygous and homozygous spastinN384K mutants (Figure 3A). Low fold change 
proteins in both genotypes tended to be evenly distributed around the origin, with only a weak bias 
for similar fold change trends between the HET and HOM samples. However, fold change similarities 
were more apparent at extreme fold change values. Examples of this include the proteins Pcyox1 and 
Cd276 which had the respective biggest increased and decrease in abundance at the cell surface in 
both mutant genotypes. Figure 3B shows the same plot ignoring subcellular localisation annotations. 
The pattern of data is consistent with that of Figure 3A and shows the proteins with the largest 
common fold changes to be plasma membrane annotated proteins. 
 
Attention was then focussed on the plasma membrane annotated proteins with a threshold 1.5-fold 
decreased (0.67-fold change) or increased abundance at the cell surface in both HET and HOM samples 
(Figure C-E for depleted proteins, Figure F-H for enriched proteins). 
 31 proteins were depleted from the cell surface more than 1.5-fold in both mutant genotypes 
(Figure 3C). This represented 48% and 28% of all plasma membrane annotated proteins depleted more 
than 1.5-fold from the cell surface in heterozygous and homozygous spastinN384K mutant genotypes 
respectively. These 31 proteins show high homogeneity of fold change between samples 
intragenotypically, and between the two mutant genotypes (Figure 3D). The proteins from this list 
with the most statistically confident cell surface decreases include the immune regulator Cd276 and 
proteins regulating cytoskeletal organisation such as Cfl1 (Figure 3E; see Table 1 (located after Figure 
3 figure legends)). Investigations into the functions of these proteins revealed a diverse set of 
biological functions, including immune regulation, cell adhesion, and Wnt signalling (Table 1). 
 38 proteins were enriched at the cell surface more than 1.5-fold in both mutant genotypes 
(Figure 3F). This represented 30% and 25% of all plasma membrane annotated proteins enriched more 




than 1.5-fold at the cell surface in heterozygous and homozygous spastinN384K mutant genotypes 
respectively. The relative fold change of these proteins is displayed in Figure 3G, showing low 
intragenotypic variability for some proteins, but not a strong fold change correlation between the two 
spastin mutant genotypes. The proteins from this list with the lowest adjusted p-values include 
mechanosensitive ion channel Piezo 1 and cytoskeletal organisation proteins such as Erbb2 (Figure 
3H; see Table 2 (located after Figure 3 figure legends). These proteins are reported to function in ion 
exchange, cytoskeletal reorganisation, and brain development. 
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Figure 3 - Comparison between heterozygous and homozygous spastinN384K mutant MEFs reveal common 
proteins that have cell surface abundance changes in both genotypes. 
A) Scatter plot showing cell surface abundance fold change of heterozygous spastinN384K mutant MEFs 
against homozygous spastinN384K mutant MEFs for plasma membrane annotated proteins – The mean 
HET vs mean WT peptide abundance for each plasma membrane annotated protein was plotted against 
the mean HOM vs mean WT peptide abundance for the same protein. Fold change (x,y) was plotted on 
a log2 scale. Blue and cyan circles indicate proteins with both a HET-WT and HOM-WT fold change of 
<0.67/>1.5 and <0.5/>2 respectively. Proteins with both a HET-WT and HOM-WT fold change of <0.5/>2 
are named within zoom panels.  
 
B) Scatter plot showing cell surface fold change of heterozygous spastinN384K mutant MEFs against 
homozygous spastinN384K mutant MEFs for all identified proteins – Methods as in Figure 3B but 
ignoring subcellular location annotations. Grey text within zoom panels indicates non-plasma 
membrane annotated proteins.  
 
C) Analysis showing a common group of proteins reduced at the cell surface in both heterozygous and 
homozygous spastinN384K mutant MEFs – Two lists of plasma membrane annotated proteins with mean 
HET-WT and mean HOM-WT fold change of <0.67 were generated and plotted in a Venn diagram.  
 
D) Heatmap showing common proteins reduced at the cell surface in both heterozygous and 
homozygous spastinN384K MEFs – The fold change of each sample relative to the mean WT peptide 
abundance was calculated for each protein. The heatmap displays these values for plasma membrane 
annotated proteins commonly reduced from the cell surface <0.67 fold in both HET and HOM MEFs 
identified in Figure 3C. Data was plotted on a log2 scale, with the maximum values set at 2 and -2 
(equivalent of 4-fold increase and 0.25-fold decrease) to aid data visualisation. Bold names indicate the 
12 proteins from the list with the lowest summed HET-WT and HOM-WT Benjamini-Hochberg adjusted 
p-values. 
 
E) Bar charts of plasma membrane annotated proteins with the lowest Benjamini-Hochberg adjusted p-
values commonly reduced from the cell surface in heterozygous and homozygous spastinN384K mutant 
MEFs – Bar charts of the 12 proteins plasma membrane annotated with the lowest HET-WT and HOM-
WT Benjamini-Hochberg adjusted p-values identified in Figure 3D were plotted. The chart axes show 
linear fold change relative to the mean WT peptide abundance. 
 
F) Analysis showing a common group of proteins increased at the cell surface in both heterozygous and 
homozygous spastinN384K MEFs – Two lists of plasma membrane annotated proteins with mean HET-
WT and mean HOM-WT fold change of >1.5 was generated and plotted in a Venn diagram. 
 
G) Heatmap showing common proteins increased at the cell surface in both heterozygous and 
homozygous spastinN384K MEFs – Methods as in Figure 3D, but with the heatmap displaying plasma 
membrane annotated proteins commonly increased at the cell surface >1.5 fold in both HET and HOM 
MEFs identified in Figure 3D. 
 
H) Bar charts of proteins with the lowest Benjamini-Hochberg adjusted p-values commonly increased at 
the cell surface in heterozygous and homozygous spastinN384K mutant MEFs – Bar charts of the 12 
plasma membrane annotated proteins with the lowest HET-WT and HOM-WT Benjamini-Hochberg 
adjusted p-values identified in Figure 3G were plotted. Chart maxima were set at a linear 6-fold 
increase, with samples exceeding these values denoted by having open bars. 
  




Gene Name Protein Function Reference Proteomics Results 
(Fold Change) 





Cfl1 Cytoskeletal rearrangement 
regulation 
Gohla, Birkenfeld, 










F11r Epithelial tight junction formation Itoh et al. 2001 Decrease – 
HET: 0.54 
HOM: 0.55 
Sfrp2 Modulator of Wnt signalling Jin et al. 2017 Decrease – 
HET: 0.18 
HOM: 0.24 
Bace1 Proteolytic processing of amyloid 
precursor protein 
Okada et al. 2010 Decrease – 
HET: 0.44 
HOM: 0.43 
Raet1e Natural killer cell cytotoxicity 
regulator 
Bacon et al. 2004 Decrease – 
HET: 0.50 
HOM: 0.20 
Ephb2 Ephrin-b receptor mediating 
synaptic transmission and 
plasticity 
Alapin et al. 2018 Decrease – 
HET: 0.26 
HOM: 0.36 
Thsd1 Nascent focal adhesion regulation Rui et al. 2017 Decrease – 
HET: 0.50 
HOM: 0.42 
Vcan Extracellular matrix assembly and 
cell adhesion regulation 





Ncstn Member of gamma secretase 
complex to process Notch and 
Wnt signalling receptors 
Yu et al. 2000 Decrease – 
HET: 0.46 
HOM: 0.42 
Npr2 Regulates axon bifurcation in 
dorsal root ganglion axons 





Table 1 - Common proteins depleted from the cell surface in HET and HOM spastinN384KMEFs. The proteins 
described are the proteins listed in Figure 3E. 
  




Gene Name Protein Function Reference Proteomics Results 
(Fold Change) 
Epha7 Brain development by modulating 
cell-cell adhesion and synaptic 
terminal stabilisation 





Piezo1 Mechanosensitive ion channel Lacroix, Botello-





Il1rap Regulation of T cell and mast cell 
immune response 
Ali et al. 2007 Increase – 
HET: 4.43 
HOM: 2.31 
Myh9 Myosin involved in cytoskeleton 
reorganisation and focal contact 
formation 
Pecci et al. 2018 Increase – 
HET: 1.86 
HOM: 2.77 
Erbb2 Regulates outgrowth and 
stabilisation of peripheral 
microtubules 

























Pcyox1 Processing of prenylated proteins Herrera-Marcos 




Lrrc8c Volume regulated anion channel Voss et al. 2014 Increase – 
HET: 2.00 
HOM: 1.53 
Hbegf Growth factor that functions in 
forebrain development 
Shim et al. 2016 Increase – 
HET: 2.17 
HOM: 2.86 
Slc4a2 Anion exchanger Coury et al. 2013 Increase – 
HET: 2.09 
HOM: 1.79 
Table 2 - Common proteins increased at the cell surface in HET and HOM spastinN384KMEFs. The proteins 
described are the proteins listed in Figure 3H. 
  




5.2.5 – Heterozygous and homozygous spastinN384K mutations drive alterations in focal adhesion 
pathways in MEFs 
Gene ontology analysis allows common subcellular localisations, molecular properties, or biological 
functions to be highlighted from a list of proteins. Gene ontology analysis using the DAVID resource 
(Huang et al. 2009b, 2009a) allowed the identification of cell surface pathways significantly affected 
by the spastinN384K mutation. From this analysis, only proteins involved in focal adhesions 
(GO:0005925) were highlighted as being significantly enriched in both HET and HOM samples (Figure 
4A). Analysis of HOM samples alone gave similar results to the HET and HOM samples combined (data 
not shown). 
 The fold change magnitude and variation for the focal adhesion identified proteins were 
examined across the samples from both mutant genotypes (Figure 4B). 22 proteins were identified as 
having annotations of both involvement in focal adhesions and plasma membrane annotations (4% of 
all plasma membrane proteins). However less than half of the identified proteins had strong fold 
changes compared to WT MEFs. 8 proteins with the largest fold changes were identified (Figure 4C). 
This showed the proteins Itgb5, Itga2, Flnb, and Flrt2 to have a greater than 1.5-fold increase in 
abundance at the cell surface in both mutant genotypes. Msn and Trpv4 were also reduced at the cell 
surface more than 1.5-fold in both mutant genotypes. 
  





Figure 4 - DAVID analysis reveals heterozygous and homozygous spastinN384K mutations to significantly alter the 
cell surface abundance of Wnt signalling and focal adhesion proteins in MEF. 
A) DAVID gene ontology analysis of proteins reduced <0.67 or increased >1.5 at the cell surface in both 
heterozygous and homozygous spastinN384K mutant MEFs – DAVID enrichment analysis was performed 
on proteins with a 1.5-fold increase or decrease in both spastinN384K mutant genotypes against a 
background of all plasma membrane identified proteins. 
 
B) Heatmap of all identified plasma membrane annotated focal adhesion proteins – The fold change of 
each sample relative to mean WT cell surface abundance was plotted for all plasma membrane 
annotated proteins annotated with the ‘Focal Adhesion’ (GO:0005925) term. Data was plotted on a log2 
scale, with maximum and minimum values set at 2 and -2 to aid data visualisation. Bold names indicate 
four proteins with a common increased/decreased abundance at the cell surface in both heterozygous 
and homozygous spastinN384K mutant MEFs. 
 
C) Bar charts of focal adhesion proteins commonly increased/decreased at the cell surface in 
heterozygous and homozygous spastinN384K mutant MEFs – Bar charts of four Focal Adhesion 
annotated proteins with an increased/decreased cell surface abundance in both heterozygous and 
homozygous spastinN384K mutant MEFs from Figure 4B were plotted. The chart axes show linear fold 
change relative to the mean WT peptide abundance 
  
DAVID Analysis Terms Benjamini-Adjusted P Value
Focal Adhesion (GO:0005925) 0.05
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5.2.6 – Primary cortical neuron plasma membrane proteomics selectively quantified cell surface 
proteins, showing the spastinN384K mutation to drive intergenotypic differences 
Having piloted the methods and analysis in an easily manipulable cell line, quantitative cell surface 
proteomics was next performed using primary embryonic cortical neurons from heterozygous and 
homozygous spastinN384K mutant mice. This allowed both a comparison with the MEF proteomic data 
and provided insight into a model system that better resembled the neuron-specific pathology of HSP. 
This allowed the identification of neuron-specific proteins that could be relevant to the axonal 
degeneration of HSP. 
 
The experimental protocol used was similar to that for the MEF proteomics. Primary cortical neurons 
were dissected from spastinN384K mutant E16 foetuses and grown in 10cm2 dishes for 14 days. Due to 
the current maximum of 11-plex TMT labelling, 4 WT, 3 HET, and 4 HOM samples were used. Samples 
were only used if they showed no signs of glial contamination or neurite fragmentation visible by light 
microscopy (Figure 5A). The experimental methodology also involved an addition step as labelled 
peptide samples were fractionated by strong cation exchange (SCX) fractionation. This allowed 
enhanced detection of low abundance proteins as it reduced the risk of masking by high abundance 
peptides. The resulting 6 fractions were analysed separately by mass spectrometry, and the output 
from all 6 runs was combined for final analysis (Figure 5B). 
 2009 proteins were quantified in total, a 2.4-fold increase compared the MEF proteomics data 
(Figure 5C). This was likely due to the increased sensitivity gained from the SCX fractionation. Of these 
proteins, 1125 (56%) were annotated with plasma membrane associated terms, 743 (37%) were 
annotated as being uniquely nuclear, and 141 (7%) were not categorised in either of these categories. 
Although the proportion of plasma membrane to nuclear proteins was lower than in the MEF data, 
this result is in line with other published TMT cell surface proteomics experiments that used 
fractionated samples (Weekes et al. 2014). However, the benefit of using this method was clear, as 
there was a 1.9-fold increase in the number of plasma membrane quantified proteins in the neuron 
proteomics compared to the MEF proteomics. Collectively, this indicated that the plasma membrane 
enrichment protocol had been successful. 
 
Hierarchical clustering of the 11 samples was performed. As before, this allowed an assessment of the 
validity of investigating the intergenotypic differences between the wildtype and spastinN384K mutant 
samples. For the most part there was good intragenotypic clustering, with 3 of the WT samples 
clustering, 2 of the HET samples clustering, and HOM samples either clustering with each other or with 




the HET samples (Figure 5D). Two samples, ‘HET2’ and ‘WT4’ did not cluster with any other samples 
apart from each other. As a result, these samples were excluded in all future analysis. The analysis 
also revealed the HET and HOM samples to preferentially cluster compared to the WT cluster. The 
‘HOM2’ sample was seen to cluster with the HET mutant cluster preferentially over the other HOM 
samples. Together, this suggests overall strong similarities between the cell surface proteome 
alterations driven by the two spastinN384K mutant genotypes. 
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Figure 5 - Overview of cell surface proteomics on WT (spastinwt/wt), HET (spastinwt/N384K), HOM (spastinN384K/N384K) 
primary cortical neurons. 
A) Microscopic imaging to verify the purity and health of the primary neuron cultures – Primary neuron 
samples were imaged using phase contrast microscopy 2 hours before cell surface biotinylation to verify 
a high purity of primary neurons. Phase contrast imaging was performed using a Thermo EVOS widefield 
microscope with a 20x/0.65NA objective. Scale bars indicate 100µm. 
 
B) Schematic of cell surface proteomic protocol – 4 WT, 3 HET, and 4 HOM primary neuron samples were 
grown for 14 days and their cell surface proteins biotinylated. Cells lysates were generated, and 
biotinylated proteins extracted using streptavidin pull down. Isolated proteins were washed extensively 
before being tryptically digested, with digested proteins from each sample labelled with a different 
Tandem Mass Tag (TMT) label. Labelled peptides were then combined before being fractionated using 
Strong Cation Exchange (SCX) peptide fractionation to generate 6 fractions of differing hydrophobicity. 
These 6 fractions were then run separately using Liquid Chromatography Tandem Mass Spectrometry 
with a rising gradient of MeCN for 180 minutes in a Thermo Orbitrap Fusion Lumos mass spectrometer. 
Obtained data was then pooled for analysis.  
 
C) Cell compartment analysis of identified proteins – All proteins identified from mass spectrometry 
analysis were annotated with their subcellular location by comparison against the mouse Uniprot 
(Swiss-Prot) subcellular location database. Plasma membrane terms were defined as annotations of 
‘plasma membrane’, ‘cell surface’, ‘cell membrane part’, ‘cell projection membrane’, and ‘extracellular’, 
with ‘nuclear’ annotations also recorded. If multiple annotations existed for any protein, they were 
given only one label of the first occurring term in the above list.  
 
D) Clustergram analysis showing intragenotypic and intergenotypic sample clustering – Peptide counts 
for each sample for each identified protein were normalised by the ratio of peptide counts for each 
sample summated over all proteins. These peptide counts were then normalised to the maximum 
peptide count for each protein, with the maximum value for each identified protein set to 1. A 
clustergram representing the hierarchical clustering of the protein set based on Euclidean pairwise 
distance analysis was generated with the heatmap showing samples by row, and individual proteins by 
column. The heatmap scalebar ranges from bright red (1) for the maximum quantified value to black 
(0), with dark regions showing fewer detected peptides. The clustergram shows both intragenotypic 
clustering for most samples, and that sample ‘HET2’ and ‘WT4’ fail to cluster with their respective 
genotypes. 
  




5.2.7 – Heterozygous and homozygous spastinN384K mutation drive significant changes in the cell 
surface proteome of primary cortical neurons 
As for the MEF proteomics, cell surface protein abundance changes in the spastinN384K mutant 
genotypes was assessed by plotting the mutant vs wildtype fold change for each protein against its 
adjusted p-value. This was done for both mutant genotypes including and excluding filtering for 
plasma membrane proteins. 
 
For the WT vs HET comparisons, no proteins had significantly increased or decreased cell surface 
abundance compared to the wildtype samples (Figure 6A). This result can be attributed to the 
exclusion of the ‘WT4’ and ‘HET2’ samples, resulting in t-tests with low statistical power due to the 3 
vs 2 sample comparison. Despite this, using the adjusted p-values provided a measure of sample 
variation and allowed the identification of proteins with large fold changes at the cell surface with low 
intersample variation. Ignoring the adjusted p-value and considering only plasma membrane 
annotated proteins, using a threshold of a 2-fold change, 15 proteins (1%) had an increased abundance 
at the cell surface, and 44 proteins (4%) had a decreased abundance at the cell surface. Selecting the 
highest changers with the lowest p-values, all the 12 highlighted proteins had at least a 2.5-fold 
increased or decreased abundance at the cell surface (Figure 6B). Overall, there was good consistency 
between the fold changes of HET and HOM spatinN384K neurons for the highlighted proteins (Figure 
6B). 
 The WT vs HOM comparison did not have the same sample number problem as the WT vs HET 
comparison, and there were a modest number of proteins with a significantly increased or decreased 
cell surface abundance compared to the wildtype condition (Figure 6C). Filtering for proteins that had 
at least a 2-fold change, a plasma membrane annotation, and an adjusted p-value of 0.01, 9 proteins 
(1%) had a decreased abundance at the cell surface, and only 1 protein had an increased abundance 
at the cell surface. When relaxing the criteria to a 1.5-fold fold change, 31 proteins (3%) had decreased 
cell surface abundance, and 11 proteins (1%) had increased cell surface abundance. Selecting the 
proteins with the most statistically significant fold changes, all the 12 highlighted proteins had at least 
a 2-fold increased or decreased abundance at the cell surface (Figure 6D). Overall there was good 
consistency between the mean fold changes of the HET and HOM spastinN384K mutant neurons, with 
very little intragenotypic variation (Figure 6D). 
 As for the MEF proteomics, plots were also produced for the HET and HOM mutant data 
without the filter of a plasma membrane annotation (Figure 6E and Figure 6F). Both plots show very 
similar distributions to their respective plasma membrane partners, and do not reveal any proteins 




without plasma membrane annotations to have both a very high fold change and statistical 
significance.  
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Figure 6 - Volcano plots reveal the changes in protein cell surface abundance driven by heterozygous and 
homozygous spastinN384K mutations in primary cortical neurons.  
A) Volcano plots showing changes in the cell surface abundance of plasma membrane annotated 
proteins driven by the heterozygous spastinN384K mutation – The mean HET vs mean WT peptide 
abundance for each plasma membrane protein was plotted against its Benjamini-Hochberg adjusted p-
value (generated from unpaired two-tail t-tests between HET vs WT samples). Due to poor hierarchical 
clustering, samples ‘WT4’ and ‘HET2’ were excluded from calculations, resulting in low overall statistical 
power. Fold change (x) was plotted on a log2 scale and adjusted p-value (y) plotted on a -log10 scale. 
Horizontal lines indicate p-values of 0.05 and 0.01 respectively, and vertical lines indicate fold changes 
of 0.5, 0.67, 1.5, 2 respectively. 6 proteins with the lowest p-value and less/more 0.5/2-fold change are 
named with bar charts plotted below.  
 
B) Bar charts of proteins with the largest cell surface increase/decrease driven by the heterozygous 
spastinN384K mutation – 6 plasma membrane annotated proteins with the largest HET-WT fold 
increase/decrease with the lowest HET-WT Benjamini-Hochberg adjusted p-values were selected, and 
the fold change relative to the mean WT peptide abundance for each sample was plotted for each 
protein. Due to poor hierarchical clustering, samples ‘WT4’ and ‘HET2’ were excluded. Chart axes show 
linear fold change. 
 
C) Volcano plot showing changes in the cell surface abundance of plasma membrane annotated proteins 
driven by homozygous spastinN384K mutations – The mean HOM vs mean WT peptide abundance for 
each plasma membrane protein was plotted against its Benjamini-Hochberg adjusted p-value 
(generated from unpaired two-tail t-tests between HOM vs WT samples). Due to poor hierarchical 
clustering, sample ‘WT4’ was excluded from calculations. 6 proteins with low p-values and low/high 
fold changes are named, with bold italic names given to proteins with plotted bar charts. Other chart 
details as in Figure 6A. 
 
D) Bar charts of proteins with largest cell surface increase/decrease driven by homozygous spastinN384K 
mutations – 6 plasma membrane annotated proteins with the largest HOM-WT fold increase/decrease 
with the lowest HOM-WT Benjamini-Hochberg adjusted p-values were selected, and the fold change 
relative to the mean WT peptide abundance for each sample was plotted for each protein. Due to poor 
hierarchical clustering, samples ‘WT4’ and ‘HET2’ were excluded. Chart axes show linear fold change.  
 
E) Volcano plot showing changes in the cell surface abundance of all detected proteins driven by the 
heterozygous spastinN384K mutation – As in Figure 6A but ignoring subcellular location annotations. 
 
F) Volcano plot showing changes in the cell surface abundance of all detected proteins driven by 
homozygous spastinN384K mutations – As in Figure 6C but ignoring subcellular location annotations. 
Only proteins with a p-value of lower than 0.01 and less/more 0.5/2-fold change are named. Grey text 
indicates non-plasma membrane annotated proteins. 
  




5.2.8 - Comparisons between heterozygous and homozygous spastinN384K mutant primary cortical 
neurons reveals proteins with common cell surface abundance changes 
Comparisons of the cell surface protein abundance changes from the HET and HOM spastinN384K 
primary cortical neuron proteomics were performed to analyse correlations in protein abundance. 
This was performed as described for the MEF proteomics. 
 
There was a remarkably strong positive correlation between the fold changes of the spastinN384K 
mutant genotypes filtered for plasma membrane annotated proteins (Figure 7A). This was also true 
when ignoring the subcellular localisation annotation (Figure 7B). Few dramatic outliers were revealed 
by the data, with the exception of the cell adhesion molecule Icam1 which had a fold reduction in both 
mutant genotypes far in excess of any other protein. Overall, the data contrasted sharply to the data 
distribution produced for the MEF proteomics data. This indicated a stronger intergenotypic 
consistency between the spastin mutants in the neuron data compared to the MEF data. Overall, this 
showed that the HET and HOM spastinN384K mutations drove similar size alterations in the cell surface 
proteome of cortical neurons. 
 
Cell surface proteins most dramatically affected by the spastinN384K mutation in both mutant 
genotypes were highlighted by focussing on plasma membrane annotated proteins with at least a 1.5-
fold change. 105 proteins (9%) were reduced more than 1.5-fold at the cell surface in both mutant 
genotypes (Figure 7C). This was 69% and 90% of all the plasma membrane proteins with a minimum 
fold change of 1.5 in the HET and HOM samples respectively. The 105 proteins showed a low 
intragenotypic and intergenotypic variation (Figure 7D). The proteins from this list with the most 
statistically confident fold changes include the cell adhesion molecule Bcam and Icam1 (Figure 7E). 
The functions of the 12 proteins with the most statistically significant reduction in their cell surface 
abundance (Figure 7E) were examined (Table 3 (located after Figure 7 figure legends)). This revealed 
two main groups of proteins: those involved in cell adhesion and migration, and those involved in 
neuronal signalling, development and survival (Table 3). 
 53 proteins (5%) had an increased cell surface abundance of more than 1.5-fold in both 
heterozygous and homozygous spastinN384K mutant genotypes (Figure 7F). These 53 proteins 
comprised 70% and 90% of all HET and HOM mutant primary neuron proteins increased at the cell 
surface respectively. With few exceptions, the 53 identified proteins showed low intragenotypic and 
intergenotypic variation between the mutant genotypes (Figure 7G). The overall magnitude of fold 
change was smaller for this group compared to their equivalents that were lost at the cell surface. 




Proteins from this list with the most statistically confidence cell surface abundance increases include 
the neurotransmitter regulating proteins Chrm1 and Slc6a11 (Figure 7H). Investigating the functions 
of the top 12 proteins with the most statistically significant increase at the cell revealed mostly 
neuron-specific proteins that were involved in cell adhesion and maintenance, synaptic transmission, 
and ion transport (Table 4 (located after Figure 7 legends)). 
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Figure 7 - Comparison between heterozygous and homozygous spastinN384K mutant primary cortical neurons 
reveal common proteins that have strong cell surface abundance changes in both genotypes. 
A) Scatter plot showing cell surface abundance fold change of heterozygous spastinN384K mutant primary 
cortical neurons against homozygous spastinN384K mutant primary cortical neurons for plasma 
membrane annotated proteins – The mean HET vs mean WT peptide abundance for each plasma 
membrane annotated protein was plotted against the mean HOM vs mean WT peptide abundance for 
the same protein. Fold change (x,y) was plotted on a log2 scale. Blue and cyan circles indicate proteins 
with both a HET-WT and HOM-WT fold change of <0.67/>1.5 and <0.5/>2 respectively. Proteins with 
both a HET-WT and HOM-WT fold change of <0.5/>2 are named within zoom panels. Due to poor 
hierarchical clustering, samples ‘WT4’ and ‘HET2’ were excluded from calculations. 
 
B) Scatter plot showing cell surface fold change of heterozygous spastinN384K mutant primary cortical 
neurons against homozygous spastinN384K mutant primary cortical neurons for all identified proteins 
– Methods as in Figure 7A but ignoring subcellular location annotations. Grey text within zoom panels 
indicates non-plasma membrane annotated proteins.  
 
C) Analysis showing a common group of proteins lost at the cell surface in both heterozygous and 
homozygous spastinN384K mutant primary cortical neurons – Two lists of plasma membrane annotated 
proteins with a mean HET-WT and mean HOM-WT fold change of <0.67 were generated and plotted in 
a Venn diagram. Due to poor hierarchical clustering, samples ‘WT4’ and ‘HET2’ were excluded from 
calculations. 
 
D) Heatmap showing common proteins lost at the cell surface in both heterozygous and homozygous 
spastinN384K primary cortical neurons – The fold change of each sample relative to the mean WT peptide 
abundance was calculated for each protein. The heatmap displays these values for plasma membrane 
annotated proteins commonly lost from the cell surface <0.67 fold in both HET and HOM primary 
cortical neurons identified in Figure 7C. Data was plotted on a log2 scale, with the maximum values set 
at 2 and -2 (equivalent to a 4-fold increase and a 0.25-fold decrease) to aid data visualisation. Bold 
names indicate the 12 proteins from the list with the lowest summed HET-WT and HOM-WT Benjamini-
Hochberg adjusted p-values. Due to poor hierarchical clustering, samples ‘WT4’ and ‘HET2’ were 
excluded. 
 
E) Bar charts of proteins with the lowest Benjamini-Hochberg adjusted p-values commonly lost from 
the cell surface in heterozygous and homozygous spastinN384K mutant primary cortical neurons – Bar 
charts of the 12 plasma membrane annotated proteins with the lowest summed HET-WT and HOM-WT 
Benjamini-Hochberg adjusted p-values identified in Figure 7C-D were plotted. Chart axes show linear 
fold change relative to the mean WT peptide abundance. Due to poor hierarchical clustering, samples 
‘WT4’ and ‘HET2’ were excluded.   
 
F) Analysis showing a common group of proteins gained at the cell surface in both heterozygous and 
homozygous spastinN384K mutant primary cortical neurons – Two lists of plasma membrane annotated 
proteins with mean HET-WT and mean HOM-WT fold change of >1.5 were generated and plotted in a 
Venn diagram. Due to poor hierarchical clustering, sample ‘WT4’ was excluded from calculations.  
 
G) Heatmap showing common proteins gained at the cell surface in both heterozygous and homozygous 
spastinN384K primary cortical neurons – Methods as in Figure 7D, but with the heatmap displaying 
plasma membrane annotated proteins commonly gained at the cell surface >1.5 fold in both HET and 








H) Bar charts of proteins with the lowest Benjamini-Hochberg adjusted p-values commonly gained at 
the cell surface in heterozygous and homozygous spastinN384K mutant primary cortical neurons – Bar 
charts of 12 plasma membrane annotated proteins with the lowest HET-WT and HOM-WT Benjamini-
Hochberg adjusted p-values identified in Figure 7F-G were plotted. Chart axes show linear fold change 
relative to the mean WT peptide abundance. Due to poor hierarchical clustering, samples ‘WT4’ and 
‘HET2’ were excluded.   
 
Gene Name Protein Function Reference Proteomics Results 
(Fold Change) 
Pdpn Functions in cell migration, 







Icam1 Endothelial cell adhesion during 
immune response 
Smith et al. 1989 Decrease – 
HET: 0.07 
HOM: 0.07 
Ngfr Neurotrophin receptor regulating 
axonal health 





Brinp3 Bone morphogenic protein 
inducible inhibition of neuronal 
proliferation 













Itga8 Integrin functioning cell 
mediation of cell-cell interaction, 
cell recruitment, and neurite 
outgrowth regulation 





Bcam Laminin receptor functioning in 
cell adhesion 
Udani et al. 1998 Decrease – 
HET: 0.31 
HOM: 0.34 
Nrp2 Regulates axon bifurcation in 
dorsal root ganglion axons 





Ache Terminates signal transduction at 







Lamc1 Laminin that mediates cell 







Prom1 Regulation of cell differentiation 
and proliferation, and regulation 
of neurite extension 





Itgb5 Integrin involved in cell adhesion, 







Table 3 - Common proteins depleted from the cell surface in HET and HOM spastinN384K primary cortical 
neurons. The proteins described are the proteins listed in Figure 7E. 
  




Gene Name Protein Function Reference Proteomics Result 
(Fold Change) 








Cacna2d1 Voltage dependent calcium 
channel 
Gao et al. 2000 Increase – 
HET: 1.58 
HOM: 1.68 





Slc8a2 Sodium/calcium exchanger 
protein crucial in synaptic 
plasticity, learning and memory 




exchanger crucial in nervous 
impulse termination 





Nptn Homophilic cell adhesion protein 
important for long-term 
potentiation of synapses 





Acvr1 Activin receptor that mediates 
Bone Morphogenic Protein 
signalling for development and 
repair 





Rtn4rl2 Nogo receptor that inhibits 
neurite outgrowth, and dendrite 
spine and synapse formation, but 
facilitates axon migration 
Wills et al. 2012 Increase – 
HET: 1.76 
HOM: 1.66 
Kcnj10 Potassium channel associated 
with epilepsy 





Slc6a11 GABA transporter terminating the 
action of GABA at the synaptic 
cleft 





Npy1r Neuropeptide Y receptor that 
functions in stress, pain 
perception and circadian rhythm 
control 
Tatemoto 2004 Increase – 
HET: 1.67 
HOM: 1.74 
Flrt3 Cell adhesion, cell migration, and 
axon guidance, mediating spatial 
organisation of neurons, and 
mediates neurite number and 
length 





Table 4 - Common proteins increased at the cell surface in HET and HOM spastinN384K primary cortical neurons. 
The proteins described are the proteins listed in Figure 7H. 
  




5.2.9 - Heterozygous and homozygous spastinN384K mutations drive alterations in cell adhesion and 
nervous system development pathways in primary cortical neurons 
DAVID gene ontology enrichment analysis was used to identify cell surface pathways that may be 
specifically affected by the spastinN384K mutation in primary neurons. Using a similar strategy to that 
described for the MEF proteomics, DAVID analysis was performed on proteins that had a 1.5-fold 
increase or decrease at the cell surface in both mutant genotypes. This revealed an enrichment of 
proteins with annotations related to cell adhesion (GO:0007155) and nervous system development 
(GO:0007399; Figure 8A). 
 In total, 194 plasma membrane annotated proteins also had an annotation of being involved 
in cell adhesion (Figure 8B). Out of these, 22 proteins (11%) were identified with more than 1.5-fold 
increased abundance at the cell surface, and 13 proteins (7%) were identified with more than 1.5-fold 
decreased abundance at the cell surface. These high fold change proteins showed a low variability in 
fold change between samples intragenotypically and intergenotypically. Out of the top four proteins 
identified that had the highest statistically significant increase at the cell surface, all had at least a 2-
fold increased abundance in both mutant genotypes (Figure 8C). Likewise, of the top four proteins 
that had the highest statistically significant decrease at the cell surface, all had at least a 2-fold 
reduction in cell surface abundance in both mutant genotypes. This group included Icam1 which was 
the protein identified with the largest fold change out of all analysed proteins. 
 DAVID analysis revealed 32 plasma membrane annotated proteins that were also annotated 
to be involved in nervous system development (Figure 8D). Out of these, 6 proteins (19%) had at least 
a 1.5-fold reduction in cell surface abundance, and 2 proteins (6%) had at least a 1.5-fold increase in 
cell surface abundance. These proteins showed a low variability in fold change intragenotypically and 
intergenotypically. The top 4 proteins with the most statistically significant increase and decrease at 
the cell surface are presented in Figure 8E.






WT1 WT2 WT3 HET1HET3 KI1 KI2 KI3 KI4
Identified Cell Adhesion Pathway Genes
DAVID Analysis Terms Benjamini-Adjusted P Value
Cell Adhesion (GO:0007155) 0.014
Nervous System Development (GO:0007399) 0.026
Identified Nervous System Develpment Genes
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Figure 8 - DAVID analysis reveals heterozygous and homozygous spastinN384K mutations to significantly alter the 
cell surface abundance of cell adhesion and nervous system development proteins in primary cortical neurons. 
A) DAVID gene ontology analysis of proteins reduced <0.67 or increased >1.5 at the cell surface in both 
heterozygous and homozygous spastinN384K mutant primary cortical neurons – DAVID enrichment 
analysis was performed on proteins with a 1.5-fold increase or decrease in both spastinN384K mutant 
genotypes against a background of all plasma membrane identified proteins. 
 
B) Heatmap of all identified plasma membrane annotated cell adhesion proteins – The fold change of 
each sample relative to mean WT cell surface abundance was plotted for all plasma membrane 
annotated proteins annotated with the ‘cell adhesion’ (GO:0007155) term. Data was plotted on a log2 
scale, with maximum and minimum values set to 2 and -2 to aid data visualisation. Bold names indicate 
four proteins with a common increased/decreased abundance at the cell surface in both heterozygous 
and homozygous spastinN384K mutant primary cortical neurons.  
 
C) Bar charts of focal adhesion proteins commonly increased/decreased at the cell surface in 
heterozygous and homozygous spastinN384K mutant primary cortical neurons – Bar charts of four focal 
adhesion annotated proteins with an increased/decreased cell surface abundance in both heterozygous 
and homozygous spastinN384K mutant primary cortical neurons from Figure 8B were plotted. The chart 
axes show linear fold change relative to the mean WT peptide abundance. 
 
D) Heatmap of all identified plasma membrane annotated nervous system development proteins – 
Methods as in Figure 8B, but with fold change of each sample relative to mean WT cell surface 
abundance plotted for all plasma membrane annotated proteins annotated with the ‘Nervous System 
Development’ (GO:0007399) term.  
 
E) Bar charts of nervous system development proteins commonly gained/lost at the cell surface in 
heterozygous and homozygous spastinN384K mutant primary cortical neurons – Methods as in Figure 
8C, but with bar charts were plotted of the four nervous system development annotated proteins with 
an increased/decreased cell surface abundance in both heterozygous and homozygous spastinN384K 
mutant primary neurons.  
  




5.2.10 – Comparisons between spastinN384K mutant MEFs and primary cortical neurons reveals 
proteins with common cell surface abundance changes in both cell types 
A comparison between the MEF and primary cortical neuron proteomics data was made to highlight 
proteins that had similar fold changes in both cell types. This would represent a set of proteins in 
which there was a very high confidence that their plasma membrane abundance was influenced by 
spastin. 366 plasma membrane annotated proteins were common to the MEF and neuron proteomics 
analysis. This represented 63% of the MEF plasma membrane proteomics data and 33% of the neuron 
plasma membrane proteomics data. 
 Focussing on proteins that were commonly reduced more than 1.5-fold from the cell surface, 
only 1 protein, Vcan, was reduced from the cell surface in all MEF spastin mutant samples and neuron 
spastin mutant samples (Figure 9A and Figure 9B). Vcan had low fold change variability between all 
the HET and HOM samples in both the MEF and neuron data (Figure 9C), with at least a 1.7-fold 
reduction in cell surface abundance in all samples. 7 proteins were identified when considering 
proteins that were more than 1.5-fold at the cell surface in 3/4 of the mutant samples (Figure 9B). The 
largest group of these was where these three sample types were the HOM MEFs, HET neurons, and 
HOM neurons. The function of the proteins with at least a 1.5-fold reduction in cell surface abundance 
in at least 3 mutant samples was investigated (Table 5 (located after Figure 9 legends)). This revealed 
a diverse set of proteins involved in ion transport, adhesion, and neuronal survival. 
 No plasma membrane annotated proteins had a greater than 1.5-fold increase in cell surface 
abundance in all 4 mutant samples (Figure 9D and Figure 9E). However, 4 proteins were identified 
that had more than a 1.5-fold increase at the cell surface in the HET MEFs, HET neurons, and HOM 
neurons grouping, and 4 identified in the HOM MEFs, HET neurons, and HOM neurons grouping 
(Figure 9E). Investigations into the functions of these proteins showed them to have a connection to 
neuronal health (e.g. Slitrk2, Flrt3, Unc5c), but also function in general cell maintenance (e.g. Pdgfra, 
Mertk) and transport across membranes (e.g. Slc7a11, Cacna2d1) as shown in Table 6 (located after 
Figure 9 legends). These proteins generally showed low fold change variability both intragenotypically 
and intergenotypically (Figure 9C). 
  
















+ + + + 1 Vcan
+ + + - 1 Slc11a2
+ + - + 0 -
+ - + + 1 Slc39a10
- + + + 5 Heg1, Got2, Gfra1, Anxa1, Calr
+ - + - 0 -
+ - - + 0 -
- + + - 3 Krt5, Slc29a1, Lypd6

































+ + + + 0
+ + + - 0
+ + - + 0 -
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Figure 9 - Comparisons between heterozygous and homozygous spastinN384K mutant MEFs and heterozygous and 
homozygous spastinN384K mutant primary cortical neurons reveal common proteins with cell surface abundance 
changes both cell types. 
A) Analysis showing the common groups of proteins reduced at the cell surface when comparing 
heterozygous/homozygous spastin mutant MEFs/primary cortical neurons – A list of proteins 
identified in both the MEF sample proteomics and the neuron sample proteomics was compiled. From 
this list, lists of plasma membrane annotated proteins with mean HE-WT and mean HOM-WT fold 
change <0.67 from both MEF and neuron data was generated and plotted in a Venn diagram. Due to 
poor hierarchical clustering, ‘WT4’ and ‘HET2’ from the neuron data set were excluded from 
calculations. 
 
B) Table showing the outcome of Figure 9A – The proteins determined from Figure 9A are identified in 
the table shown. Roman numerals correspond to areas defined in the heatmap (Figure 9C). 
 
C) Heatmap showing all plasma membrane proteins common to both MEF proteomics and neuron 
proteomics – The fold change of each sample relative to the mean WT peptide abundance was plotted 
for MEF and neuron samples, with the heatmap only displaying proteins with a plasma membrane 
annotation. Data was plotted on a log2 scale, with maximum/minimum values set at 2 and -2 (equivalent 
of a 4-fold increase and a 0.25-fold decrease) to aid data visualisation. Line markers and roman 
numerals indicate regions of proteins identified in Figure 9A,B,D,E. Bold names indicate highlighted 
proteins. Due to poor hierarchical clustering, ‘WT4’ and ‘HET2’ from the neuron data set were excluded. 
 
D) Analysis showing the common groups of proteins increased at the cell surface when comparing 
heterozygous/homozygous spastin mutant MEFs/primary cortical neurons – Methods as in Figure 9A, 
but lists of plasma membrane annotated proteins with mean HET-WT and mean HOM-WT fold change 
>1.5 from both MEF and neuron data was generated and plotted in a Venn diagram. 
 
E) Table showing the outcome of Figure 9D – The proteins determined from Figure 9D are identified in 
the table shown. Roman numerals correspond to areas defined in the heatmap (Figure 9C). 
  




Gene Name Protein Function Reference Proteomics Result 
(Fold Change) 
Vcan Extracellular matrix assembly and 




MEF HET: 0.46 
MEF HOM: 0.33 
Neuron HET: 0.49 
Neuron KI: 0.59 
Slc11a2 Divalent metal-ion transporter Mackenzie et al. 
2007 
Decrease – 
MEF HET: 0.52 
MEF HOM: 0.65 
Neuron HET: 0.67 
Neuron HOM: 0.82 
Slc39a10 Zinc influx transporter Kagara et al. 
2007 
Decrease – 
MEF HET: 0.67 
MEF HOM: 0.92 
Neuron HET: 0.61 
Neuron HOM: 0.57 
Heg1 Regulation of endothelial cell-cell 
junctions for heart formation and 
blood vessels 
Kleaveland et al. 
2009 
Mixed – 
MEF HET: 1.51 
MEF HOM: 0.65 
Neuron HET: 0.66 
Neuron HOM: 0.68 
Got2 Long-chain free fatty acid uptake Zhou et al. 1998 Decrease – 
MEF HET: 1.07 
MEF HOM: 0.39 
Neuron HET: 0.50 
Neuron HOM: 0.65 
Gfra1 Receptor for glial cell line-derived 
neurotrophic factor that functions 
in neuronal survival and 
differentiation 
Konishi et al. 
2014 
Mixed – 
MEF HET: 6.64 
MEF HOM: 0.49 
Neuron HET: 0.57 
Neuron HOM: 0.56 
Anxa1 Regulator of immunity by actin 
cytoskeleton rearrangement 
D’Acquisto et al. 
2007 
Mixed – 
MEF HET: 1.23 
MEF HOM: 0.67 
Neuron HET: 0.41 
Neuron HOM: 0.38 
Calr Chaperone to promote protein 





MEF HET: 0.56 
MEF HOM: 0.60 
Neuron HET: 0.56 
Neuron HOM: 0.60 
Table 5 - Common proteins reduced at the cell surface in HET and HOM spastinN384K MEFs and primary cortical 
neurons, or from 3/4 of these categories. The proteins described are the proteins listed in Figure 9B. 
  




Gene Name Protein Function Reference Proteomics Result 
(Fold Change) 
Slitrk2 Promotes excitatory synapse 
differentiation and supresses 
neurite outgrowth 
Beaubien et al. 
2016 
Mixed – 
MEF HET: 4.04 
MEF HOM: 0.41 
Neuron HET: 1.55 
Neuron HOM: 1.58 
Slc7a11 Anionic amino acid transporter Gasol et al. 2004 Mixed – 
MEF HET: 1.80 
MEF HOM: 0.91 
Neuron HET: 2.00 
Neuron HOM: 2.10 
Pdgfra Tyrosine-protein kinase essential 
in regulation of embryonic 
development, cell proliferation 
and survival 
Vantler et al. 
2006 
Increase – 
MEF HET: 1.56 
MEF HOM: 1.11 
Neuron HET: 2.92 
Neuron HOM: 3.18 
Unc5c Netrin receptor required in axonal 
guidance in the corticospinal tract 
Finger et al. 
2002 
Increase – 
MEF HET: 1.56 
MEF HOM: 1.40 
Neuron HET: 1.63 
Neuron HOM: 1.51 
Cacna2d1 Voltage dependent calcium 
channel 
Gao et al. 2000 
 
Increase – 
MEF HET: 1.02 
MEF HOM: 3.04 
Neuron HET: 1.58 
Neuron HOM: 1.68 
Acvr1 Activin receptor that mediates 
Bone Morphogenic Protein 
signalling for development and 
repair 
Kishigami et al. 
2004 
Mixed – 
MEF HET: 0.96 
MEF HOM: 1.91 
Neuron HET: 1.38 
Neuron HOM: 1.28 
Flrt3 Cell adhesion, cell migration, and 
axon guidance, mediating spatial 
organisation of neurons, and 
mediates neurite number and 
length 
Tsuji et al. 2004 Mixed – 
MEF HET: 0.97 
MEF HOM: 1.54 
Neuron HET: 2.00 
Neuron HOM: 1.75 
Mertk Tyrosine-protein kinase essential 
for maintenance and survival of a 





MEF HET: 1.07 
MEF HOM: 1.50 
Neuron HET: 1.67 
Neuron HOM: 1.56 
Table 6 - Common proteins increased at the cell surface in HET and HOM spastinN384K MEFs and primary cortical 
neurons, or from 3/4 of these categories. The proteins described are the proteins listed in Figure 9E. 
  




5.2.11 – Comparison between spastinN384K mutant MEFs/primary cortical neurons with SNX17 and 
SNX27 depletion data reveals proteins with common cell surface abundance changes in plasma 
membrane recycling 
Previous experiments have been performed investigating the effect of depletion of retromer and 
retriever cargo recruitment components on the cell surface proteome (McNally et al. 2017; Steinberg 
et al. 2013). By comparing the spastin mutation data to the SNX17 or SNX27 depletion data, it could 
provide clues as to which recycling pathways the spastinN384K mutation could be affecting.  
It should be noted that whilst similarities may be revealing, a lack of similarity would be hard 
to interpret. This is as a result of several factors: 1) the SNX17 and SNX27 proteomic experiments were 
performed using a different peptide labelling method, namely SILAC rather than TMT; 2) the SNX17 
and SNX27 experiments were performed using a different cell type and species (HeLa rather than MEFs 
or neurons); and 3) the effect of the spastin mutation is likely to affect the endocytic pathway more 
generally than by just blocking endocytic recycling (as discussed in Chapter 5 Introduction – Section 
5.1.1). 
The SNX17 depletion data set was obtained from McNally et al. (2017). Proteins from this 
dataset were only included in the comparison if they were identified in at least two of the SNX17 
depletion cell surface proteome SILAC experiments. The SNX27 depletion data set was obtained from 
Steinberg et al. (2013). Unlike the SNX17 dataset, the full proteomics results were not publicly 
available, with the data presented already pre-filtered to a threshold fold change of 1.4-fold, and with 
a subcellular localisation annotation of ‘integral membrane proteins’. It is unclear to what degree the 
difference in subcellular localisation annotation made to the comparison. For both imported datasets, 
proteins were annotated using the same subcellular localisation annotation methodology as for the 
MEF and neuron data sets. For the comparisons between the MEF or neuron data and the SNX17 or 
SNX27 depletion data, proteins were only included if were annotated with a plasma membrane 
annotation and were identified in both datasets being compared. 
 
  




MEF vs SNX17 
211 plasma membrane annotated proteins were identified in both the spastinN384K mutant MEF data 
and the SNX17 siRNA depletion HeLa data. This represented 37% of MEF plasma membrane annotated 
data and 44% of SNX17 plasma membrane annotated data.  
When filtering proteins by a threshold 1.5-fold change in cell surface abundance, only 2 
proteins, Ephb2 and Lama4 showed more than a 1.5-fold reduction from the cell surface in both HET 
and HOM MEFs and the SNX17 depletion data (Figure 10A and Figure 10B). However, there were 
substantially more proteins identified when filtering for proteins that showed a reduction of more 
than 1.5-fold in only one of the MEF data sets and the SNX17 data (Figure 10A and Figure 10B). On 
average, these proteins showed a considerable reduction in abundance at the cell surface, and a low 
fold-change variation between the samples (Figure 10C). Investigations into the functions of these 
proteins revealed functions in ion and substrate transport, migration and cell adhesion, receptor 
signalling, and neuronal development and maintenance (Table 7 (located after Figure 10 legends)). 
 For plasma membrane annotated proteins that had an abundance of more than 1.5-fold at 
the cell surface in both the HET and HOM MEF datasets and the SNX17 depletion, only 1 protein, Gas1, 
was identified (Figure 10D and Figure 10E). Furthermore, when relaxing this threshold to including 
any proteins identified in either the HET or HOM MEF data and the SNX17 data, only 1 additional 
protein was identified, Gnai2 (Figure 10D and Figure 10E). Of these proteins, Gas1 showed a high fold 
change variability, but Gnai2 showed a consistent level of fold change between samples (Figure 10C). 
These proteins were identified to function in development and proliferation (Table 8 (located after 
Figure 10 legends)). 
 
Neurons vs SNX17 
258 plasma membrane annotated proteins were identified in both the neuron and SNX17 depletion 
proteomic analyses. This represented 24% of the neuron plasma membrane annotated data and 54% 
of the SNX17 plasma membrane annotated data. 
 When filtering proteins by a threshold 1.5-fold change, 13 proteins were reduced more than 
1.5-fold from the cell surface in both HET and HOM neuron data sets, and the SNX17 data (Figure 10F 
and Figure 10G). 8 additional proteins were identified when relaxing the filtering criteria to proteins 
reduced more than 1.5-fold in either the HET or HOM neuron data and the SNX17 data (Figure 10F 
and Figure 10G). These proteins showed a high homogeneity of fold change across all samples (Figure 




10H). The functions of these identified proteins were investigated, revealing proteins involved in 
neuronal survival, immune activation, and cell adhesion (Table 9 (located after Figure 10 legends)). 
 No proteins had increased cell surface abundance in both the neuron proteomics and the 
SNX17 data. One potentially explanation for this was the heavy bias of the SNX17 depletion data 
towards proteins with reduced rather than increased abundance at the cell surface (Figure 10C and 
Figure 10H). 
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Ak2, Pkm, Actn4, Hspa8, Slc29a1, Flnaiii
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Figure 10 - Comparisons between heterozygous and homozygous spastinN384K mutant MEFs/neurons and SNX17 
siRNA depleted HeLa cells reveal proteins that have common cell surface abundance changes.  
A) Analysis showing the common proteins reduced at the cell surface when comparing heterozygous 
and homozygous spastinN384K mutant MEFs and SNX17 siRNA depleted HeLa cells from McNally et al. 
(2017) – A list of proteins identified in both the MEF sample proteomics and the published SNX17 siRNA 
depleted HeLa cell proteomics was compiled. From this list, lists of plasma membrane annotated 
proteins with mean HET-WT, mean HOM-WT, and mean Medium/Heavy ratios fold change of <0.67 
were generated and plotted in a Venn diagram. ‘SNX17 KD’ refers to SNX17 siRNA depleted cells. 
 
B) Table showing the outcome of Figure 10A – The proteins determined from Figure 10A are identified in 
the table shown. Roman numerals correspond to areas defined in the heatmap (Figure 10C).  
 
C) Heatmap showing all plasma membrane annotated proteins common to both MEF proteomics and 
SNX17 siRNA depleted HeLa cell proteomics from McNally et al. (2017) – The fold change of each 
sample relative to the mean WT peptide abundance was plotted for MEF samples, and for SNX17 siRNA 
KD samples the Medium/Heavy ratio for each independent experimental repeat was plotted. The 
heatmap only displays plasma membrane annotated proteins. Data was plotted on a log2 scale, with 
maximum/minimum values set at 2 and -2 (equivalent of 4-fold increase and a 0.25-fold decrease) to 
aid data visualisation. Where a protein was only identified in two independent experiments in the 
SNX17 siRNA depleted data set, the average of these values was displayed in the third SNX17 KD column 
to aid data visualisation. Line markers and roman numerals indicate regions of proteins identified in 
Figures 10A,B,D,E. Bold names indicate highlighted proteins. 
 
D) Analysis showing the common groups of proteins increased at the cell surface when comparing 
heterozygous and homozygous spastinN384K mutant MEFs and SNX17 siRNA depleted HeLa cells from 
McNally et al. (2017) – Methods as in Figure 10A, but lists of plasma membrane annotated proteins 
with mean HET-WT, mean HOM-WT, and mean Medium/Heavy ratios fold change of >1.5 were 
generated and plotted in a Venn diagram. 
 
E) Table showing the outcome of Figure 10D – The proteins determined from Figure 10D are identified in 
the table shown. Roman numerals correspond to areas defined in the heatmap (Figure 10C). 
 
F) Analysis showing the common proteins reduced at the cell surface when comparing heterozygous 
and homozygous spastinN384K mutant primary cortical neurons and SNX17 siRNA depleted HeLa cells 
from McNally et al. (2017) – A list of proteins identified in both the neuron sample proteomics and the 
published SNX17 siRNA depleted HeLa cell proteomics was compiled. From this list, lists of plasma 
membrane annotated proteins with mean HET-WT, mean HOM-WT, and mean Medium/Heavy ratios 
fold change of <0.67 were generated and plotted in a Venn diagram. ‘SNX17 KD’ refers to SNX17 siRNA 
depleted cells. 
 
G) Table showing the outcome of Figure 10F – The proteins determined from Figure 10F are identified in 
the table shown. Roman numerals correspond to areas defined heatmap in Figure 10H. 
 
H) Heatmap showing all plasma membrane annotated proteins common to both neuron proteomics and 
SNX17 siRNA depleted HeLa cell proteomics from McNally et al. (2017) – The fold change of each 
sample relative to the mean WT peptide abundance was plotted for neuron samples, and for SNX17 
siRNA KD samples the Medium/Heavy for each independent experimental repeat was plotted. The 
heatmap only displays plasma membrane annotated proteins. Data was plotted on a log2 scale, with 
maximum values set at 2 and -2 (equivalent to 4-fold increase and 0.25-fold decrease) to aid data 
visualisation. Where a protein was only identified in two independent experiments in the SNX17 siRNA 
depleted data set, the average of these values was displayed in the third SNX17 KD column to aid data 




visualisation. Line markers and roman numerals indicate proteins identified in Figures 10F,G,I,J. Bold 
names indicate highlighted proteins. 
 
I) Analysis showing the common proteins increased at the cell surface when comparing heterozygous 
and homozygous spastinN384K mutant primary neurons and SNX17 siRNA depleted HeLa cells from 
McNally et al. (2017) – Methods in Figure 10F, but lists of plasma membrane annotated proteins with 
mean HET-WT, mean HOM-WT, and mean Medium/Heavy ratios fold change of >1.5 were generated 
and plotted in a Venn diagram. 
 
J) Table showing the outcome of Figure 10I – The proteins determined from Figure 10I are identified in 




Gene Name Protein Function Reference Proteomics Results 
(Fold Change) 
Ephb2 Ephrin-b receptor mediating 
synaptic transmission and 
plasticity 






Lama4 Neuromuscular junction 
formation 






Ywhae Regulation of neurite formation 
during cortical development 






Itgb1 Integrin associating the cell and 
the extracellular matrix regulating 
processes such as migration and 
adhesion 















Lrp1 Myelin development, nerve 
conduction and axonal 
regeneration 




Fam129b Regulator of cell cycle progression 
by Ras activation 






Tfrc Facilities the uptake of iron van Renswoude 









Gene Name Protein Function Reference Proteomics Results 
(Fold Change) 















Antxr2 Necessary for cellular interactions 
with laminin and the extracellular 
matrix 











Efnb2 Ligand for ephrin receptors 
regulating migration and 
adhesion during development 








Crim1 Modulates bone morphogenetic 
protein activity 






Igsf3 Regulates axonal growth and 
branching during development 












Slc20a1 Sodium dependent phosphate 
transporter 








Heg1 Regulation of endothelial cell-cell 
junctions for heart formation and 
blood vessels 










Gene Name Protein Function Reference Proteomics Results 
(Fold Change) 
Anxa1 Regulator of immunity by actin 
cytoskeleton rearrangement 






Calr Chaperone to promote protein 
folding in the ER 






Table 7 - Common proteins reduced at the cell surface in HET and HOM spastinN384K MEFs and SNX17 depleted 
data from McNally et al. (2017), or from either a HET or HOM MEF data set and the SNX17 data. The proteins 
described are the proteins listed in Figure 10B. 
 
Gene Name Protein Function Reference Proteomics Results 
(Fold Change) 
Gas1 Promotes the formation of 
neurites and neuronal 
differentiation  
Bautista et al. 
2018 




Gnai2 Promotes epithelial cell 
proliferation 






Table 8 - Common proteins increased at the cell surface in HET and HOM spastinN384K MEFs and SNX17 depleted 
data from McNally et al. (2017), or from either a HET or HOM MEF data set and the SNX17 data. The proteins 
described are the proteins listed in Figure 10E. 
 
 
Gene Name Protein Function Reference Proteomics Result 
(Fold Change) 
Lamc1 Laminin that mediates cell 








Cd109 Modulates transforming growth 
factor beta 1 regulating cell 
survival 






Tnc Matrix protein regulating neuron 
migration, neural regeneration, 
neurite outgrowth, and synaptic 
plasticity 






Anxa1 Regulator of immunity by actin 
cytoskeleton rearrangement 










Gene Name Protein Function Reference Proteomics Result 
(Fold Change) 
Ilf2 Regulation of T cell activation Harashima, 
Guettouche, 





Enpp1 Regulation of pyrophosphate 
levels regulating purinergic 
signalling 






Cd81 Tetraspanin functioning in cell 
adhesion and immune cell 
activation 






Calr Chaperone to promote protein 
folding in the ER 






Ptgfrn Regulates the activity of 
prostaglandin F receptor that 
functions in endothelial cell 
network formation 






Sdc2 Regulation of dendritic initiation 
and elongation and arborisation 




Rala Multifunctional GTPase involved 
in integrin-dependant membrane 
raft exocytosis and in growth 
signalling 
Balasubramania





Bcap31 ER chaperone protein that 
recognises abnormally folded 
proteins and targets them for 
degradation 






Heg1 Regulation of endothelial cell-cell 
junctions for heart formation and 
blood vessels 






Table 9 - Common proteins reduced at the cell surface in HET and HOM spastinN384K primary cortical neurons 
and SNX17 depleted data from McNally et al. (2017), or from either a HET or HOM neuron data set and the 
SNX17 data. The proteins described are the proteins listed in Figure 10G. 
 
  




MEFs vs SNX27 
77 plasma membrane annotated proteins overlapped between the spastinN384K mutant MEF data and 
the SNX27 siRNA depletion HeLa data. This represented 13% of the MEF plasma membrane annotated 
data, and 73% of the SNX27 plasma membrane annotated data. 
 2 proteins were identified when filtering for proteins that had a 1.5-fold reduction in their 
abundance at the cell surface in both MEF data sets and the SNX27 data (Figure 11A and Figure 11B). 
These were Slc44a1 and Sco2a1. 9 addition proteins where identified when relaxing the filter to 
include proteins reduced more than 1.5-fold in either MEF mutant genotype and the SNX27 data. 
These 11 proteins showed a substantial reduction in cell surface abundance and low variation between 
samples (Figure 11C). These proteins were identified to function in ion and solute transport, receptor 
signalling, and lipid transport (Table 10 (located after Figure 11 legends)). 
 Only 1 protein, Itga2, was increased more than 1.5-fold in both MEF mutant genotypes and 
the SNX27 data (Figure 11D and Figure 11E). Two additional proteins, Sema4c and Flrt3, were 
identified by relaxing this criterion to include proteins identified in either mutant genotype and the 
SNX27 data. All three proteins showed a high level of fold change, and low variability between samples 
(Figure 11C). These proteins were identified to function in cell adhesion and migration, with Sema4c 
and Flrt3 particularly fulfilling these functions in neurons (Table 11 (located after Figure 11 legends)). 
 
Neurons vs SNX27 
73 plasma membrane annotated proteins overlapped between the spastinN384K mutant primary 
cortical neuron data and the SNX27 siRNA depletion HeLa data. This represented 7% of the plasma 
membrane annotated primary neuron data, and 69% of the plasma membrane annotated SNX27 data 
set. 
 5 proteins were reduced more than 1.5-fold in their cell surface abundance in both neuron 
data sets and the SNX27 data (Figure 11F and Figure 11G). Two additional proteins were also included 
when relaxing the filter to include proteins from only one of the mutant genotypes that were also 
found in the SNX27 data. There was very low intragenotypic and cell type variation between samples 
(Figure 11H). These proteins were identified to function in a diverse range of functions, including cell 
adhesion and dendritic initiation and elongation (Table 12 (located after Figure 11 legends)). 
 Only 1 protein, Flrt3, was increased more than 1.5-fold at the cell surface in either neuron 
dataset and the SNX27 data (Figure 11I and Figure 11J). Flrt3 functions in regulating neuronal 
interaction with its environment by mediating processes such as adhesion, axon guidance, and neurite 




number and length (Table 13 (located after Figure 11 legends)). Flrt3 had a good intragenotypic and 
intergenotypic fold change consistency in the spastin experiments, although the SNX27 results were 
more variable (Figure 11H). 
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Figure 11 - Comparisons between heterozygous and homozygous spastinN384K mutant MEFs/neurons and SNX27 
siRNA depleted HeLa cells reveal proteins that have common cell surface abundance changes.  
A) Analysis showing the common proteins reduced at the cell surface when comparing heterozygous 
and homozygous spastinN384K mutant MEFs and SNX27 siRNA depleted HeLa cells from Steinberg et 
al. (2013) – A list of proteins identified in both the MEF sample proteomics and the published SNX27 
siRNA depleted HeLa cell proteomics was compiled. From this list, lists of plasma membrane annotated 
proteins with mean HET-WT, mean HOM-WT, and mean Medium/Heavy ratios fold change of <0.67 
were generated and plotted in a Venn diagram. ‘SNX27 KD’ refers to SNX27 siRNA depleted cells. 
 
B) Table showing the outcome of Figure 11A – The proteins determined from Figure 11A are identified in 
the table shown. Roman numerals correspond to areas defined in the heatmap (Figure 11C).  
 
C) Heatmap showing all plasma membrane annotated proteins common to both MEF proteomics and 
SNX27 siRNA depleted HeLa cell proteomics from Steinberg et al. (2013) – The fold change of each 
sample relative to the mean WT peptide abundance was plotted for MEF samples, and for SNX27 siRNA 
KD samples the Medium/Heavy ratio for each independent experimental repeat was plotted. The 
heatmap only displays plasma membrane annotated proteins. Data was plotted on a log2 scale, with 
maximum/minimum values set at 2 and -2 (equivalent of 4-fold increase and a 0.25-fold decrease) to 
aid data visualisation. Where a protein was not identified in all independent experiments in the SNX27 
siRNA depleted data set, the average of these values was displayed in the empty SNX27 KD columns to 
aid data visualisation. Line markers and roman numerals indicate regions of proteins identified in 
Figures 11A,B,D,E. Bold names indicate highlighted proteins. 
 
D) Analysis showing the common groups of proteins increased at the cell surface when comparing 
heterozygous and homozygous spastinN384K mutant MEFs and SNX27 siRNA depleted HeLa cells from 
Steinberg et al. (2013) – Methods as in Figure 11A, but lists of plasma membrane annotated proteins 
with mean HET-WT, mean HOM-WT, and mean Medium/Heavy ratios fold change of >1.5 were 
generated and plotted in a Venn diagram. 
 
E) Table showing the outcome of Figure 11D – The proteins determined from Figure 11D are identified in 
the table shown. Roman numerals correspond to areas defined in the heatmap (Figure 11C). 
 
F) Analysis showing the common proteins reduced at the cell surface when comparing heterozygous 
and homozygous spastinN384K mutant primary cortical neurons and SNX27 siRNA depleted HeLa cells 
from Steinberg et al. (2013) – A list of proteins identified in both the neuron sample proteomics and 
the published SNX27 siRNA depleted HeLa cell proteomics was compiled. From this list, lists of plasma 
membrane annotated proteins with mean HET-WT, mean HOM-WT, and mean Medium/Heavy ratios 
fold change of <0.67 were generated and plotted in a Venn diagram. ‘SNX27 KD’ refers to SNX27 siRNA 
depleted cells. 
 
G) Table showing the outcome of Figure 11F – The proteins determined from Figure 11F are identified in 
the table shown. Roman numerals correspond to areas defined heatmap in Figure 11H. 
 
H) Heatmap showing all plasma membrane annotated proteins common to both neuron proteomics and 
SNX27 siRNA depleted HeLa cell proteomics from Steinberg et al. (2013) – The fold change of each 
sample relative to the mean WT peptide abundance was plotted for neuron samples, and for SNX27 
siRNA KD samples the Medium/Heavy for each independent experimental repeat was plotted. The 
heatmap only displays plasma membrane annotated proteins. Data was plotted on a log2 scale, with 
maximum values set at 2 and -2 (equivalent to 4-fold increase and 0.25-fold decrease) to aid data 
visualisation. Where a protein was not identified in all independent experiments in the SNX27 siRNA 
depleted data set, the average of these values was displayed in the empty SNX27 KD columns to aid 




data visualisation. Line markers and roman numerals indicate proteins identified in Figures 11F,G,I,J. 
Bold names indicate highlighted proteins. 
 
I) Analysis showing the common proteins increased at the cell surface when comparing heterozygous 
and homozygous spastinN384K mutant primary neurons and SN27 siRNA depleted HeLa cells from 
Steinberg et al. (2013) – Methods in Figure 11F, but lists of plasma membrane annotated proteins with 
mean HET-WT, mean HOM-WT, and mean Medium/Heavy ratios fold change of >1.5 were generated 
and plotted in a Venn diagram. 
 
J) Table showing the outcome of Figure 11I – The proteins determined from Figure 11I are identified in 






Gene Name Protein Function Reference Proteomics Results 
(Fold Change) 












Atp11c Transport of aminophospholipids 
between leaflets of the plasma 
membrane 


















Crim1 Modulates bone morphogenetic 
protein activity 






Adrb2 Adrenergic receptor mediating 
responses to adrenaline 
















Gene Name Protein Function Reference Proteomics Results 
(Fold Change) 




Heg1 Regulation of endothelial cell-cell 
junctions for heart formation and 
blood vessels 






Tmem30a Transport of aminophospholipids 
between leaflets of the plasma 
membrane  




Table 10 - Common proteins reduced at the cell surface in HET and HOM spastinN384K MEFs and SNX27 depleted 
data from Steinberg et al. (2013), or from either a HET or HOM MEF data set and the SNX27 data. The proteins 
described are the proteins listed in Figure 11B. 
 
Gene Name Protein Function Reference Proteomics Results 
(Fold Change) 
Itga2 Integrin that allows the binding of 
collagen functioning in cell 
attachment and migration 




Sema4c Semaphorin that functions in 
axonal guidance and 
development 




Flrt3 Cell adhesion, cell migration, and 
axon guidance, mediating spatial 
organisation of neurons, and 
mediates neurite number and 
length 




Table 11 - Common proteins increased at the cell surface in HET and HOM spastinN384K MEFs and SNX27 
depleted data from Steinberg et al. (2013), or from either a HET or HOM MEF data set and the SNX27 data. 
The proteins described are the proteins listed in Figure 11E. 
  




Gene Name Protein Function Reference Proteomics Result 
(Fold Change) 
Bcam Laminin receptor functioning in 
cell adhesion 




Ptgfrn Regulates the activity of 
prostaglandin F receptor that 
functions in endothelial cell 
network formation 






Sdc2 Regulation of dendritic initiation 
and elongation and arborisation 




Itgb5 Integrin involved in cell adhesion, 








Slc39a10 Zinc influx transporter Kagara et al. 
2007 




Table 12 - Common proteins reduced at the cell surface in HET and HOM spastinN384K primary cortical neurons 
and SNX27 depleted data from Steinberg et al. (2013), or from either a HET or HOM neuron data set and the 
SNX27 data. The proteins described are the proteins listed in Figure 11G. 
 
Gene Name Protein Function Reference Proteomics Result 
(Fold Change) 
Flrt3 Cell adhesion, cell migration, and 
axon guidance, mediating spatial 
organisation of neurons, and 
mediates neurite number and 
length 




Table 13 - Common proteins increased at the cell surface in HET and HOM spastinN384K primary cortical neurons 
and SNX27 depleted data from Steinberg et al. (2013), or from either a HET or HOM neuron data set and the 
SNX27 data. The proteins described are the proteins listed in Figure 11J. 
 
  




5.3 – Discussion 
5.3.1 – Summary of results 
Quantitative cell surface proteomics was performed on MEFs and primary cortical neurons derived 
from a spastinN384K mutant mouse. This was done for two main reasons: 1) to investigate whether 
spastin loss of function would affect the plasma membrane protein landscape; 2) to identify a subset 
of proteins whose altered cell surface abundance could drive the axonopathy observed in spastin-HSP. 
 The cell surface proteomic experiments using MEFs and primary cortical neurons were 
technically successful. The protein abundance data showed the spastinN384K mutation to drive major 
changes in the cell surface protein landscape in both MEFs and primary cortical neurons in both 
heterozygous and homozygous genetic backgrounds. These changes were reflected in the substantial 
increased or decreased abundance of a large number of plasma membrane proteins. Moreover, 
performing the proteomics on primary cortical neurons allowed the successful identification of a 
subset of proteins whose changes in surface abundance could drive the axonal degeneration observed 
in spastin-HSP.  In addition, these experiments provided proof of concept that cell surface biotinylation 
coupled to quantitative TMT-labelling cell surface proteomics could be performed on neurons, as no 
previous experiments of this type had been performed.  
 
5.3.2 – Spastin loss of function drives major remodelling of the cell surface proteome 
Plasma membrane proteins are constantly at flux at the cell surface. Proteins are continually being 
removed from the plasma membrane by endocytic events but are also constantly being replaced. This 
replacement comes from either newly synthesised proteins, or proteins that are recycling back to the 
cell surface after having been internalised. 
 Disruption to either of these processes causes major changes to the typical cell surface protein 
landscape. Evidence for this includes proteomic experiments that have analysed the effect of 
disrupted endocytic cargo sorting on the cell surface proteome. Depletion of the retriever and 
retromer cargo adaptors, SNX17 and SNX27, both led to a substantial remodelling of protein 
abundance on the cell surface (McNally et al. 2017; Steinberg et al. 2013). Non-proteomics methods 
have also regularly shown alterations in protein abundance at the cell surface upon manipulation of 
the cell surface input or output pathways. Examples include the increased surface abundance of TfnR 
upon dynamin inhibition (Marks et al. 2001), or the decreased abundance of LDLR at the cell surface 
upon depletion of the CCC cargo sorting machinery component COMMD1 (Bartuzi et al. 2016). 




 Like SNX17, SNX27 or COMMD1, spastin plays an important function in the endocytic 
pathway. Spastin functions specifically to mediate the fission of endosomal recycling tubules (Allison 
et al. 2017). Loss of functional spastin causes impaired cargo recycling both from the endosome to the 
cell surface (e.g. TfnR; Allison et al. 2013), and to the TGN (e.g. CI-M6PR; Allison et al. 2017). This 
results in the mistrafficking of lysosomal hydrolases, and causes lysosomal abnormalities, such as 
increased lysosomal acidity, swelling, and the presence of an intralumenal substrate that had the 
appearance of undigested membrane (Allison et al. 2017). As a result of these disruptions to the 
endocytic pathway, it was predicted that the cells extracted from a spastin mouse expressing a 
functionally null AAA+ domain would also have a significantly altered plasma membrane proteome. 
 
These predictions were supported by the quantitative cell surface proteomic experiments. A 
substantial remodelling of the plasma membrane proteome was observed in spastinN383K MEFs and 
primary neurons from both heterozygous and homozygous backgrounds. This remodelling was in the 
form of substantial changes to the cell surface abundance of many proteins involved in a diverse range 
of biological functions. Proteins with both an increased and decreased surface abundance were 
observed in all the mutant samples, with many proteins having abundance changes in excess of either 
double or half their wildtype abundance. Gene ontology enrichment analysis identified cell adhesion 
proteins to have statistically significant changes in their cell surface abundance for both cell types. 
 
The proteomics data from the spastinN384K mutant MEFs showed a large number of cell surface 
proteins with a statistically robust increased or decreased surface abundance. This result was 
interesting in that impaired endosomal tubule has been directly identified in these cells (Chapter 3; 
Allison et al. 2017). It should be noted however that this correlation does not imply causality (as 
discussed below).  
Of further note from this MEF dataset was the substantial difference observed between the 
two spastin mutant genotypes. This difference was not manifested as a less extreme version of the 
homozygote equivalent samples, but rather as an equally strong effect on a largely different subset of 
proteins. This is surprising given that spastin-HSP is an autosomal dominant disease that almost 
certainly functions through loss of function haploinsufficiency (detailed in Introduction Section 1.3.4) 
and a similar phenomenon was not observed in neuronal data. Currently it is not clear why these 
differences arose, but they indicate that differing levels of functional spastin have different effects on 
protein trafficking to and from the cell surface in MEFs. 





As for the MEF proteomics, the surface proteomics performed on the primary cortical neurons also 
showed many proteins with statistically robust increased or decreased abundance at the cell surface. 
Unlike the MEF data however, these changes were similar irrespective of heterozygosity or 
homozygosity for the spastin mutant genotypes, with a very strong correlation between the 
abundance changes observed for almost all proteins between HET and HOM samples.  
This data is important for furthering our understanding of the disease mechanism of spastin-
HSP as it provides evidence that the axons that undergo degeneration in HSP likely have a highly 
atypical cell surface protein landscape. This is likely to impact many facets of the biology of these 
neurons, including their growth and development by changed abundance of receptor proteins, 
migration and adhesion by changes to protein such as integrins and cadherins, and signal transmission 
by changes to ion channel abundance. Both cell adhesion pathways and nervous system development 
related proteins were identified by gene ontology enrichment analysis as being significantly affected 
by the spastin mutation. A list of proteins whose altered cell surface abundance could have major 
implications for axonal health were identified and is presented below. In addition, the 1125 plasma 
membrane proteins identified are likely to represent a substantial part of the embryonic cortical 
neuronal plasma membrane proteome. 
 
  




5.3.3 – Spastin’s effect on the cell surface proteome is likely to come through multiple pathways 
How may spastin loss of function induce such large-scale changes in the protein landscape at the cell 
surface? As mentioned above, this could result from multiple functional effects on the endo-lysosomal 
pathway that are a consequence of failed endosomal tubule fission. These effects would include 
impaired endosomal recycling and altered lysosomal degradation. 
 Proteomic experiments that have quantified the effect of impaired endocytic cargo sorting on 
surface protein abundance have been published (McNally et al. 2017; Steinberg et al. 2013). These 
datasets provide a resource by which the MEF and neuron data can be cross-referenced to provide 
potential insight into the processes that may be disrupted by the spastinN384K mutation. A high amount 
of similarity between the MEF or neuron data and one or both of the SNX17 and SNX27 datasets may 
suggest that surface changes observed in spastin mutant cells were predominately due to direct 
impairment of endosome to plasma membrane recycling. However, little similarity was observed 
between either the MEF or neuron datasets and the SNX17 or SNX27 data sets. This was true when 
comparing proteins that either had increased or decreased abundance at the cell surface. In particular, 
this was evident when comparing proteins that had increased abundance at the cell surface, with 
almost no overlap between any of the datasets. One reason for this was that both the SNX17 and 
SNX27 datasets quantified many more proteins that had decreased rather than increased abundance 
at the cell surface (McNally et al. 2017; Steinberg et al. 2013). 
 
What may explain this lack of similarity? One reason may be cell type and species-specific differences. 
Both SNX17 and SNX27 depletion experiments were performed using human HeLa cells, whilst the 
spastin experiments were performed using mouse fibroblasts and neurons. Comparisons between the 
MEF and neuron datasets show the clear effect of cell type differences, with relatively few proteins 
showing similar fold changes between the two datasets.  
 However, this lack of similarity may also provide some insight into the complex consequence 
of spastin loss of function beyond a direct inhibition of endocytic recycling. For example, impaired 
lysosomal function as a result of lysosomal hydrolase mistrafficking may cause a backlog of undigested 
cargos in the endocytic system, further amplifying the direct impairment of endosome to plasma 
membrane recycling. Furthermore, lysosome dysfunction may impair related pathways such as 
autophagy. Autophagic pathways have an intimate association with the cell surface, with one example 
being that the plasma membrane can act as a source of membrane for autophagosome biogenesis 
(Pavel and Rubinsztein 2017). 




Spastin loss of function is likely to have implications beyond endocytosis which could also impact on 
protein abundance at the plasma membrane. As described in Introduction Section 1.3.5, spastin has a 
diverse set of cellular functions. These are likely to relate to spastin’s ability to remodel microtubules, 
either inducing new microtubule formation, increasing microtubule stability, or by severing 
microtubules (Vemu et al. 2018). Microtubules function in the long-range transport of organelles and 
vesicles, including during endocytosis (Renard et al. 2015), but also in secretion (Presley et al. 1997; 
Watson et al. 2005), although the experiments performed in this thesis do not support a secretion-
regulating function of spastin (Thesis Chapter 4). 
Spastin may impact protein abundance by directly affecting protein synthesis or degradation. 
A specific block or increased synthesis or degradation of some proteins could lead to their changed 
abundance on the cell surface. Lysosomal degradation is likely impaired upon spastin loss of function 
as mentioned above. Spastin has also been shown to be a repressor of transcription (Daftary et al. 
2011), although systemic analyses on this function of spastin have not been performed. In summary, 
it seems probable that the effect of spastin’s loss of function on the cell surface proteome results from 
complex interplay between many disrupted cellular pathways. 
 
5.3.4 – Identification of a subset of proteins whose changed surface abundance could contribute to 
the axonopathy of spastin-HSP 
Cell surface proteins are crucial for cellular health by mediating the interaction between a cell and its 
environment. This controls processes such as cell survival, proliferation, differentiation, nutrient 
uptake, ion exchange, migration and adhesion. Cell surface proteins with an aberrant increase or 
decrease in their surface abundance are therefore good candidates to drive the axonopathy observed 
in HSP. Top pathological candidates identified from the neuron proteomics were identified by their 
known functions. These are shown and described below (Table 14), with the reasoning behind their 
inclusion discussed below.  
  




Protein Name Protein Function Reference Neuron Proteomics 
Result (Fold Change) 
Itga8 Integrin functioning cell mediation 
of cell-cell interaction, cell 
recruitment, and neurite 
outgrowth regulation 
Denda et al. 1998 Decrease –  
Het:0.37 
KI: 0.36 
Tnc Matrix protein regulating neuron 
migration, neural regeneration, 
neurite outgrowth, and synaptic 
plasticity 





Erbb4 Central nervous system 
development and axonal guidance 





Ngfr Neurotrophin receptor regulating 
axonal health 





Prom1 Regulation of cell differentiation 
and proliferation, and regulation of 
neurite extension 





Brinp3 Bone morphogenic protein 
inducible inhibition of neuronal 
proliferation 





Sdc2 Regulation of dendritic initiation 
and elongation and arborisation 
Chen et al. 2011 Decrease – 
Het: 0.57 
KI: 0.54 
Rtn4rl2 Nogo receptor that inhibits neurite 
outgrowth, and dendrite spine and 
synapse formation, but facilitates 
axon migration 
Wills et al. 2012 Increase –  
Het: 1.76 
KI: 1.67 
Flrt3 Cell adhesion, cell migration, and 
axon guidance, mediating spatial 
organisation of neurons, and 
mediates neurite number and 
length 
Tsuji et al. 2004 Increase – 
Het: 2.00 
KI: 1.75 
Slitrk2 Promotes excitatory synapse 
differentiation and supresses 
neurite outgrowth 





Unc5c Netrin receptor required in axonal 
guidance in the corticospinal tract 
Finger et al. 2002 Increase – 
Het: 1.63 
KI: 1.51 
Icam1 Endothelial cell adhesion during 
immune response 
Smith et al. 1989 Decrease – 
Het: 0.07 
KI: 0.07 
Bcam Laminin receptor functioning in cell 
adhesion 
Udani et al. 1998 Decrease – 
Het: 0.31 
KI: 0.34 
Vcan Extracellular matrix assembly and 
cell adhesion regulation 
Damasceno et al. 
2016 
Decrease –  
Het: 0.49 
KI: 0.59 
Acvr1 Activin receptor that mediates 
Bone Morphogenic Protein 








Protein Name Protein Function Reference Neuron Proteomics 
Result (Fold Change) 
signalling for development and 
repair 
KI: 1.60 
Table 14 - Table showing the top pathological candidate proteins whose altered cell surface abundance could 
drive the axonopathy observed in spastin-HSP. Proteins were identified from the neuron proteomics based on 
their fold change and protein function. 
 
Itga8, Tnc, Erbb4 
One method of filtering proteins was analysing whether the proteins of specific pathways were 
especially altered in their cell surface abundance. This was performed using gene ontology analysis, 
and in spastin-mutant neurons revealed proteins functioning in cell adhesion and nervous system 
development. Both of these processes are essential for neuronal health, with focal adhesion proteins 
mediating essential neuronal processes such as neurite outgrowth (Ivins et al. 2000), axon arborisation 
(Kalil and Dent 2014), and axonal guidance (Bixby and Harris 1991), and nervous system development 
proteins essential to allow synapse formation and differentiation (Williams et al. 2010). The magnitude 
of change for some of these proteins was dramatic, with cell adhesion protein Itga8 and Tnc and 
nervous system development protein Erbb4 reduced more than 2.5-fold from the cell surface. 
 
Ngfr, Prom1, Brinp3, Sdc2, Rtn4rl2, Flrt3, Slitrk2, Unc5c 
Some proteins involved in neuronal maintenance and function were not identified by the gene 
ontology analysis. One example is the nerve growth factor receptor (Ngfr) which was reduced more 
than 2-fold from the cell surface in both spastin mutant genotypes. This protein is fundamental to 
neuronal health. It regulates the survival of sympathetic and sensory neurons during nervous system 
differentiation (Levi-Montalcini 1987), regulates axonal growth and synapse formation (Harrington 
and Ginty 2013), regulates the expression of ion channels (Zhang et al. 2005) and neurotransmitters 
and neuropeptides (Levi-Montalcini et al. 1975). Additionally, it has reported functions in regulating 
neuronal body size, and axonal and dendritic arborisation (Spillane et al. 2012). 
 Further examples of proteins important in neuronal health include the protrusion protein 
Prom1 and the bone morphogenetic protein inducible Brinp3, both of which regulate neuronal 
proliferation (Kawano et al. 2004; Takenobu et al. 2011), and both of which were reduced at the 
neuronal cell surface more than 2-fold in both mutant genotypes. Furthermore, the protein Sdc2 was 
reduced from the cell surface in both spastin-mutant genotypes and the SNX17 and SNX27 data and 
has been added to the shortlist due to its role in elongation and arborisation of dendrites (Chen et al. 
2011). 




 Looking at proteins with increased abundance at the cell surface potentially related to axonal 
degeneration, the Nogo receptor (Rtn4rl2) and Flrt3 present themselves as pathological candidates as 
both are important in the regulation of neurite outgrowth and axon guidance (Tsuji et al. 2004; Wills 
et al. 2012), with Flrt3 having an increase in abundance in mutant spastin samples and the SNX27 
proteomics. Additionally, the proteins Slitrk2 and Unc5c had increased cell surface abundance in both 
MEF and neuronal data sets, and, given their role in neurite outgrowth (Beaubien et al. 2016) and 
axonal guidance in the corticospinal tract (Finger et al. 2002), both are pathological candidates. 
 
Icam1, Bcam, Vcan 
Beyond this list, some proteins that do not have clear neuronal function are interesting candidates for 
further investigation. One set of examples are the cell adhesion proteins Icam1 (Smith et al. 1989) and 
Bcam (Udani et al. 1998). These had the largest reduction in their cell surface abundance of any of the 
quantified proteins in the neuronal dataset but have no known roles in neuronal health. On a similar 
theme, the adhesion protein Vcan (Damasceno et al. 2016) was reduced from the cell surface more 
than 1.5-fold in mutant genotypes from MEF and neuronal datasets. 
 
Acvr1 
Previous work on HSP has shown spastin depleted cells to have upregulated BMP signalling (Tsang et 
al. 2009). This has also been observed in cells and organisms with mutations in other HSP proteins 
such as atlastin-1 and spartin (Fassier et al. 2010; Nahm et al. 2013; Tsang et al. 2009; X. Wang et al. 
2007; Zhao and Hedera 2013). BMP signalling is important in neuronal health as it functions in nervous 
system development, neural proliferation, neural precursor cell commitment, and nervous system 
injury (Sabo et al. 2009). A disruption to any of these processes could potential give rise to the 
axonopathy of HSP. Given this, alterations in the surface abundance of activin receptor 1 (Acvr1 (a 
BMP signalling receptor)) are interesting, with the protein increased in its cell surface abundance in 
both spastin mutant neuron genotypes and homozygous spastin-mutant MEFs. 
 
  





One caveat to these experiments was that embryonic neurons were used for experimentation, whilst 
axonal degeneration in spastin-HSP affects adult neurons (Blackstone et al. 2011). Whilst embryonic 
neurons are the typical model used in neuronal cell biology experiments (Arbab et al. 2014), their use 
has the potential to skew results towards proteins involved in axonal development vs axonal 
maintenance. It is not clear how much overlap exists between these processes. However, substantial 
differences in neuron physiology between development and later stages has been reported, with one 
example being that the expression of the axonal sodium transport pump Atpb1b1 begins only 15 days 
after birth (Safronov et al. 1999). 
 This problem is not unique to studies of HSP and is a general problem affecting most research 
into adult-onset neurodegenerative diseases (Arbab et al. 2014). Even new strategies using neurons 
derived from adult IPSCs are unable to produce neurons with entirely the same characteristics as adult 
neurons (Ho et al. 2016). To help ensure that the neurons used in experimentation were as mature as 
possible, neurons were only used for experimentation after 14 days in vitro. Whilst not equivalent to 
adult neurons, these neurons have many of the characteristics of maturity, such as the development 
of dendritic spines that are required for synaptic connectivity and showing responsiveness to NMDA 
and AMPA neurotransmitters (Edwards et al. 2017). 
 
  




5.3.5 – Future aims 
Verification of cell surface abundance changes 
An important future experiment that needs to be performed is the validation of the cell surface 
abundance changes observed for proteins in Table 14. An effective low-to-medium throughput 
method of doing this would be to use flow cytometry with fluorescent antibodies specific to the 
extracellular epitopes of these proteins. 
 
Investigations into effects on the synthesis or degradation of proteins upon spastin loss of function 
One suggested cause of altered plasma membrane protein abundance was changes in the rate of 
proteins synthesis or degradation for specific proteins. One way of determining this is by looking at 
the total cellular protein abundance, irrespective of subcellular localisation. Changes in the total 
cellular protein abundance could indicate that the changes observed were caused in part by changed 
synthesis or degradation, in addition to other spastin related-causes. A further refinement would be 
to determine whether increases in total protein abundances are transcriptionally driven. 
 These experiments could be performed in an unbiased way by using both further proteomics 
and transcriptomics. Whole cell lysates labelled with TMT coupled with mass spectrometry could be 
used to obtain a quantitative representation of total cellular protein abundance, while a measure on 
the effect of spastin’s loss of function on protein synthesis could be obtained by performing whole 
transcriptome sequencing experiments (RNA-seq). This would provide an unbiased quantitative 
measure on the mRNA levels corresponding to each protein in wildtype and spastin mutant cells. 
Alternatively, the use of antibodies and western blotting could be used to determine the total cellular 
abundance for specific proteins, while quantitative real-time PCR experiments could be used to report 
specific transcript levels. 
 
Cell compartmentalisation assays 
Given the heterogenous anatomy of neurons, it is possible that different endocytic or secretory 
pathways dominate in different areas of the cell. For example, it has been previously described that 
neurons have accelerated pathways for neurotransmitter release at synapses (Fei et al. 2008; de Lange 
et al. 2003). To investigate this, a compartmentalised cell culture device could be used to separate 
somatodendrities from axons (Cheng et al. 2017), with each compartment then analysed by cell 
surface proteomics.  
 




Other HSP mouse models 
A further extension of the project would be to perform the cell surface proteomics on neurons 
extracted from mice mutated in other HSP genes. This would allow the production of a list of proteins 
whose cell surface abundance show similar alterations generally in HSP. These proteins would 
therefore be high priority candidates in the investigation into the causes of the axonopathy in HSP. 
Examples of existing HSP mice include the spartin knockout mouse (Renvoisé et al. 2012), and the 
REEP1 knockout mouse (Beetz et al. 2013), both of which develop the gait abnormalities typical of 
HSP. 
 
Neuron behaviour assays 
Assays could be designed which test the predicted effects that changes in the abundance of proteins 
in Table 14 would cause on neuron behaviour. For example, neurite length and arborisation could be 
tested by simple neuronal immunofluorescence staining and imaging, followed by well-established 
automated neuronal morphology analysis (Ferreira et al. 2014). Axonal guidance could be measured 
by using the stripe assay, which uses microscopy to measure the direction of axonal growth relative 
to the striped pattern of axonal guidance molecules (Knöll et al. 2007). Cell adhesion could be 
measured by polyacrylamide-traction force microscopy (Khalili and Ahmad 2015). This technique 
relies on adhesion and spreading of cells grown on polyacrylamide gels to create forces within the gel, 
leading to displacement of fluorescent beads within the gel. Measuring the displacement of these 
beads provides a metric of the cell adhesion properties of the cell. In the final analysis, proof of the 
involvement of a pathway in HSP pathogenesis would be to show that is it perturbed in vivo and that 
rescue of this perturbation improves axonal and gait phenotypes. The spastinN384K mouse would be an 
ideal tool for these experiments. 
 
  




Chapter 6 – Final Discussion 
 
6.1 – Overview 
In this thesis I have investigated the function of spastin in endosomal tubule fission (Chapter 3) and in 
cargo secretion from the ER (Chapter 4). I have also performed quantitative unbiased cell surface 
proteomics on MEFs and primary cortical neurons derived from ATPase defective spastin mutant mice, 
identifying a list of pathogenic candidate proteins whose cell surface abundance changes may drive 
HSP (Chapter 5). For each results chapter, I have provided a discussion that both integrates my 
research into the wider literature, and details future experiments that could be performed. In this 
Final Discussion, I will therefore discuss how these results further our understanding of the 
mechanisms underlying spastin-HSP pathogenesis. The topics discussed are: 1) the relationship 
between endosomal tubule fission and neurodegeneration; 2) whether pathology results directly from 
dysfunctional microtubule remodelling with endosomal tubule fission and lysosome defects merely 
epiphenomena; and 3) potential unknown functions of spastin. 
 
6.2 – The relationship between endosomal tubule fission and neurodegeneration 
I have shown in fibroblasts that spastin functions in the fission of endosomal recycling tubules. Two 
observations provide supporting evidence that spastin also has this function in neurons. Firstly, Allison 
et al. (2013) observed that spastin depletion in zebrafish neurons led to the formation of elongated 
SNX1 tubules which my works shows is indicative of a defect in tubule fission. Secondly, a suggested 
outcome of defective endosomal tubule fission is lysosomal dysfunction through the mistrafficking of 
lysosomal hydrolases, and lysosomal abnormalities were observed in both fibroblasts, in primary 
cortical neurons from spastinN384K mice, and in IPSC-derived neurons from spastin-HSP patients (Allison 
et al. 2017).  
 It is valid therefore to ask how a defect in endosomal tubule fission caused by dysfunctional 
spastin could result in the axonopathy observed in spastin-HSP. Although defects in spastin could 
affect neuronal health outside spastin’s role in endosomal tubule fission (discussed below), there are 
at least two major pathogenic consequences of defects in endosomal tubule fission. These are: 1) 
pathogenicity resulting from lysosome dysfunction, and 2) pathogenicity resulting from a remodelling 
of the cell surface proteome. It should be noted that these two potential causes of pathology may not 
be mutually exclusive. 




Endosomal tubule fission defects as a cause of lysosome-based neuropathology 
Inefficient endosomal tubule fission correlates with the defective endosome-to-Golgi trafficking of 
M6PR and the aberrant secretion of M6P-tagged lysosomal enzyme from the cell (Allison et al. 2017). 
Thus, receptor mistrafficking as a result of defective tubule fission likely explains some of the 
abnormalities observed in the lysosomes of spastin depleted or mutated cell lines and neurons. These 
abnormalities include an increase in lysosome size and acidity, and the lysosomal lumen containing 
abundant membrane whorls by electron microscopy that likely represent membrane substrate 
accumulation (Allison et al. 2017). It should be noted that similar phenotypes have also been 
associated with an increasing list of HSP proteins, including HSP components of the endolysosomal 
pathways such as strumpellin (Song et al. 2018), AP5 (Hirst et al. 2015), spastizin (Khundadze et al. 
2013), spatacsin (Boutry et al. 2018; Branchu et al. 2017; Renvoisé et al. 2014; Varga et al. 2015), ER-
shaping proteins such as REEP1 (Allison et al. 2017), and even the recently discovered mitochondrial 
HSP protein ATAD3A (Cooper et al. 2017). Collectively therefore, lysosome dysfunction is potentially 
a unifying mechanism of pathology, and not unique to spastin-HSP pathogenesis.  
 How may lysosome dysfunction cause neurodegeneration? One established possibility is 
through an impairment in autophagic flux (Ballabio 2009; Platt et al. 2012; Raben et al. 2009). 
Autophagosomes function in cells to facilitate the degradation of damaged organelles and toxic 
cytoplasmic protein aggregates. Once toxic cargos have been internalised, autophagosomes fuse with 
lysosomes (forming autolysosomes), allowing lysosomal hydrolytic enzymes to degrade lumenal 
substrates. Impaired lysosomal substrate degradation has been associated with defective autophagy 
through several mechanisms. Firstly, it has been shown that a lysosomal accumulation of undigested 
cholesterols inhibits the lysosomal SNARES that mediate lysosome-autophagosome fusion (Fraldi et 
al. 2010). This could result in an aberrant sequestration of autophagic machinery and membrane into 
degradation-incompetent autophagosomes. Secondly, an accumulation of ganglioside lipids has been 
shown to impair the reformation of lysosomes from autolysosomes (Boutry et al. 2018). Similarly, this 
would generate a backlog in the autophagic pathway, but by creating an imbalance between 
autophagosome and lysosome abundance. Importantly, impaired autophagic flux has been directly 
related to neurodegeneration by the decreased ability to clear cytotoxic protein aggregates or 
damaged organelles (Ashrafi et al. 2014; Gowrishankar et al. 2015; Hara et al. 2006; de Pablo-Latorre 
et al. 2012; Xie et al. 2015). To test this hypothesis, it will be important to examine whether IPSC-
derived neurons from spastin-HSP patients or derived primary cortical neurons from the spastin 
ATPase defective mouse have alterations in autophagy. 
 In addition to affecting autophagic flux, non-mutually exclusive alternative models have been 
proposed of how defective lysosomes can lead to neurodegeneration. These include increased 




metabolic stress as a result of sequestered metabolites (Platt et al. 2012), and an accumulation of 
toxic lipid droplets in the neuronal-support cells, astrocytes (Branchu et al. 2017). In addition, impaired 
lysosome fusion is also likely to result in a backlog in the endocytic pathway as well as in the autophagic 
pathway. This could sequester endocytic machinery in late endosomes that were unable to fuse with 
lysosomes, with this generating further pressure on the early endocytic sorting machinery through an 
increase in cargo that cannot be lysosomally degraded. This may exacerbate the effect of defective 
cargo transport generated through inefficient tubule fission by spastin dysfunction, with one potential 
outcome being a remodelling of proteins on the cell surface (discussed below). 
 An important test of the relationship between lysosome dysfunction and axonopathy will be 
to see whether improved lysosome function can rescue the effect of spastin mutation. One potential 
therapeutic candidate protein is the lysosomal biogenesis master regulator, transcription factor EB 
(TFEB). Upregulation of TFEB increases autophagic flux and the clearance of undigested lysosomal 
substrates in cellular models of the lysosomal storage Niemann-Pick disease (Martini-Stoica et al. 
2016; Wang et al. 2015). Studies on the increased activity of TFEB could therefore provide insight into 
the relevance of lysosome dysfunction on spastin-HSP neuropathology, and even a potential 
therapeutic route for spastin-HSP treatment. 
 
Endosomal tubule fission defects as a cause of cell surface proteome remodelling-based 
neuropathology 
Defective endosomal tubule fission is likely to induce a remodelling of the cell surface proteome. This 
may arise through a direct impairment of endosome to plasma membrane recycling, or through the 
wider consequences of lysosome dysfunction or other downstream effects on defective sorting away 
from the degradative compartment as described above. Through the use of quantitative cell surface 
proteomics in pathological-relevant primary cortical neurons expressing spastin with a non-functional 
ATPase, I have shown that cortical neurons have a significantly altered cell surface proteome and have 
identified a list of pathological candidates that could drive the axonopathy observed in spastin-HSP. 
Although it remains to be tested, it also probable therefore that mutations in other HSP proteins 
associated with the endolysosomal pathway would result in similar remodelling of the cell surface 
protein landscape. 
 How could changes in the abundance of identified proteins induce neurodegeneration? Cell 
surface proteins are crucial to facilitate the interaction between the neuron and its environment, and 
changes in this interaction could have substantial consequences on many facets of a cell’s typical 
function. Three potentially significant groups of proteins whose cell surface abundance changes may 




be pathogenic are highlighted below. Although this list is not exhaustive, and the cell surface 
abundance changes have not yet been validated, it provides an example of the range of neuronal 
defects that may be caused by plasma membrane remodelling at the neuronal cell surface. To validate 
their importance in spastin-HSP pathology, manipulations of each protein’s cell surface abundance or 
activity need to be made to see if this can rescue the axonal degeneration phenotype, with the spastin 
mouse model described previously being a suitable tool for this. 
One potentially significant protein that showed increased abundance on the cell surface was 
the BMP signalling receptor activin-1. Aberrant BMP signalling has been associated with spastin-HSP 
previously, with spastin identified as an inhibitor of BMP signalling (Tsang et al. 2009), with this 
recently shown to be specific to the M1 isoform of spastin in zebrafish (Jardin et al. 2018). BMP 
functions in neuronal development, dendritogenesis, motor axon targeting, in axonal repair after 
injury, and synaptic function, potentially by altering the stability of the cytoskeleton (Charron and 
Tessier-Lavigne 2007; Fassier et al. 2010; Jardin et al. 2018; O'Connor-Giles, Ho, and Ganetzky 2008; 
Sabo, Kilpatrick, and Cate 2009; Wang et al. 2007; Zhong and Zou 2014). The increased abundance of 
the BMP signalling receptor is likely to promote BMP signalling in neurons. Excessive activation of BMP 
signalling has been shown to result in the repression of myelin synthesis (Cate et al. 2010; Colak et al. 
2008; See et al. 2004), potential autoimmunity (Yoshioka et al. 2012), and defective motor neuron 
targeting (Jardin et al. 2018), although given the function of BMP signalling in cytoskeletal remodelling, 
excessive activation of BMP signalling may also affect axonal transport (Ellis et al. 2010; X. Wang et al. 
2007).  In particular, the function of BMP signalling in axonal transport seems particularly relevant to 
spastin-HSP, as axonal degeneration is characterised by degeneration of the furthest points of the 
axon and spastin KO mice show defective axonal transport of some cargos (Kasher et al. 2009). 
Investigations into defective BMP signalling in spastin-HSP neurons are therefore pertinent and could 
highlight potential druggable targets if the relationship between BMP signalling and spastin-HSP 
axonal degeneration was validated. 
 A second group of proteins that were altered in their cell surface abundance in mutant mouse 
neurons were proteins involved in cell adhesion. A change in neuronal cell adhesion has been 
implicated in neurodegeneration, for example in Alzheimer’s disease (Bao et al. 2015; Caltagarone et 
al. 2007). One mechanism of action is through disruption of synaptic junctions, with adhesion proteins 
critical to facilitate the formation synaptic scaffolds in synapse formation and synaptic plasticity 
(Washbourne 2004). However, it is also likely that the changed abundance of neuronal adhesion 
proteins may influence axonal guidance during development, or the retraction of the axon during 
axonal degeneration (Wang et al. 2012). 




 Finally, the change in the plasma membrane abundance of neurodevelopmental proteins such 
as neuronal growth factor receptor (Ngfr) may be significant to spastin-HSP pathology. For example, 
amongst other functions, NGF signalling is suggested to be neuroprotective after neuronal injury by 
preventing apoptosis (Lebrun-Julien et al. 2009; María Frade et al. 1996). In addition, the action of 
NGF can induce axonal regeneration by promoting axonal growth, with a lack of NGF directly 
associated with axonal degeneration (MacInnis and Campenot 2005). It is therefore potentially 
pathologically significant that a substantial decreased abundance of Ngfr in spastin-HSP cortical 
neurons was observed.  
 
Is the pathologically-relevant endosomal tubule fission reaction in the cell body or the axon? 
Spastin-HSP pathology is characterised by the distal degeneration of axons (Blackstone et al. 2011). 
However, it is currently not understood where defects in endosomal tubule fission occur in relation to 
the distal axon. Two potential non-mutually exclusive models are: 1) that endosomal tubule fission 
defects occur in the neuronal soma, resulting in directly affected (e.g. recycling endosomal tubules 
transport) or indirectly affected (e.g. hydrolytic lysosome transport) membrane cargo transport to the 
distal axon; 2) that endosomal tubule fission defects occur in situ at the axon tip, causing localised 
aberrations in the local axon environment. 
Experiments to differentiate between these two models have not yet been performed. 
However, the evidence that zebrafish lacking spastin have increased endosomal tubulation in axons 
(Allison et al. 2013), and that mammalian neurons do have SNX1 at the distal axon (Freeman et al. 
2013), suggests that endosomal tubule fission defects within the axon itself are possible. Example 
experiments to test this would involve the live cell imaging of endosomal tubule fission within the 
axons of neurons derived from wildtype and spastinN384K ATPase defective mice. However, this may be 
difficult technically, both in relation to the expression of cell markers of endosomal tubules in the 
axon, and in the resolution of individually endosomal tubule fission events in the narrow axon. An 
alternative approach could be to use super-resolution SIM microscopy in spastin depleted cells to see 
if endosomal tubules were elongated.  
 
  




6.3 – Are endosomal tubule fission defects merely a marker of microtubule defects and not directly 
related to disease pathology? 
As spastin regulates microtubules, a relevant question is whether it is simply defective axonal 
microtubule remodelling which drives spastin-HSP pathology, with defective endosomal tubule fission 
and lysosomal dysfunction only non-pathogenic epiphenomena. Indeed, spastin-mediated 
microtubule remodelling could directly drive many functions of spastin in neurons including axonal 
growth and pruning.  
 However, the data suggests that microtubule dysfunction in the axon alone is unlikely to 
completely explain the axonal degeneration of HSP. Studies of microtubules in the axons of spastin-
HSP neurons revealed few obvious differences along the length of the axon compared to wildtype cells 
(Fassier et al. 2013; Riano et al. 2009), although a systematic study of microtubule posttranslational 
modifications in the wildtype and spastin dysfunctional neurons has not yet been performed. In 
addition, whilst lysosome dysfunction has been associated with microtubule-related HSP proteins 
such as spastin, it has also been observed in mutations of HSP proteins with functions seemingly 
unrelated to microtubules, such as the mitochondrial HSP protein ATAD3A (Cooper et al. 2017). This 
suggests that lysosome dysfunction may be a true pathogenic convergence point in HSP. Furthermore, 
the many cell surface abundance changes identified from the cortical neuron proteomics are also very 
likely to have at least some pathogenic impact on the cell’s interaction with the environment. Thus, a 
likely scenario seems that defects in spastin’s microtubule-regulatory function underpin spastin-HSP, 
but the best pathological candidate amongst the many cell biological processes linked to this is 
lysosomal dysfunction and cell surface proteome remodelling caused by defective endosomal tubule 
fission. 
  




6.4 – Perspectives for further unknown functions of spastin 
Major progress has been made in our understanding of spastin since its initially discovery 19 years 
ago. Remarkably, new functions of spastin continue to be discovered suggesting that more functions 
may remain to be found. By homology to endosomal tubule fission, these may include fission of other 
tubular structures in the cell, with candidates including the fission of lysosomal tubules or 
autophagosomes from the ER membrane. Further investigations in spastin’s function will likely 
continue to use existing powerful tools such as the spastinN384K mouse coupled to high-resolution 
microscopy, proteomics and transcriptomics, but could also be supplemented by tools supplied by the 
combined developments in CRISPR and IPSC technology. Together, these approaches will eventually 
lead to a full understanding of spastin’s normal and pathological function in human neurons. Spastin 
research has progressed remarkably in ~20 years; it will be remarkable how it will have progressed in 
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